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I 
Riassunto  
 materiali peptidici basati sull’aggregazione di monomeri anfifilici 
rappresentano, allo stato dell’arte, piattaforme versatili per la 
moderna scienza dei materiali. Attraverso un appropriato design ed 
utilizzando metodologie di “bottom-up”, strutture supramolecolari 
ordinate possono essere generate spontaneamente grazie alla 
formazione di network di interazioni intra- ed inter-molecolari. La 
presenza di residui aromatici nella struttura primaria rappresenta un 
sostanziale e comune denominatore strutturale di questa variegata 
categoria di molecole.   
Il capostipite di questa classe di monomeri aromatici è l’omodimero di 
fenilalanina (Phe-Phe) che, grazie ad una combinazione di interazioni di 
stacking e di legami ad idrogeno, è in grado di auto-organizzarsi in 
morfologie estremamente varie, sia nella nano che nella microscala. Gli 
omodimeri di difenilalanina e i sui stretti omologhi hanno inoltre 
dimostrato peculiari caratteristiche fisiche (dal magnetismo alla 
piezoelettricità) che hanno consentito l’applicazione di tali sistemi nei 
campi dell’ottica e dell’elettronica. Tuttavia, la spiccata natura aromatica 
di tali molecole si traduce prevedibilmente in bassi valori di solubilità 
intrinseca in acqua, fattore quest’ultimo che ha limitato fortemente le 
prospettive di applicazione nel campo biomedico.  
Il presente progetto di dottorato in Scienza del Farmaco (XXX ciclo) ha 
avuto come scopo la progettazione e lo sviluppo di nuove 
nanopiattaforme basate su peptidi aromatici come sonde per l’imaging 
diagnostico, con particolare riferimento alle tecnologie MRI (Magnetic 
Resonance Imaging) e all’imaging in fluorescenza. Questo obiettivo è 
stato perseguito attraverso un approccio di design chimico razionale sui 
monomeri costituenti, inserendo opportune modifiche chimiche di 
sequenza (sostituzioni di residuo, utilizzo di aminoacidi non codificati, 
alternanza di residui, allungamento del framework amminoacidico) e 
funzionalizzazioni puntuali (inserzioni di catene PEG, decorazione con 
chelanti polidentati, complessazione di metalli di interesse diagnostico). 
La caratterizzazione e lo studio dei nuovi sistemi proposti è stata 
perseguita attarverso l’utilizzo di tecniche complementari. 
Nello specifico, la derivatizzazione di sequenze omopeptidiche (basate 
su fenilalanina e naftilalanina) con chelanti polidentati per la 
complessazione di ioni paramagnetici come lo ione Gd(III) ha portato 
allo sviluppo di una nuova classe di mezzi di contrasto T1 
supramolecolari per MRI. Come ampiamente dimostrato dalla 
caratterizzazione sia in soluzione che allo stato solido, i nuovi 
monomeri proposti si auto-organizzano in nanoarchitetture fibrillari con 
buoni valori di solubilità in acqua e struttura secondaria di tipo β-sheet 
antiparallelo. L’evidenza di un effettivo incremento del contrasto positivo 
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delle immagini e l’incapsulamento di molecole farmacologicamente 
attive apre prospettive di sviluppo di tali sistemi nel campo della 
medicina teranostica. 
L’aggregazione di sequenze di omo-fenilalanine (esaPhe PEGylate) in 
stabili materiali ricchi in β-sheet è risultata, inoltre, essere correlata a 
fenomeni di fotoluminescenza. Grazie all’incapsulamento o al 
confinamento di opportuni fluorofori come l’NBD (4-nitro-7-
clorobenzofurazano) ed attraverso fenomeni FRET, la 
fotoluminescenza intrinseca è stata spostata a più alte lunghezze 
d’onda (vicino infrarosso). L’incremento del numero di legami ammidici 
nella porzione PEG in una serie omologhi strutturali ha inoltre 
evidenziato un red- shift del picco di emissione intrinseco in funzione 
del numero di legami ammidici.  
Le possibili relazioni tra la sequenza chimica dei monomeri peptidici, 
l’organizzazione finale delle nanostrutture e le caratteristiche fisiche del 
materiale sono state esplorate attraverso la sintesi di analoghi di 
sequenza. Nel dettaglio, la parziale o totale sostituzione nella porzione 
peptidica dei residui di Phe con tirosina (Tyr) ha messo in luce la 
possibilità di ottenere idrogel peptidici con alti profili di biocompatibilità. 
L’analisi dell’organizzazione di omologhi di tetra-triptofano (W4) ha 
evidenziato l’importanza dei parametri sterici  nell’impacchettamento 
supramolecolare della struttura.  
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1.1 Bio-medical imaging: basic principles and techniques 
io-imaging or optical biological imaging is computer vision 
technology that takes advantage from artificial vision to acquire, 
capture, extract, process and present structural or functional 
images of bio-objects or bio-systems. Using a variety of 
equipment to extract information from biological samples, optical 
biological imaging is based on the optical contrast (in terms of light 
reflection, difference of transmission and fluorescence intensity) between 
the selected samples and the surrounding background region. During the 
last decades, medical imaging and microscope/fluorescence processing 
have been taken on a central rule referring to the methodologies used to 
produce images of the human body.1 These visualisation methods offer 
the useful advantage to allow a multidimensional analysis scale, from 
macroscopic anatomical areas, tissues, down to the microscopic cellular, 
intra-plasmatic and molecular levels (Figure 1). 
  
 
Figure 1: Multidimensional scale of a bio-imaging analysis, from anatomical 
sectors to organs, cells and organelles. 
 
Consequently, bio-medical imaging techniques have become ones of the 
most beneficial tools in healthcare science for the diagnosis and 
treatment of human pathological states. The evolution of bio-medical 
visualizing techniques from radioisotope imaging to more complex and 
sensible methodologies, such as Computer-Assisted Tomography (CAT 
scans), Magnetoencephalogram (MEG), Positron Emission Tomography 
(PET) and ultrasound imaging, has led to revolutionary improvements in 
the quality of healthcare available today.2 
However, the urgency of more accurate information about the early 
cellular and molecular pathological contexts explains clearly the need for 
extending deeply bio-imaging to these organization levels. This 
knowledge may support rapid detection, screening, diagnosis, and 
image-guided treatment of life-threatening diseases such as cancer, 
metabolic inborn errors and neurodegenerative diseases.  
B 
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Nanotechnology can help in this sense. Innovative nanomaterials (NMs) 
and nanostructured platforms (NPs) had and have a revolutionary and 
radical impact to the modern science and technology.3,4,5  
One of the important potential applications of nanoparticles is their use 
as tracer6, marker7 or contrast agents8 for in vitro and in vivo optical 
biological imaging. Indeed, nano-particles can offer a number of 
advantages, including tunable physical properties (e.g. luminescence 
and ferromagneticity), high stability (e.g. against photobleaching), 
possibility of targeted delivery, and specific binding via chemical 
functionalization, multimodality (ability to combine several functions in 
one particle), high sensitivity and selectivity.3,4,5  
A number of different limitations affects the currently used medical bio-
imaging techniques. Some of them regard the noxious effect of ionizing 
radiations (X-ray and CAT scan)9, the harmful effect of radioactivity (in 
radioscopic techniques)10, the low sensibility (e.g. MRI, Magnetic 
Resonance Imaging)11, the inability to provide resolution 
 smaller than millimetres (as reported for ultrasound imaging)12 and the 
general impossibility to distinguish between different pathological 
compartments (e.g. benign and malignant tumours).13 
Combining the traditional techniques with the new field of 
nanotechnology, NMs and NPs can help to overcome some of the 
previous reported limitations. For this, nanostructured materials became 
promising tools for a range of bio-imaging techniques.14  
Referring to the object of this PhD final thesis, applications of self-
assembly peptide-based materials (PBMs) will be delve into the Magnetic 
Resonance Imaging (MRI) for obtain T1 contrast agents and fluorescence 
imaging.  
With the aim of design and perfect innovative and potential bio-imaging 
nanoprobes and tracers, an initial comprehension of the physical basis 
of MRI, fluorescence and self-assembly is required.  
 
1.2 Magnetic Resonance Imaging and contrast agent 
Magnetic resonance imaging is a non-invasive medical diagnostic bio-
imaging procedure. This technique provides images by detecting tiny 
changes in the structures within the body. In many cases, MRI gives 
different information about structures in the body that cannot be seen with 
an X-ray, ultrasound, or CAT scan.  
MRI technology is based on the same principles of hydrogen nuclear 
magnetic resonance (1HNMR). Detectable signals are generated 
measuring parameters related to the relaxation of hydrogen nuclei of 
water exited by magnetic fields.15,16 An additional magnetic field in 
gradient allows retrieving the spatial information in order to obtain 3D 
images for MRI experiment. (Figure 2). 
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Figure 2: Schematic representation of MRI based physical phenomenon and 
its application in bio-imaging. 
 
Three parameters affect MRI acquisitions: proton density, longitudinal 
relaxation time (T1) and transverse relation time (T2). The variation in the 
proton density between tissues is not very relevant, so the pulse 
sequence that measures T1 and T2 provides the necessary contrast for 
diagnosis. Contrast agent (CAs) can enhance the quality of the images 
in terms of contrast, improving the sensitivity and specificity of MRI 
technique.17  
The CAs can be classified in two categories, T1 or T2, depending on the 
ratio between two specific parameters, longitudinal relaxivity (r1) and the 
transverse relaxivity (r2). T1 agent have an r2/r1 slightly higher than 1, give 
a positive contrast and are usually based on paramagnetic ions (primarily 
complexes of paramagnetic ions such as Gd, gadolinium)18, whereas T2 
agent have much higher (>10) ratios, give a negative contrast and are 
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based on superparamagnetic compound (especially superparamagnetic 
iron oxide, SPIOs).19  
The performance of a CA agent is evaluated by relaxivity parameter, R. 
Relaxivity described the efficacy of the contrast agent at 1mM 
concentration in changing the rate of water proton relaxation.20 The 
physical relaxation process is due to dipole-dipole interactions between 
the proton nuclear spins and the fluctuating local magnetic field that 
results from the paramagnetic or superparamagnetic metal center. 
 
1.2.1 Gadolinium based T1 CAs: efficiency analysis  
Gadolinium complexes are the most common paramagnetic compounds 
for obtain T1 CAs.  
Gadolinium (electron configuration: [Xe] 4f75d16s2, atomic number 64) is 
a silvery-white, malleable, and ductile rare earth metal. It is found in 
nature only in oxidized form, and even when separated, it usually has 
impurities of the other rare earths. Like most of the rare earths, Gd forms 
trivalent ions with fluorescent properties, and salts of Gd(III) are used as 
phosphors in various applications.  
Due to the high magnetic moment of the paramagnetic Gd3+ ion (with its 
seven unpaired electrons), the relaxation time of water molecules in the 
proximity of Gd3+ ions is greatly reduced and signal intensity is thereby 
enhanced (Figure 3). 
 
 
 
Figure 3: External electronical configuration of paramagnetic Gd3+ ions and 
their influence of water exchange rate (K). 
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The kinds of Gd(III) ions occurring in water-soluble salts are toxic to 
mammals.21 However, chelated Gd3+ adducts are far less toxic because 
they carry the metal through the kidneys for excretion before the free ion 
can be released into the tissues. For this reason, Gd(III) based CAs are 
manufactured by a chelating process. The chelating agent, acting as 
Lewis’s base, forms a stable complex around the metal center, saturating 
seven or eight coordination position and leaving one or two free positions 
for water molecules.  
The coordinated water molecules give a direct contribution to the 
relaxivity, while the bulk solvent molecules experience the paramagnetic 
effect when they diffuse around the metal centre.22 These two 
interactions give the most important contributes to the observed relaxivity 
and are known as the inner-sphere relaxation rate and outer-sphere 
relaxation rate, respectively. In addition, water molecules may be 
retained in the periphery of the coordinated centre by hydrogen bonds for 
a relatively long time. This phenomenon is referred as the second-sphere 
relaxation effect.8  
The overall measured relaxivity (R1obs) is, thus, a result of different 
contributions as indicated by Equation 1: 
 
R1
obs = R1
IS + R1
SS + R1
OS + R1
W  (1) 
 
Where R1IS, R1SS R1OS are the inner-sphere, the second-sphere and 
outer-sphere relaxation enhancement in the presence of the 
paramagnetic complex at 1mM concentration, respectively, and R1W is 
the relaxation rate of the water solvent in the absence of the 
paramagnetic complex.23,24,25  
The inner sphere contribution depends on four factors that, according to 
Equation 2, are: i) the molar concentration of the paramagnetic complex 
[C], ii) the number of water molecules coordinated to the paramagnetic 
center, q, iii) the mean residence lifetime of the coordinated water protons 
τm, and iv) their relaxation time, T1M. 23,24 
 
)(5.55
][
m1
 1




M
IS
T
Cq
R   (2) 
From Equation 2, it is clear that increasing the hydration number, q, will 
increase the inner-sphere relaxivity. However, an increase in q is often 
accompanied by a decrease in thermodynamic stability and/or kinetic 
inertness. T1M, is directly proportional to the sixth power of the distance, 
rGdH, between the metal centre and the coordinated water protons. 
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Moreover, T1M depends from the molecular reorientation time, τr, of the 
chelate, from the applied magnetic field strength, from the electronic 
relaxation times, TiE (i = 1, 2), of the unpaired electrons of the metal 
(which also depends on the applied magnetic field strength) according to 
the modified Solomon-Bloembergen equations (Equation 3 and 
Equation 4):  
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in which γ2I is the square of nuclear giromagnetic ratio, S is the electron 
spin quantum number (7/2 for Gd(III) ions), g is the electron g-factor, μB 
is the Bohr magneton, rGdH is the electron spin – proton distance, ωI and 
ωS are the nuclear and electron Larmor frequencies respectively, τr is the 
rotational correlation time, related to the reorientation of the metal ion-
solvent nucleus vector, and τc1 and τc2 are longitudinal and transverse 
electron spin relaxation times. 
Relaxivity of the contrast agents can be increased, by introducing 
structural modifications on ligands with the aim to influence the three 
parameters τr, τm and TiE.26,27 The exchange lifetime τm can represent a 
limiting factor to the attainable relaxation enhancement promoted by the 
gadolinium complexes. The τm is inversely proportional to the water 
exchange rate (Kex = 1/τm). Thus, an increase in the relaxivity can be 
achieved by increasing the water exchange rate up to an optimal value 
of exchange rate.  
The tuning of the steric environment in the proximity of the Gd(III) centre 
can increase the dissociative water exchange rate as well as the increase 
relaxivity.28  
At the frequencies most commonly used in commercial tomographs (20 
– 60 MHz), the molecular reorientational time τr of the Gd(III) chelates is 
the most important determinant of the observed relaxivity. Therefore, the 
achievement of higher water proton relaxation rates may be pursued 
through an increase of this parameter, since the increase of the number 
of the metal bound water molecules (q), which would lead to the same 
result, is likely accompanied by a decrease of the stability of the complex.  
Several strategies are developed in order to lengthen τr from a typical 
range of 50–90 ps to hundreds of picoseconds.  
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It has been shown that the effectiveness of Gd(III) complexes as CA may 
be significantly improved by using protein-chelate conjugates in which 
the metal complex is covalently attached to amino acid residues of the 
protein29 or by non-covalently binding of the complex to 
macromolecules.30 This kind of approach permits to couple the strong 
chelation of the metal ion with the slow molecular tumbling of the 
macromolecules.  
The outer sphere contribution (R1obs) depends on TiE, on the distance of 
maximum approach between the solvent and the paramagnetic solute, 
on the relative diffusion coefficients and again on the magnetic field 
strength.26  
The contribution of the magnetic field strength to the R1IS, R1SS and R1obs 
values is very important, in fact the analysis of the magnetic field 
dependence allows the determination of the principal parameters 
characterizing the relaxivity of a Gd(III) complex. This information can be 
obtained through a Field-Cycling Relaxometer, an NMR instrument in 
which the magnetic field is changed to obtain the measure of r1 on a wide 
range of frequencies, typically 0.01 – 50 MHz.10  
 
1.2.2 Classical CAs based on Gd(III) ions 
The first gadolinium-based MRI contrast agent, the Gd(III) complex Gd-
DTPA (Magnevist®), was prepared by Schering AG in 1981 and 
approved for clinical use in 1987. It has been administered to more than 
20 million patients in more than 15 years of clinical experimentation. 
Other Gd(III) complexes which became soon available are Gd-DOTA 
(Dotarem®, Guerbert SA, France), Gd-DTPA-BMA (Omniscan®, GE 
Health, USA), Gd-HPDO3A (Prohance®, Bracco Imaging, Italy), Gd-MS-
325 (Ablavar®, BayerSchering Pharma, USA) and Gd-DTPA-BMEA 
(OptiMARK®, Mallinckrodt, USA) (Figure 4). 
These compounds, as all clinical CAs, are regarded as non-specific 
agents or extracellular fluid space (EFS) agents. They present very 
similar pharmacokinetic properties because they distribute in the 
extracellular fluid and are eliminated via glomerular filtration. They are 
particularly useful to delineate lesions as a result of the disruption of the 
blood–brain barrier. Successively, two other derivatives of Gd-DTPA 
have been introduced in the market, Gd-EOBDTPA31 (Eovist®, Schering 
AG, Germany) and Gd-BOPTA (Multihance®, Bracco Imaging, Italy).32 
They are characterized by an increased lipophilicity due to the 
introduction of an aromatic substituent on the carbon backbone of the 
DTPA ligand. This modification significantly alters the pharmacokinetics 
and the biodistribution of these CA as compared to the parent Gd-DTPA. 
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Figure 4: Structures of the six Gd(III) based MRI contrast agents (DOTAREM®, 
MAGNEVIST®, PROHANCE®, OMNISCAN®, MS-325 Ablavar®, OptiMARK®) 
currently used in the clinical practice, and of the two hepatobiliary agents 
(MULTIHANCE® and EOVIST®) which present pendent hydrophobic phenyl 
ring as aromatic substituent on the carbon backbone of the DTPA ligand. 
 
Introduction: MRI, fluorescence and FF self-assembly systems 
 
11 
These hepatobiliary agents have affinity towards HAS and are 
specificially uptaken by the hepatocytes. They are partially excreted 
through the biliary system and the kidneys. By comparing the structure 
of hepatic agents with that of EFS agents, the liver specificity can be 
ascribed to the pendent hydrophobic phenyl rings. Both MultiHance® and 
Eovist® have a faster water exchange rate (kex = 7.0×106 s−1) and a 
shorter rGdH than those of Magnevist® because of a more steric 
environment for water exchange.33 
 
1.2.3 Improved and supramolecular multi-Gd CAs  
The previously reported gadolinium complexes clinically have promising 
relaxivity behaviour, diffusion, and penetration that can be modified 
according to different physiological states. The classical Gd complexes 
are characterized by low molecular weight and rapid in vivo elimination 
and extravasation out of the vasculature that reduces contrast from the 
neighbours tissue.34  
Macromolecular gadolinium complexes have been designed with a 
molecular weight greater than 30 kDa limiting the extravasation, but 
favoring the enhanced permeability and retention (EPR).  
A relevant aspect of these compounds is the increase of the relaxivity per 
unit dose of the paramagnetic ion. Because of their size, the τm is longer 
than the low molecular weight agents as Magnevist or Dotarem. 
Additional advantage is the opportunity to append to a macromolecular 
platform multiple chelates reducing the dose of agent needed for 
obtaining well-resolved images. 
For all these reasons, research was voted to increase relaxivity 
properties and targeting ability.35 In order to reach this goal, several 
contrast agents, with improved properties, have been proposed: 
 
 “multimeric or macromolecular contrast agents” in which a large 
number of gadolinium complexes are combined together and the 
total relaxivity results from the single contribution of each 
gadolinium ion.36,37 
 
 “smart contrast agents” in which a change in the relaxivity value is 
observed upon activation in the in vivo environment where they 
act.38 Smart contrast agents, also referred to as responsive or 
activated CAs, are agents that react to variables in their 
environment, such as temperature39, pH40, partial pressure of 
oxygen41, metal ion concentration42 or enzyme activity43, giving a 
strong increase or decrease of the observed relaxivity.  
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 “target selective contrast agents” in which the gadolinium complex 
is delivered in a selective way on cells or on tissues of interest by 
bioactive molecules such as peptides or antibodies.44,45 
 
A plethora of improved and supramolecular multi-Gd CAs have reported 
over the last 30 years such as dendrimers,46 linear polymers,47 
gadofullurenes,48 gadonanotubes,49 or large protein derivatives obtained 
by using the strong interaction present in the avidin-biotin or in the β-
ciclodextrin-dextran complexes (Figure 5).50 
 
 
 
Figure 5: Schematic representation of macromolecular adducts: a) dendrimers; 
b) linear polymers; c) and d) carbon nanotubes such as gadofullerenes and 
nanotubes externally derivatized by stable gadolinium complexes, respectively; 
e) macromolecular adducts obtained by non-covalent interactions between high 
molecular weight molecules such as avidin or -ciclodextrin polymers with 
monomeric gadolinium complexes of biotin or dextran.  
 
1.3 Photoluminescent phenomena: fluorescence and 
phosphorescence  
 
The totality of phenomena that involves energy absorption and 
subsequent emission of light are referred generically under the term of 
photoluminescence (PL). Excitation as consequence of photons 
absorbance leads to a major class of technically important luminescent 
molecular entities, correlated to fluorescence and phosphorescence. 
In a simplistic vision and in the time scale, fluorescence is “fast” 
phenomenon (requiring ns) while phosphorescence is a “slow” one 
(longer in time scale, up to hours or even days).  
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For convenience, the topic of photoluminescence (PL) will be broadly 
divided into that based on relatively large-scale inorganic materials, 
mainly exhibiting phosphorescence, and that of smaller dye molecules 
and new nanomaterials, which can either fluoresce or phosphoresce.51  
Phosphors and fluorophores are luminescent materials that release light 
when excited by specific wavelength radiation. They are usually 
microcrystalline powders chemically designed and modified to provide 
emission in the visible portion of the spectrum (350-700 nm).  
After decades of research and development, thousands of PL molecules 
have been synthesized and optimized. In the prospective of this thesis, 
central role will be give to fluorescence supramolecular probes for 
potential application in bio-imaging.  
 
1.3.1 Fluorescence bio-imaging  
Fluorescent labelling and staining, when combined with an appropriate 
imaging instrument, is a sensitive and quantitative method that is widely 
used in molecular biology and biochemistry fields for a variety of 
experimental, analytical, and quality control applications.52,53 The 
concentrations, chemical modifications, and interactions of biomolecules 
in complex organisms are generally precisely controlled, both spatially 
and temporally.  
As previously mentioned, deciphering this complex system of interacting 
molecules inside and among the cells can help the diagnosis and 
treatment of disease, as well as for research into the basic processes of 
life. 
Fluorescence bio-imaging is an optical imaging technique that uses 
fluorescence and phosphorescence instead of, or in addition to, reflection 
and absorption optic phenomena to study the properties of organic or 
inorganic substances. Compared to other technologies, such as 
radioisotope labeling, CT, ESR, and electrochemical detection, 
fluorescent detection and imaging offer a number of important 
advantages for this purpose, as it enables highly sensitive, multiple label 
possibility, low hazard, non-invasive, and safe detection using readily 
available instruments. Another advantage of fluorescence bio-imaging is 
that the fluorescence signal of a molecule can be drastically modulated 
and give information about surrounding space.  
For bio-imaging application, fluorescent probes are administered to the 
subject and emit a signal within the body. Fluorescent probes are found 
be molecules that can interact specifically with biological molecules to 
induce a concomitant change of their photochemical properties (in terms 
of fluorescence intensity, excitation/emission wavelength).54  
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1.3.2 Principle of fluorescence imaging  
Fluorescence results from a process that occurs when certain molecules 
(generally polyaromatic hydrocarbons or heterocycles) called 
fluorophores, fluorochromes, or fluorescent dyes absorb light. 
Fluorescence phenomenon is simply recapitulated by Jablonski diagram 
(reported in Figure 6), illustrating the processes involved in creating an 
excited electronic singlet state by optical absorption and subsequent 
emission of fluorescence.51 The absorption of light by a population of 
molecules raises their energy level to a brief excited state (S1’). As they 
decay from this excited state, they emit fluorescent light. 
The excited state of a fluorophore is characterized by a very short half-
life, usually in the order of a few nanoseconds.55 During this brief period, 
the excited molecules generally relax toward the lowest vibrational 
energy level (S1) within the electronic excited state (Figure 6). The 
energy lost in this relaxation is generally dissipated as heat. It is from the 
resulting relaxed singlet excited state (S1) that fluorescence emission 
originates.51  
 
 
Figure 6: Fluorescence phenomenon is simply illustrated by Jablonski diagram. 
Process involved in the phenomenon are 1) Excitation; 2) Vibrational relaxation; 
3) Emission. 
 
When a fluorochrome molecule falls from the excited state to the ground 
state, light is often emitted at a characteristic and specific wavelength. 
The energy of the emitted photon (hνEM) is related to the difference 
between the energy levels of the two states.  
The energy difference determines the wavelength of the emitted light 
(λEM) according to the sequent relation: 
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λEM = hc/EEM 
 
in which EEM is the energy difference between the energy levels of the 
two states during emission (EM) of light, h is the Planck’s constant and c 
represents the speed of light. 
A laser-scanning instrument or a CCD-camera can be used to measure 
the intensity of the fluorescent light and subsequently create a digital 
image of the sample. Image analysis makes it possible to view, measure, 
render, and quantify the resulting image. 
 
3.3 Fluorochromes properties  
A fluorescent molecule has two characteristic spectra- the excitation and 
the emission spectra.  
The relative probability that a fluorochrome will be excited by a given 
wavelength of incident light is shown in its excitation spectrum. This 
spectrum is a plot of total emitted fluorescence versus excitation 
wavelength, and it is identical or very similar to the absorption spectrum 
(Figure 7). 
 
 
Figure 7: Exemplificative graph for excitation (blue) and emission (red) spectra 
for a generic fluorescent dye.  
 
The photon energy at the apex of the excitation peak equals the energy 
difference between the ground state of the fluorochrome (S0) and a 
favoured vibrational level of the first excited state (S1) of the molecule 
(Figure 8). 
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Figure 8: Diagram of energy levels for a generic fluorochrome dye. In green 
and red are reported the phenomenon and relative spectrum for excitation and 
emission, respectively. The difference in emission and excitation maximum is 
identified as Stokes shift.  
 
In some cases, the excitation spectrum shows a second peak at a shorter 
wavelength (higher energy) that indicates transition of the molecule from 
the ground state to the second excited state (S2). The width of the 
excitation spectrum reflects the fact that the fluorochrome molecule can 
be in any of several vibrational and rotational energy levels within the 
ground state and can end up in any of several vibrational and rotational 
energy levels within the excited state. In practice, a fluorochrome is most 
effectively excited by wavelengths near the apex of its excitation peak. 
The shape of the emission band is approximately a mirror image of the 
longest-wavelength absorption band (Figure 8), providing that the 
vibronic structures of the excited and ground states are similar. In theory, 
the transition in excitation and transition in emission should occur at the 
same wavelength. However, this is usually not the case in solution, 
mainly due to solvent relaxation.56  
In solution, Stokes shift is predominantly accounted for by solvent effects 
(increasing with the polarity of the solvent and the polarity of the excited 
state). Heat exchange is essentially caused by internal vibrational 
relaxation. The emission spectrum is always shifted toward a longer 
wavelength (lower energy) relative to the excitation spectrum.  
The difference in wavelength between the apex of the emission peak and 
the apex of the excitation peak is known as the Stokes shift.  
This shift in wavelength (energy) represents the energy dissipated as 
heat during the lifetime of the excited state before the fluorescent light is 
emitted. The Stokes shift is fundamental to the sensitivity of fluorescent 
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techniques because it allows emission photons to be detected against a 
low background spectrally removed from excitation photons. 
The intensity of the emitted fluorescent light is a linear function of the 
amount of fluorochrome present when the wavelength and intensity of 
the illuminating light are constant (e.g. when using a controlled laser light 
source). Although the signal becomes non-linear at very high 
fluorochrome concentrations, linearity is maintained over a very wide 
range of concentrations.57 
Fluorochromes differ in the level of intensity (brightness) they are capable 
of producing. This is important because a dull fluorochrome is a less 
sensitive probe than a bright fluorochrome. Brightness depends on two 
properties of the fluorochrome: 
 
 its ability to absorb light (extinction coefficient) 
 the efficiency with which it converts absorbed light into emitted 
fluorescent light (quantum efficiency) 
 
The brightness of a fluorochrome is proportional to the product of its 
extinction coefficient (ε) and its quantum efficiency (φ), as indicated in the 
following relationship:51 
 
Brightness ~ εφ 
 
The extinction coefficient of a fluorochrome is the amount of light that a 
fluorochrome absorbs at a particular wavelength.  
The molar extinction coefficient is defined as the optical density of a 1 M 
solution of the fluorochrome measured through a 1 cm light path.  
For fluorochromes that are useful molecular labels, the molar extinction 
coefficient at peak absorption is in the tens of thousands.51 
The probability that an excited fluorochrome will emit light is its quantum 
efficiency and is given by the following ratio: 
 
φ = number of photons emitted / number of photons absorbed 
 
Values for φ range from 0 (for non-fluorescent compounds) to 1 (for 100% 
efficiency). 
Fluorescence intensity is also affected by the intensity of incident 
radiation. Although in theory, the more intense source will yield the 
greater fluorescence, in actual practice, photodestruction of the sample 
can occur when high intensity light is delivered over a prolonged period 
of time.58 
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1.4 Supramolecular chemistry as new tool for bio-imaging  
Since the beginning of the last century, supramolecular chemistry has 
imposed itself as revolutionary scientific area to the interface of different 
disciplines, such as chemistry, medicine, material science and biology. 
Specializing themselves in the manipulation of matter, researchers have 
tried to obtain various nano-dimensional structures, in terms of 
morphology, shape, compatibility and functionality, all associated with 
desirable physical and chemical attributes.1,2,3  
The emerging importance of nanotechnology supports the idea of nano-
organized systems as versatile starting point for explore new possibility 
in bio-imaging.  
Indeed, bio-imaging probes based on nanoparticles14,59 and 
nanoconjugated polymers60 have been introduced, and some of them 
have already been applied to in vivo and in vitro imaging.61,62 
Regarding the MRI technology, micelles and liposomes were proposed 
as nanoplatform for bio-imaging applications.63,64 They can be obtained 
by spontaneous self-assembling in aqueous solution of amphiphilic 
molecules consisting of a hydrophobic and a hydrophilic moiety. The 
driving forces of the aggregation into well-defined structures derive from 
the hydrophobic Van der Waals associative interactions and the repulsive 
interactions between the charged hydrophilic moieties. 
Nanotechnology changed also the assortment of fluorescence reporters. 
NMs came up beside the traditional fluorescent dye. Among them are 
nano-fibers65 and nanotubes66, nanocrystals67, nanodiamonds68 and 
carbon dots.69 They demonstrated diverse photophysical behavior and 
allow one to obtain diverse information when used in analytical tools or 
when they form images in biological systems. 
Even if small organic fluorescent probes have become indispensable 
tools, nan-structured particles has attracted great interest for the peculiar 
and innovative fluorescence features, related to quantum mechanical 
phenomena like quantum confinement.70 According to this evidence, a 
deep knowledge about nano-fabrication and self-assembling 
methodologies is required.  
 
1.4.1 Nano-fabrication: bottom-up and top-down approach  
The broad use of nanoplatforms for practical applications referenced in 
literature revealed the need to obtain nanoparticles with well-defined 
characteristics of uniformity, purity, size, and chemical compositions. 
Generally, the approaches that may be used for manufacturing different 
NPs are referred with the generic names of “bottom-up” and “top-down” 
methodologies (Figure 9).  
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More specifically, the top-down procedures search for design devices at 
nano- and micro-scale by using the externally controlled micro-fabrication 
methods to direct crumbling and dismantling of bulk materials into its 
meso-components. Examples of this approach are photolithography71, 
3D printing72, vapour deposition73 and micropatterning.74 
 
 
 
 
Figure 9: Top-down and bottom-up approaches to generate new nanoplatforms 
(NPs) associated with desirable physical and chemical attributes. 
 
On the other side, bottom-up methodology takes advantage of chemical 
properties and combinations of molecular recognition between small 
molecular monomers.They serve as building blocks to self-organize in 
complex supramolecular assemblies.  
Since the birth of supramolecular chemistry, following Lehn, Cram and 
Pedersen’s study, the comprehension of the forces that rule the 
intramolecular recognition and the study about non-covalent interactions 
allowed to use self-assembly phenomena as bottom-up tools.  
In the classic way, self-assembly is the spontaneous and reversible 
organization of molecular entities in orderly structures by weak 
interactions. In other words, with this term are pinpointed processes in 
which a cluttered system of pre-existent components create an organized 
structure or a repetitive modulus as a consequence of specific and local 
non-covalent interaction (like hydrogen bond, Van der Waals interaction, 
aromatic staking, London’s dispersion forces and metal coordination).  
According to Whitesides and Grzybowski’ definition, self-assembly 
phenomena can be identified as either static (S) or dynamic (D).75 Self-
assembly processes in S class might require energetic activations 
(mechanical, thermal or chemical ones). These systems, once formed, 
are in global or local equilibrium at meso- and micro-scales, no needing 
to dissipate energy. Biological examples of these processes are the 
formation of phospholipid membrane bilayers, virus capsids, crystal 
formations and DNA double helix. Otherwise, systems originated by 
dynamic self-assembly, in order to maintain their organization, require 
dissipation of their energy. This is the case of more complex entities like 
cells cytoskeleton and superior organisms. 
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Molecular self-assembly is a static and spontaneous process associated 
with a negative variation of the free energy (ΔG<0). The interaction 
network created by the system is a consequence of its tendency to 
increase the entropy (S), simply referred as the grade of randomness. 
According to the second law of thermodynamics, entropy can not 
decrease (it can only remain unchanged as in the adiabatic processes or 
increase), so each system evolves in the way to increase the 
randomness ensuring an increase of S. However, assembled systems 
are recall as more “ordered” than “disordered”. The self-assembly driven 
by the entropy might appear counterintuitive. This apparent paradox 
could be explained considering that the thermodynamic behaviour 
between polar and non-polar entities represents the driving force of this 
process. The apparent paradox is clarified studying the hydrophobicity of 
materials, the polar modulus and the electronegativity of constituent of 
the atoms. 
Focusing on aqueous media, the molecules of H2O form and demolish 
continuously and spontaneously hydrogen bonds, safeguarding a high 
grade of randomness and charging neutrality. This tendency affects also 
the water solubility of the compound. 
More specifically, a non-polar molecule (like aromatic/aliphatic 
compound or fatty acid) induces a more “rigid” behaviour of water 
molecules that, in order to guarantee electro-neutrality, produce a local 
increase of order (Figure 10a). In the case of amphiphilic molecules, or 
rather molecules that have simultaneously polar and non-polar regions 
(surfactants or phospholipids) in molecular structure, the polar part can 
take part to the dynamic hydrogen bonding process of water whereas 
non-polar one decrease the entropy as mentioned previously. Increasing 
the amphiphilic concentration, the molecules start to self-assemble in 
clusters with the aim to minimize the contact between nonpolar and the 
aqueous interface, fostering intramolecular non-polar interaction (Figure 
10b). In addition, the entropic solvent organization was proposed be the 
a basic phenomenon related to the entropic hydrophobic effect. The 
hydrophobic effect is the observed tendency of nonpolar substances to 
aggregate in aqueous media, excluding water molecules According to 
this prospective, some authors argued that the hydrophobic interaction is 
mostly an entropic effect originating from the disruption of highly dynamic 
hydrogen bonds between molecules of liquid water by the nonpolar 
solute. Consequently, no physical interaction or fundamental forces could 
be ascribed to hydrophobic forces. However in this manuscript it will be 
preferred report the aggregation driving force as stacking one. 
Depending on different structural parameters identified as “paking 
parameters” (like ratio between non polar and polar parts or relative size 
and charges), monomers could aggregate into a range of various and 
heterogeneous geometries. The local and weak interactions are 
Introduction: MRI, fluorescence and FF self-assembly systems 
 
21 
additional and fundamental factors that stabilize and could direct the 
aggregation process. In fact, although each non-covalent force does not 
prove energetically relevant (hydrogen bonds: 2–30 kcal/mol, 
electrostatic forces: 2–21 kcal/mol, hydrophobic forces: 10 kcal/mol and 
– aromatic stacking: 1–11 kcal/mol), the total network of them 
generates a final condition of high stability and hierarchical order.  
The advantage derived by this particular organization is located in the 
reversibility of the process if it is compared with all-covalent systems (C–
C bond: 85 kcal/mol, C–H bond: 103 kcal/mol, C–O bond: 81 kcal/mol). 
For this reason, the self-assembly process can be reversed or 
transformed by external stimuli, including pH76, temperature77 and 
solvents.78 
 
 
a) 
 
b) 
 
Figure 10: An aliphatic molecule increases the order of aqueous media (red 
region) inducing a decrease of entropy (a). Amphiphilic molecules submerged 
in water the aqueous media interact with water by polar region whereas non-
polar parts, at a typical concentration, start to interact by non-covalent 
interaction (white circles) to self-assemble and minimize the non-compatible 
interfaces areas. 
 
On the evidence that supramolecular self-assembly is the basis of a lot 
of essential biochemical processes, scientists have begun researching 
building blocks for bottom-up inspired by biology. In this field and as 
mentioned before, amphiphilic molecules are particularly attractive 
building blocks. This new design imitation approach, known as 
“biomimetic” or “biomimicry”, allows new applications to the nano- and 
micro-scales inspired by supramolecular molecular biology. 
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1.4.2 Biomimicry approach: peptide for bottom-up  
Among all the natural building blocks proposed for the bottom-up 
approach, amino acids and peptides open very large prospective for the 
design and the generation of complex supramolecular architectures. 
Numerous structures are consequence of natural self-assemble of 
proteinaceous building blocks and the organization in supramolecular 
protein structures is a common process in living systems; illustrative 
examples are viral capsid79, fibrils80, microtubules81, and S-layers.82 
Because of the natural level of organization ranges from nano-to macro-
scale, rather than proteins short peptides are proposed as simpler and 
more controllable constitutive elements to direct the self-assembly on 
different length-scales.83 
Peptides have well-known advantages ranging from high versatility, 
intrinsic biocompatibility, possibility of functionalization pre- and post-
aggregation to high synthetic accessibility and convergence, low 
immunogenicity and relative low cost.  
More than two decade ago, in 1993 Ghadiri and co-workers produced the 
first demonstration of manufactured supramolecular nanostructures 
using peptides.84 The monomer, a cyclic peptide, was designed and bio-
inspired by non-ribosomal bacterial peptides that contain residues in 
alternate configurations (D and L). This latter structural characteristic 
allows the stacking of the building blocks, conferring them a flat β-sheet 
conformation. The interaction network of hydrogen bonding bears the 
supramolecular structure of hallow cylindrical nanotubes. 
At the state of art, a large number of peptide-based building blocks, 
comprising cyclic peptides85, amphiphilic peptides86, surfactant-like 
peptides87, dendritic peptides88 and aromatic dipeptides89, have been 
considered for generating self-assembled nanostructures. 
Both final morphology and proprieties of the self-assembled system are 
related to the monomer structure in terms of chemical nature of residues, 
functional group in side chains and monomer length. 
Owing to such unique chemical properties, de novo designed peptides 
can be decorated with chemical functionality, like polymers90, alkyl chain 
and lipids91, and the sequences can be easily designed as amphiphilic 
chemical structure, with both hydrophobic and hydrophilic domains in the 
same building block. Additionally, peptides for bottom-up approach 
opened many opportunities to the exploration of the relationship between 
physiochemical properties and the molecular architectures.92 
However, all these scientific topics are complementary to the knowledge 
of the amino acid and peptide chemistry, taking advantage from current 
synthetic methods and the relative simple chemistry of the amino acids. 
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1.5 Amyloids: from pathogenicity to biomimicry starting 
point  
 
At molecular level and in its complex, protein folding is the physical-
chemical process by which a protein stabilizes and acquires its three 
dimensional and functional shape (known as native state). 
In biological systems, proteins are synthesized by ribosomes, 
transforming a sequence of mRNA codons into the correspondent linear 
chain of amino acids. Amino acids in the unfolded primary sequence start 
to interact each other to generate the native state. For this, the specific 
amino acid residues and their position in the polypeptide chain are the 
driving forces of the folding process (a concept known as Anfinsen's 
dogma).  
The correct folding state is essential to guarantee the protein 
physiological function and, in normal physiological conditions, all the 
proteins prove to be degradable and recyclable biochemical entities.93 
Alterations or evasion from one of the pathways that control normal 
proteins turnover and folding (like proteasome94 or molecular 
chaperons95) could provoke pathological situations.96,97,98 
Between these, amyloidosis represents an inclusive category of disturbs 
correlated with protein misfolding. This process can be the consequence 
of different causes such as mistranscription99, gene alteration and 
mutation100 or mistranslation.101 Modifications of surrounding conditions 
(pH, temperature, concentrations of salts) could also provoke proteins 
destabilization, resulting in misfolding or unfolding.102,103 
Amyloidosis are transversely characterized by a similar aetiology of 
extracellular deposition of insoluble and intractable clusters and 
aggregates of protein-based materials with low molecular weight.104 This 
material is usually pinpointed as 'amyloid' because of its propriety to react 
with iodine, similarly to starch (amylum in Latin). Currently, more of 25 
proteins are identified as involved in amyloidogenic processes.105 As 
mentioned, amyloid fibrillary materials do not represent the native 
conformation but are an alternative quaternary one, formed because its 
organization process seems thermodynamically favorable. 
Supramolecular aggregated and misfolding protein materials are the 
hallmark of major human illnesses, including bovine spongiform 
encephalopathy (mad cow disease),106 Marfan’s syndrome,107 
Creutzfeldt–Jakob disease,108 Alzheimer's disease,109 Huntington's110 
and Parkinson's disease111 and polyneuropathy.112 
Although first identified as pathological entities, a new research line has 
recently shown that amyloid proteinaceous materials contribute to 
generate complex and physiological functional materials as constitutive 
elements.113 It is demonstrated that amyloid materials have evolved from 
prokaryotes to eukaryotes as structural matter for a lot of biological 
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functionality, recognized involved in microbial biofilms formation,114 cell 
adhesion,115 signal transduction for hormone release,116 templates the 
synthesis of melanin,117 RNA traffic118 and memory persistence.119 
For these reason, the amyloid materials, once exclusively affiliated as 
pathological structures, are now raising interest as biomimicred self-
assembling class of biological building blocks for artificial materials. Their 
potential engineering is a consequence of the study and comprehension 
of the supramolecular structuration.  
 
1.5.1 Amyloids structure 
An initial theory supposed an amorphous organization of amyloid 
materials plaques. Isolation of heterogeneous amyloids and their 
structural characterization confuted this hypothesis (Figure 11).120 
Despite having different physiological functions and chemical structure, 
all the misfolded amyloid proteins are composed of a quaternary ordered 
arrangement of many (usually thousands) peptide monomers sharing the 
same morphologic ultrastructure and resistance to protease 
degradation.121 
At superior grade of organizations, amyloids plaques appear formed by 
unbranched, linear and rigid peptide fibrils with non-constant length and 
medium diameter of 7-10 nm. These assemblies contain usually 2-8 
protofilaments (the fibrillar subunits) twisted around each other.122,123 In 
turn, each protofilament is composed by a repeating substructure of beta 
strand that run perpendicular to the fiber axis, arranging in a polymeric 
organization of indefinite length known as a cross-beta structure.124,125  
In cross-section, amyloid fibrils appear as hollow ribbons or cylinders. All 
the structure is stabilized by beta sheet packing by specific region of 
amino acid of interaction, generally aromatic and hydrophobic, called 
steric zipper-like regions, and by long network of hydrogen bond between 
beta strands.126,127 
 
Figure 11: Hierarchical assembly of amyloid materials, from plaques to 
secondary structure. 
 
This kind of organization is also confirmed by different and 
complementary techniques.  Fluorescent dyes, such as Congo Red 
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(CR)128 and Thioflavin T (Th T)129, stain the amyloid fibres and 
protofilaments while Circular Dichroism130, optical birefringence131 and 
Infrared spectroscopy132 can identify the β-secondary structure. In 
addition to all of this indirect measurements, organized and partially 
aligned amyloids materials give a characteristic X-ray diffraction known 
as "cross-β pattern" (Figure 12).133 This evidence is considered the 
diagnostic and direct hallmark of amyloid structuration. Cross beta 
pattern consists of two sets of diffraction lines, located on two axes 
mutually perpendicular (meridional and equatorial directions). Along 
meridional direction, parallel to fibre axis, an intense and sharp reflection 
generates an arch at 4.7 Å corresponding to stacking distances between 
two consecutive β sheets. On the equatorial direction, a signal around 10 
Å is generally detectable as index of the distance between stacked β-
sheets.133 
 
Figure 12: Schematic representation of amyloid organized quaternary structure 
and its characteristic X-ray cross-β pattern diffractogram collected by fibril 
exposure at X-ray source. Cross-β pattern is correlated to the stacking distance 
between β-sheets. 
  
This kind of organization explains the central rule of the dense hydrogen 
bonding network and the strong intermolecular backbone-backbone 
interactions, both associated to the high Young’s and elastic moduli 
connected to amyloid fibrils. These are only two of the motivation for why 
amyloid fibrils structures attracted attention. These materials are at the 
crossing between nanotechnological, medical and biological areas.  
 
5.2 Aromatic residues as molecular denominators of 
amyloid fibril formation 
 
Concerning the attempts to clarify molecular aspects of fibrils formation, 
great dedication was devoted toward understanding the rational 
mechanism underlying amyloid self-assembly.  
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As first approach, the design of peptide and peptidoids agents as 
inhibitors of amyloid formation are pursued.134,135 Mediating the process 
of molecular self-assembly, these compounds paved the way to a 
reductionist research aimed to determine the minimal intrinsic peptide 
sequences that would guide the fibres formation. This approach was 
successfully applied to figure out the basis of amyloid fibril self-assembly 
of human islet amyloid polypeptides (hIAPP).136 IAPP is 37-amino acid 
hormone responsible to form fibrils in pancreas in case of type II diabetes. 
The two pentapeptides, hIAPP14-18 (NFLVH) and hIAPP15-19 (FLVHS), 
identified as part of the central molecular recognition module, are able to 
form fibrillar aggregates.137 Analogously, studies about amyloid materials 
in medullary carcinoma of the thyroid formed by human calcitonin 
polypeptide hormone (hCT), has demonstrated the formation of amyloid-
like fibrils for two peptides (DFNKF and DFNK).138 Additionally, a peptide 
fragment of medin, Med42-47 (NFGSVQ), the constituent of protinaceous 
deposits in all the individuals above the age of 60, can mime the fibrillary 
self-assembly of the full-length polypeptide.138 
This approach, reducing gradually the high systems complexity, allowed 
to compare short peptide fragments, identifying the presence of aromatic 
residues as the common molecular and structural denominators that 
guide the formation of analogues supramolecular morphologies in 
different protinaceous building-blocks.  
On the basis of this evidence, amyloid fibril formation was attributed to a 
process in which -stacking interactions play a key role, providing a high 
enthalpic contribution (staking hypothesis). These interactions, 
associated also with the high hydrophobicity, the backbone hydrogen 
bounding network and β-sheet propensity, should contribute to generate 
order and directionality in this self-assembly process. 
The stacking hypothesis associated with hydrophobicity is particularly 
suitable regarding the case of Aβ1-40 and Aβ1-42 polypeptides involved in 
the formation of Alzheimer's disease plaques.109 The previously 
mentioned systematic and reductionist approach was also applied to 
these peptides, identifying the region Aβ16-22 (KLVFFAE) as one of the 
shorter aggregation-prone sequence.140 Inside the primary structure, the 
region 17-21 is the crucial, essential hydrophobic cluster for 
polymerization of the full-length peptide.141,142 
According to the evidence that - staking provide a restriction of 
conformational space, geometry and directionality143 in the hydrophobic 
clusters and that all short peptide able to interact with Aβ contain an 
analogue recurring part, in 2003 Gazit and Reches pinpointed the 
diphenylalanine homopeptide (FF or Phe-Phe), in the middle of Aβ (FF, 
Aβ19-20), as core recognition motif of Alzheimer’s polypeptide.144 Initially, 
the parental origin from amylogenic matrix supported the hypothesis that 
FF structuration were amyloid too. Meanwhile Aβ1-40/42 and Aβ16-22 self-
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organize in fibril water filled morphology,140,145 FF is able to self-
assembles into ordered and discrete aromatic dipeptide nanotubes 
(ADNTs) with micro-scale persistence length in a process identified as 
“one dimensional crystallization”.146  
The FF motif became of special interest rapidly because it is the first 
pioneering reported case of minimal amyloid related fibrils formed by an 
ultra-short and all-aromatic dipeptide. By the unexpected evidence of a 
novel type of nanomaterial, FF became the paradigm for exploring 
supramolecular aggregative peptide behaviours representing a new 
class of simple building blocks containing all the molecular information 
for the self-assembling. 
 
1.6 Diphenylalanine molecular and structural organization 
The organization and the interactions of the individual FF monomers 
explain the overall properties of the assembled ADNTs. Consequently, 
the internal arrangement of FF nanotubes was extensively analysed.  
Two types of interactions are pinpointed as the driving forces at the basis 
of supramolecular phenomena. By X ray crystallography studies, - 
interaction (between phenyl rings) and hydrogen bonding (that engage 
backbone terminals).147 This hypothesis is consistent with previous 
evidences that highlight the centrality of π-π staking in the self-
organization phenomena more than hydrogen bounding of backbone 
terminals. A study conducted about eight FF analogues chemically 
differentiated both at N- and C- terminus (cyclization hand-to-tail, Nα 
protection via Boc, Fmoc) and at side chain (saturation, nor- modification 
of the phenyl ring) reported that saturated analogues does not show high 
aggregation propensity, tendencies that are preserved in terminal 
modified analogues.148 
Molecular Dynamics algorithms, supported and confirmed by X-Ray 
diffraction, proposed a hierarchical and multiscale aggregative model for 
diphenylalanine homopeptide based on a particular arrangement of FF 
monomers in aqueous media.149,150 In vacuum, the simulated monomer 
configuration suggests the two phenyls rings located on either side of the 
peptide backbone (Figure 13a). On the contrary, in polar environment, 
thanks to the rotational freedom around the peptide bond (θ angle), the 
two side residues are constricted in the same face of peptide backbone 
with an unusual torsion dihedral angle between the two side chains 
centred around 0°(Figure 13b). This anomalous configuration is 
favourable in aqueous media because the hydrophobic groups can be 
shielded from the non-compatible polar interface, limiting the contacts 
between aromatic residues and water molecules and increasing the total 
entropy of the system.150  
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In this conformation, six homopeptides organized in a cyclic hexamer 
(Van der Waals diameter 9.2 Å) stabilized by head-to-tall hydrogen 
bounding (Figure 13c).151 Subsequently, according to packing 
parameters, hexamers generate a hexagonal peptide matrix in which 
hydrophobic groups are packed inside the wall of single ADNT by staking 
interaction. 
Growing in one-dimension propagation, inside the matrix hallow 
hydrophilic channels and hydrophobic zipper zone (reported in in red and 
blue in Figure 13c, respectively) are recognizable.147,149 The water 
settle in the central columns is an integral participating of the structure 
both in structural and energetic way. Because hardly removed from it, 
either by heating or vacuum, it is generally referred as "crystallographic 
water". 
Figure 13: a) Simulated FF conformation in vacuum. b) Side chain constriction 
in polar environment. Hydrophilic and  hydrophobic molecular region are 
indicated. c) The cyclic hexamer, formed by six homopeptides, generate a 
peptide matrix in which an hydrophilic (red circle) and staking region (blue 
circles) can be recognized . 
 
The one-dimension propagation step of the individual ADNT into larger 
meso-structures is a slower process than the organization of the 
individual nanotubes. The self-aggregation of them in the matrix further 
reduces the total entropy so that the packaging of the hydrophobic side 
 
a) 
 
b) 
 
c) 
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chains alone is not sufficient to lean on the process. Therefore, energy is 
gained by the creation of larger supra assemblies formed by individual 
nanotubes fused together. Eventually, the expensive matrix produces 
sheets and the closure of the two-dimensional layer forms nanotubes with 
external hydrophobic walls. At larger scale, nanotubes forms bundles in 
a final arrangement of microscale hollow tubular structures.( Figure 
14)152  
 
 
Figure 14: Schematic representation of FF cyclic hexamers (left) in their 
progressive organization. By clustering together (middle), singles nanotubes 
form a microscale nanotube (left).  
 
Unexpected mechanical, thermal and chemical properties, not typically 
associated with biological matter, are related with this aggregation 
behaviour and inherited from the individual molecules, individual 
nanotubes or from their mutual intersection. TEM and SEM images for 
FF nanostructure suggest that ADNTs are rigid and strong assemblies.153 
Different experiments conducted by AFM highlighted the mechanical 
proprieties of FF nanotubes like the high stiffness (160 N/m)154 and a 
Young's modulus in the range of 19-27 GPa.154,155 In addition, ADNTs 
display remarkable thermal stability up to 90 °C and the surrounding 
humidity did not seem to affect in any predictable manner these physical 
properties.156 
Simultaneously, the chemical stability of ADNTs was proved analysing 
the morphology of preformed aggregate against organic solvents 
(acetone, ethanol, methanol, acetonitrile),156 meanwhile the electrical 
characteristics of ADNTs regard direct conductivity and 
photominescence157, piezoelectricity158 and polarization.159 
 
1.6.1 Diphenylalanine ADNTs: preparation in water 
Since the emergence of FF as the simplest self-assembling building 
blocks and thanks to the ease synthetic accessibility and bulk preparation 
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possibility, deep exploration FF aromatic homo-dipeptides self-assembly 
was scrutinized.  
The simplest and most common approach for the formation of FF 
supramolecular structure is the aqueous solution based assembly. This 
is in routine manufactured by two different methods (or pathways), 
established by Gazit's and Song's group, respectively. Gazit's protocol 
(pathway A) involves dissolving FF power at high concentration 
(100mg/mL) in the organic fluorinate solvent HFIP (1,1,1,3,3,3- 
hexafluoropropan-2-ol) followed by a consequent water dilution.144 
In reverse, Song developed a preparation (pathway A*) by which the FF 
powder in water is heated for thirty minutes at 65°C. Then the sample (as 
solution) is cooled at room temperature. Once the concentration of the 
peptide monomers reaches a critical concentration during cooling 
process, the peptide nanotubes will form in solution.160 The latter 
preparation omits the recourse to the toxic HFIP, a well-known mucous 
and tissues destroyer,161 making this protocol more fitting for 
pharmaceutical and in vivo application.  
For completeness, a systematic study about the solubility of 
diphenylalanine peptide in other solvent system was reported in 2004 by 
Mason et al., highlighting the accessibility to different morphologies 
simply changing the self-assembly liquid media characteristics.162 
 
1.6.2 Preparation by physical methods  
Alternative approaches for the formation of peptide nanostructure 
involves physical and mechanical methods of manufacturing and can 
produce different patterns.   
Microfluidic technology was successfully applied for the formation of 
ADNTs mixing in a merging laminar chip channel the FF stock solution in 
HFIP and water media.163 Taking advantage from the low-molecular-
weight of monomers and the inherent volatility of aromatic systems, FF 
dipeptides are also excellent candidates for physical methods that work 
with thermal induced vapor deposition (physical vapor deposition or PVD 
methods). Avoiding the use of solvents media, these technologies 
allowed a vertical deposition of monomers. After the evaporation phase 
of the powder from a plate at 220°C, peptide monomers undergo a 
chemical cyclization and finally assembles in a dense and uniform 
ADNTs nanoforests on a large variety of substrates (maintained at lower 
temperature, 80°C).164A thin film of FF in HFIP can be converted in 
peptide nanowires heating it in the presence of aniline vapors. The wires 
vertical alignment is ensured by the gradient of the aniline vapor away 
from the support choose for the growth.165  
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ADNTs can be manufactured by electrospinning procedures166 and, in 
addition, patterned ADNTs organization can be obtained using inkjet 
technology167, magnetic fields168 or Langmuir-Blodgett method.169 
 
1.6.3 Influence of solvent media  
It is increasingly evident the concept that the peptide monomers are able 
to self-organized in different nanomorphologies (ranging from nanotubes, 
organogels, nano-rods to spherical vesicles and nanofibers) according to 
the preparation method. In addition, the selection of the final 
supramolecular polymorph can be controlled by varying environment 
conditions parameters such as solvent, temperature or 
concentration.162,170 Regarding this latter parameter, the FF self-
assembly was found be a monomer-concentration-induced shape 
phenomenon, confirming the dependence from concentration and the 
nucleation-dependent nature of the process.171 
Three energy factors were identified by Li at al. as determinant 
parameters for the final morphology: the internal cohesion energy, the 
shape-dependent curvature elastic energy and the monomer-oligomers 
interface energy.172 
Interestingly, Demirel et al. described a straightforward and versatile 
solvent-mediated method for directing the FF self-assembly into tubular 
or vesicular structures by using ethanol or acetone respectively, while a 
reversible shape transition from nanotubes to nanovesicles was also 
observed by concentration modulation of monomers.173 
 
1.6.4 Chemical modification: neighbour homologues of FF 
sequence 
 
A broad chemical exploration of the FF motif enlarged the molecular 
library of the ancestor peptide through a typical approach used for 
peptidomimetic compound (modification of the backbone, N-alkylations, 
protection of terminals, cyclization, inversion of configuration, sequence 
analogues with non-coded amino acids). This approach was allowed by 
very simple and easy synthetic access to the chemistry of peptides. 
Molecular structures of simple representative diphenylalanine-based 
building blocks are reported in Figure 15. 
Cationic FF differs from FF (or zwitterionic FF) for the amidation of the C-
terminus. In the amide form, the C-terminus is not more able to generate 
head-to-tail hydrogen bound interaction.  
Interestingly, this simple chemical modification, altering the interaction 
pathway, strongly affect the self-assembling propriety. Cationic FF can 
self-assemble into nanowires rather than into nanotubes easily.174 
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With the rationale of generate a covalent attachment to fabricated gold 
electrodes for application in nano-devices, Gazit and Reches discovered 
that the tripeptide Cys-FF does not self-aggregate in nanotube but rather 
in regular nanospheres.146 This evidence is explains by the concept that 
the introduction of a thiol group contributes energetically to a cross-linking 
phenomenon that makes possible to warp and to close the stacking layer 
without interference with π- π-staking interaction along two axes. 
 
 
Figure 15: Chemical structure of zwitterionic and cationic FF, Cys-FF and 
Fmoc-FF. Relative self-assembled morphology is reported in the square image.  
 
Strictly correlated with FF are also the molecules Nα protected and 
capped. Remarkably, it has been observed that a 9-
fluorenylmethoxycarbonyl (Fmoc) protected diphenylalanine (Fmoc-FF), 
self-assembles into nanofibrils in water and thus results in a hydrogel 
held together in a network by hydrogen bonding and π–π interaction. The 
water dilution of a stock solution of Fmoc-FF (in dimethyl sulfoxide or 
HFIP) forms strong nanostructured hydrogels with remarkable non-
Newtonians rheological properties.174,175. Compared with other peptide or 
protein hydrogels, Fmoc-FF hydrogel is considerably stronger and stiffer, 
and can be stable at a wide range of temperatures and pH values 
including extreme acidic conditions. Thus Fmoc-FF hydrogels can be 
more advantageous for certain applications such as controlled drug 
release and 3D cell culture 
The tert-Butyloxycarbonyl (Boc)-FF monomer analogue allows to obtain 
peptide spheres or small peptide particles when an its HFIP stock 
solution is diluted in ethanol.167 Instead, the feasible co-assembly of Boc-
FF with FF monomers guides the formation of nanonecklace that show a 
comparable steel stiffness and applicable as molecular ink.177  
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N-capped FF with heterocyclic, N-indole-FF and N-carbazole-FF, are 
reported as indicative example of the crucial role of terminal charges in 
the self-assembly mechanism. Using small angle neutron scattering 
(SANS) and cryo-TEM techniques revealed indole-FF as able to generate 
highly bundled fibres network in acidic condition, whereas the more 
hydrophobic carbazole derivatives self-organize in fibers or wormlike 
micelles in the same range of pH.178 
Other unique micro-structures, like flat plates, flattened micro-planks and 
micro-rods, are referred as self-assembly consequences of side-chain 
elongated diphenylalanine analogues179 (dihomophenylalanine, DiHpa; 
di-2-amino-5-phenylpentanoic acid, DiApp; di-2-amino-6-phenylhexanoic 
acid, DiAph) in which the R lateral group is progressively lengthened by 
the addition of a methylene. (Figure 16)  
 
 
Figure 16: Chemical structure and SEM images of diphenylalanine peptide 
analogues DiHpa, DiApp.  
 
1.6.5 Polymer decoration: amphiphilic derivatives  
Tri-180,181, tetra-182,183 and penta-183 phenylalanine are further molecular 
building blocks derived by elongation of FF motif.  
As foreseeable, these oligo-Phe sequences show a very low water 
solubility. For this, oligo-Phe and high aromatic peptide sequences are 
often decorated with hydrophilic polymers fragment in an effort to improve 
their hydrophilicity.184 This aim is particularly relevant for bio-application 
of self-organized NPs.  
The combination of peptides with synthetic polymers permits to 
synergistically congregate (generally in amphiphilic blocks) peptide 
functionality and recognition capability with polymer cheapness and 
responsiveness in order to obtain new molecular building block with 
enhanced solubility and features.185 
A poly(ethylene oxide)-tetraphenylalanine (PEO-F4) polymer-peptide 
conjugate has been prepared by Tzokova et al.184,186 Using a click-
reaction between an alkyne-modified peptide and an azide-terminated 
PEO oligomer the building-block self-assembled in nanotubes, involving 
the formation of antiparallel -sheet. The PEO length was also fount to 
affect deeply the aggregation morphology. As the length of the PEO block 
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is increased, F4 conjugates giving rise to nanotubes, fibers, and wormlike 
micelles, respectively.184,186 
Crystallization effect of a PEG 5000 fragment was identified by 
Castelletto et al. in a tetra-Phe oligo-sequence using different techniques 
(Polarized Optical Microscopy, X-ray and IR Spectroscopy).187 
The versatility of polymer conjugation was demonstrated also by 
Liberato. A hybrid material was formulated through the conjugation of 
electrospun polycaprolactone (PCL) fibers and micro/nanotubes 
diphenylalanine (FF-MNTs). This material represented a new peptide-
based scaffold able to control the drug delivery with a completely 
biodegradable matrix profile.90 
The rational design of peptide building blocks and the handily synthetic 
procedures of polymer decorations make possible to combine peptides 
self-assembling with a range of other functional moieties. This approach 
seems be a good strategy to overcome the low solubility of aromatic self-
assembling peptide, opening application in biological, pharmaceutical 
and medicinal fields.   
 
6.6 Applications of supramolecular FF based NPs 
The discovery of supramolecular organization of FF puts into effect the 
concept of using aromatic building blocks for designing nanometric 
platforms.  
The demonstrated possibility to alter the final morphology of the 
aggregate (by simply chemical modification, functionalization or ligation) 
can advantageously have a role in the development of new application in 
both non-biological and biological fields. In particular, the previously 
mentioned physical153, chemical156 and thermal157,158 stability of FF 
derivatives opens innovative prospective in material nanoengineering. In 
this field, the better-known application of carbon nanotubes and 
semicondu 
cting nanowires have inspired the FF purpose in same direction. Two of 
the principal support that ADNTs can give in nanofabrication concerns 
the possibility to increase exponentially and functionalize the surface 
area of interest. This approach was successfully applied to electrodes 
fabrication for chemical detection of dopamine188, neurotoxins or 
glucose.189  
In fabrication and manufacturing areas, peptide nanotubes can work as 
filler for composite polymers,190 achieving better materials with enhanced 
properties of mechanical strength and ions transport.191 In metal 
organization, the preformed nanotubular structure was utilized as 
template for silver nanowires.144  
Other remarkable examples regard the use of FF nano-tubes in the 
optimization process of piezoelectrical systems,159 the development of 
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new masks for complex nanowires growth, for nanocables microfluidic 
chips fabrication.164  
Remarkable improvement concerned the inorganic functionalization of 
FF-based materials with the possibility to generate hybrid 
nanocomposites (with Co, Au or Ni) or xerogels.192 The chemical/optical 
behaviour of lanthanides ions (like Eu, Gd or Tb) have inspired their 
incorporation in supramolecular architectures with the aim to improve 
diagnostic methods, produce photoluminescent layers and increase the 
bio-imaging performances.193 
In regards to biological fields, FF based materials have found application 
prospective for new regenerative medicine therapies. The N-Fmoc 
protected analogue of diphenylalanine is largely studied for its possibility 
to generate hard hydrogel as extracellular matrix mimetic and as tri-
dimensional support for cell growth.174,175 Other hydrogels based on 
aromatic building blocks have also proven the ability to encapsulate 
nanocrystal or active pharmaceutical ingredients (API)194 and be 
responsive to external stimuli like enzymes, temperature, and light.195 FF-
based nanostructures possess potential for in vitro drug delivery systems 
and vehiculation of genic therapy. 174 
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2.1 Scope and thesis structure 
eptide-based materials (PBMs) generate by the aggregation of 
amphiphilic monomers represent a rapidly growing tool within 
materials science. They have been considered for several 
applications in different fields from electronic to nanomedicine.  
According to an appropriate design, amphiphilic peptides can 
spontaneously assemble in well-structured supramolecular materials as 
result of an intricate network of inter- and/or intra-molecular interactions 
between hydrophobic and hydrophilic portions. The interaction manner 
can strongly influence both morphology and properties of the final 
supramolecular materials.  
Aromaticity is the terms used to describe the particular molecular stability 
associated to a cyclic shaped and planar chemical entity with a ring of 
resonance bonds. The peculiar electronic structure of aromatics 
molecules arouses their interesting physicochemical properties. All the 
classes of intermolecular forces known as the aromatic interaction give 
raise from it. The knowledge and the study of aromatic interaction 
contaminated peptide based material field too.  
To this day, using self-assembly as instrument of bottom-up nano-
plenning, it is a clear evidence that aromatic peptide sequences, 
containing phenylalanine (Phe), tyrosine (Tyr) or tryptophan (Trp), can be 
opportunely modulated to the aim of generate the required 
supramolecular architecture. 
The forefather of this new class of peptide monomers is the well-known 
diphenylalanine (FF) homopeptide. Through a combination of π-π 
staking and hydrogen-bonding, different method of preparation, specific 
pH values or solvent, FF is able to self-organize in different kinds of nano- 
and macro- morphologies (hollow nanotubes, fibers, vesicles, metastable 
hydrogels or organogels). By this evidence, many structural analogues 
of diphenylalanine were studied and peptide nanostructures containing 
the FF motif or more extended aromatic sequences have been 
investigated for their mechanical, electrochemical and optical properties, 
and more recently for some nanomedicine applications. Nevertheless, 
the majority of studies reported in literature are principally focused on 
clarifying the physicochemical aspects responsible for array stability in 
FF based nanostructures, whereas only few studies have been devoted 
in the investigation of FF aggregates for biomedical applications. This 
essentially because of the intrinsic low water solubility of these peptide 
sequences.  
According to these considerations, during the three years of the PhD 
project, novel poly-phenylalanine self-assembling conjugates were 
carefully designed, synthetized and fully characterized.  
The final peptide materials were evaluated for potential applications in 
bio-imaging field (with particular bearing to Magnetic Resonance Imaging 
P 
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and fluorescence imaging). It was also appreciate as the chemical 
modification of the aromatic framework with chelating agents, gadolinium 
(Gd) complexes, and polyethylene glycol (PEG) fragments with different 
length can affect the structural organization and the supramolecular 
behavior of the nanomaterial.  
The result produced on the hierarchical organization by the chemical 
replacement of the Phe with others aromatic amino acids (such as 
tryptophan, tyrosine and 2-naphthylalanine) was also investigated.  
The entirety of collected data during this PhD project permits to highlight 
the possible relationship existing between the chemical structure of the 
proposed building blocks, the final supramolecular nanostructure, and 
their functional features.  
In order to simplify the comprehension and the discussion of the results 
(Chapter III), they will be argued in three separate sections: 
 
 Section I: PBMs as supramolecular contrast agents for MRI.  
 
 Section II: PBMs as photoluminescent supramolecular probes. 
 
 Section III:  PBMs obtained by punctual chemical modifications of 
homophenylalanine sequences.  
 
In Section I, an innovative class of supramolecular CAs for MRI, based 
on peptide self-assembly monomers, is described and analyzed. 
Different design strategies were applied to obtain and improve the 
aggregation phenomenon. The structural and relaxometric properties of 
each self-assembling system are discussed and mutually compared. The 
improved values of relaxivity and the exanimated capability to 
encapsulate the doxorubicin anticancer drug suggest a potential use of 
the proposed nanostructures as new theranostic platform. 
Photoluminescent (PL) phenomena in peptide-based materials are the 
subject of Section II. A class of novel PEGylated homo-phenylalanine 
was synthetized and, due to the high content of β-sheet, the final self-
assembled systems show blue PL emission. A red-shift of the 
fluorescence was actualized by FRET phenomena between the 
nanostructure and a internalized NBD dye. Committing to the hydrogen 
bonding hypothesis, a relationship between observed PL and the number 
of interaction sites in nanostructures was developed.  
In Section III the effect of a punctual chemical modification on peptide 
primary sequence will be elucidated. Hetero- and homo-sequences were 
derived simply by the replacement of Phe residues with tyrosine and 
tryptophan ones. Characteristic gelification behavior was found for 
peptides containing Tyr. WAXS/SAXS studies and molecular dynamic 
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simulations supported the structural analysis of the new peptide-based 
materials. 
The experimental protocols are totally collected in the dedicated 
Experimental section.  
The full characterization of synthetized peptides, conjugates and 
derivatives is reported in Appendix I, meanwhile additional information, 
Tables and Figures are gather together in Appendix II. 
The first pages of published papers during the PhD period consist of 
Publication section 
  
Purposes 
 
42 
 
Results and Discussion 
 
43 
 
  
Results and Discussion 
 
44 
 
Section I: PBMs as supramolecular contrast agents for MRI  
 
45 
 
  
Section I: PBMs as supramolecular contrast agents for MRI  
 
46 
 
  
Section I: PBMs as supramolecular contrast agents for MRI  
 
47 
3.1 Peptide-based materials for MRI 
upramolecular contrast agents (CAs)64 can be prepared for 
self-assembling of a monomeric units containing two different 
portions: i) a chelating agents able to allow kinetically and 
thermodynamically stable coordination of paramagnetic metal 
ions (like Gd3+ for T1 positive CAs) for diagnostic applications in MRI, ii) 
a hydrophobic portion (one or more alkyl chains or a peptide sequence) 
able to prompt the self-assembling in water.  
Due to the well-known capability of the diphenylalnine144 and of its 
strictly related derivatives (FFF180,181, FFFF182,183, Fmoc-FF175, Boc-
FF177) to self-assemble in a large variety of supramolecular 
nanostructured materials,192 FF sequence was selected as hydrophobic 
portion in order to obtain self-assembling monomeric units. Moreover, to 
enhance the foreseeable low water solubility, different polyethylene 
glycol (PEG) spacers were inserted at N-terminus between the Gd-
complex and the aromatic framework. According to this design 
approach, the effect of the chemical modification of the FF homodimer 
has been careful evaluated in terms of structural organization of the 
final material.  
The relative simple self-organization of di-phenylalanine depends on a 
combination of two kinds of not covalent interactions: i) head-to-tail 
backbone hydrogen bonds and ii)  π-π stacking between the aromatic 
ring of side chains.147  
  
 
Figure 1: a) Schematic representation of diphenylalanine or 
tetraphenylalanine designed conjugates obtained using L2 or L6 polyethoxylic 
linkers and the DTPA(Gd) or DOTA(Gd) as gadolinium complexes. b) Putative 
aggregation pattern for poly-phenylalanine conjugates. 
 
Hydrogen bonds and π-π stacking are weak not covalent interactions 
that occur only if mutual guidance and directionality of the counterparts 
S 
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are kept. For a successful design, it is required remember that chemical 
modifications of Phe-Phe homodimer both at C or N-terminus may 
destroy the head-to-tail intermolecular hydrogen bonds, whereas π-π 
intermolecular interaction of the aromatic framework should be kept.  
The first and simplest approach used was the derivatization at the N-
terminus of the FF sequence with a two different bifunctional chelating 
agent, 1,4,7,10-tetraazacyclododecane- N,N,N,N- tetraacetic acid 
(DOTA) or diethylenetriaminepentaacetic acid (DTPA), for achieving 
Gd(III) coordination. DOTA and DTPA are a cyclic and a linear chelating 
agent, respectively. The compounds DOTA-F2 and DTPA-F2 (Figure 1) 
were easily synthetized according to solid phase peptide synthesis 
(SPPS).196 After purification, products were characterized and identified 
by LC-ESI mass spectroscopy and 1HNMR. Extended characterization 
data are reported in Appendix I 
Gadolinium complexation was achieved coincubating peptide 
conjugates with GdCl3 in equimolar ratios (1/1).  
Independently from the chelating agent used, di-phenylalanine 
conjugates DOTA(Gd)-F2 and DTPA(Gd)-F2 did not show propensity to 
aggregate in water solution (data not shown). The verified incapability to 
self-assemble of these conjugated was related to the steric hindrance of 
the bulk gadolinium complex and to the loss of head-tail hydrogel bond 
interaction.196  
In order to restore the self-association between the Phe residues in the 
monomeric units, we designed and synthesized novel peptide 
conjugates, DOTA-L2-F2 and DTPA-L2-F2 (Figure 1), in which an 
ethoxylic linker, consisting of two (L2) or six (L6).  
As previously observed for DOTA(Gd)-F2 and DTPA(Gd)-F2, also 
DOTA(Gd)-L2-F2 and DTPA(Gd)-L2-F2 did not show any self-
assembling features.  
Indeed, fluorescence spectra of these samples showed an emission 
peak at 282 nm, typically observed for the phenylalanine residue in its 
monomeric form.  
Differently from these peptide conjugates, UV-Vis and fluorescence 
measurements suggest a weak aggregation tendency for DOTA-L6-F2 
and DTPA-L6-F2 conjugates, in which L2 spacer is replaced with L6 
spacer at six ethoxylic units (Figure 2). 
UV-Vis spectra show the typical maximum of Phe residue at 257 nm (n 
π transition of the aromatic residue), and another maximum at 282 
nm, distinctive of the Phe excimer formation (data not shown).187  
Accordingly, fluorescence spectrum of DOTA-L6-F2 at 2.0 mg/mL 
reported in Figure 2 clearly shows the monomer emission at 282 nm 
and the conspicuous excimer emission around 310 nm.184,186 
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Figure 2: Fluorescence spectra of DOTA-L6-F2 and its gadolinium complex 
DOTA(Gd)-L6-F2 in water solution at 2.0 mg/mL 
 
However, the emission peak of phenylalanine excimer almost 
disappears after the gadolinium complexation (Figure 2). The same 
behaviour is also displayed by DTPA-L6-F2. This outcome could be 
attributed to the higher steric effect of gadolinium complex with respect 
to the chelating agent as free base. 
In order to restore the interactions between the phenylalanine side 
chains, two different strategy were proposed:  
 
 Strategy I: elongation of the aromatic framework by increasing the 
number of the phenylalanine residues from two to four, keeping 
unaltered the length of the spacer.196,197 
 
 Strategy II: The replacement of the phenylalanine residues with 
others non-coded amino acids having a more extended aromatic 
side chain. In particular, was used the 2-naphtylalanine amino 
acid.198 
 
3.2. Elongation of the aromatic framework (Strategy I) 
According to the first strategy, the aromatic framework was elongated 
increasing the Phe residue from two to four. In addition, the position of 
the chelating agent was studied. The chelating agent was alternatively 
positioned at the N-terminus (Strategy Ia)196 or at the center (Strategy 
Ib)197 of the molecular organization.  
The different position of the chelating agent permits to evaluate how the 
steric hindrance of the bulk Gd-complex affect the structural and the 
relaxivity properties of the supramolecular aggregate.  
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All the peptide conjugates as free bases and as gadolinium complexes 
were full characterized from the structural point of view both in solution 
and at the solid state. A variety of techniques such as fluorescence, 
Circular Dichroism (CD), Fourier Transform Infrared (FTIR), Dynamic 
Light Scattering (DLS), NMR, Wide-Angle (WAXS) and Small-Angle X-
ray Scattering (SAXS) were employed to achieve the definition of the 
structural organization of the peptide monomeric units in the self-
assembled nanostructure. Moreover, the relaxometric behavior, 
cytotoxicity and cellular uptake in J774A.1 and 3T3 cells of self-
organized nanostructures were also investigated. 
 
3.2.1 Elongation of the aromatic framework- N- 
derivatization (Strategy Ia) 
 
According to the rational of Strategy Ia, two tetra-phenylalanines 
derivatized on their N-termini with a Gd-complex (DOTA(Gd)-L6-F4 and 
DTPA(Gd)-L6-F4) were synthesized. A PEG linker having six 
oxyethelenic units was interposed between the chelating agent and the 
aromatic framework (Figure 1).  
 
 
Figure 4. Fluorescence spectra of DOTA(Gd)-L6-F4 tetra-phenylalanine at 
0.01 mg/mL, 0.1 mg/mL and 2.0 mg/mL concentration. All emission spectra 
were recorded at 25°C between 265 and 400 nm with excitation at 258 nm. 
 
Both the peptide Gd-complexes showed high water solubility: their 
solutions appear perfectly clear up to 35 mg/mL; whereas higher 
concentration (~50 mg/mL) leads to a weak hydrogel formation. The 
same behavior was also observed for L6-F4 derivative lacking of 
chelating agent at the N-terminus.199  
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Preliminarily, propensity to self-assemble of both peptides was initially 
evaluated by fluorescence spectroscopy.  
As previously described, fluorescence spectrum of Phe based peptides 
is characterized by an emission peak at 282 nm upon excitation at 257 
nm.184,186 However, an additional peak at 310 nm appears when the 
formation of Phe excimers occurs. This phenomenon is often related to 
the peptide concentration. In Figure 4, spectra of DOTA(Gd)-L6-F4 at 
three different concentrations (0.01 mg/mL, 0.1 mg/mL and 2.0 mg/mL) 
are reported. From the inspection of the spectra is clearly visible the 
excimer emission peak at 301 nm also at low concentration. 
Furthermore, by increasing the concentration of DOTA(Gd)-L6-F4 from 
0.01 to 2.0 mg/mL, a progressive increase (from 1.7 to 4.0) of the ratio 
between the fluorescence intensities at λ310 and λ 282 is observed.  
 
3.2.2 Determination of the Critical Aggregation 
Concentration (CAC) 
 
Critical aggregate concentration (CAC) values of tetra-phenylalanine 
derivatives as free basis or as gadolinium complexes were 
quantitatively estimated by using two fluorescence-based methods: i) 
the 8-anilinonaphthalene-1-sulfonate ammonium salt (ANS) and ii) the 
pyrene (Pyr). Results obtained with these two complementary methods 
are listed in Table 1.  
ANS fluorophore gives fluorescence emission at 460-480 nm only in a 
hydrophobic environment, such as in the micelle core.63 The 
fluorescence intensity of an ANS solutions (20 mM in water) at 475 nm 
as function of tetra-phenylalanine derivatives concentration are reported 
in Figure 5.  
 
a) 
 
b
) 
 
 
Figure 5: Fluorescence intensity emission of ANS fluorophore at 475 nm vs. 
concentration of DTPA-L6-F4 (a) and DOTA-L6-F4 (b) as free bases or as 
gadolinium complexes. CAC values are established from the break points. 
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During the titration experiment, the fluorescence emission of DOTA-L6-
F4 remains unchanged until 75 mM (~ 0.099 mg/mL), whereas an 
increase in the signal at 475 nm was detected above this concentration 
value, indicating the self-organization of the tetra-phenylalanine 
derivative (Figure 5a). Usually, in the molecules containing chelating 
agents, aggregation properties can be influenced by two different 
phenomena: electrostatic repulsions and/or steric hindrance.200 
However, only a slight decrease in the CAC value is observed after the 
gadolinium complexation that reduces the negative charge from -3 to 0 
(CAC = 0.076 mg/mL for DOTA(Gd)-L6-F4).  
On the contrary, a significant change has been observed when DOTA is 
replaced by the branched chelator DTPA (CAC = 0.59 mg/mL) or by its 
Gd(III) complex DTPA(Gd) (CAC = 0.51 mg/mL) (Figure 5b and Table 
1).  
 
Table 1. Critical aggregate concentration (CAC) values of tetra-phenylalanine 
derivatives measured by titration of ANS fluorophore. 
 
Sample CAC (M) CAC (mg/mL) 
DOTA-L6-F4 7.5 ·10
-5 9.9 · 10-2 
DOTA(Gd)-L6-F4 5.1 · 10
-5 7.6 · 10-2 
DTPA-L6-F4 4.5 · 10
-4 59 · 10-2 
DTPA(Gd)-L6-F4 3.5 · 10
-4 51 · 10-2 
 
These results suggest that the influence of electrostatic repulsions is 
almost negligible, whereas the replacement of the macrocycle DOTA 
with the branched and bulky DTPA produces an increase of the CAC 
values. Aggregation of tetra-phenylalanine derivatives was also 
investigated by monitoring fluorescence behaviour of pyrene (Pyr). 1 
mM Pyr solution was titrated by adding increasing amounts of tetra-
phenylalanine derivatives. Fluorescence spectra of Pyr/ DOTA(Gd)-L6-
F4 solutions are reported in Figure 6a,b.  
Pyr is a poorly soluble water molecule that shows an emission spectrum 
in water with five vibrational bands when excited at l = 335 nm: the first 
(I1 at 373 nm) and the third (I3 at 383 nm) of them are strongly affected 
by the polarity of the surrounding environment.201  
Moreover, at high concentration Pyr gives stacking phenomena 
resulting in excimer’s formation that can be diagnosed by the 
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appearance of a maximum at around 480 nm.202 The addition of small 
amounts of DOTA(Gd)-L6-F4 to Pyr solution causes a progressive 
decrease of fluorescence signal (Figure 6a). 
 
a) 
 
 
b) 
 
 
Figure 6: Fluorescence spectra of 1mM pyrene solution titrated with 
DOTA(Gd)-L6-F4. Pyr emission spectra were recorded at 25°C between 350 
and 550 nm with excitation at 335 nm. 
 
This effect was observed until concentration 14.3 mM of tetra-
phenylalanine derivative, in which Pyr/DOTA(Gd)-L6-F4 molar ratio is 
1/10. On the contrary, at concentration of 167 mM and higher, an 
increase of the fluorescence intensities occurs.  
These data indicate that the aggregation phenomenon occurs at 
concentration within the 14.3 - 167 mM range, in agreement with the 
CAC value (51 mM) found by ANS titration, suggesting that when 
DOTA(Gd)-L6-F4 concentration is lower than 14.3 mM, the predominant 
effect is a quenching due to the aromatic stacking between 
phenylalanine residues and pyrene, whereas above this concentration, 
a Fluorescence Resonance Energy Transfer (FRET) effect occurs in 
which tetra-phenylalanines, in their aggregated form, act as donor for 
pyrene. 
 
3.2.3 Secondary structure assignment  
The secondary structure of DOTA-L6-F4 and DTPA-L6-F4 peptide 
derivatives, as free bases or as gadolinium complexes, was assessed 
using circular dichroism (CD in Figures 7 and 8) and Fourier transform 
infrared spectroscopies (FTIR in Figure 9a). These spectroscopic 
methods are typically employed for monitoring the conformational 
behavior of peptide-based nanostructures and mainly for revealing 
secondary structural features, such as β-sheet structures, 
accompanying the formation of amyloid fibers.  
CD spectra of solutions at several concentrations were recorded 
between 280 and 195 nm. CD spectra at concentrations below or close 
to CAC values clearly show two maxima around 205 and 220 nm, due 
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to aromatic side-chains stacking, and pronounced minimum at 232 nm, 
which can be associated with a β-structure184,186,203  
From the inspection of Figure 7, the CD spectra of peptide derivatives 
show similar trend irrespective of chelating agent. 
 
 
Figure 7: Selected Far-UV CD spectra of (a) DOTA-L6-F4, (b) DOTA(Gd)-L6-
F4, (c) DTPA-L6-F4 and (d) DTPA(Gd)-L6-F4 in 0.1-35 mg/mL concentration 
range. 
 
However, the conformational transition described above was detected 
at higher concentration for DTPA-L6-F4 than DOTA-L6-F4, in agreement 
with the difference in CAC values between these conjugates. Dichroic 
tendency of DOTA(Gd)-L6-F4 at 20 mg/mL (well above the CAC value 
determined by fluorescence) was also evaluated as function of the 
temperature between 10 and 80°C. At low temperature, it was observed 
a distinct minimum around 235 nm, typical of the poly-phenylalanine in 
β-aggregate form (Figure 8a).  
By increasing the temperature, the shape of the spectra remains 
unchanged, but a progressive decrease of the signal intensities with a 
red-shift effect occurs probably due to a progressive unfolding of the 
peptide conjugate with higher molecular mobility.  
However, the conformational features are kept almost until 80°C, thus 
indicating a good thermal stability of the aggregate.204 The integrity of 
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the gadolinium complex in DOTA(Gd)-L6-F4 at the final temperature 
(80°C) was confirmed by the mass peak reported in Figure 8b. 
 
a) 
 
b) 
 
Figure 8: a) CD spectra of DOTA(Gd)-L6-F4 aggregate solution at 20 mg/mL: 
aggregate solution was heated from 10 °C to 80 °C; b) ESI mass spectrum of 
DOTA(Gd)-L6-F4 after heating at 80°C. 
 
FTIR spectroscopy is often employed to probe the secondary structure 
assumed by di- or tetra-phenylalanine derivatives.205,206  
Usually, the attention is focused on the amide I bands able to provide 
information on the secondary structure adopted. FTIR spectra in the 
amide I region are shown in Figure 9a for DTPA(Gd)-L6-F4 and 
DOTA(Gd)-L6-F4 solutions at 2.0 mg/mL. 
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Both the spectra show a principal peak at 1637 cm-1 and a minor peak 
at 1680 cm-1.  
 
a) 
 
b)  
 
c) 
 
d) 
 
 
Figure 9: a) FTIR spectra of DOTA(Gd)-L6-F4 and DTPA(Gd)-L6-F4 in the 
amide I region at 2.0 mg/mL concentration. b) Fluorescence spectrum of ThT 
before and immediately after the addition of DOTA-L6-F4 in aqueous solution. 
Spectra of DOTA-L6-F4 and its gadolinium complex DOTA(Gd)-L6-F4 are also 
reported for comparison. Final concentration of poly-phenylalanine derivative 
in cuvette is 2.0 mg/mL. c) The UV-Vis spectra of DOTA(Gd)-L6-F4, stained 
with Congo Red, at 0.1 and 1.0 mg/mL. The spectrum of Congo Red is also 
reported for comparison. In the insert are reported the spectra of DOTA(Gd)-
L6-F4 0.1 mg (○) and 1.0 mg/mL (●) after the subtraction of CR spectrum. d) 
Polarized optical microscopy image of dried DOTA(Gd)-L6-F4 onto a glass 
microscopy slide stained with Congo Red solution.  
 
The peak at 1637 cm-1 is strongly indicative of β-sheet formation, 
whereas the fewer intensity of the second peak at 1680 cm-1 is 
indicative of an antiparallel orientation of the b-sheets.207 FTIR spectra 
were also recorded on a dried film of DTPA(Gd)-L6-F4 and DOTA(Gd)-
L6-F4 (data not shown).  
These spectra reported show a similar profile with respect to samples in 
solution.  
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Amyloid type fibril formation was also confirmed by using the typical 
Thioflavin T208 (ThT) and Congo Red spectroscopic assays.209  
Fluorescence spectra of ThT, before and after the addition of DOTA-L6-
F4, are reported in Figure 9b. Spectra of DOTA-L6-F4 and its Gd(III) 
complex in absence of ThT are also reported for comparison.  
As shown in Figure 9b, DOTA(Gd)-L6-F4 gadolinium complex alone 
gives an emission peak in the same region in which the emission of 
ThT-β aggregate is expected. Therefore, in this sample we cannot 
attribute the peak at 482 nm to the interaction between ThT and the 
tetra-phenylalanine aggregate. On the contrary, in its uncomplexed 
form, DOTA chelating agent did not provide fluorescence signals. The 
sudden appearance of an emission peak at 482 nm after the addition of 
DOTA-L6-F4 (2.0 mg/mL as final concentration) indicates 
unambiguously the binding of the ThT to the peptide derivatives.125 The 
fluorescence signal remains unchanged until 2h from the incubation, 
thus confirming the immediate interaction of ThT with peptides.  
 
a) 
 
b) 
 
c) 
 
d) 
 
 
Figure 10: Images of a,b) DTPA(Gd)-L6-F4 and c,d) DOTA(Gd)-L6-F4 fibers 
stained with Congo Red and observed with a Nikon microscope under bring 
field illumination (on the left) and between crossed polars (on the right). Fibers 
containing Congo Red were obtained by the stretch frame method. 10 μL of 
peptide aqueous solution (3 wt%), containing was suspended between the 
ends of a wax-coated capillary and dried.  
 
The same behavior was also observed for tetra-phenylalanine 
analogues containing DTPA chelating agent and its gadolinium complex 
(data not shown). According to the ThT assay, Congo Red (CR) 
staining (both UV-Vis spectroscopy and polarized optical microscopy) 
confirms the amyloid type fibril formation.209 CR is an azoic dye, 
frequently used as indicator of the occurrence of amyloid like fibrils. UV-
Vis spectra, reported in Figure 9c, show the spectral shift of the 
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conventional CR band from 488 to 540 nm after the addition of 
DOTA(Gd)-L6-F4 in the couvette for two different concentrations (0.1 
and 1.0 mg/mL). At the same time, both air-dried films of Gd(III) poly-
phenylalanine derivatives stained with CR and F4 peptide dried fibers 
containing CR exhibit intense green birefringence when imaged with 
polarized optical microscopy (Figure 9d and Figure 10). 
 
3.2.4 Solid state characterization: TEM and X-ray 
Diffraction 
 
The morphology of the self-assembled nanostructures was also 
assessed by transmission electron microscopy (TEM) and X-ray 
diffraction.  
Selected images of DTPA(Gd)-L6-F4 and DOTA(Gd)-L6-F4 gadolinium 
complexes in water solution at 5.0 mg/mL show the presence of long 
nanofibers with a minimum thickness around 10 nm (Figure 11).  
 
 
Figure 11: Selected TEM images for (a-b) DOTA(Gd)-L6-F4 at 5.0 mg/mL and 
(c-d) DTPA(Gd)-L6-F4 at 5.0 mg/mL. Scale bars are 200 nm for A and D 
images; 100 nm for B and 500 nm for c. 
 
The recorded X-ray diffraction (XRD) patterns from DOTA(Gd)-L6-F4 
and L6-F4 peptide dried stalks are shown in Figure 12a,b. Miller indices 
and d-spacings for both fiber types were determined using the software 
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CLEARER210 and are reported in (Table A1 and Table A2 reported in 
Appendix II).  
 
   
Figure 12: Selected X-ray fiber diffraction for DOTA-L6-F4 (A) and L6-F4 (B). 
These patterns show the diffraction features associated with the b structure. 
Based on our experimental results, on the right side it is reported a model of 
DOTA(Gd)-L6-F4 as monomer, dimer and stacked-dimers. 
 
As clearly indicated from the diffraction pattern, the structural 
arrangement of the PEGylated cationic tetra-phenylalanine was not 
significantly affected from the functionalization of the N-terminus with 
the DOTA (or DTPA, data not shown) chelating agents.199 Both the X 
ray diffractions show the typical “cross-β” diffraction pattern of amyloid 
fibers, with a Bragg spacing of 4.8-4.9 Å along the meridian, generally 
attributed to the inter-chain distance between the hydrogen-bonded-
strands oriented perpendicularly to the fiber axis, and a more diffuse 
Section I: PBMs as supramolecular contrast agents for MRI  
 
60 
periodicity of ~10 Å in the equatorial direction, usually ascribed to the 
staking of these β-sheets perpendicularly to the fiber axis.124 
These XRD and TEM results are in agreement with the above reported 
CD (Figure 7) and IR data (Figure 9a) indicating a β-sheet 
conformation of DOTA(Gd)-L6-F4 in a dried film. In Figure 12 it is also 
reported a simplified theoretical model in extended conformation of 
DOTA(Gd)-L6-F4 based on experimental results.  
To better appreciate the monomer dimension (estimated in ~50 Å), it is 
imagined that the antiparallel two-stranded in -disposition pointed up 
the plane of the paper, and the stacked-dimers with the fiber axis 
pointed toward the observer. 
 
3.2.5 Relaxometry 
As widely described in the Introduction section, Gd-complexes are used 
as positive MRI contrast agents (CAs) as they are able to strongly 
enhance the water protons relaxation rate in aqueous solutions thanks 
to the magnetic dipolar interaction between unpaired electrons on the 
Gd3+ ions and the water protons. Their efficacy as MRI CAs is thus 
measured on the basis of this ability, which is usually defined as 
longitudinal “relaxivity” (r1p) and is referred to the water proton relaxation 
rate of a solution containing one millimolar concentration of the Gd-
complex.  
The relaxivity of a Gd-containing system depends on the complex 
interplay among structural, dynamic and electronic parameters.15,16 At 
the frequencies most commonly used in commercial tomographs (20-60 
MHz), r1p is generally determined by the reorientational correlation time 
(τR) of the chelate so that high molecular weight systems display higher 
relaxivity.211  
Based on this property, it is possible to follow the occurrence of an 
aggregation process involving a Gd-complex through the measure of 
the water proton longitudinal relaxation rate of its aqueous solution.  
The relaxivities of DOTA(Gd)-L6-F4 and DTPA(Gd)-L6-F4, measured at 
21.5 MHz (0.5 T) and 298K as a function of the complex concentration, 
are reported in Figure 13a. The observed progressive enhancement in 
relaxivity is indicative of the self-aggregation of the two Gd-complexes. 
The insert in Figure 13a shows an amplification of the graph at low 
concentration values from which it is possible to observe that 
DTPA(Gd)-L6-F4 starts to aggregate at higher concentrations than 
DOTA(Gd)-L6-F4, reflecting the CAC values determined by 
fluorescence spectroscopy.  
The analysis of the magnetic field dependence of the relaxivity, 
obtained through the registration of the so called NMRD (Nuclear 
Magnetic Resonance Dispersion) profiles, allows the determination of 
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the principal parameters characterising the relaxivity of a Gd(III) 
chelate.  
The NMRD profiles of DOTA(Gd)-L6-F4 and DTPA(Gd)-L6-F4, 
measured at 40 mg/mL concentration, are reported in Figure 13b. The 
shape of both the profiles, with the characteristic peak of relaxivity in the 
region of Proton Larmor Frequencies 10-70 MHz, is a clear indication 
that, at this concentration, the Gd-complexes are in an aggregated 
form.  
Data were fitted to the conventional Solomon-Bloembergen-Morgan 
theory212,213 and the relative fitting parameters are reported in Table 2.  
The high field relaxivity of the two complexes are quite similar, being, at 
20 MHz, 14.8 and 14.0 mM-1s-1 for DOTA(Gd)-L6-F4 and DTPA(Gd)-L6-
F4, respectively. The tR values found for the two complexes are in fact 
very close. On the other hand, the big difference in relaxivity observed 
in the low field region has to be ascribed to the difference in the 
electronic relaxation time (ts0) of the two Gd-complexes (Table 2). 
 
 
a
) 
 
b
) 
 
 
Figure 13: (A) Longitudinal proton relaxivity of DOTA(Gd)-L6-F4 and 
DTPA(Gd)-L6-F4 measured at 21.5 MHz (0.5 T) and 298 K as a function of the 
concentration of the poly-phenylalanine Gd-complexes. (B) NMRD profiles of 
the 40 mg/mL aqueous solutions of the two poly-phenylalanine Gd-complexes 
at 298K. The data refer to 1 mM concentration of the paramagnetic 
complexes. 
 
It is in fact known, that highly symmetric and rigid DOTA-type chelates 
generally have longer ts0 values than DTPA-like, and this physically 
translates to a higher low-field relaxivity.214 
It is worth to note that the tR values extracted from the fitting procedure 
for DOTA(Gd)-L6-F4 and DTPA(Gd)-L6-F4 in the aggregated form are 
quite short if compared to those usually found for nano-sized 
aggregates (1-30 ns).  
Likely, this finding can be explained with the occurrence of a quite fast 
internal motility of the Gd-complexes along the linker spacer with 
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respect to the overall fibril-like structures, as evidenced in the model 
arrangement proposed in Figure 12.  
 
Table 2. Main relaxometric parameters derived from fitting of NMRD profiles at 
21.5 MHz reported in Figure 10B.[a
] 
System r1p (mM
-1s-
1) 
Δ
2
(s
-2
)[b] τV (ps)
[c] τ
s0
 
(ps)[d] 
τ
R
 (ps)[e] 
DOTA(Gd)-L6-F4 14.8 8.0×10
18
 49 212 490 
DTPA(Gd)-L6-F4 14.0 1.25×10
19
 52 127 457 
[a]On carrying out the fitting procedure, some parameters were fixed to 
reasonable values: rGd-H (distance between Gd and protons of the inner sphere 
water molecule) = 3.1 Å; a (distance of minimum approach of solvent water 
molecules to Gd3+ ion) = 3.8 Å; D (solvent diffusion coefficient) = 2.2∙10-5 cm2 
s-1. [b]Squared mean transient zero-field splitting (ZFS) energy. [c] Correlation 
time for the collision-related modulation of the ZFS Hamiltonian. [d]Electronic 
relaxation time at zero field (calculated as 1/τs0=12Δ
2×τv ). 
[e]Reorientational 
correlation time.  
 
3.2.6 Cytotoxicity and MRI evaluation of the cellular 
uptake  
 
The cytotoxicity of the fibril nanoaggregates of DOTA(Gd)-L6-F4 and 
DTPA(Gd)-L6-F4 has been initially tested in the mouse embryonic 
fibroblast cell line 3T3 in the concentration range 0.5-5.0 mg/mL 
(Figure 14a). With a view to the subsequent experiments on the 
evaluation of the MRI cellular response, given that the particles, in this 
preliminary stage, are not functionalized for a target-specific cellular 
internalization, it was necessary to push the uptake experiment with an 
overnight incubation.  
The cytotoxicity assay revealed a significant reduction in fibroblast 
viability along with the increase of the Gd-complexes concentration, 
with a higher effect in the case of DOTA(Gd)-L6-F4 particles.  
The cytotoxicity appears to be higher than that reported in the case of 
analogous di-phenylalanine microtubes in the same cell line152 because 
of the longer incubation time (overnight in our experiments vs. 2 hours 
in the literature data152).  
A recent work on the assessment of the cellular response to dissolution 
and degradation products from self-assembled Fmoc-FF gels revealed 
that the critical factor affecting cell viability is the time a gel is allowed to 
degrade and leach into the media.213  
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It is hypnotized that a way to elude a long incubation time while 
maintaining a sufficient amount of internalized probes to test their ability 
to enhance the MRI cellular response would be to use a macrophagic 
cell line which attitude is to phagocytize a huge amounts of particles in 
short times Thus, the cytotoxicity of the fibril nanoaggregates of 
DOTA(Gd)-L6-F4 and DTPA(Gd)-L6-F4 was investigated in J774A.1 
mouse macrophages (Figure 14b) in the same concentration range 
(0.5-5.0 mg/mL) but with an incubation time of 3h. In this case, the 
treated cells showed the same viability of the control cells even at the 
higher concentrations. 
 
Figure 14: Cell viability percentage, evaluated by CellTiter-Blue® reagent test, 
after overnight treatment of the 3T3 fibroblasts (a) and 3h treatment of 
J774A.1 macrophages (b) with various concentrations of DOTA(Gd)-L6-F4 and 
DTPA(Gd)-L6-F4. Data are expressed as the mean ± SD (n = 3). 
 
a) 
 
b) 
 
 
Figure 15: a) Amount of internalized gadolinium ions, evaluated by ICP-MS, in 
J774A.1 cells incubated with increasing concentrations of DOTA(Gd)-L6-F4, 
DTPA(Gd)-L6-F4, Gd-DOTA and Gd-DTPA for 3 hours. b) T1-weighted MR-
images, and relative observed relaxation rates, of pellets of J774A.1 cells 
labelled with 1.5 and 3.5 mM DOTA(Gd)-L6-F4, DTPA(Gd)-L6-F4, Gd-DOTA 
and Gd-DTPA. 
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Next, the uptake efficiency of DOTA(Gd)-L6-F4 and DTPA(Gd)-L6-F4 
nanoaggregates and their efficacy in enhancing the MR-signal upon 
internalization, were investigated in J774A.1 cells and compared to 
those of the parents Gd-DOTA (Dotarem®, Guerbert SA, France) and 
Gd-DTPA (Magnevist®, Schering AG, Germany) complexes. The cells 
were incubated with increasing concentrations of DOTA(Gd)-L6-F4 and 
DTPA(Gd)-L6-F4 for 3h at 37 C and the amount of internalized 
gadolinium determined through ICP-MS analysis (Figure 15a).  
 
3.3 Elongation of the aromatic framework- Gd containing 
telechelic PEG end-capped by FF motives (Strategy Ib). 
 
As an alternative the Gd-complex can be positioned at the center of the 
aromatic framework. According to this approach, it was designed and 
the synthetized asymmetric analogue monomer for obtain 
supramolecular CA. FF-AdOO-Lys(DOTA-Gd)-AdOO-FF [indicated as 
FF-DOTA(Gd)-FF] is designed as a telechelic PEG-polymer end-
capped by FF motives (for a total of four Phe residue for molecule). The 
Gd-complex is placed at the center of F4-PEG-motive, bounded to a Nε 
of a lysine (Lys) residue (Figure 16).  
 
a) 
 
b) 
 
 
Figure 16: Schematic representation of a) FF-DOTA-FF and b) ff-DOTA-FF. 
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This peptide conjugate has been designed with the idea to confer 
higher rigidity to the DOTA(Gd) complex with respect to the already 
studied tetraphenylyalanine derivatives, in which the chelating agent is 
anchored to a long and flexible oxoethylene linkers.196 Thanks to their 
high tendency to associate via non covalent interactions, the two 
hydrophobic phenylalanine residues on the N and C termini should 
guarantee aggregating properties for the final adducts.  
The objective of this study is aimed to evaluate how the relaxivity 
properties of the self-assembled CA can be affected by the different 
position having the Gd(III) complex in the aromatic framework.  
Due the high symmetry of the molecule and in order to investigate the 
effect of the phenylalanine chirality on the self-aggregation and 
relaxivity properties, an analogue, ff-DOTA(Gd)-FF, in which the two L-
Phe residues at the N-teminus are replaced with two D-Phe (f), was 
also synthesized and studied.  
Schematic representation of FF-DOTA(Gd)-FF peptide conjugate and 
its analogue ff-DOTA(Gd)-FF is reported in Figure 16a and Figure 16b. 
On the basis of the literature,153 the building block based on the D-
amino acid analogue of the FF dipeptide should self-assemble into 
highly persistent discrete nanotubes having the same structural features 
as the corresponding L-amino acid peptide.  
The observed variations in terms of relaxometric performances are 
analyzed and correlated to the structural morphology of the aggregate 
using several techniques: fluorescence, Circular Dichroism (CD) and 
Fourier Transform Infrared (FTIR) spectroscopies for aggregation 
tendency and secondary structure determination; Dynamic Light 
Scattering (DLS) and Transmission Electron Microscopy (TEM) for 
morphological definition. 
  
3.3.1 Peptide conjugates synthesis  
Peptide synthesis of the two gadolinium compounds was performed by 
using solid phase methods (SPPS) using the Fmoc chemistry215, as 
reported in Scheme 1.  
In agreement with previous reported synthesis of F4-conjugate,196 Rink 
amide MBHA resin, which releases peptide adducts as amide on the C-
terminus, was used. After the coupling of two phenylalanine residues 
and of Fmoc-AdOO-OH ethoxylic spacer on the solid support, a Lys 
residue orthogonally protected with Mtt on the epsilon amino function 
was added. The removal of the Mtt protecting group allowed 
introduction of DOTA(OtBu)3-OH on the Lys side chain. The synthesis 
was completed by introducing the second ethoxylic spacer and the 
other two phenylalanine residues. Therefore the peptide-DOTA(OtBu)3 
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derivatives were fully deprotected, cleaved from the resin and purified 
by RP-HPLC. Purity (> 95%) and identity of the products were 
confirmed by HPLC and mass spectra. 1HNMR studies were also 
performed in CD3OD solution at 600 MHz and the mono-dimensional 
spectrum is reported in Appendix I.  
The complexation of Gd(III) ions to the DOTA containing peptide 
conjugates to obtain FF-DOTA(Gd)-FF and ff-DOTA(Gd)-FF has been 
carried out by adding equimolar amounts of GdCl3 to the aqueous 
solutions of the DOTA derivatives at neutral pH and room temperature, 
as already reported.196 
 
 
Scheme 1: Schematization of the synthetic route for the solid-state 
obtainment of FF-DOTA-FF.  
X 2
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3.3.2 Structural characterization 
Critical aggregation concentration (CAC) values of peptide conjugate 
FF-DOTA-FF and of its corresponding Gd-complex were determined 
using the fluorescence spectroscopy. Upon titration of ANS (20 μM in 
cuvette) with increasing amounts of our peptide conjugates a distinctive 
emission peak at 460 nm appears. 
 
a) 
 
b) 
 
Figure 17: Fluorescence intensity emission of ANS fluorophore at 460 nm 
versus concentration of FF-DOTA-FF (a) and ff-DOTA-FF (b) as free basis 
and as gadolinium complex. CAC values, established from the break points, 
are 8.1·10-4 M and 6.0·10-4 M, respectively. 
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The CAC values have been determined from the graphical break points 
of the plot in Figure 17, in which is reported the variation of the ANS 
fluorescence intensity as function of peptide concentration.  
The CAC values of FF-DOTA-FF peptide conjugate and its Gd-complex 
are 7.7·10-4 M (1.1 mg/mL) and 5.8·10-4 M (0.9 mg/mL), respectively. 
By these results, an initial aggregation phenomenon can be assumed 
starting at concentration of 1.0 mg/mL for the Gd free peptide 
derivatives. Not significant differences are observed for peptide 
sequences in which the two Phe in configuration L were replaced with 
Phe in D ones. (CAC values determined are 8.1·10-4 M and 6.0·10-4 M 
for ff-DOTA-FF and ff-DOTA(Gd)-FF, respectively).  
 
a) 
 
b) 
 
Figure 18: a) Intensity correlation function of FF-DOTA(Gd)-FF. b) Selected 
TEM images for FF-DOTA(Gd)-FF (left) and ff-DOTA(Gd)-FF (right) at 10.0 
mg/mL. 
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As expected, after the gadolinium coordination, the neutralization of the 
three negative charges on the DOTA macrocyclic chelating agent 
causes a slight decrease of the CAC value, thus favoring peptide self-
aggregation. However, the CAC values, here determined, are one order 
of magnitude higher that values previously found for DOTA-L6-F4 and 
its Gd-complex (0.1 and 0.08 mg/mL). 
Self-assembled aggregates were further characterized from the 
structural and morphological point of view.  
Mean diameters and diffusion coefficients of the gadolinium self-
assembled contrast agents in water solution were measured by 
Dynamic Light Scattering (DLS) at 10 mg/mL. The intensity profile of 
FF-DOTA(Gd)-FF, reported in shows a mono-modal distribution due to 
translational diffusion process (Figure 18a) of aggregate with an 
apparent translational diffusion coefficient D = 2.2· 10-12 m2s-1. Through 
the Stokes-Einstein equation, it was calculate the mean diameter of ~ 
230 nm, which is compatible with supramolecular aggregates.  
The morphology of the self-assembled nanostructures assessed by 
TEM is reported in Figure 18b. Images of the Gd-complex in water 
solution at 10 mg/mL-1 clearly indicate the presence of fibrillary 
networks, typically observed for others aromatic-based peptides. 
 
3.3.3 Secondary structure analysis  
The secondary structure of the peptide conjugates in water solution was 
achieved by Circular Dichroism (CD) and Fourier Transform Infrared 
(FTIR) spectroscopies (Figure 19).  
CD measurements of the peptides were recorded between 280 and 195 
nm at several concentrations in 2.5 - 20 mg/mL range and spectra are 
reported in Figure 19a. CD spectrum of FF-DOTA(Gd)-FF, recorded at 
2.5 mg/mL, show two maxima at 202 and 221 nm. These maxima can 
be attributed to the stacking of the aromatic side chains. The main 
maximum at 221 nm undergoes to a red-shift as function of the 
concentration, indicating an increase of the β-sheet content.203,216 In 
Figure 19b, CD spectrum of ff-DOTA(Gd)-FF at 2.5 mg/mL reveals a 
minimum at 218 nm, consistent with a substantial β-sheet content. As 
for FF-DOTA(Gd)-FF analogue, a progressive red-shift of the minimum, 
due to the increase of concentration, was observed.  
Further information on the secondary structure adopted by peptide 
conjugates and their Gd-complexes was obtained investigating the 
amide I region of FTIR spectra in aqueous solution (10 mg/mL). FTIR 
spectra of LLLL isomer and DDLL one showed a similar profile, with 
very slight differences between the free bases and the Gd-complexes.  
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From the inspection of the spectra of FF-DOTA-FF and FF-DOTA(Gd)-
FF, reported in Figure 19C, it is possible to detect with three peaks at 
1637, 1674 and 1680 cm-1.  
 
 
Figure 19: Selected Far-UV CD spectra of (a) FF-DOTA-FF and of (b) ff-
DOTA-FF in a concentration range of 2.5-20 mg mL-1. Spectra are recorded 
between 280 and 195 nm. In the insert it is reported the variation of the 
wavelength as function of the peptide concentration. c) FTIR amide I region for 
FF-DOTA-FF and FF-DOTA(Gd)-FF 
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The peak at 1674 cm-1 is associated with residual trifluoroacetate 
counterions,217 deriving from the peptide chromatographic purification. 
Instead, both 1637 and 1680 cm-1 are indicatives of β-sheet formation 
with an antiparallel orientation.203,216,217  
CD and FTIR results, together with TEM images, indicate the ability of 
the peptide Gd-complex to self-aggregate in fibrillary and intricate 
network dominated by an antiparallel β-shift arrangement.  
Based on these results and of the models previously proposed in 
literature for oligo-phenylalanines, we speculated and proposed one of 
the possible aggregation pathway (Figure 20). 
In FF-DOTA(Gd)-FF, or its analogue containing D-Phe, the aromatic 
framework composed of four Phe residues is interrupted by the -AdOO-
Lys[DOTA(Gd)]-AdOO- structural portion. At high concentration, it is 
feasible that a folding of the peptide backbone occurs as reported in 
Figure 20. This folding should favor the intramolecular approach of 
phenyl rings of the C and N termini and permits intermolecular T-shape 
staking. As suggested by CD and FTIR data, the peptide conjugates 
interact with an antiparallel β-arrangement. From this evidence widely 
supported by experimental results, it is imagined that the Gd-DOTA 
complexes point far from the spine of the aggregate. 
 
 
Figure 20: Schematic representation of the proposed aggregation pathway for 
FF-DOTA-FF peptide conjugate. 
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3.3.4 Relaxivity performaces 
The NMRD profiles of FF-DOTA(Gd)-FF and ff-DOTA(Gd)-FF, 
measured at 50 and 5 mg/mL concentrations, are reported in Figure 
21. From a qualitative point of view, the shape of the profiles gives 
information on the aggregation state of the system: low molecular 
weight Gd-complexes, in fact, show NMRD profiles with a dispersion in 
the region 1-10 MHz, while a characteristic peak of relaxivity appears, in 
the region of proton Larmor frequencies 10-70 MHz, in the case of high 
molecular weight Gd-containing systems. Inspection into Figure 21 
reveals that both FF-DOTA(Gd)-FF and ff-DOTA(Gd)-FF are mostly in 
monomeric form at a concentration of 5 mg/mL, while, at a 
concentration ten times higher, the aggregation process is definitively 
completed, particularly in the case of ff-DOTA(Gd)-FF where the high 
field relaxivity peak is better evidenced. Data were fitted to the 
conventional Solomon-Bloembergen-Morgan theory212,213 and the 
relative fitting parameters are reported in Table 3.  
 
Figure 21: The magnetic-field dependence of the relaxivity (r1) measured over 
an extended range of magnetic field strengths (from 0.01 to 70 MHz). The 
nuclear magnetic relaxation dispersion (NMRD) profiles were obtained for the 
aqueous suspensions of FF-DOTA(Gd)-FF at 5 mg/mL (□) and 50 mg/mL (■) 
and ff-DOTA(Gd)-FF at 5 mg/mL (∆) and 50 mg/mL (▲). The temperature was 
set to 298K and data were normalized to 1mM concentration of Gd3+ 
These aggregates showed enhanced properties with respect to low-
molecular weight Gd-DOTA complexes. FF-DOTA(Gd)-FF and ff-
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DOTA(Gd)-FF complexes showed two different shape of the NMRD 
profiles at 5 and 50 mg/mL: at high concentration the characteristic 
peak of high molecular weight Gd-containing system appears in the 
region of proton Larmor frequencies 10-70 MHz. These result suggests 
that only well above 5 mg/mL, both the peptide conjugates are 
definitively self-assembled in a supramolecular structure. As expected, 
the relaxivity values of the two Gd-complexes (r1p = 10.1 and 11.5 mM
-
1s-1) in the aggregated form were found higher those in the monomeric 
form (7.1 and 7.9 mM-1s-1).  
 
Table 3. Main relaxometric parameters derived from fitting of NMRD profiles 
reported in Figure 21.[a] 
System r1p(mM-
1s1) 
Δ
2
(s
-2
)[b] τV 
(ps)[c] 
τ
s0
 
(ps)[d] 
τ
R
 
(ps)[e] 
LLLL 
isomer 
monomer 7.1 1.66×10
19
 32.8 153 190 
aggregate 10.1 1.86×10
19
 41.0 109 270 
LLDD 
isomer 
monomer 7.9 1.06×10
19
 41.7 188 227 
aggregate 11.5 2.21×10
19
 35.0 108 341 
[a] On carrying out the fitting procedure, some parameters were fixed to 
reasonable values: rGd-H (distance between Gd and protons of the inner sphere 
water molecule) = 3.1 Å; a (distance of minimum approach of solvent water 
molecules to Gd3+ ion) = 3.8 Å; D (solvent diffusion coefficient) = 2.2∙10-5 cm2 
s-1. [b] Squared mean transient zero-field splitting (ZFS) energy. [c] Correlation 
time for the collision-related modulation of the ZFS Hamiltonian. [d] Electronic 
relaxation time at zero field (calculated as 1/τs0=12 Δ
2×τv )[e] Reorientational 
correlation time.  
 
The τR values found for the two complexes (270 and 341 ps for all L and 
D/L isomers, respectively) reflect the slight increase in relaxivity passing 
from LLLL isomer to the DDLL one. However, the τR values extracted 
from the fitting procedure, and consequently the high field relaxivities of 
the aggregated forms of the two isomers, are shorter than what 
expected for slowly moving nano-sized aggregates as well as than 
those (τR = 490 ps) previously published for DOTA(Gd)-L6-F4 
systems.196 This finding can be ascribed to their lower tendency to form 
stably aggregated supramolecular systems if compared to the systems 
based on the aggregation of tetraphenylalanine peptides derivatives. 
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3.4 Extension of the aromatic side chain (Strategy II) 
The very short peptide conjugate Gd-DOTA-L6-F2 has been previously 
synthesized and characterized.196 Physicochemical characterization 
pointed out that this peptide was able to weakly self-aggregate and only 
before Gd coordination. Due to steric repulsion of the Gd-complex, after 
metal coordination, the dipeptide seems unable to keep π-π 
interactions.  
The replacement of the phenyl group with a more extended aromatic 
one could in principle restore the stacking.  
According to the second strategy principles, the replacement of Phe 
residues with 2-naphthylalanine (Nal2), a non coded amino acid having 
a more extended aromatic group in its side chain, was analysed. In 
principle, the increase of the aromatic group area could increase the 
self-assembling propensity of the dipeptide. The novel proposed 
monomer DOTA-L6-(2Nal)2 is schematically reported Figure 22a. Both 
the aromatic conjugate DOTA-L6-(2Nal)2 (mentioned as 2Nal2) and its 
gadolinium complex Gd-DOTA-L6-(2Nal)2 (reported as Gd-2Nal2) were 
able to self-assemble spontaneously in water solution.  
 
3.4.1 Structural characterization 
The morphology of the supramolecular assemblies as free basis and as 
Gd-complex was evaluated by transmission electron microscopy (TEM). 
A deep characterization of nanostructures at the nano- and atomic 
scale was achieved both in solution and at the solid state with 
SAXS/WAXS, fluorescence, 1HNMR, Fourier Transform Infrared (FTIR), 
circular dichroism (CD), and molecular modelling. The relaxivity 
properties of these nanostructures were studied. In order to prepare a 
potential theranostic agent, it was assayed the incorporation of the 
cytotoxic doxorubicin (DOX) as model drug in the Gd-2Nal2 
paramagnetic nanostructures. DOX is an established anticancer agent 
clinically effective for the treatment of many cancer types (breast and 
ovarian cancers).218 Fluorescence spectroscopy and 1HNMR studies 
and optical microscopy images provide the evidence for their capability 
to encapsulate doxorubicin. 
 
3.4.2 Synthesis and fluorescence studies 
The peptide synthesis of 2Nal2 was achieved according to the standard 
protocols of the solid phase synthesis with Fmoc/tBu strategy,215 the 
peptide was then characterized with LC-MS and 1HNMR (data collected 
in Appendix I). After purification, the DOTA chelating agent was 
complexed with lanthanide metal ions, i.e. gadolinium (Gd) or 
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lanthanum (La) for MRI or NMR studies, respectively. Nevertheless, in 
spite of the higher hydrophobicity of the naphthyl group with respect to 
the phenyl one, the Gd-2Nal2 derivative keeps high water solubility, and 
the solutions remain perfectly clear up to 50 mg/mL; whereas a further 
increase of the concentration causes its hydrogelation. Lowering the 
temperature below 5°C, fast hydrogel formation occurs yet at 20 
mg/mL.  
The peptide conjugate Gd-2Nal2 shows high stability also in 
physiological conditions (10 mM phosphate buffer 0.9 wt.% NaCl at pH 
7.4) (Appendix II, Figure A1). In Figure 23a and Figure 23b are 
reported fluorescence spectra of 2Nal2 and Gd-2Nal2 at several 
concentrations (from 0.025 to 20.0 mg/mL) obtained by exciting the 
samples at 280 nm, which corresponds to the wavelength of absorption 
for the 2-naphthylalanine (Figure 22b). 
 
 
 
Figure 22: a) Schematic representation of di-aromatic compounds obtained 
by SPPS with Fmoc chemistry. Conjugates contain an aromatic framework 
consisting of two 2-naphthylalanine (2-Nal) residues, an ethoxylic linker (L6) 
formed by six PEG units and bifunctional and macrociclic chelating agent 
(DOTA) for gadolinum (III) coordination. b) UV-Vis spectrum of 2-Nal2 
 
Section I: PBMs as supramolecular contrast agents for MRI  
 
76 
From ispection of Figure 22c, the typical emission spectrum of the 2-
naphthyl group with three maxima at 325, 340 and 355 nm, 
respectively, can be detected.  
The fluorescence intensity of 2Nal2 increases gradually in the range of 
concentration between 0.025 and 0.2 mg/mL. After this concentration a 
progressive intensity decrease, attributable to the stacking of the 
aromatic rings, occurs. Since 2.0 mg/mL, the fluorescence intensity is 
very low.  
From inspection of the inset in Figure 22b a weak peak that is centered 
between 380-430 nm and indicative of excimer formation is visible.  
 
Figure 23: Fluorescence spectra of 2Nal2 (a) and Gd-2Nal2 (b) in 0.025-20.0 
mg/mL concentration range. Samples were excited at λ = 280 nm and 
recorded between 290 and 500 nm. 
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These results suggest that the peptide derivative begins to undergo 
self-aggregation phenomena at 0.2-0.5 mg/mL (150-375 μM). However, 
the appearance of the excimer peak above 2.0 mg/mL leaves suppose 
that very stable aggregates can be formed above 2.0 mg/mL. A similar 
behavior was observed after the gadolinium coordination (see Figure 
22c).However in Gd-2Nal2, both the decrease of the fluorescence 
intensity (0.1 mg/mL) and the appearance of the excimeric peak (1.0 
mg/mL) were observed at lower concentration with respect to 2Nal2, 
thus confirming that the neutralization of the negative charges on the 
chelating agent, after the Gd-coordination, induces a better self-
assembling in these peptide conjugates.196  
Determination of the critical aggregation concentration (CAC) value of 
Gd-2Nal2 was carried out using the previously described ANS 
fluorescence-based method.63 A solution of ANS in cuvette (20 μM) was 
titrated with Gd-2Nal2 and the fluorescence intensities maximum 
measured at 470 nm have been plotted in Figure 24. CAC value, 
determined from the graphical break-point, is  6.70·10-4 M (0.86 
mg/mL). This value is 10-fold higher than the CAC value (5.1·10-5 M, 
0.076 mg/mL) previously found for tetraphenylalanine Gd-complex Gd-
DOTA-L6-F4.
196  
 
 
 
Figure 24: Fluorescence intensity emission of ANS fluorophore at 470 nm vs. 
concentration of 2Nal2 Gd(III) complex. CAC value is established from the 
break point. 
 
This consideration suggests that the replacement of the phenyl ring with 
the naphthyl one allows to increase the aggregation propensity with 
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respect to diphenylalanine conjugates (Gd-DOTA-L6-F2). However from 
the comparison of CAC values (Gd-DOTA-L6-F2 > Gd-DOTA-L6-Nal2 > 
Gd-DOTA-L6-F4) it emerges that the increase of the number of aromatic 
residues causes a better aggregation with respect to the replacement of 
Phe with more extended aromatic group.  
 
3.4.3 NMR studies 
The fluorescence studies were supported by 1HNMR measurements 
(Figure 25). 1D [1H] and 2D [1H, 1H] NMR spectroscopy were used to 
study two different compounds: DOTA-L6-F2 and 2Nal2 analogue in 
absence and in presence of the DOTA coordinated metal ion 
lanthanum(III), La.  
. 
  
Figure 25: Left panel a) 1D 1H NMR spectra recorded for DOTA-L6-F2 at 5 
mg/mL (4.8 mM), 2.5 mg/mL (2.4 mM), 1.2 mg/mL (1.2 mM), 0.6 mg/mL (0.6 
mM), 0.3 mg/mL (0.29 mM). b) 1D 1H NMR spectra recorded with La-DOTA-
L6-F2 at 10 mg/mL (8.5 mM), 5 mg/mL (4.3 mM), 2.5 mg/mL (2.1 mM), 1.2 
mg/mL (1 mM), 0.6 mg/mL (0.5 mM), 0.3 mg/mL (0.26 mM). Right panel a) 
1D 1H NMR spectra recorded for 2Nal2 at 5 mg/mL (4.4 mM), 2.5 mg/mL (2.2 
mM), 1.2 mg/mL (1.1 mM), 0.6 mg/mL (0.5 mM), 0.3 mg/mL (0.3 mM), 0.1 
mg/mL (0.1 mM). b) 1D 1H NMR spectra recorded with La-2Nal2 at 2.5 mg/mL 
(2 mM), 1.2 mg/mL (0.9 mM), 0.8 mg/mL (0.6 mM), 0.4 mg/mL (0.3 mM), 0.2 
mg/mL (0.2 mM).  
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Both DOTA-L6-F2 and 2Nal2 present low aggregation propensities. The 
process of resonance assignments of the two molecules could be easily 
achieved at a concentration equal to 1 mM (see Appendix II Tables 
A3, A4 and Figure A2). For the DOTA-L6-F2 relevant changes in the 
spectra, indicating occurrence of potential aggregation processes, take 
place at a concentration higher than 1.2 mg/mL (Figure 25a, left panel). 
In detail by comparing spectra recorded at 0.3 mg/mL and 5.0 mg/mL 
chemical shift changes appear relevant in the spectral regions between 
8.0 and 8.2 ppm, where signals from HN amide protons are present and 
between 3.0 and 3.5 ppm where several peaks overlap (Appendix I, 
Table A4). However, even at the highest investigated concentrations, 
peaks in the NMR spectra remain rather sharp thus pointing towards 
formation of small size aggregates  
Once complexed with La(III) the DOTA-L6-F2 presents similar weak 
aggregation propensity (Figure 25b, left panel). For 2Nal2 in the 
absence of coordinated metal ions, from 0.1 mg/mL till 5.0 mg/mL, we 
cannot reveal significant aggregation as the signals in the NMR spectra 
do not become broad or change their chemical shifts (Figure 25a, rigth 
panel). Once La(III) is inserted in 2Nal2 the aggregation tendency 
increases and line broadening starts to affect the spectra thus indicating 
formation of aggregated species already at 0.8 mg/mL concentration; at 
2.5 mg/mL concentration extensive line broadening causes partial 
signal loss thus indicating the presence of larger aggregates (Figure 
25b, right panel) 
Aggregation as witnessed by line broadening is affecting all signals in 
the NMR spectrum of 2Nal2 (See for instance the HN amide and 
aromatic protons region in Figure 25b, right panel). This different 
aggregation property in presence and absence of the metal ion likely 
indicates that La(III) by neutralizing DOTA negative charges is favoring 
intermolecular interaction by lowering electrostatic repulsions. 
Moreover, NMR data show that La-2Nal2 has a higher tendency to 
aggregate with respect to La-DOTA-L6-F2; this outcome can be easily 
explained by the larger aromatic patches present in the former molecule 
which are likely favoring larger intermolecular π-stacking interactions. 
These data indicate consequently that the Gd-2Nal2 may work better as 
a potential MRI contrast agent than Gd-DOTA-L6-F2.  
 
3.4.4 Secondary structure assignment 
As for the others peptide conjugates, the secondary structure of 2Nal2, 
as free bases or as gadolinium complex, was investigated by CD and 
by FTIR spectroscopies.  
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CD spectra, reported in Figure 26, were recorded both below and 
above the self-aggregation concentration. Independently from the 
coordination of the metal, 2Nal2 peptide shows a similar dichroic 
signature: at 0.5 mg/mL, there are two minima around 205 and 218 nm 
and a maximum at 232 nm.  
 
  
Figure 26: Selected Far-UV CD spectra of 2Nal2 (a) and Gd-2Nal2 (b) in a 
concentration range of 0.5-20.0 mg mL-1. Spectra are recorded between 280 
and 195 nm.  
 
This dichroic signature is perfectly identical and symmetric to that 
previously observed for tetra-phenylalanine conjugates.196 The two 
minima are attributable to the stacking between the 2-naphthyl aromatic 
rings, whereas the maximum is typically observed in presence of β-
structure.203 Above this concentration value a progressive red-shift of 
the maximum (up to 340 nm), as function of the peptide concentration, 
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occurs. This spectral shift is accompanied by the decrease of the 
maximum and by the presence of an isobestic point. Both the shift and 
the decrease of the maximum indicate the formation in solution of 
nanostructures with a dominant β-sheet arrangement.216 
FTIR spectra of 2Nal2 and Gd-2Nal2 at 5.0 mg/mL in the amide I region 
are reported in Figure 27a. Spectrum of Gd-2Nal2 as dried film is also 
reported. Gd-2Nal2 FTIR spectra, both at the solid state and in solution, 
show a dominant peak around 1638 cm-1, expected for β-sheet 
formation. In addition, both spectra have a secondary peak around 
1680 cm-1, that is normally observed for antiparallel orientation of the β-
sheet.  
 
 
Figure 27: a) FTIR spectra of 2Nal2 and Gd-2Nal2 in the amide I region at 5.0 
mg/mL. b) UV-Vis spectra of 2Nal2 and Gd-2Nal2, stained with Congo Red at 
0.1 and 1.0 mg/mL. The spectrum of Congo Red is also reported for 
comparison. 
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By comparing these spectra with spectrum of 2Nal2, it appears a very 
broad peak at 1642 cm-1. 
The high tendency of Gd-2Nal2 to self-aggregate in amyloid-like fibrillary 
nanostructures in solution was confirmed by Congo Red (CR) staining 
assay (Figure 27b).209 When incubated with fibrillary aggregates, CR 
spectral profile changes and a shift of the CR band from 490 to 540 nm 
is expected. CR UV-Vis maximum undergoes a clear shift after 
incubation with Gd-2Nal2 at 2.5 mg/mL. Instead, any variation or a slight 
shift can be evidenced for CR incubated with 0.1 and 1.0 mg/mL, 
respectively. 
 
3.6 Materials characterization and molecular modelling 
Self-assembled peptide conjugate at 5.0 mg/mL, as free base or as 
metal complex, was initially characterized using TEM.  
TEM images reported in Figure 28 demonstrate the assembling of both 
2Nal2 and Gd-2Nal2 in long fibrillary nanostructures. On the other hand, 
TEM images of Gd-DOTA-L6-F2 do not show any supramolecular 
aggregate (data not shown).  
Figure 28: Selected TEM images for 2Nal2 (a) and Gd-2Nal2 (b) at 5.0 mg/mL. 
To further analyze the supramolecular morphology of 2Nal2 and Gd-
2Nal2 at the micro and nano scale, WAXS and SAXS measurements 
were performed on dried fibers. 
Figure 29a,b and 30a,b present the two-dimensional (2D) WAXS and 
SAXS patterns collected on the 2Nal2 and Gd-2Nal2 samples, 
respectively. The 2D patterns, once centered, calibrated and radially 
folded into 1D profiles, are shown in Figure 29c,d and 30c,d, 
respectively. The low-q region of each WAXS pattern is displayed 
Section I: PBMs as supramolecular contrast agents for MRI  
 
83 
separately in Figure 29e and 30e to better visualize the diffraction 
peaks. The red and black WAXS/SAXS profiles correspond to the 
meridional and equatorial directions marked by the red arrows in panels 
(b). The position of most intense meridional and equatorial diffraction 
peaks are reported in Table 4. Both fibers show the typical cross-β fiber 
2D WAXS diffraction pattern with the β-strands distance at dβ1= 4.7±0.3 
Å along the meridional direction (fiber axis)  
The 2D SAXS patterns display a clear diffraction structure. The most 
intense peaks lay along the equatorial direction, for both samples. The 
presence of a diffraction pattern both in SAXS and in WAXS is 
fingerprint of a hierarchical organization of the molecules in fibers from 
the atomic to the nanoscale. The most intense SAXS peak in the Gd-
2Nal2 sample, labelled as e1 in Figure 30d, corresponding to d=57 Å, 
almost disappears in the 2Nal2, where the most intense SAXS peak 
occurs at d=48 Å (e2 equatorial peak in Figure 29d).  
 
 
 
Figure 29: 2Nal2 fiber at solid state: (a,b) 2D WAXS and SAXS data; (c,d) 1D 
WAXS and SAXS profiles (red and black corresponding to the meridional and 
equatorial directions) as obtained once the corresponding 2D WAXS (a) and 
SAXS (b) data are centered, calibrated and radially folded; the inset in panel 
(d) refers to the equatorial e2 reflection, with an estimated FWHM(e2-
2Nal2)=19°; (e) expanded WAXS region marked by a dotted rectangle in (c).  
 
It was suggested that the full-width-at-half-maximum along the azimuth 
angle for the e1 and e2 peaks in the insets of Figure 30d and Figure 
29d, which are FWHM(e1-Gd-2Nal2)=27° and FWHM(e2-2Nal2)=19°, 
respectively. Furthermore, for both aggregates intense equatorial peaks 
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were observed in WAXS experiments (d range 21-25 Å). Although 
peaks in this region occur in both 2Nal2 and Gd-2Nal2 samples their 
location and intensity are not identical. This observation suggests that 
the metal complexation of 2Nal2 induces some structural 
rearrangements. Altogether, SAXS and WAXS experiments provide 
some interesting clues on the organization of the peptide spine of these 
assemblies at different structural level. In particular, (a) the meridional 
peak at 4.7 Å atomic distance clearly indicates a cross-β structure in 
which the β-strands run perpendicular to the fiber axis, (b) the 
equatorial reflections at 21-25 Å likely represent regularities within the 
inter-sheet distances, and (c) the peaks at d=48 and 57 Å provide some 
preliminary information on the nanofiber organization. 
 
 
 
Figure 30: Gd-2Nal2 fiber at solid state: (a,b) 2D WAXS and SAXS data; (c,d) 
1D WAXS and SAXS profiles (red and black corresponding to the meridional 
and equatorial directions) as obtained once the corresponding 2D WAXS (a) 
and SAXS (b) data are centered, calibrated and radially folded; the inset in 
panel (d) refers to the equatorial e1 reflection, with an estimated FWHM (e1-
Gd-2Nal2) = 27°; (e) expanded WAXS region marked by a dotted rectangle in 
(c). 
 
In this framework, molecular modeling was performed to gain insights 
into the atomic structure of the peptide moiety of these assemblies 
using the programs Coot and Pymol. Accordingly, a antiparallel cross-β 
models was generated, stabilized by four inter-strand hydrogen bonds, 
to check whether Nal side chains could contribute to the stabilization of 
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this motif. In particular, it was evaluated the interactions between Nal 
side chains of consecutive β-strands within the cross β-sheet by 
considering all its possible rotameric states. It was detected 
acombinations of rotameric states that maximized hydrophobic 
interactions between side chains of consecutive strands (Figure 31a).  
 
Table 4. q positions, and corresponding d=2/q values, of meridional and 
equatorial reflections for the 2-Nal and Gd-2Nal2fibers. The error on the d 
values amounts to 0.3Å. 
 
 2-Nal Gd-2Nal2 
Label q (Å
-1
) d (Å) q (Å
-1
) d (Å) 
e1 0.11 57 0.11 57 
e2 0.13 48 0.18 35 
e3 0.15 42 0.24 26 
e4 0.26 24 0.26 24 
e5 0.3 21 0.28 22.5 
e6 0.4 16 0.29 22 
e7 --  0.34 18.5 
e8 --  0.40 16 
e9 --  1.35 4.5 
e10   1.94 3 
   2.23 2.8 
     
m1 0.11 57 0.11 57 
m2 0.125 50 0.17 37 
m3 0.14 45 0.22 28.5 
m4 1.28 5 0.26 24 
m5 1.34 4.7 0.28 22.5 
m6 --  1.32 4.75 
m7 --  1.9 3.3 
  
Then, it was scrutinized how different β-sheets could laterally interact. It 
was found that optimal interactions between the Nal side chains of 
facing β-sheets could be established when the inter-sheet distance was 
about 16-17 Å (Figure 31b). Notably, although as minor peaks, 
equatorial reflections with this spacing were observed for both samples 
(Figures 29e and 30e). However, as mentioned above, the largest 
equatorial peaks that likely correspond to inter-sheet distances present 
spacings with d = 21-25 Å. This observation suggests that there are 
multiple ways in which β-sheets interact in these assemblies and that 
other species may mediate these inter-sheet interactions. In this 
scenario, it cannot be excluded that the hydrophobic rings of individual 
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Nal molecules intercalate within the hydrophobic surfaces of facing β-
sheets (Figure 31c) 
 
 
Figure 31:. Three-dimensional model of the assembly formed by the peptide 
moiety of 2Nal2/Gd-2Nal2. In panel (a) the cross β-structure of a single β-sheet 
is reported. In the inset the extensive hydrophobic interactions established by 
Nal side chains are highlighted. In panel (b), the possible direct interactions 
between two facing β-sheets is reported. In panel (c) a three-dimensional 
model of the possible insertion way of a Nal side chain within the dry interface 
of two facing β-sheets. 
 
In conclusion, MD simulations suggest that the basic structural 
elements of these assemblies is a cross β-sheet that is stabilized by 
both the hydrogen bonding and hydrophobic interactions established by 
Nal aromatic side chains. The larger size of the Nal hydrophobic side 
chain compared to Phe makes dipeptide cross β-sheets formed by the 
former residues stable enough to generate well-defined aggregates at 
microscale level. Finally, individual β-sheets can then mutually interact 
in different ways to generate the structural variability of the lateral 
packing observed in these aggregates. 
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3.4.6 Relaxivity performances 
The relaxivity of Gd-2Nal2 was measured, at 21.5 MHz (0.5 T) and 
298K, as a function of the complex concentration (Figure 32a). The 
observed progressive enhancement in relaxivity is indicative of the fact 
that a self-aggregation process starts occurring already at very low 
concentration (ca. 1.0 mg/mL), confirming the values determined by 
fluorescence spectroscopy and 1HNMR. At concentrations higher than 
10-15 mg/mL the relaxivity R assumes an almost stable value which 
corresponds to the system in the completely aggregated form. By 
analyzing the profile of the relaxivity data as a function of the applied 
field strength (NMRD - Nuclear Magnetic Relaxation Dispersion) it is 
possible to obtain an accurate determination of the reorientational 
correlation time (τR), that is strictly related to the molecular size of the 
investigated system. NMRD profiles were acquired below (black circles) 
and above (white ones) the CAC values determined by ANS titration 
and 1HNMR. In Figure 32b the NMRD profiles of Gd- 2Nal2 at 1.0 and 
25.0 mg/mL concentrations are reported and compared to those of the 
corresponding di-phenylalanine conjugate Gd-DOTA-L6-F2 at the same 
concentrations. Data were analyzed using the Solomon-Bloembergen-
Morgan model, considering one water molecule in the inner 
coordination sphere (q=1) and fixing the exchange lifetime (τM) to a 
reliable value (700 ps) on the basis of those previously reported for 
mono-amido DOTA derivatives..  
 
a) 
 
b) 
 
Figure 32: a) Longitudinal proton relaxivity of Gd-DOTA-L6-(2Nal)2 measured 
at 21.5 MHz (0.5 T) and 298 K as a function of the concentration of the Gd-
complex. b) NMRD profiles of Gd-DOTA-L6-(2Nal)2 (1.0 mg/mL (●) and 25.0 
mg/mL (○)) compared to those of Gd-DOTA-L6-F2 (1.0 mg/mL (■) and 25.0 
mg/mL (□)). Experimental data points were measured on aqueous solutions of 
the Gd-complexes at 298K. The data refer to 1 mM concentration of the 
paramagnetic complexes. 
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Table 5. Main relaxometric parameters derived from fitting of NMRD profiles 
reported in Figure 32.[a] 
System (mg/mL) r1p  
(mM-1s-1) 
τ
2
(s
-2
)[b] τV (ps)
[c] τ
R
 (ps)[e] 
Gd-DOTA-(2Nal)2 1  7.3 1.02×10
19
 50 184 
25  12.3 8.10×10
18
 43 τR
l τR
g S2 
423 4800 0.23 
Gd-DOTA-F2 1  5.7 2.97×10
19
 28 120 
25  6.0 2.28×10
19
 35 127 
[a]On carrying out the fitting procedure, some parameters were fixed to 
reasonable values: rGd-H (distance between Gd and protons of the inner sphere 
water molecule) = 3.1 Å; a (distance of minimum approach of solvent water 
molecules to Gd3+ ion) = 3.8 Å; D (solvent diffusion coefficient) = 2.2∙10-5 cm2 
s-1. [b]Squared mean transient zero-field splitting (ZFS) energy. [c]Correlation 
time for the collision-related modulation of the ZFS Hamiltonian. [d] Electronic 
relaxation time at zero field (calculated as 1/τs0=12∆
2×τv )
[e] Reorientational 
correlation time.  
 
The quantitative analysis of the NMRD profile of the aggregated form 
was not satisfactory when the simple inner- outer-sphere model was 
used, so the Lipari-Szabo approach was used for the description of the 
rotational dynamicsThis model allows one to take into account the 
presence of a certain degree of internal rotation superimposed on the 
overall tumbling motion. These two types of motion, a relatively fast 
local rotation of the coordination cage about the linker to the peptide 
scaffold superimposed on the global reorientation of the system, are 
characterized by different correlation times: τR
l and τR
g, respectively. 
The degree of correlation between global and local rotations is given by 
the parameter S2, which takes values between 0 (completely 
independent motions) and 1 (entirely correlated motions).  
Both the shape of the profiles and the τR values determined from the 
fitting of the experimental results (Table 5) validate the hypothesis of 
the formation of aggregates for Gd-2Nal2 at 25.0 mg/mL.  
On the contrary, the system is in the monomeric state when it is 
dissolved in solution at 1 mg/mL concentration.  
In the case of Gd-DOTA-L6-F2, both qualitative and quantitative 
analysis confirm the inability of the system to self-aggregate even at 
high concentration.  
The quantitative analysis of the NMRD profiles indicates that both the 
local and the global rotational correlation times (Table 5) are 
significantly increased as compared to the τR value of the Gd-complex 
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in the monomeric form, whereas the S2 value is relatively low (S2 = 
0.23), suggesting great flexibility of Gd-coordination cage around the 
oxoethylenic linker. 
 
3.4.7 Doxorubicin loading and release 
The incorporation and release of Doxorubicin (DOX) into nanostructures 
was estimated by fluorescence spectroscopy (Figure 33, Figure 34).  
 
a) 
 
b) 
 
Figure 33: a) Fluorescence spectra of 1·10-4 M DOX (58 μg/mL) solution alone 
and after the addition of growing amounts of Gd-2Nal2 peptide conjugate (from 
0.25 to 10.0 mg/mL). The progressive decrease of the DOX fluorescence 
intensity is due to the stacking of the anthracycline with the naphthylalanine 
ring. The excitation wavelength of DOX was settled at 480 nm and spectra 
recorded between 490 and 700 nm. b) Fluorescence intensity in the maximum 
at 590 nm as function of the Gd-2Nal2 concentration reported in mg/mL.  
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The addition of increasing amounts of the peptide conjugate to the DOX 
solution causes a progressive decrease of the fluorescence intensity of 
DOX (Figure 33a). This quenching effect is attributable to the 
electrostatic interaction between the aromatic rings of the anthracycline 
with the naphthylalanine one. 
By plotting the fluorescence intensity in the maximum at 590 nm as 
function of the Gd-2Nal2 concentration (Figure 33b) we estimated that 
gDrug/gPeptide is 0.028 (60 μg of DOX for  2.0 mg of peptide). The 
leakage assay, reported in Figure 34 indicates a very low efflux of DOX 
across the peptide aggregate ( 6% of drug released after 72h).  
 
 
Figure 34: Leakage (%) of DOX from Gd-2Nal2 aggregates over the time. 
 
The ability of 2Nal2 aggregates to encapsulate DOX was also checked 
by running 1D [1H] spectra of La-2Nal2 (at 2.5 mg/mL) at increasing 
DOX concentrations (Figure 35).  
At a concentration equal to 2.5 mg/mL, as indicated above, La-2Nal2 
has formed relatively large aggregates (Figure 35a). In absence of La-
2Nal2, doxorubicin NMR spectrum in water (0.5 mg/mL concentration) 
contains sharp peaks (Figure 35b).  In presence of La-2Nal2 
aggregates, doxorubicin signals are large and can be barely recognized 
in the spectrum, thus indicating the encapsulation of the drug inside the 
aggregates (Figure 35c-i).  
The extensive line broadening and loss of signal is caused by the 
improved relaxation rate reflecting an increase of molecular weight with 
respect to the free doxorubicin.  
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Figure 35. 1D 1H NMR spectra acquired at 298 K of (a) La-(2-Nal)2 at 2.5 
mg/mL, (b) DOX 0.5 mg/mL, (c) La-(2-Nal)2 at 2.5 mg/mL+DOX 0.05 mg/mL, 
(d) La-(2-Nal)2 at 2.5 mg/mL+DOX 0.1 mg/mL, (e) La-(2-Nal)2 at 2.5 
mg/mL+DOX 0.2 mg/mL, (f) La-(2-Nal)2 at 2.5 mg/mL+ DOX 0.3 mg/mL, (g) 
La-(2-Nal)2 at 2.5 mg/mL+DOX 0.4 mg/mL, (h) La-(2-Nal)2 at 2.5 mg/mL+DOX 
0.5 mg/mL, (i) La-(2-Nal)2 at 2.5 mg/mL+DOX 1 mg/mL. In the lowest 
spectrum a few peaks arising from doxorubicin appear, as indicated by the 
black lines. 
 
Once all the pores inside the supramolecular aggregates of La-2Nal2 
are saturated, the drug starts to be released and this occurs at a 
concentration of doxorubicin close to 1.0 mg/mL (Figure 35i). At this 
drug concentration signals are still affected by line broadening thus 
indicating that most of the molecules are still entrapped inside the 
aggregates. Incorporation of DOX in Gd-2Nal2 nanostructures was 
further examined by optical microscopy.  
Incorporation of DOX in Gd-2Nal2 nanostructures was further examined 
by optical microscopy. Figure 36 shows polarizing optical micrographs 
(POM) of empty Gd-2Nal2 nanostructures compared to DOX filled Gd-
2Nal2 ones. Polarized light interacts strongly with both the birefringent 
samples, generating contrast with the background. 
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Figure 36: Polarized optical microscopy image of 1-cm vials containing (a) 
Gd-2Nal2 and (b) DOX encapsulating Gd-2Nal2 hydrogels. Images are 
observed with a Nikon microscope. 
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3.5 Photoluminescent peptide-based nanostructures 
owadays, the major obstacle in many applications of light in 
biomedicine is represented by the limited penetration of light 
into biological tissue. Optical fibers represent the current gold-
standard solution in clinical uses. However, most light-guiding 
systems are based on solid materials, not compatible with in vivo 
application.219 On the other hand, optical waveguides based on 
biocompatible materials such as silk,220 polyethylene glycol (PEG),221 
and gels222 present a scarce efficiency for delivering light over an organ-
scale distance. The employment of water soluble biocompatible optical 
fibers based on peptide building blocks with enhanced PL properties 
could help to overcome these limitations. 
In more recent years, a great interest has been generated around 
peptide-based nanostructures (NSs) with interesting blue-green 
photoluminescent (PL) properties.223 This PL phenomenon has also 
been observed in FF224,225 and FFF226 nanostructures. This PL 
phenomenon has been observed exciting self-assembled oligopeptides 
at 370 or 410 nm, only after heating the sample at 140-180°C, as a 
consequence of an irreversible reconstructive phase transition in the 
nanostructure.224,225  
A similar PL effect has been also observed for amyloid-like fibrils 
considering the nanofiber morphology with antiparallel β-sheet 
structures.227  
The definition of the structural determinants of these intriguing PL 
properties exhibited by -cross rich systems is still a debated topic, 
subject of intense current investigations. However, a proved explanation 
on the origins of this unexpected PL has not been provided until now 
and this theme remains currently under debate.  
The most accredited hypothesis concerning the origins of the PL is the 
electron delocalization via hydrogen bonds in the β-sheet rich 
structure223,228,229 or the proton transfer.230  
In order to develop novel bio-imaging tools based on peptide NSs, a 
novel peptide building block composed of six phenylalanine residues 
and eight PEG units (PEG8-F6, Figure 37a) was designed and 
synthetized.231  
The high number of Phe residues should prompt the aggregation of the 
peptide derivative in nanostructures rich of β-sheet structures.  
The photoluminescence properties of the self-assembled material have 
been investigated and correlated with the structural organization of the 
peptide building block at the micro- and nano-scale. A variety of 
techniques, including fluorescence, FTIR, CD, DLS, SEM, SAXS and 
WAXS allowed to: 
 
N 
Section II: PBMs as photoluminescent supramolecular probes 
 
96 
 investigate the aggregation behavior 
  assign and study the secondary structure 
 visualize the morphology of the final aggregates.  
 
The total characterization of PEG8-F6 nanostructures in solution 
highlighted the  strong propensity of hexaphenylalanine monomer to 
self-organize in stable and well-defined NSs with a hydrodynamic 
diameter of ~ 60 nm and an antiparallel β-sheet arrangement. The 
proposed NSs showed also a blue PL phenomenon.  
Wide-Angle X-ray Scattering characterization on dried fibers also 
revealed a typical “cross-β” diffraction pattern observed for amyloid-like 
fibers with meridional and equatorial peaks at 4.8 Å and 12.5 Å, 
respectively.124 Finally, a model of F6 framework spine in aqueous 
solution by molecular dynamics (MD) simulations is presented to 
identified and understand the molecular, chemical and energetic factors 
controlling the formation of nanostructures.  
After the assessment of PEG8-F6 structural properties we explored: 
 
 the possibility to transfer the intrinsic fluorescence of a cross-β 
material (donor), like PEG8-F6 based nanostructures, into an 
encapsulated fluorescent dye by FRET (Foster Resonance 
Electron Transfer); 
 
 the effect of the PEG derivatization (length and chemical 
composition) on the supramolecular organization and on 
optoelectronic properties of the oligo-Phe building blocks. 
 
3.6 Design, synthesis and fluorescence spectroscopy of 
PEG8-F6 
 
PEGylated hexaphenylalanine PEG8-F6 was obtained by Fmoc/tBu 
solid phase synthesis in good yield and high purity. LC-MS and 1HNMR 
are reported in Appendix I.  
PEG8-F6 is formed by two blocks: an aromatic one, formed by the 
repetition of six phenylalanine residues (F6), and a hydrophilic one 
composed of eight ethoxylic repetitions, here indicated as PEG8 (MW ~ 
600 Da). This PEG chain was coupled at the N-terminus of the peptide 
sequence (Figure 37a).  
The PEG chain was inserted with the aim of producing a water soluble 
material for a large field of applications and not preclude its potential 
usage in nanomedicine for the delivery of drugs or contrast agents. 
Nonetheless, PEG8-F6 shows very limited solubility in water, whereas it 
shows an excellent solubility in 1,1,1,3,3,3-hexafluoro-2-propanol 
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(HFIP). After dissolution the peptide solution appear clear up to a 
concentration of 100 mg/mL. According to the procedure described for 
cationic diphenylalanine,144 this stock solution in HFIP was diluted five-
fold in water. After dilution and removal of HFIP, peptide solution 
remains perfectly limpid until 20 mg/mL.  
 
a) 
 
b) 
 
c) 
 
Figure 37: a) Schematic representation of hexaphenylalanine PEG8-F6. b) 
Fluorescence spectra of PEG8-F6 in water solution at 0.1 (●), 1.0 (○) and 2.5 
mg/mL (▲). In the insert, fluorescence spectra of PEG8-F6 at 0.02 and 0.05 
mg/mL. All emission spectra were recorded at 25°C between 265 and 400 nm 
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with excitation at 258 nm. c) Figure 1c reports fluorescence intensity emission 
of ANS fluorophore at 470 nm vs. concentration of PEG8-F6. CAC values are 
established from the break point. 
The tendency of PEG8-F6 to self-aggregate was previously evaluated 
with fluorescence spectroscopy, by exciting the sample at 257 nm 
(Figure 37b).  
At all the concentrations studied, the expected emission peak at 282 
nm, ascribed to the phenylalanine residue, appears weakly outlined, 
whereas it is well observable the peak at 310 nm, typical of -stacking 
phenomena observed during the excimer Phe formation. This result 
suggests the high tendency of PEGylated peptide PEG8-F6 to self-
aggregate and indicates that the critical aggregate concentration (CAC) 
value of this compound is lower than 0.02 mg/mL. However, two 
different trends can be identified for the maximum as function of the 
concentration.  
At very low concentrations (0.02 and 0.05 mg/mL), the fluorescence 
intensity at 310 nm increases gradually, whereas at high concentration 
(0.1, 1.0, and 2.5 mg/mL) an opposite behavior was observed. The 
decrease of the signal intensity for concentrations above 0.1 mg/mL, 
can be attributed to quenching that arises from the stacking of the 
aromatic rings.  
A more accurate determination of the critical aggregation concentration 
(CAC) was carried out using ANS fluorescence-based method. Figure 
37c reports the fluorescence intensity of an ANS solution (20 μM in 
cuvette) at 470 nm, as function of hexaphenylalanine concentration. 
From the graphical break point it can be established the CAC value (7.5 
μM, 0.01 mg/mL). This value is significantly lower (around one order of 
magnitude) than the value found for the polymeric tetraphenylalanine 
analogues previously studied.196,197 In details, all the polymeric F4-
peptides showed CAC values ranging between 43 and 167 μM. As 
expected, the elongation of the aromatic framework from four to six F 
residues permits to reduce the CAC value and in turn to increase the 
stability of the aggregate upon dilution. 
 
3.6.1Secondary structure  
Secondary structure of PEGylated hexapeptide in water solution was 
assessed by CD and FTIR spectroscopies. CD spectra of PEG8-F6 at 
0.1, 1.0 and 10.0 mg/mL, well-above the CAC value, were recorded 
between 280 and 195 nm and the dichroic behavior was reported in 
Figure 38a. 
Due to the very low CAC value of this aromatic derivative, is not able to 
record CD spectra of acceptable quality for solution concentration below 
CAC (< 0.01 mg/mL). All the spectra show two peaks: a maximum 
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around 205 nm, attributable to aromatic side-chains stacking, and a 
minimum around 230 nm, associated with a β-structure.184,203,216  
 
a) 
 
b) 
 
c) 
 
Figure 38: Spectroscopic characterization of PEG8-F6 by CD and FTIR. a) 
Far-UV CD spectra of hexaphenylalanine in aqueous solution at 0.1 
mg/mL(▲), 1.0 mg/mL (□) and 10.0 mg/mL (■). Spectra are recorded between 
280 and 195 nm. In the insert is reported a zoom of PEG8-F6 spectrum at 10 
mg/mL. b) FTIR spectra of PEG8-F6 in solution and at the solid state, in the 
amide I region. c) FTIR spectrum of PEG8-F6 in the region of the NH 
stretching. 
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However, the relative ratio between the intensity of the two peaks 
decreases progressively as function of the concentration (from 5.8 to 
1.2). This decrease indicates the progressive formation of 
supramolecular aggregates in solution. According to CD data, the 
presence of β-sheet structures is supported by FTIR analysis in the 
region of the amide I vibrational band (1600-1700 cm-1). FTIR spectra 
for PEG8-F6, as dried film or in solution (2.0 mg/mL), are reported in 
Figure 38b. Both spectra show a dominant peak at 1637 and 1640 cm-1 
for dried film and sample in solution, respectively. Peaks at these 
wavenumbers are strongly indicative of β-sheet formation. In addition, 
both spectra show a secondary broad peak around 1680 cm-1, that 
appears better defined for the solid state sample (1672 cm-1). The 
occurring of this peak indicates an antiparallel orientation of the β-
sheet.205,206 
FTIR spectrum of PEG8-F6 shows also a peak at 3280 cm
-1, 
corresponding to NH stretching in fibrillary assembly (Figure 38c) As 
expected, in HFIP FTIR spectrum does not present peaks in the amide I 
region, thus confirming the disaggregation of PEG8-F6 in this solvent 
(data not shown). 
 
3.6.2 Congo Red assays 
Further confirmation of PEG8-F6 ability to aggregate in amyloid-like 
fibers was obtained with Congo Red staining assay.209 UV-Vis spectra 
of CR alone and after incubation with 0.1 or 1.0 mg/mL of peptide are 
reported in Figure 39a.  
 
 
Figure 39: On the left, UV-Vis spectra of PEG8-F6, stained with Congo Red at 
0.1 and 1.0 mg/mL. The spectrum of Congo Red is also reported for 
comparison. Polarized optical microscopy: a) images of PEG8-F6 dried onto a 
glass slide and stained with Congo Red solution; b) and c) PEG8-F6 fibers 
stained with CR and observed with a Nikon microscope under bright field 
illumination and between crossed polars, respectively.  
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As expected, CR absorbs at 490 nm, whereas a spectral shift of the CR 
band from 490 to 540 nm was observed for solutions containing 1.0 
mg/mL. Instead, only a negligible shift can be invocated for the sample 
containing 0.1 mg/mL of PEG8-F6. At the same time, air-dried film and 
solid state PEG8-F6 were stained with Congo Red and visualized by 
optical microscopy under cross-polarized light. From the inspection of 
Figure 3, both air-dried film (Figure 39b) and solid state sample (Figure 
39c) exhibit the characteristic blue-green birefringence. 
 
3.6.3 Dynamic Light Scattering analysis 
DLS measurements were performed in order to reveal the presence of 
peptide aggregation in solution and to monitor the system evolution as a 
function of the concentration and time. The intensity profiles of PEG8-F6 
in water solution, in the 0.05 - 5.0 mg/mL range, are reported in Figure 
40 and structural data (mean diameter and diffusion coefficients, D) are 
collected in Table 6.  
 
 
Figure 40: Mean diameter distribution as function of the concentration.  
From the inspection of Figure 40, monomodal and bimodal distributions 
were observed for peptide solutions at high concentration (until 0.5 
mg/mL) and low concentration (0.1 and 0.05 mg/mL), respectively. 
These results indicate that PEG8-F6 nanostructures remain stable upon 
dilution until 0.5 mg/mL. Below this concentration a second population 
arises. At the same time, the size of the nanostructures in solution 
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remains unaltered up to one month (data not shown). It is well-know 
that -sheet rich peptides tend to aggregate, according to their kinetics, 
in oligomers, protofibrils and finally in fibers.232 However, PEGylation of 
amyloid fragments such as Aβ(10-35) peptide induces the inhibition of 
the fibrillation process, as compared to the peptide alone.233,234 
 
Table 6: Mean diameter and diffusion coefficient for PEG8-F6 in water at 
different concentration. Each measure is in triplicate. 
 
PEG8-F6 concentration Mean diameter (nm) D x 10
-12 m2 s-1 
5.0 mg/mL 56.9± 0.5 8.66±0.1 
2.0 mg/mL 56.7±0.1 8.68 ±0.1 
1.0 mg/mL 56.9±0.6 8.65±0.1 
0.5 mg/mL 58.8±0.6 8.37±0.1 
0.1 mg/mL 67.8±2.1 7.28±0.2 
0.05 mg/mL 74.5±0.8 6.60±0.1 
 
3.6.4 Scanning Electron Microscopy 
Scanning electron microscopy (SEM) images confirmed the capability of 
the aromatic peptide to assemble with an high morphological variability 
(Figure 41).  
PEG8-F6 self-assemblies yet at very low concentration (0.05 mg/mL) 
giving several amorphous conglomerates (Figure 41a and 41b). These 
data are in good agreement with the critical aggregation concentration 
experimentally determined (~ 0.01 mg/mL). The increase of the 
concentration causes changes of the morphology up to obtain long and 
well-ordered nanostructures at 2mg/mL (Figure 41). At 0.2 mg/mL 
crystallization effects are observed (Figure 41c and 41d).  
In FF dipeptide, the crystal structure is due to hydrogen-bonded head-
to-tail chains, which form hydrophilic channels embedded in a 
hydrophobic matrix created by the peptide side chains. However, in this 
case in which head-to-tail interactions are absent, the crystallization can 
be attributed to the PEG chain on the N-terminus.217At 0.5 mg/mL 
formation of highly ordered tree-like multi-branch nanostructures is 
shown. Several nucleation centers are visible on these multi-branch 
nanostructures (Figure 41e and 41f). Finally, at 1.0 and 2.0 mg/mL, 
small conglomerated fibers and very long nanostructures can be 
observed together on the plate (Figure 41g and 41h).  
Many sheaf of fibers with variable length (between 1.5 and 12.5 μm) 
and thickness (between 250 and 5000 nm) appear. Each sheaf is 
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formed by small fibers of 65-350 nm width, placed side by side. Beside 
them, also the long nanostructures (from 150 to 4000 μm) present a 
high morphological variability: some nanostructures with a flat ribbon 
shape (Figure 42a and 42c) and others with a twisted ribbon shape 
(Figure 42b and 42d).  
 
 
Figure 41: Selected SEM microphoto for PEG8-F6: (a), (b) 50 μg/mL (16000x, 
10µm and 60000x, 2 µm scale bar, respectively), (c), (d) 0.2 mg/mL (30000x, 
5µm and 60000x, 2 µm scale bar, respectively), (e), (f) 0.5 mg/mL (26000x, 
10µm and 60000x, 4 µm scale bar, respectively), (g), (h) 2 mg/mL(1000x, 100 
µm and 12000x, 10 µm scale bar, respectively). 
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Twisted ribbons are expected for amyloid peptides functionalized with 
short PEG chains.235 In tubular nanoaggregates (Figure 42a and 42c), 
the width maintains an homogeneous size (~10-15 μm) along its full 
length, whereas in the twisted nanostructures thickness changes of 20 
μm are measured along the different parts of the aggregate. 
 
 
Figure 42: SEM microphotos for PEG8-F6 nanostructures at 2 mg/mL, with flat 
(a and c 1000x, 100µm scale bar) and twisted shape in evidence (b, 2000x, 
50µm scale bar; d, 16000x, 10µm scale bar). 
 
From these images it can realistically speculate that above 1.0 or 2.0 
mg/mL the small fibers begin to collapse to give stacks. These stacks 
aggregate beyond in long nanostructures. DLS and SEM measures 
indicate different size for self-assembled PEG8-F6 at the same 
concentration (for instance at 2.0 mg/mL). However, this mismatch 
depends on different physical state of the sample, which is in solution 
and at the solid state for DLS and SEM, respectively.  
 
3.6.5 Wide-Angle and Small-Angle X-ray Scattering 
To gain better insight into the assembly process and molecular 
organizations, ordered fibers in Wide-Angle and Small-Angle X-ray 
Scattering (WAXS/SAXS)were acquired. Figure 43a shows PEG8-F6 
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dried fibers as placed under the micro-focused X-ray beam. Four 
different regions were explored, at a relative distance of 0.2 mm, 
marked as 1 (red), 2 (green), 3 (blue), and 4 (orange) in Figure 43a, to 
control the lateral homogeneity of the fiber. 
 
 
 
Figure 43: a) PEG8-F6 sample, as placed under the micro-focused X-ray 
beam, with marked in red (1), green (2), blue, (3) and orange (4) the regions 
explored, placed at a relative distance of 0.2 mm; b) WAXS and SAXS data 
with different slightly overlapped Δq ranges: Δq(WAXS) = 0.006-2.5Å-1 and 
Δq(SAXS) = 0.007-0.189 Å-1; c) two-dimensional (2D) WAXS and SAXS 
diffraction patterns collected for each sample position in (a).  
 
The WAXS and SAXS detectors, placed at 10 mm and 2.2 m from the 
sample allowed to collect the diffraction in two different slightly 
overlapped Δq ranges: Δq(WAXS) = 0.006-2.5Å-1 and Δq(SAXS) = 
0.007-0.189 Å-1. The two-dimensional (2D) WAXS and SAXS diffraction 
patterns are displayed for each sample position in Figure 43a. Several 
diffraction peaks were measured either along the meridional (along the 
fiber) and equatorial direction (perpendicular to the fiber) and no 
difference was found moving across the different positions, proving a 
high lateral homogeneity of the fiber, either at the atomic (WAXS) and 
at the nanoscale (SAXS). The 2D WAXS and SAXS patterns were 
centered, calibrated and folded into one-dimensional (1D) profiles, by 
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integrating along the equatorial and meridional directions (white arrows) 
of Figure 44a and Figure 44b, respectively. 
 
 
Figure 44: a) 2D WAXS and b) SAXS patterns, recorded for sample position 
3; c) meridional and d) equatorial 1D SAXS (blue) and WAXS (black) as 
obtained once the 2D WAXS (a) and SAXS patterns (b) are centered, 
calibrated and folded into uni-dimensional (1D) profiles by integrating along 
the equatorial and meridional directions (white arrows). 
 
The corresponding 1D patterns were reported, as blue (SAXS) and 
black (WAXS) profiles, in Figure 44c,d  for the meridional and 
equatorial direction, respectively. Table 7 summarizes the peak 
positions (in q) of the most intense SAXS and WAXS peaks, measured 
along the equatorial and meridional directions. The same meridional 
reflections were measured either in SAXS and WAXS, marked as m1 
and m2 in Figure 44c. No equatorial SAXS peak was detected in the 
explored range. Therefore, the equatorial profile contains only 
morphological information. The experimental data were fitted with the 
GNOM program,236 as reported in Figure 45a (dotted curve 
corresponds to the experimental data, red line to the fitted profile). The 
pair distribution function extracted by this analysis, reported in Figure 
45b, is a typical distribution of an elongated scattering objects. The 
gyration radius, determined by this analysis, is Rg = 69±1nm. The 
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diffraction peak positions in Table 2 were converted in lattice spacings 
(d). Three relevant distances can be distinguished: the typical β-strands 
distance at dm4=4.8±0.3 Å, more represented along the meridional 
direction; the sharp peak at de1=12.2±0.3 Å, with its replica at half 
lattice spacing (de2=6.1±0.3 Å), which correspond to the β-sheet 
distance; the meridional peak at dm1=48±0.3 Å, which corresponds to 
10 times the β-strands distance. This meridional reflection with the 
spacing of 48 Å may be indicative of additional regularities along this 
direction. The presence of a clear fiber diffraction pattern either in SAXS 
and in WAXS is fingerprint of a hierarchical organization of the 
molecules in fibers from the atomic to the nanoscale, the latter footprint 
of the quaternary level of the fiber. 
 
 
 
Figure 45: a) Equatorial SAXS (dotted curve) and best fit (full line). b) pair 
distribution function extracted from (a). The gyration radius, determined by this 
analysis, is Rg = 69±1nm. 
Table 7: Equatorial and meridional reflections for PEG8-F6 fibers. 
Meridional reflections 
Label q (Å-1) d (Å) 
m1 0.132 48.0 
m2 0.171 37.0 
m3 0.514 12.2 
m4    ( strand) 1.32 4.8 
Equatorial reflections 
e1 0.514 12.2 
e2 1.026 6.1 
e3    ( strand) 1.319 4.8 
e4 1.536 4.1 
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3.6.6 Photoluminescence in PEG8-F6 Nanostructures 
PEG8-F6 at a concentration of 10 mg/mL shows a blue PL between 
420-460 nm, when the sample is excited at a wavelength of 370 or 410 
nm (Figure 46). The narrow peak at λ = 420 nm, that appears upon 
excitation at 370 nm, can be associated to the Raman scattering in 
water. PEG8-F6 keep PL effect also at the solid state. Figure 46 reports 
the immunofluorescence and confocal images of the sample deposited 
on a clean coverslip glass and slowly dried at room temperature.  
 
 
Figure 46: PL of PEG8-F6 nanostructures at 10 mg/mL. a) Blue PL emission 
spectra for sample in solution upon excitation at ∼370 nm (blue line) and at 
∼410 nm (red line). b) Fluorescence microscopy images of dried film of PEG8-
F6 obtained by exciting in the UV spectral region (DAPI filter). c) Confocal 
microscopy images of dried film of PEG8-F6: Fluorescence images (on the 
left), bright field images (on the right) and the merge of fluorescence and 
bright field images (at the center). Scale bar = 50 m. 
 
3.6.7 Molecular modelling and dynamics 
To gain insights into the atomic structure of these supramolecular 
aggregates molecular dynamics simulations were performed. Although, 
in principle, PEG moieties could influence the PEG8-F6 structure, it was 
assumed that the self-assembling is essentially dictated by the aromatic 
peptide region, as PEG is completely disordered, even in the crystal 
state, in the only 3D-structure available of a highly PEGylated 
protein.237 Accordingly, MD simulations were performed on distinct F6 
models generated using the steric zipper structure of the KLVFFA 
hexapeptide as template (Table A5, Figure A2 in Appendix II). These 
assemblies were characterized by a different number of β-strands per 
β-sheet.  
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Models here investigated were denoted as SHx_STy_F6, where x and y 
indicate the number of β-sheets and β-strands per sheet, respectively; 
F6 indicates the number of Phe residues per chain. Preliminary, 
simulations carried out on the smaller systems (SH2_ST10_F6 and 
SH2_ST26_F6) suggested that these steric zipper models were rather 
stable in the simulation timescale (data not shown).  
 
 
Figure 47: Evolution of the SH2_ST50_F6 model during the simulation. Panel 
(a) shows the starting flat model whereas panels (b) and (c) show two different 
views of the average structure calculated in the equilibrated region of the 
trajectory. 
 
However, to reduce the impact of the assembly termination effects, 
most extensive analyses were conducted on the larger SH2_ST50_F6 
system (Figure 47a).The inspection of the root mean square values 
(RMSD) of SH2_ST50_F6 trajectory structures versus the initial 
structure clearly shows that the starting model undergoes major 
transition during the simulation (Figure 48a,b).  
The analysis of the evolution of the trajectory also indicates that the 
structural transition is followed by states characterized by rather 
constant RMSD values (Figure 48a). This behavior suggests that the 
system adopts a novel structural state in the equilibrated region of the 
trajectory (20-100 ns). 
This transition is also coupled with a significant variation of the 
assembly gyration radius (Figure 48b). Notably, the secondary 
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structure of SH2_ST50_F6 is well preserved in the simulation (Figure 
48c). The visual analysis of trajectory structures clearly indicates that 
the initially flat SH2_ST50_F6 β-sheet motif undergoes a significant 
twist. 
 
a) 
 
b) 
 
c) 
 
Figure 48: Structural parameters evaluated in the trajectory structures for 
SH2_ST50_F6: RMSD values of MD structures against the starting flat model 
computed on the Cα atoms (a), gyration radius (b), and secondary structure 
time evolution (c). For clarity, the secondary structure is reported only for the 
residues belonging to the terminal ends and to the central region.  
 
This is also evident when the average structure calculated in the 
equilibrated region of the trajectory is visualized (Figure 47b,c). This 
behavior has been observed for several other peptides forming cross-
beta structures. It has been suggested that the β-sheet twisting is better 
suited for fiber formation, whereas the growth of single crystals forces 
the β-sheets to adopt flat states. The analysis of the evolution of the 
inter-sheet distance shows that the two facing sheets are more 
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separated in the equilibrated region compared to their relative position 
in the KLVFFA structure (Figure 49). 
Indeed, in the starting crystallographic KLVFFA structure the distances 
between facing Cα atoms belonging to the two distinct β-sheet are on 
average 10.5 Å (range 9.4 – 11.6 Å). The modelling in this scaffold of 
the F6 homopeptide produces some steric hindrance. Consequently, it 
was observe an increase of the β-sheet separation during the 
simulation (Figure 49). 
 
 
Figure 49: The evolution of the distance between two representative Cα 
atoms of the facing sheets along the trajectory. The values of the monitored 
distances for both the flat starting model and the twisted average structure are 
shown in the insets. 
 
The shortest distances between Cα atoms of the two β-sheets are 
approximately 12.5 Å. This indicates a close agreement between the 
inter-sheet distance of the equilibrated model and the WAXS data. The 
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good agreement between the resulting model and the experimental 
WAXS data corroborate our assumption that PEG moiety has a limited 
impact on PEG8-F6 structure, which is essentially dictated by the 
peptide region. The structural transition occurring in the simulation 
leads to the staggering of the facing strands of the two β-sheets along 
the fiber axis.  
 
a) 
 
b) 
 
c) 
 
Figure 50: RMSF values of the model computed in the equilibrated region of 
the trajectory (20-100 ns). In panel (a) the values of RMSF computed on the 
Cα atoms of each strand are shown whereas panels (b) and (c) report the 
distribution of RMSF values exhibited by the Phe sidechains located in the dry 
interface and exposed surface, respectively. For clarity only the values of the 
central ten β-strands are reported. 
 
However, no twisting has been observed for the Gln homopeptides. In 
this latter case the strong interdigitation of the Gln side chains has likely 
prevented the β-sheet twisting. The examination of the flexibility of this 
novel state, carried out by computing root mean square fluctuation 
(RMSF) values, demonstrates that, with the exception of terminal 
residues within each strand, the backbone atoms are rather rigid 
(Figure 50a). A limited level of flexibility is also shown by Phe side 
chains. Indeed, the flexibility of Phe side chain located in the inter-sheet 
dry interface is comparable to the mobility of the backbone atoms 
(Figure 50b).Phe side chains of the solvent-exposed interface, 
although displaying larger RMSF values, still retain a restricted mobility. 
The limited flexibility of Phe side chains is also highlighted by the 
analysis of their rotameric states. Each strand presents rather recurrent 
values of the χ1 dihedral angle (Figure 51). All residues within the 
same strand adopt predominantly the same χ1 value. Furthermore, 
strands with all gauche+ (g+) Phe side chains alternate with strands 
showing all trans (t) rotameric states. This trend does not depend on the 
location of the Phe residue in terms of dry interface or exposed surface. 
The inspection of the Phe side chain interactions clearly indicates that 
this recurrent rotameric motif plays an important role in the stabilizations 
of the SH2_ST50_F6 assembly. Indeed, the juxtaposition of alternating 
antiparallel F6 strands with side chains presenting either g+ or t states 
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leads to the formation of staggered -stacking interactions within the 
same β-sheet (Figure 52a). 
 
a) 
 
b) 
 
Figure 51: Persistence of Phe side-chain rotameric states along the 
simulation timescale. Representative examples of Phe side chains adopting 
either g+ (a) or t (b) conformations are shown.  
 
In line with literature classification of these interactions, the distance 
between the centers of mass of the stacking aromatic rings is on 
average close to 5.0 Å.  
 
Figure 52: Conformations of the Phe side chains and their interactions at the 
exposed interface and at the dry interface. The inter-strand interaction within 
the same sheet are reported in panel (a) whereas the inter-sheet interactions 
are reported in panel (b). The rotameric states of Phe residues are shown in 
both panels. The T-shaped interactions established at the dry interface are 
also indicated in panel (b).  
 
This particular configuration of the Phe side chains within the individual 
sheets is suitable for the formation of stabilizing interaction at the inter-
sheet level. As shown in Figure 52b, the dry interface is characterized 
by the presence of recurrent T-shaped aromatic interactions.  
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These findings provide a clear structural pattern for the stabilization of 
antiparallel β-sheets by Phe side chains. They also indicate that 
individual Phe-rich β-sheets are pre-organized to form steric zipper 
assemblies. However, Phe side chains, although closely packed 
through the formation of hydrophobic and steric interactions, do not lead 
to the inter-digitation that frequently characterizes amyloid-like peptides. 
 
3.7 Photoluminescent PBMS as FRET donor for 
fluorophore dye 
 
PEG8-F6 NSs (Figure. 53a) showed a blue photoluminescence (PL) 
between 420-460 nm, when excited at wavelengths of 370 or 410 nm.  
It was explored the possibility to transfer by Förster Resonace Energy 
Transfer (FRET) phenomenon the fluorescence of a cross-β material 
(donor), like PEG8-F6 based nanostructures, into an encapsulated 
fluorescent dye such as 4-Chloro-7-nitrobenzofurazan (NBD-Figure 
53b).  
Due to its spectral window (λex = 465 nm; λem = 530 nm), the poorly 
water soluble NBD, was chosen as a suitable model fluorophore to 
check the capability of these peptide-based NSs to transfer by FRET 
their intrinsic fluorescence to a fluorophore, strictly associated with the 
peptide NS. The FRET should cause a red-shift of the 
photoluminescence of the NSs, thus opening concrete opportunity to 
their application in the bioimaging field. 
  
3.7.1 Synthesis and preparation of NBD filled NSs  
PEG8-F6, composed of six phenylalanine residues and eight ethoxylic 
groups, is poorly soluble in water, whereas is soluble in 1,1,1,3,3,3-
hexafluoro-2-propanol (HFIP) up to 100 mg/mL. Stable and well-
organized NSs are obtained by five-fold diluting this stock solution in 
water and removing the organic solvent by a slow nitrogen flow. NBD 
dye also has very limited water solubility and good solubility in HFIP 
According to these evidences, NBD-filled NSs were synthetized 
dissolving both PEG8-F6 and NBD powders (Figure 53a,b) in HFIP in 
10/1 (w/w) ratio. In this solution, the starting peptide and fluorophore 
concentrations are 100 and 10 mg/mL, which correspond to 6.8·10-5 
and 5.0·10-5 mol, respectively. Subsequently, this solution was diluted in 
water, HFIP removed and the resulting solution centrifuged to clear the 
excess of non-encapsulated NBD (Figure 53c). 
The light yellow supernatant was further purified from potential traces of 
free NBD by gel-filtration on Sephadex G-50 column.  
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According to the dilution achieved during the purification, the final 
concentration of hexaphenylalanine estimated by UV-Vis was 10 
mg/mL. 
Due to its low water solubility, the detection and the quantification of 
encapsulated NBD were unfeasible in water.  
Consequently, the amount of NBD encapsulated in NSs (200 μg/mL) 
was determined by UV-Vis on the sample lyophilized and re-dissolved 
in methanol (Figure 54a). From the experimental quantification of the 
species, the molar ratio between NBD molecule and PEG8-F6 peptide 
was determined to be 1:7 mol/mol.  
 
 
 
Figure 53: Schematic representation of PEG8-F6 (a) and NBD chloride (b), 
respectively. (c) Preparation of NBD/PEG8-F6 nanostructures: both PEG8-F6 
and NBD were dissolved in 1,1,1,3,3,3-hexafluoro-2-propanol in 10/1 (w/w) 
ratio. Then, this solution was ten-fold diluted in water and HFIP removed with 
a slow nitrogen flux.  
 
The fluorescent dye remains associated with the NS also after repeated 
washing, thus suggesting the existence of a tight interaction between 
the dye and the NS. In order to exclude the occurrence of a covalent 
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bond between the NBD fluorophore and the N-terminus of the oligo-
peptide, we analyzed NBD-PEG8-F6 NSs by LC-MS.  
The mass spectrum, reported in Figure 54b, shown only the mass 
corresponding to the peptide.  
Altogether, these experiments suggest that, in this preparation protocol, 
the NBD encapsulation is favored by the self-aggregation of the peptide 
based NS directly around the NBD dye, as a consequence of the HFIP 
evaporation.  
 
 
 
Figure 54: a) UV-Vis Spectrum of NBD/PEG8-F6 solution, lyophilized and 
dissolved in methanol. b) ESI spectrum of NBD/PEG8-F6 solution diluted 10-
fold in water. 
 
3.7.2 Structural characterization of NBD-filled NSs: 
secondary structure  
 
In order to evaluate the potential structural modifications induced by the 
NBD encapsulation in PEGylated peptide nanostructures, NBD/PEG8-
a) 
 
b) 
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F6 was deeply characterized at the atomic level by CD and FTIR. CD 
and FTIR spectra of filled peptide nanostructures are reported in Figure 
55 and Figure 56, respectively.  
Spectra of the empty NSs are also reported for comparison. CD 
spectrum of NBD/PEG8-F6 at 10 mg/mL (Figure 55a) shows the same 
dichroic tendency previously observed for the empty peptide NSs, with 
a maximum around 205 nm, attributable to aromatic side-chains 
stacking, and a minimum around 230 nm, associated with a β-structure. 
 
a) 
 
b) 
0 20 40 60 80 100 120 140
-1796
-1794
-1792
-1790
-1788
-1786

M
R
W
 (
d
e
g
 c
m
2
 d
m
o
l-1
re
s
-1
)
Time (min)
 
 
Figure 55: a) Comparison between the CD spectra of PEG8-F6 and 
NBD/PEG8-F6 in water at 10 mg/mL. Spectra were recorded in the range 
between 280-195 nm and reported in mean residue ellipticity (Θ). b) Molar 
ellipticity of NBD/PEG8-F6 in the minimum at 230 nm as function as the time. 
 
A slight red-shift of the minimum, from 227 to 230 nm, occurs for NSs 
encapsulating NBD. Moreover, the molar ellipticity (θ) of NBD/PEG8-F6 
at 230 nm does not change significantly as function of time (Figure 
55b). A slight variation of θ value is detectable over time with a more 
significant variation during the first ten minutes. This trend suggests a 
time dependent structural rearrangement of the dye containing NS. 
Analogously to CD data, also FTIR spectra of NBD filled PEG8-F6 in the 
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region of the amide I vibrational band (1600-1700 cm-1) are very similar 
to spectra of empty PEG8-F6 both in solution and at the solid state 
(Figure 56).  
FTIR spectra show a peak at 1637-1640 cm-1 typically attributable to 
β-sheet formation. In addition to this peak, all the spectra show a 
secondary broad peak at 1680 cm-1 that indicates an antiparallel 
orientation of the β-sheet.205,206 These results clearly indicate that 
although the tight binding between the dye and the peptide NSs, the 
encapsulation of NBD does not alter significantly the secondary 
structure of the supramolecular aggregate. 
 
 
 
Figure 56: Characterization of the secondary structure: FTIR spectra of PEG8-
F6 and NBD/PEG8-F6 in solution (a) and at the solid state (b) in the amide I 
region.  
 
3.7.3 Photoluminescence properties 
After association and purification of NBD filled NSs, optoelectronic 
features were studied both in solution and at the solid state. Differently 
from the spectra of empty PEG8-F6 NSs (Figure 46a), having an 
emission peak at 460 nm, NBD/PEG8-F6 spectra (see Figure 57a,b) 
show a peak at 535 nm, corresponding to the typical emission 
Section II: PBMs as photoluminescent supramolecular probes 
 
119 
wavelength of the NBD. The occurrence of this red-shift and the 
simultaneous disappearance of the expected maximum at 460 nm 
suggest that NBD dye is close enough to the NSs to accept the energy 
emitted by the NS according to a FRET phenomenon.  
 
 
 
Figure 57: PL of NBD/PEG8-F6 nanostructures at 10 mg/mL as function of the 
time. PL emission spectra for sample in solution upon excitation at 370 nm (a) 
and at 410 nm (b). 
 
The FRET is a distance-dependent physical process by which energy of 
an excited fluorophore (donor) is transferred non-radiatively to another 
fluorophore (acceptor). FRET strongly depends from the proximity 
between the donor and the acceptor species and the maximum of the 
efficiency occurs if the donor and acceptor are positioned within the 
Förster radius (the distance at which half the excitation energy of the 
donor is transferred to the acceptor; typically 3-6 nm).51 From the 
qualitative point of view, a macroscopic variation in the color of the 
solution, from light to dark yellow, was also detected during the time 
(Figure 57, insert).  
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This change of color suggested to follow the fluorescence of the sample 
upon the time. Surprisingly, we observed a progressive increase of the 
fluorescence up to 2 h; whereas further increases were not observed 
after this time. 
 
 
Figure 58: Fluorescence microscopy images of a dried film of NBD/PEG8-F6 
obtained by exciting in the UV spectral region of DAPI (a), GFP (b) and 
rhodamine (c) filters; and images of NBD/PEG8-F6 fibers recorded by exciting 
in the bright light (d), GFP (e) and rhodamine (f) filters. 
 
It is plausible to speculate that this increase of the fluorescence 
intensity is due to an increase of the fibrillary species in solution during 
the time. In order to verify this hypothesis, also the kinetic of 
aggregation of empty PEG8-F6 nanostructures was studied up to 24 h 
at the same concentration (data not shown). However, no significant 
variation could be detected in the fluorescence spectra of empty NSs. 
This result brought to the conclusion that the kinetic of aggregation for 
empty NSs is very fast and for this reason not observable. 
On the contrary, the increase of the fluorescence of NBD/PEG8-F6 
(Figure 57) can depend by a molecular rearrangement of the dye in the 
peptide aggregate or by a slowing of the kinetic of aggregation of the 
NS due to the NBD encapsulation. NBD/PEG8-F6 emits 
photoluminescence also at the solid state. Figure 58 reports 
respectively the immunofluorescence images of the dried sample 
deposited on a clean coverslip glass (Figure 58a,b,c) and of the 
oriented fibers (Figure 58d,e,f) obtained with the stretch frame method. 
Both the microscopy images of the dried film (Figure 58a,b,c) and of 
the oriented fiber (Figure 58d,e,f) demonstrate the capability of 
NBD/PEG8-F6 to emit in blue, green and red fields. This result is in 
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agreement with the width of the emission peak observed for the sample 
in solution (Figure 57).  
 
 
Figure 59: PL emission spectra for NBD/PEG8-F6 nanostructures in solution 
upon excitation at at 410 nm. In both the samples the concentration of PEG8-
F6 is 10 mg/ml, whereasthe concentration of the NBD is 100g/mL in (a) and 
10 g/mL in (b) 
 
The same behavior, as function of the time, was also observed in others 
two preparations, in which the peptide concentration was kept fix at 10 
mg/mL, whereas the NBD amount was reduced at 100 or 10 g/mL 
(Figure 59). 
In addition, it was ascertained if it is possible to obtain self-assembled 
nanostructures (Figure 60a) starting from the peptide conjugate NBD-
PEG8-F6, in which NBD is covalently bound to the amine function of the 
PEGylated hexaphenylalanine.  
These nanostructures, which have a univocally defined NBD/PEG8-F6 
ratio (1/1), keep the optoelectronic properties of the NBD-filled NSs (see 
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Figure 60b) even if they present a lower water solubility due to the N-
terminus functionalization. FRET here observed for NBD-PEG8-F6 is in 
good agreement with that detected for the covalently conjugates 
between the α-Synuclein and Yellow Fluorescent Protein (AS-YFP).238  
 
a) 
 
b) 
 
Figure 60: Characterization of NBD-PEG8-F6 NSs in which NBD dye is 
covalently bound to the oligo-peptide PEG8-F6: a) Dynamic Light Scattering 
spectrum of NBD-PEG8-F6 in water at 1.0 mg/mL. b) PL emission spectra of 
NBD-PEG8-F6 at 1.0 mg/mL upon excitation at ∼370 nm (blue line) and at 
∼410 nm (red line). 
 
3.7.4 Wide- and Small-angle X-ray scattering 
To gain deeper insight into the assembly process and molecular 
organizations, we acquired WAXS/SAXS data on ordered fibers. Figure 
61a and 61b show the as-prepared fibers which were placed under the 
X-ray beam in transmission geometry.  
The two-dimensional (2D) WAXS and SAXS fiber diffraction patterns, 
collected on the PEG8-F6 and PEG8-F6/NDB samples, are displayed in 
Fig. 61 c,d and 61 e,f, respectively. Two main directions are indicated 
by the white arrows: the meridional direction which coincides to the fiber 
axis and the equatorial direction, perpendicular to it. They show a cross-
 diffraction pattern both in WAXS (atomic distances) and in SAXS 
(nanoscale distances), fingerprint of hierarchically organized fibers. 
 The 2D patterns were centered, calibrated and radially folded into uni-
dimensional (1D) profiles. WAXS data were integrated across the 
meridional and equatorial axes and the resulting 1D WAXS profiles 
displayed in Figure 61g (blue for PEG8-F6 and red for NBD/PEG8-F6), 
reporting separately the meridional (upper) and equatorial (lower) 
profiles. SAXS data were integrated across the whole azimuth and the 
1D SAXS profiles were reported in Figure 46.  
The peak positions (in q) of the most intense WAXS and SAXS peaks, 
measured along the equatorial and meridional directions are 
summarized in Table 8. Collectively, these experiments indicate that 
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the encapsulation of the dye has a minimal impact on the atomic 
structure of the peptide spine of these assemblies. Indeed, PEG8-F6 
and NBD/PEG8-F6 share several meridional and equatorial reflections. 
The only significant difference is related to the m1 reflection (d=48Å) of 
PEG8-F6 which disappears in NDB/PEG8-F6 (marked by the arrows in 
Figure 61 e,f,h).  
 
 
 
 
Figure 61: Blue lines refer to empty PEG8-F6; red lines to NBD/PEG8-F6. (a) 
and (b) as prepared fibers; (c) and (d) 2D WAXS data; (e) and (f) 2D SAXS 
data; (g) 1D WAXS profiles (upper: meridional and lower: equatorial); (h) 1D 
SAXS profiles. 
 
These observations suggest that the three-dimensional model proposed 
for the peptide spine PEG8-F6, which corresponds to anti-parallel β-
sheets separated by a dry interface made of interacting Phe side 
chains,[16] can be reliable extended to NDB/PEG8-F6. In particular, the 
preservation of the equatorial reflection e1 at 12.2Å, which is indicative 
of the inter-sheet distance, suggests that the dye is not inserted in the 
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dry interface, in contrast with what has been observed in the 
complexation of the dye orange G with the cross-β assembly formed by 
the peptide KLVFFA.[24] 
 
Table 8: Meridional and equatorial reflections of NBD/PEG8-F6 measured 
from WAXS and SAXS data. 
 
Label q (Å-1) d (Å) ±0.3 Å 
Equatorial Reflections 
e1 0.51 12 
e2 1.0 6.1 
e3 1.3 4.8 
e5 1.4 4.5 
e6 1.6 4.1 
e7 1.7 3.8 
e8 2.1 3.1 
e9 2.2 2.8 
Meridional Reflections 
m1 0.13 48 
m2 0.17 37 
m3 1.3 4.8 
m4 1.4 4.5 
m5 1.6 4.1 
m6 1.7 3.8 
m7 2.2 2.8 
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It is likely that, on analogy with the proposed binding of ThT to amyloid-
like nanofibers,[25] the dye may either bind the groove parallel to the 
fiber axis formed by the side-chain ladders or at the edges of the flat β-
sheet surface. 
 
3.7.5 Scanning electron microscopy 
Scanning electron microscopy (SEM) images of NBD-filled NSs at 
different concentration (50 g/mL, 200 g/mL and 2.0 mg/mL) are 
reported in Figure 62. Pervious  SEM studies on the empty PEG8-F6 
self-assembled NSs indicated a high morphological variability of this 
aromatic peptide (Figure 41 and Figure 42).231  
At low concentration (50 and 200 g/mL), NBD/PEG8-F6 forms either 
amorphous conglomerates or crystalline structures (Figure 62a and 
62b), in line with the empty PEG8-F6 aggregates. On the other hand, at 
high concentration (2.0 mg/mL) images of NBD containing NSs reveal 
the presence of branched structures in place of the sheaf of fibers and 
of long nanostructures (flat or twisted ribbon shape) previously 
observed for empty NSs.  
These branched structures are typically observed for aromatic peptides 
dissolved in solutions with high ionic strength.  
According to the models proposed for these solutions, branched 
architectures in NBD/PEG8-F6 could be explained hypothesizing that 
the some NBD crystals coat the surface of peptide fibers and in 
correspondence of these nucleation sites, the grown of the branch 
occurs.  
 
 
 
Figure 62: Selected SEM microphotos for NBD-filled PEG8-F6: a) 50 g/mL 
(24000x, 5m scale bar); b) 200 g/mL (50000x, 3 m scale bar), c) 2.0 
mg/mL (80000V, 2 m scale bar) 
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3.8. Effect of PEG derivatization on PL phenomena 
In order to evaluate the effect of the PEG derivatization on the PL 
phenomena in peptide based NSs, a series of PEGylated 
hexaphenylalanines (PEG12-F6, PEG18-F6 and PEG24-F6) was 
synthesized and characterized 239 These peptide derivatives were 
obtained by coupling a variable number of amino-hexaoxoethylenic acid 
moieties at the N-terminus of the hexaphenilalanine.  
The supramolecular behavior of F6-copolymers, both in solution and at 
the solid state, was investigated by fluorescence, Circular Dicrohism 
(CD), Fourier Transform Infrared spectroscopy (FTIR), Polarized Optical 
Microscopy (POM), Dynamic Light Scattering (DLS), Scanning Electron 
Microscopy (SEM), Wide Angle X-ray Scattering (WAXS) both in 
transmission and reflection (GIWAXS) geometry. Particular attention is 
given to the effect of PEG polymer length and to the presence of the 
amide bonds on the supramolecular organization. 
The optoelectronic properties of the PEG-series were also studied and 
compared with PL properties of PEG8-F6 or NBD/PEG8-F6 NSs 
previously reported.231 These investigations pointed out the capability of 
cross-β nanostructures to exhibit green photoluminescent emission. 
 
3.8.1 Design, synthesis and fluorescence studies 
PEGylated hexaphenylalanine conjugates (PEG12-F6, PEG18-F6 and 
PEG24-F6), schematically represented in Figure 63a, were manually 
synthesized by solid phase method according to the 9-
fluorenylmethoxycarbonyl (Fmoc) protocols.215  
The polymer/peptide derivatives PEG12-F6, PEG18-F6 and PEG24-F6 
were obtained in good yield and high purity, coupling respectively, two, 
three or four units of commercial poly(ethylene glycol) residue using the 
Fmoc derivative Fmoc-Ahoh-OH, PEG6, each one containing six 
ethoxylic repetitions. Coupling reaction of Fmoc-Ahoh-OH was achieved 
directly in solid phase via carbodiimide activation. This synthetic 
method, largely used to prepare short PEG conjugates with a molecular 
weight of 350800, allows to obtain PEGylated conjugates with 
monodisperse profiles.185,240  
Nullifying the predictable effect of PEG polydispersity, it is possible to 
obtain amphiphilic peptides with a well-defined hydrophile/lipophile 
balance (HLB). PEG moiety is expected to enhance the peptide water 
solubility; nevertheless, due to the high hydrophobicity of phenylalanine 
residues the three peptides show moderate solubility ( 20.0 mg/mL).  
As predictable, the progressive increase of ethoxylic fragments 
translates also into fewer values of retention time (tR) in RP-HPLC for 
the three polymer/peptide conjugates (Table 9).  
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Similarly to the previously studied PEG8-F6 compound, containing the 
same F6-aromatic framework, also these peptides show a high 
tendency to self-assemble.231  
 
 
 
Figure 63: a) Schematic representation of PEGylated hexaphenylalanine 
PEG12-F6, PEG18-F6 and PEG24-F6. b) Fluorescence emission spectra of 
PEG24-F6 at several concentrations in 0.01-5.0 mg/mL range. Samples are 
excited at 257 nm and spectra recorded between 270 and 400 nm. Both 
PEG12-F6 and PEG18-F6 show the same behavior of PEG24-F6 (data not 
shown). c) Fluorescence intensity emission of ANS fluorophore at 475 nm vs. 
concentration of PEG12-F6, PEG18-F6 and PEG24-F6. CAC values are 
established from the break points. 
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The first evidence on their aggregation phenomena comes from the 
inspection of the fluorescence spectra, reported in Figure 63b, for 
peptides at different concentrations (between 0.025 and 5.0 mg/mL). 
Samples were excited at 257 nm, that corresponds to λMAX of Phe 
residue, and the emission spectra were recorded between 270 and 400 
nm. 
All spectra show a weak emission peak at 282 nm, expected for the 
nude Phe chromophore and a well observable peak centered at 312 
nm, typically attributed to Phe excimers, induced by π-π interactions 
between the aromatic side chain rings. Besides these two peaks, a third 
one centered around 350-360 nm appears at concentration above 1.0 
mg/mL. These peaks (312 and 350) are indicative of a complex 
supramolecular organization of PEGylated hexaphenylalanines. 
An analytical characterization of the aggregation properties of these 
PEGylated peptides was achieved by the fluorescence-based method 
that allows evaluating the critical aggregate concentration (CAC). CAC 
values for the three peptide polymers were established from the 
graphical break point of the plots in Figure 63c.  
 
Table 9: Formula, retention time (Rt) and theoretical molecular weight (MW) of 
PEGylated hexaphenylalanines. RP-HPLC method and column details are 
reported in the experimental section. Critical aggregate concentration (CAC) 
values of PEG-derivatives measured by titration of ANS fluorophore.  
Sample Formula Rt (min) MW 
(u.m.a.) 
CAC 
(µM) 
CAC 
(μg/mL) 
PEG12-F6 C84H115N9O20 12.5 1570 38.8 60.9 
PEG18-F6 C99H144N10O27 11.9 1905 10.7 20.4 
PEG24-F6 C114H173N11O34 11.2 2240 6.2 13.9 
 
CAC values, summarized in Table 9, are 60.9, 20.4 and 13.9 
μg/mL for PEG12, PEG18 and PEG24 oligopeptides, respectively. 
These values suggest a direct dependence of the PEG length on 
the aggregation tendency: the self-aggregation seems favored in 
polymers with highest hydrophilicity (PEG12>PEG18>PEG24).  
However, in traditional di- or tri-block copolymers, CAC value 
depends on the hydrophobic/hydrophilic ratio, and the CAC is 
expected higher for monomers with shorter hydrophilic portions. 
The observed discrepancy leads to speculate that the self-
assembling phenomena in these compounds could be due to 
more of one contribution. Beyond the aromatic stacking, it is 
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suggest that the formation of additional intramolecular hydrogen 
bonds between the amide bonds in the PEG chain.  
These H-bonds could encourage the self-aggregation of the entire 
PEG-peptide conjugates. This hypothesis is also supported by 
the comparison of the CAC value found for PEG24-F6 with others 
two hexaphenylalanine PEGylated analogues: PEG8-F6 and 
PEGMW1300-F6 (Figure 64a). The first one, PEG8-F6, previously 
characterized by us, contains four amide bonds in PEG fraction 
as well as PEG24-F6 and exhibits a CAC value of  10 μg/mL (7.5 
μM), slightly lower than PEG24-F6. Instead, PEGMW1300-F6, with a 
PEG chain similar to PEG24-F6 but lacking of the amide bonds, 
self-assembles above a CAC value of  40 μg/mL (15.2 μM), that 
is about 3-fold higher than the CAC value of the analog peptide 
containing the amide bonds in the PEG chain (Figure 64b). 
 
a)  
 
 
 
b) 
 
Figure 64: a) Chemical structure of PEGMW1300-F6. b) fluorescence intensity 
emission of ANS fluorophore at 475 nm vs. concentration of PEGMW1300-F6.  
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3.8.2 Dynamic Light Scattering  
The peptide capability to self-assemble above their CAC value was 
assessed by DLS technique. DLS studies, previously reported for 
PEGylated hexaphenylalanine PEG8-F6, indicated the high kinetic 
stability of the self-assembled nanostructures and the low incidence of 
the concentration on their size (Figure 40). The same size stability in 
time was also observed for the series of PEG-peptides here studied 
(data not shown). The intensity profiles of PEG12, PEG18 and PEG24 
oligopeptides in water solution, at 5.0 mg/mL, are reported in Figure 65. 
Intensity profile of PEG12-F6 shows a monomodal distribution with a 
mean diameter of 172 nm. On the contrary, both PEG18 and PEG24 
derivatives show a bimodal distribution indicating the presence of two 
aggregate populations, the first centered at 185 nm and the second one 
at 25 nm.  
 
 
Figure 65: DLS intensity profiles of PEGylated hexaphenylalanine at 5.0 
mg/mL in water 
 
3.8.3 Secondary structure characterization  
The secondary structure of PEGylated oligopeptides in solution was 
fully investigated by CD, FTIR and UV-Vis spectroscopies.  
Figure 66a shows the CD spectra of the three PEGylated 
hexaphenylalanine conjugates at 5.0 mg/mL, well-above their CAC 
value. All the spectra show a maximum centered between 205 and 207 
nm, typical of the aromatic side-chains stacking, and a minimum at 227 
nm, associated with a β-sheet arrangement.216 This dichroic tendency is 
similar to that previously observed for PEG8-F6 analog.
231 However, a 
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progressive reduction of the intensity of the two peaks can be detected 
by increasing the PEG length.  
The reduction of both peaks confirms the capability of the PEG length to 
affect the self-aggregation propensity of the hexaphenylalanine and; in 
agreement with the fluorescence studies, the polymeric peptide 
containing the PEG24 moiety presents higher tendency to self-aggregate 
under the same condition of concentration.  
The occurrence of β-sheet formation was also confirmed by FTIR 
spectroscopy in the amide I spectral region and the deconvolution in 
absorbance for the secondary structure prediction of the FTIR spectra 
in this region are reported in Figure 66b (2.0 mg/mL in water solution).  
All the F6 derivatives show a similar FTIR spectrum with two peaks at 
1638 and 1680 cm-1.  
 
a)  
 
b)  
 
c) 
 
Figure 66: a) Comparison between the CD spectra of PEG12-F6, PEG18-F6 
and PEG24-F6. All the sample are 5.0 mg/mL (concentration above CAC); b) 
FTIR spectra for F6/polymer conjugates at 2.0 mg/mL in the amide I region. c) 
FTIR spectra of PEG12-F6, PEG18-F6 and PEG24-F6 in blue, black and red, 
respectively. 
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This profile is typically observed for β-sheet with antiparallel orientation 
of the β-strands.205,206 Moreover, the NH stretching occurring at 3280 
cm-1 frequency in amide A region (Figure 66c), indicates strong 
intermolecular amide-amide bonds.241 The absence of a band around 
3400 cm-1 and the presence of a band at 1530 cm-1 in the amide II 
region, indicate that all NH groups in PEG24-F6 are involved in tight 
intermolecular hydrogen-bonding interactions in the fibrillary network.217 
As previously observed for PEG8-F6,
231 FTIR spectra of these peptides 
dissolved in HFIP (disaggregating conditions) do not show peaks in the 
amide I region (data not shown).  
All these structural data support the hypothesis of a supramolecular 
organization in amyloid-like fibrillary nanostructure. 
A confirmation on this structural organization was obtained by CR 
staining assay.209As expected, UV-Vis spectra show a bathochromic 
shift of the maximum when the azoic dye is incubated with PEGylated-
F6 peptides at 1.0 and 2.5 mg/mL (Figure 67) supporting the 
hypothesis of amyloid-like organization.   
 
 
Figure 67: UV-Vis spectra of PEG12-F6, PEG18-F6 and PEG24-F6 at 2.5 
mg/mL after incubation with Congo Red; CR spectrum is also reported for 
comparison. 
 
3.8.4 Wide Angle X-ray Scattering  
A deep characterization of the nanostructures at the solid state was 
performed by WAXS and GIWAXS scattering techniques, in 
transmission and reflection mode respectively. 
Figures 68b,c,d (left panel) display the two-dimensional (2D) WAXS 
patterns collected on the fibers with PEG of different lengths (PEG12, 
PEG18 and PEG24, respectively). 2D-WAXS pattern of PEG8 derivative, 
previously studied231, is also reported for comparison (Figure 68a). The 
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2D patterns, once centered, calibrated and radially folded into 1D 
profiles, are shown in Figures 68a,b,c,d (right panel), respectively. 
Figure 68e shows the same 1D patterns which have been shifted 
vertically of the same value for sake of clarity. This comparison shows 
that the diffraction patterns are almost identical, with two relevant peaks 
occurring at q = 0.518Å-1 and q = 1.32 Å-1, that we assigned to the 
equatorial β-sheet distance de = 12.2±0.3 Å and to the meridional β-
strands distance of dm = 4.8±0.3 Å, respectively. The reflection 
corresponding to d  4.8 Å could be, in principle, ascribed to the PEG 
crystallization (4.7 Å).243 However, the simultaneous presence of the 
equatorial reflection at d  12.2 Å is symptomatic of cross-β amyloid 
structures. 
Scaling the diffraction patterns to make them coinciding for the 
background, as reported in Figure 68f, allows to appreciate difference 
in the intensity of the most represented reflection at q=0.518Å-1, 
relevant to the equatorial β-sheet. 
  
 
Figure 68: (a,b,c,d) 2D (left panel) and 1D (right panel) WAXS data; (e) 1D 
WAXS patterns vertically shifted for sake of clarity; (f) detail of the equatorial 
β-sheet distance at q=0.158Å-1 (de=12.2±0.3 Å); (g) equatorial β-sheet 
reflection, integrated along the azimuth  angle (i.e. along the diffraction 
circle). 
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Figure 69: 2D GIWAXS (upper panels) and corresponding 1D GIWAXS data 
(lower panels, green curves) for PEG8 (a), PEG12 (b), PEG18 (c) and PEG24 (d) 
fibers, deposited on silicon substrates. The black profiles in the lower panels 
are the corresponding WAXS profiles collected for the same samples.  
 
As a result, the most intense peak is registered for PEG8, then almost 
equal intensities are found for PEG12 and PEG18 and the lowest 
intensity for the PEG24 fiber. This difference in intensity can be 
attributed to the partial effect of PEG crystallization that occurs in 
proportional way to the PEG length / molecular weight.  
Finally, for the same equatorial β-sheet reflection, it was estimated the 
full-width-at-half-maximum (FWHM) along the azimuth  angle (i.e. 
along the diffraction circle): FWHM(PEG8) = FWHM(PEG12) =542°, 
FWHM(PEG18) = 622°, FWHM(PEG24)>180° (Figure 68g). They 
reflect a clear increase in the fiber disorder which is maximum for the 
PEG24 sample where it is not possible to identify any preferred 
orientation direction of the fiber. 
It was excluded that fiber disorder can be attributed to the PEG 
crystallization. Indeed, polarized optical microscopy images of dried 
samples at high concentration (5wt%) do not show the spherulite, 
typical structures of PEG crystallization, but the formation of a liquid 
crystal phase via birefringence (data not shown).  
To analyze possible differences in the fiber structure due to the different 
sample preparation or influences due to the substrate, fibers were 
deposited on top surface of silicon substrates and studied by GIWAXS. 
Figure 59 shows the GIWAXS 2D data of the PEG8 (a), PEG12 (b), 
PEG18 (c) and PEG24 (d) fibers, (upper panels) respectively; the 
corresponding lower panels display the horizontal cut (green line) 
extracted from each 2D GIWAXS data along the green arrow compared 
to the relevant meridional WAXS profiles (black line) previously shown 
in Figure 68. The comparison clearly shows the same relevant peaks, 
occurring at q = 0.518Å-1 (equatorial β-sheet distance de = 12.2±0.3 Å) 
and q = 1.32 Å-1 (meridional β-strands of dm = 4.8±0.3 Å) are measured 
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either for the fibers studied in transmission (WAXS, Figure. 68) and 
reflection (GIWAXS, Figure 69) mode, proving that the sample 
preparation does not modify the atomic arrangement of the fibers. In 
Figure.70 the WAXS/GIWAXS characterization of PEGMW1300-F6 is 
reported. Figure 70a compares the optical microscopy of a single fiber 
of PEGMW1300-F6 to the image of the same material deposited on silicon 
substrate (Figure 70b).  
The corresponding 2D WAXS (c) and GIWAXS (d) data are displayed in 
the same figure with the integrated 1D profiles (e) reported as green 
(GIWAXS cut of the 2D data, extracted along the green arrow) and 
black (WAXS) lines. Also in this case the most important reflections, 
corresponding to the equatorial β-sheet (de=12.2±0.3 Å) and the 
meridional β-strands (dm=4.8±0.3 Å) distances, coincide between 
WAXS and GIWAXS data. In analogy to what measured for the PEG8, 
PEG12, PEG18 and PEG24 fibers (see Figure 68g), it was estimated also 
for the PEGMW1300-F6 sample the full-width-at-half-maximum (FWHM) 
along the azimuth  angle, in correspondence of the same equatorial β-
sheet reflection (see comparison in Figure 70f, where the added 
magenta profile corresponds to the PEGMW1300-F6 sample).  
The FWHM(PEGMW1300) is comparable to what measured for PEG18-F6, 
thus confirming an effect of the amide bonds in the PEG chain also on 
the fiber order. 
 
 
 
Figure 70: Microscopy of a single PEGMW1300-F6 fiber (a) and the fibers 
deposited on silicon substrate (b); 2D WAXS data of the single fiber (c); 2D 
GIWAXS data of the fibers onto a silicon substrate; (e) integrated 1D profiles 
GIWAXS (green) and WAXS (black). (f) Equatorial β-sheet reflection, 
integrated along the azimuth  angle (i.e. along the diffraction circle. Magenta 
profile corresponds to the PEGMW1300-F6 sample. 
 
3.8.5 Scanning Electron Microscopy 
SEM images of PEGylated F6-peptides at 2.0 mg/mL, reported in 
Figure 71, confirmed their aptitude to self-assemble in supramolecular 
NSs.  
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Micrographs of PEG12-F6 in Figure 71a show braid-like microstructures 
growing from thin scratches. Instead, PEG18-F6 self-aggregates in 
sheaf formed by small fibers of 60-500 nm placed side by side (Figure 
71b). Each fiber has a thickness between 60 and 200 nm. On the 
contrary, SEM images of PEG24-F6 show ~600-1000 μm long and  20 
μm large nanostructures with a twisted ribbon shape (Figure 71c,d). 
This kind of structures is expected for amyloid peptides functionalized 
with short PEG chains.240  
According to Polarized Optical Microscopy (POM), it is not observed in 
SEM images the effect of crystallization typically displayed by 
PEGylated peptides.217  
 
 
Figure 71: Selected SEM micrographs for PEGylated oligomers: (a) PEG12-
F6(30000x, 5µm scale bar); (b) PEG18-F6 (30000x, 5µm scale bar); (c) and (d) 
PEG24-F6 (400x, 400µm and 3000x, 50 µm scale bar, respectively). In the 
insert of panel b an additional view of PEG18-F6 (30000x, 5µm scale bar) on 
the aluminum stub showing an intricate sheaf of fibers.    
 
The absence of crystallization phenomenon in SEM images confirms 
further that the continuous rings measured in the WAXS-diffraction 
pattern are due to the low orientation of PEG24-F6 dried fibers in space. 
From the comparison of the SEM images of the three PEGylated 
derivatives, it arises that the PEG length affects the hierarchical 
organization of the peptide and the elongation of the nanostructure. The 
trend here observed is opposite to the conventional one shown by 
Hamley et al. for PEGylated amyloid peptides.217 However, the fibers 
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observed for PEG24-F6 are very similar to fibers previously observed for 
PEG8-F6, in which the ethoxylic groups is shorter than PEG24-F6, but 
the number of the amide bonds in PEG moiety is the same. This result 
suggests once more a deep relationship between the number of the 
amide bonds and the structural aggregation of these peptides. 
 
3.8.6 Photoluminescence in peptide nanofibers 
Fluorescence behavior of PEGylated peptides (PEG12-F6, PEG18-F6 
and PEG24-F6) was investigated both in solution (Figure 72) and at 
solid state (Figure 73) and it was compared with PEG8-F6 
nanostructures, empty and filled with the NBD dye.  
 
 
Figure 72: a) PL emission spectra of PEGylated-F6 nanostructures at 10 
mg/mL upon excitation at λexc = 460 nm. b) Selected PL emission spectra of 
PEG24-F6 excited at several wavelengths in the range between 370-480 nm. 
c) Plot of the fluorescence intensity of PEG24-F6 at 530 nm as function as the 
excitation wavelength. 
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As PEG8-F6 NSs, also PEG12-F6, PEG18-F6 and PEG24-F6 derivatives, 
having a high content of β-sheet structures, show optoelectronic 
properties in water when excited at 370 or at 410 nm. However, beyond 
the emission peak at 460 nm, an additional PL emission peak at 530 
nm can be observed upon excitation of the solutions at 460 nm (Figure 
72a). This peak at 530 nm is mainly evident for PEG24-F6, whereas it 
appears to be absent or very weak for PEG12-F6 and PEG18-F6. The 
green PL emission of PEG24-derivative is well distinguishable also when 
the peptide solution is excited at different wavelengths (Figure 72b). 
The plot of the fluorescence intensity in the maximum as function as the 
excitation wavelength is reported in Figure 72c. 
 
 
  
Figure 73: Fluorescence microscopy images of PEG24-F6 at 10 mg/mL, 
deposited on a clean coverslip glass and slowly dried at room temperature. PL 
images are obtained by exciting the air dried sample in the spectral region of: 
(a) DAPI (4’,6-diamidino-2-phenylindole; λexc = 359 nm, λem = 461 nm); (b) 
GFP (Green Fluorescent Protein; λexc = 488 nm, λem = 507 nm); (c) Rho 
(Rhodamine; λexc = 555 nm, λem = 580 nm); and in the bright fields (d). The 
scale bar of all the images is 50 μm.  
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This additional excitation-emission pair of PEG24-F6 can be traced back 
to the formation of more stable electronic states resulting by the 
additional contribution of amide non-covalent interactions.  
The fluorescence microscopy images of the air-dried samples deposited 
on a clean coverslip glass are reported in Figure 72 and Figure 73. 
Due to the wide spectral region observed for the samples in solution, 
immunofluorescence images at the solid state were observed with 
different filters (DAPI, GFP and Rho) that able to cover the entire range 
of excitation and emission wavelengths. Images of PEG24-F6 (Figure 
72) show the capability of this peptide nanostructure to emit in blue, 
green, and red fields. 
On the other hand, images of PEG12 and PEG18 show a good emission 
of the NSs only in the blue-field (Figure 74). 
 
 
Figure 74: Fluorescence microscopy images of: (a) PEG12-F6 and (b) PEG18-
F6 at 10 mg/mL, deposited on a clean coverslip glass and slowly dried at room 
temperature. PL images are obtained by exciting in the UV-Vis spectral region. 
Fluorescence images (on the left), bright field images (on the right) and the 
merge of fluorescence and bright field images (at the center). 
 
These results indicate the capability of these peptides to keep the same 
optoelectronic properties both in solution and at the solid state. Taking 
into account the different number of H-bonding donors/acceptors in 
PEG24-F6 with respect to the others PEGylated analogues we assumed 
that the distinct PL behavior of these compounds could be, at least in 
part, due to the different H-bonding potential of these compounds  
This hypothesis has been supported through the investigation of the PL 
properties of PEGMW1300-F6, whose PEG moiety is comparable in size 
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to that PEG24-F6 though lacking the amide groups that could be 
potentially involved in H-bonding. In line with our suggestion, 
PEGMW1300-F6 does not give any emission peak at 530 nm in the same 
experimental condition, while retaining the usual emissions at 370 and 
410 nm (Figure. 75). 
 
 
Figure 75: Fluorescence emission spectra of PEGMW1300-F6 in water at 10 
mg/mL concentration. Spectra were recorded exciting sample at several 
wavelength ranged between 370 and 480 nm 
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3.9 Hexapeptide containing Tyrosine residues 
s previously reported, PEG8-F6 is a polymer-peptide monomer 
able to self-assemble in fibrillar amyloid like networks.231 This 
supramolecular behavior was expected for phenylalanine 
(Phe) containing polypeptides.184,184,196  
The impact of this key aromatic amino acid on the supramolecular 
structural organization was here evaluated by replacing phenylalanine 
in PEG8-F6 with tyrosine (Y), another aromatic residue. Similar to its 
ancestor peptide PEG8-F6, PEG8-Y6 (Figure 75a) keeps the same 
molecular architecture composed of an aromatic framework of six 
amino acid residues and a polymer functionality. In order to evaluate 
the effect of a partial replacement of Phe with Tyr, we also synthesized 
PEG8-(FY)3 (Figure 75 a) in which the two aromatic residues are 
alternated in the sequence. PEG moiety in these peptides is expected 
to increase their water solubility. Indeed, we observed a clear drop of 
the water solubility and self-assembling capability for PEG8-F6 as a 
consequence of the PEG removal (data not shown). 
 
 
Figure 75: Schematic representation of PEGylated hexapeptides: PEG8-Y6 
(a) and PEG8-(FY)3 (b).Fluorescence intensity emission of ANS fluorophore 
titration at 475 nm vs. concentration of PEG8-Y6 and PEG8-(FY)3 (c). CAC 
values are established from the break points. 
 
 However, an additional role of PEG in alteration of the 
structural/functional properties of these systems cannot be excluded. 
Indeed, it is well-know from the literature that PEG moiety bound at N or 
C-terminus of short peptides can induce crystallization effects. 187,240 In 
order to assess the influence of PEG on the self-assembling process, 
we also synthesized Y6 and (FY)3, that are two analogues peptides 
without PEG functionalization.  
 
 
A 
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3.9.1 Synthesis and fluorescence of tyrosinate peptides 
All the peptides were synthesized in good yields and high purity 
according to the standard protocols of the solid phase peptide synthesis 
(Fmoc/OtBu).215 For PEGylated derivatives, PEG moiety was inserted 
at the N-terminus of the peptide sequences through the sequential 
coupling of four monodisperse commercial oxyethylene linkers (Fmoc-
AdOO-OH, PEG2).  
Differently from PEG8-F6, which requires a pre-dissolution in 
1,1,1,3,3,3-hexafluoro-2-propanol (HFIP),231 PEG-tyrosinate analogues, 
having additional sites for hydrogen bonding and an increased side 
chain polarity, present good solubility in water and were directly 
dissolved in water at the final desired concentration. 
Fluorescence spectra of PEG8-(FY)3 and of PEG8-Y6 peptides (Figure 
76) were recorded in water at several concentrations (0.05, 0.1, 0.25, 
0.5, 1.0, 2.0, 4.0 and 10 mg/mL). Spectra of PEG8-(FY)3 were recorded 
by exciting the peptide at both 257 and 276 nm, that correspond to the 
absorbance wavelengths for Phe and Tyr chromophores, respectively. 
On the other hand, PEG8-Y6 samples were excited only at 276 nm. 
Independently from the λex and from the concentration studied, all the 
spectra of PEG8-(FY)3 show only a peak at 305 nm, typically observed 
for Tyr residue, whereas the peak at 282 nm is absent.  
The absence of this peak can easily be explained as a consequence of 
a RET (Resonance Energy Transfer) phenomenon occurring between 
Phe and Tyr residues. Beside the peak at 305 nm, two additional peaks 
at 360 and 376 nm appear for the sample at the highest studied 
concentration (10 mg/mL). The same peaks were also found in the 
fluorescence spectrum of PEG8-Y6 at 10 mg/mL. These peaks was 
attributed to peptide aggregation phenomena. The critical aggregate 
concentration (CAC) of PEGylated peptides was achieved by the well-
known fluorescence-based method, in which the fluorescent probe, 8-
anilinonaphthalene-1-sulfonate ammonium salt (ANS), is titrated with 
increasing amount of the peptide.63  
Critical Aggregation concentration values were established from the 
graphical break point of the plots in Figure 76c.  
ANS dye shows a very similar behavior upon titration with PEG8-(FY)3 
and PEG8-Y6 solutions and the CAC values are 1.5·10
-5 M (22.8 μg/mL) 
and 2.0·10-5 M (31.4 μg/mL), respectively. These values are of the 
same order of magnitude and slightly higher than the CAC value 
previously found for the more hydrophobic hexaphenylalanine analog 
(7.5 μM, 10μg/mL).231  
This result was expected due to the higher hydrophobicity of the 
phenylalanine with respect to the tyrosine. Moreover, the partial or 
complete replacement of the phenylalanine residues with the tyrosine 
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ones does not seem affect significantly the aggregation propensity of 
the peptide derivative. 
 
 
Figure 76: Fluorescence emission spectra of PEG8-(FY)3 excited at λex = 257 
nm (left) and λex = 276 nm (middle) and of PEG8-Y6 exited λex = 276 nm (right) 
in 0.05-10 mg/mL concentration range. In the insert, the fluorescence 
spectrum at 10 mg/mL.. 
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3.9.2 Structural characterization in solution 
The structural organization of PEGylated aromatic hexapeptides was 
investigated by Circular Dichroism (CD) and by Fourier Transform 
Infrared (FTIR). CD spectra of PEG8-(FY)3 and PEG8-Y6 in water at 
several concentrations (0.1, 1.0, 2.0 and 5.0 mg/mL) are reported in 
Figure 77a and Figure 77b.  
 
 
Figure 77: CD spectra of: (a) PEG8-(FY)3 and (b) PEG8-Y6 in water at several 
concentrations (0.1, 1.0, 2.0 and 5.0 mg/mL). (c) FTIR spectra of PEG8-Y6 
and PEG8-(FY)3 and (FY)3 in water at 5.0 mg/mL in the amide I region. 
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All the spectra of PEG8-(FY)3 show a very similar dichroic tendency 
with respect to PEG8-F6 with two maxima at 226 and 202 nm, and a 
minimum around 235 nm. The two maxima (226 and 202 nm) can be 
associated with the n→π* transition of the peptide bond and to the 
π→π* transition of the peptide bond and/or phenyl moieties, 
respectively. In details, the peak at 202 nm is characteristic of peptides 
in which an aromatic side-chain stacking occurs, whereas the minimum 
at 235 nm is associated with a β-sheet secondary structure 
arrangement.203,216  
The decreasing intensity of the peak at 202 nm, as function of 
concentration, is due to a gradual subtraction and consequent silencing 
of chromophores in the final spectrum. This evidence confirms a 
progressive self-aggregation of the peptide derivative driven by 
aromatic interactions. The other PEGylated peptide, PEG8-Y6, shows a 
slightly different CD behavior compared to PEG8-(FY)3.  
In the spectra of PEG8-Y6, two maxima red shifted at 207 and 230 nm 
are well detectable. Beyond these two maxima, there is a pronounced 
minimum at 193 nm, whereas the minimum around 235-240 nm is 
absent. These spectral differences reflect fine dissimilarities in the 
secondary structure of the two compounds. 
The obtained aggregates were also structurally examined by FTIR 
spectroscopy in the spectral region of the stretching of amide I (1600-
1700 cm-1). FTIR spectra of PEG8-(FY)3 and PEG8-Y6 peptides in 
water solution at 5.0 mg/mL, reported in Figure 77c, show a similar 
profile with two peaks at 1638 and 1680 cm-1. This profile, typically 
observed for β-sheets with an antiparallel orientation of the β-strands, 
was previously observed also for PEG8-F6.
231  
 
3.9.3 Structural characterization at the solid state 
Self-assembled aromatic peptides and their PEGylated analogues were 
further characterized at the solid state by Transmission Electron 
Microscopy (TEM) and WAXS techniques (Figure 78).  
Selected TEM images of PEG8-(FY)3 show a continuous network of 
fibers interconnected by physical cross-link points. The analogue (FY)3, 
lacking of PEG decoration, showed a smaller amount of fibrils at the 
same concentration. This result can be related to a less fiber entangling 
that has as consequence the absence of gelation ability for (FY)3. 
WAXS measurements were collected on dried fibers. Figure 78 shows 
the microscopic image of the fibers (upper row), the 2D WAXS data 
(middle row), and the 1D WAXS profiles (lower row). A comparative 
analysis of these experiments highlights analogies and differences. In 
all cases, the WAXS data present the typical fiber diffraction pattern 
with two crossed main axes: the meridional along the fiber direction and 
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the equatorial perpendicular to it (see white dotted arrows). The 2D data 
were integrated along these orthogonal axes and the corresponding 1D 
profiles, displayed in Figure 78 (lower row) as red (meridional) and 
black (equatorial) profiles, present almost the same reflections.  
The 0-4 labelled meridional and equatorial peaks were summarized in 
the Table 10, where the diffraction peak at q=1.29-1.33 Å-1 (d=4.7-4.9Å) 
corresponds to the distance between adjacent peptide backbones 
organized into β-strands along the fiber axis243 and the diffraction peak 
at q=0.49-0.3 Å-1 (d=11.9-12.8Å) corresponds to the distance between 
two distinct β-sheets.244  
 
 
Figure 78: Structural characterization at the solid state. In the top, selected 
TEM images  (YF)3 and PEG8-(FY)3. Microscopic image of the fibers (upper 
row), 2D WAXS data (middle row), 1D WAXS meridional/equatorial (red/black) 
profiles (lower row). The scale bar of the images is 0.5 mm  
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Table 10: Meridional and equatorial peaks position in q (Å-1) and 
corresponding distance d=2/q (Å). 
 
 (FY)3 PEG8-(FY)3 Y6 PEG8-Y6 
 q(Å
-1)  d(Å)±0.5 q(Å-1) ±0.02 d(Å)±0.5 q(Å-1)±0.02 d(Å)±0.5 q(Å-1)±0.02 d(Å)±0.5 
0 0.32 19.6 0.29 21.5     
1 0.49 12.8 0.52 12.05 0.51 12.3 0.53 11.9 
2 1.12 5.6 1.12 5.6 1.05 6.0 1.05 6.0 
3 1.33 4.7 1.33 4.7 1.29 4.9 1.29 4.9 
 
It is, however, important to note that the addition of the PEG moiety has 
different consequences on (FY)3 and Y6 assembly. Indeed, while the 
(FY)3 fiber are marginally affected by the addition of the PEG, the 2D 
WAXS diffraction patterns of Y6 and PEG8-Y6 show significant 
differences. In particular, the pattern exhibited by PEG8-Y6 is 
characterized by the presence of additional circles which are likely 
produced by the crystallization of PEG. 
 
3.9.4 Molecular modelling and dynamics  
In order to gain atomic-level structural data on the peptide moiety of the 
assemblies formed by Y6 and (FY)3 molecular modelling and molecular 
dynamics (MD) analyses were performed.  
Different models made of one, two, or three β-sheets, each composed 
of fifty β-strands, were generated taking the crystalline assembly of the 
hexapeptide KLVFFA fragment as reference.198,231  
For the Y6 hexapeptide, models composed by either one or two sheets 
were considered (Y_ST50_SH1 and Y_ST50_SH2). For the (FY)3 
system, which is endowed with a larger sequence complexity, we 
generated models made of either two or three β-sheets (FY_ST50_SH2 
and FY_ST50_SH3). 
Representations of the starting models are shown in Figure 79. The 
RMSIP values (data not shown) indicate that all simulations reached a 
satisfactory level of convergence 
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Figure 79: Three-dimensional representations of the starting flat models used 
in the Molecular Dynamics studies: Y_ST50_SH1 (a), Y_ST50_SH2 (b), 
FY_ST50_SH2 (c), and FY_ST50_SH3 (d).  
 
3.9.4.1 MD simulations of Y6 system 
To gain insights into the ability of a Tyr-rich peptide to adopt β-
structures, initial MD investigations were performed considering a single 
sheet made of fifty β-strands (Y_ST50_SH1, Figure 79a).  
The evaluation of the geometrical parameters commonly used to 
assess the structural stability of trajectory structures (RSMD deviations 
from the starting structure and gyration radius) indicates that the system 
undergoes a major structural transition in the initial 50 ns of the 
simulation associated with the overall twisting (Figure 80). 
Although the secondary structure of the system is rather conserved 
(Figure 80c), significant fluctuations are evident also in the later stages 
of the trajectory (Figure 80a,b). These findings indicate that Y6 has a 
propensity to adopt β-structures, although the overall structure of the 
single sheet model is somewhat unstable. Then, it was evaluated the 
possibility that Y6 could form assemblies through the tight lateral 
association of Tyr side chains. To this aim, generated a double strand 
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model denoted as Y_ST50_SH2 and shown in Figure 79b was 
generated. The inspection of the trajectory frames of the resulting 
simulation clearly indicates that, after an initial structural transition (0-
100 ns), the model reaches a rather stable structural state (Figure 81). 
The analysis of the individual trajectory structures demonstrates that the 
initial structural transition corresponds to the twisting of the originally flat 
model (Figure 81c and Figure 79). 
 
Figure 80. Time evolution of several structural parameters in the MD 
simulation performed starting from the flat model of Y_ST50_SH1: RMSD 
values computed on the Cα atoms of MD trajectory structures against the 
starting model (a), gyration radius (b), and secondary structure (c). Secondary 
structure is reported only for the residues belonging to the central region and 
to both terminal ends. The average structure, computed in the trajectory 
region 100-400 ns, is also reported in panel c. 
a) 
 
b) 
 
c) 
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Figure 81: Time evolution of several structural parameters in the MD 
simulation performed starting from the flat model of Y_ST50_SH2: RMSD 
values computed on the Cα atoms of MD trajectory structures against the 
starting model (a), gyration radius (b), and secondary structure (c). Secondary 
structure is reported only for the residues belonging to the central region and 
to both terminal ends. The average structure, computed in the trajectory 
region 100-400 ns, is also reported in panel c 
 
a) 
 
b) 
 
c) 
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The evaluation of the main chain and side chain flexibility of Y6 
residues indicates that Tyr side chains located at the inter-sheet 
interface are endowed with a limited mobility (Figure 82).  
It is also worth mentioning that also the flexibility of the solvent exposed 
residues is rather limited. To unravel the structural determinants that 
confer stability to this assembly, we evaluated the occurrence of 
preferred Tyr rotameric states and H-bonding interactions. Interestingly, 
the structure of the assembly is characterized by an alternation of Y6 
peptides in which all Tyr side chains adopt trans states (≈ 180°) for the 
χ1 dihedral angle with peptides whose residues are in gauge (either ≈ -
60° or ≈ 60°) rotameric states (Figure 82c). This juxtaposition of the 
side chains combined with the antiparallel arrangement of the main 
chain leads to the formation of stacking interactions between Tyr 
residues of consecutive strands (Figure 82b). These stacking intra-
sheet interactions also occur for exposed Tyr residues, thus limiting 
their mobility and somewhat favoring their propensity to form larger Y6 
aggregates.  
Networks of inter-sheet H-bonds contribute to the overall stability of the 
Tyr interface (Figure 82b). The analysis of other structural periodicities 
of Y_ST50_SH2 assembly indicates that the distance along the same 
polypeptide chain between Tyr residues which present the same 
orientation of the side chain is ≈ 6.5 -7.0 Å (Figure 82d). The inter-
sheet distance between facing Tyr residues is approximately 12.5 Å. 
Notably, these values are in close agreement with the equatorial 
reflections detected in the WAXS analyses (Table 10). 
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Figure 82. RMSF values of the Y_ST50_SH2 model computed in the 
equilibrated region of the trajectory (100-400 ns) are shown in panel (a). For 
clarity only the values of the central ten β-strands are reported. Representative 
examples of inter-sheet H-bonding interactions are reported in panel (b). 
Conformations of the Tyr side chains at the exposed and dry interfaces are 
shown in panel (c). Representative examples of the time evolution of the χ1 
dihedral angle are reported. The time evolution of the distance between two 
representative Cα atoms of the facing sheets along the trajectory and of the 
distance along the same polypeptide chain between Tyr residues which 
present the same orientation of the side chain is reported in panel (d). Time 
evolution of several structural parameters in the MD simulation performed 
starting from the flat model of Y_ST50_SH2: RMSD values computed on the 
Cα atoms of MD trajectory structures against the starting model (a), gyration 
radius (b), and secondary structure (c). Secondary structure is reported only 
for the residues belonging to the central region and to both terminal ends. The 
average structure, computed in the trajectory region 100-400 ns, is also 
reported in panel c. 
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3.9.4.2 MD simulations of (FY)3 system 
A three-dimensional model for (FY)3 was generated by using a step-
wise procedure. As detailed in the methods section, taking into account 
the elevated hydrophobicity of Phe residues, we preliminarily generated 
a model composed of two sheets with facing Phe side chains at the dry 
interface and exposed Tyr side chains (FY_ST50_SH2) (Figure 79c). 
MD simulations carried out on this system clearly indicate that it 
reaches a stable state after an initial structural transition (0-250 ns) As 
for Y6, this transition corresponds to the twisting of the model (Figure 
83).  
The inspection of the trajectory structures indicates that, for the Phe 
moieties, this system recapitulates the structural features of the 
previously characterized F6 assembly.231  
On the other hand, the exposed Tyr residues behave like the exposed 
residues of Y6 (data not shown).  
The ability of the Phe residues of (FY)3 to form a stable apolar interface 
and the capability of Tyr residues of Y6 to tightly associate led us to 
generate a three-sheet model characterized by two distinct interfaces: 
one apolar made of Phe residues and the other more polar made of Tyr 
residues (Figure 79d). MD simulations clearly indicate that this 
assembly is rather stable as demonstrated by the monitoring of several 
structural parameters (Figure 84).  
The analysis of both the apolar and polar interface clearly unravels the 
basis of their stability. In both of them the alternation of peptides with 
trans and gauche+ rotameric states of the side chains leads to the 
formation of stabilizing stacking interactions (Figure 85b,c).  
At the Phe-interface additional interactions are established by the 
aromatic rings of facing residues. On the other hand, the Tyr-interface is 
stabilized by both intra-sheet and inter-sheet H-bonds (Figure 85b). As 
expected, the inter-sheet distances of both Phe- and Tyr-interface are 
approximately 12.5 Å (Figure 85d).  
The combination of these two interfaces leads to a model characterized 
by a periodicity of 21 Å (Figure 85d).  
These values are in close agreement with those experimentally derived 
by WAXS (Figure 78 and Table 10). 
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a) 
 
b) 
 
c) 
 
Figure 83. Time evolution of several structural parameters in the MD 
simulation performed starting from the flat model of FY_ST50_SH2: RMSD 
values computed on the Cα atoms of MD trajectory structures against the 
starting model (a), gyration radius (b), and secondary structure (c). Secondary 
structure is reported only for the residues belonging to the terminal ends and 
to the central region. The average structure, computed in the equilibrated 
region of the trajectory (250-500 ns) is reported. 
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a) 
 
b) 
 
c) 
 
Figure 84. Time evolution of several structural parameters in the MD 
simulation performed starting from the flat model of FY_ST50_SH3: RMSD 
values computed on the Cα atoms of MD trajectory structures against the 
starting model (a), gyration radius (b), and secondary structure (c). Secondary 
structure is reported only for the residues belonging to the terminal ends and 
to the central region. The average structure, computed in the equilibrated 
region of the trajectory (100-3500 ns) is reported. 
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Figure 85. RMSF values of the FY_ST50_SH3model computed in the 
equilibrated region of the trajectory (100-350 ns) are shown in panel (a). For 
clarity only the values of the central fifteen β-strands are reported. 
Representative examples of inter-sheet H-bonding interactions at the Tyr-Tyr 
interfaces are reported in panel (b). Conformations of the residue side chains 
are shown in panel (c). Representative examples of the time evolution of the 
χ1 dihedral angle are reported. The time evolution of the distance between two 
representative Cα atoms of the external sheets along the trajectory is reported 
in panel (d). 
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3.9.5 PEG8-(FY)3 gel: rheological characterization  
From the qualitative point of view, PEG8-(FY)3 showed a certain 
tendency to gelificate in water above a concentration of 0.5wt %.  
The monitoring of the stability of the 1.0wt % gel over time indicated 
that at this concentration the gel maintains its ultrastructure up to 60 
days (Figure 86a). Although, based on sequence considerations, 
PEG8-(FY)3 is expected to have intermediate properties between PEG8-
F6 and PEG8-Y6, none of these two latter compounds form hydrogels 
under the same concentration and temperature used to prepare the 
PEG8-(FY)3 hydrogel.  
 
a) 
 
 
b) 
 
Figure 86: a) Inverted tube test for PEG8-(FY)3 at 1.0wt % until two months. 
b) Time sweep (1 hour experiment) for PEG8-(FY)3 gel at 1.0wt % 
concentration. Rheological results expressed in terms of storage (G') and loss 
modulus (G''). 
 
Section III: PBMs obtained by punctual chemical modifications 
 
160 
For the PEG8-(FY)3 system the PEG moiety is essential for gelification 
as the peptide (FY)3 peptides, lacking the PEG portion, present a very 
limited water solubility, also after pre-dissolution in organic solvent, 
leading to the formation of solid precipitates. 
In order to further examine the mechanical properties of the PEG8-(FY)3 
hydrogel, rheological analysis was performed at 1.0wt % concentration. 
The results of the experiments are reported in terms of storage modulus 
(G′) and of loss modulus (G′′) The optimal measurement parameters 
were defined according to dynamic strain sweep (at a frequency of 1 
Hz) and frequency sweep (at 0.1 % strain) oscillatory tests. Time sweep 
measurement was performed with 1 Hz frequency and 0.1 % strain for a 
time period of 1 h. G' and G'' time sweep curves are presented in 
Figure 86b. The evidence that the value of storage modulus (G′~100 
Pa) is higher than that of the loss one (G′′~28 Pa) confirms analytically 
the gel state of the system, excluding the possibility that the 
supramolecular material has a high viscose liquid behaviour.245 
Furthermore, if compared with other organogelator system, this 
modulus values point out the weak nature of the self-supporting 
hydrogel.  
 
3.9.6 In vitro biocompatibility profiles of PEG8-(FY)3 gel 
Biocompatibility of the PEG8-(FY)3 hydrogel at a concentration of 1.0 
wt% was evaluated on Chinese Hamster Ovarian (CHO) cells cultured 
in Dulbecco's Modified Eagle's medium (DMEM).  
The elution test, coupled with MTT viability assay, is an in vitro 
cytotoxicity study designed to detect the possible presence of toxic 
material eluted in the media from the gel sample. The DMEM media 
was incubated with the gel overnight. The extracted media was used to 
culture CHO cells and the viability was determined after six and twenty-
four hours of incubation.  
The cell viability, estimated by MTT assay, was certified to be 93 % and 
90% for six and twenty-four hours incubation times, respectively 
(Figure 87a and 87b, inserts). Simultaneously, after the treatment with 
the extracted media, cells were analysed for viability using live-dead 
staining with fluorescein diacetate (FDA), a cell membrane dye 
indicating live cells (green), and with propidium iodide (PI), a DNA stain 
indicating dead cells (red).246 The degree of death was determined by 
fluorescence microscopy imaging. Fluorescence micrograph (merged in 
red and green field) for live/dead assay after six hours shows high 
confluent live cells with no red spots (Figure 87a).  
A very similar result was detected for the sample with longer incubation 
(Figure 87b).  
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The high cytocompatibility detected in vitro can be probably attributed to 
the hydrogel preparation method that, contrarily to others peptide 
hydrogels, does not require the employment of any organic solvents 
(like DMSO, HFIP or MeOH).247  
 
 
Figure 87: Representative merged image for live/dead assay after six (a) and 
twenty-four (b) hours incubation of CHO cells with extract media of PEG8-
(YF)3 at 1.0wt %. The MTT viability test result are reported in the insert of the 
two panels. 
 
3.10. Self-assembled tetra-tryptophan based NPs 
In order to further investigate the effect of a punctual modification on the 
supramolecular organization, the synthesis of PEG6-W4 (Figure 88a), a 
PEG adduct of the tetra-tryptophan (W4) was achieved. In this 
PEGylated tetra-peptide the Phe residue199 was replaced with the 
tryptophan (Trp, W).  
W is one of the essential amino acids and represents the key-precursor 
for biosynthetic pathway of some neurotransmitters and hormones 
(tryptamine, serotonin and melatonin) and for all the anthranylic 
compounds (like NAD, acetil-CoA and B3 vitamin).248  
In addition, Trp fulfils an important role in enzymatic chemistry due the 
possibility to coordinate transition metals by the N- indolic group in 
active task.249 
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a) 
 
b) 
 
Figure 88. a) Schematic representation of PEG6-W4 chemical structure, b) 
Fluorescence intensity emission of ANS fluorophore at 475 nm vs. 
concentration of PEG6-W4. The CAC value of the peptide derivative is 
established from the break points. 
 
3.10.1 Synthesis of PEG6-W4 
PEG6-W4 was synthesized in solid phase according to the Fmoc 
(fluorenylmethyloxycarbonyl) standard protocols of the peptide 
synthesis.215 
Due to the high hydrophobicity of the sequence, a DMF/NMP 1/1 (v/v) 
mixture was used as reaction solvent.250  
The Boc (tert-Butyloxycarbonyl) protection on the Trp side chain 
avoided collateral reactions (polymerizations, reduction indol-indoline 
and alkylation) associated with indole chemistry.251At the end of the 
synthesis, the pure compound, obtained by RP-HPLC chromatography, 
was characterized by LC-MS spectrometry and 1HNMR spectroscopy. 
(characterization is reported in Appendix I)  
As expected on the basis of the different solubility of Trp and Phe, 
PEG6-W4 presents a smaller water solubility with respect to the 
previously characterized analogue containing the same number of Phe 
residues (PEG6-F4).
199 Indeed, while PEG6-F4 was directly solubilized 
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in water up to 30 mg/mL, tetra-Trp derivative required a preventive 
dissolution of the peptide powder in HFIP at 100 mg/mL and a 
subsequent dilution in water up to 10 mg/mL. It is plausible to suppose 
that the self-organization of the monomers occurs at the water dilution 
step by aromatic collapse, being HFIP a disintegrative solvent for 
aromatic compounds.252 
In order to analytically establish the minimal concentration for self-
aggregation, CAC was determined using ANS method.63,196  
Tracking and plotting the fluorescence intensity as function of the 
concentration, CAC value for PEG6-W4 (1.26*10
-4 M, 126 μM) was 
determined in the break point of the graph reported in Figure 88b.  
The critical concentration found for PEG6-W4 is about 3-fold higher with 
respect to the value previously measured for F4-derivative ( 43 μM).199 
On the basis of simple consideration on the hydrophilic/hydrophobic 
balance, a higher self-assembly propensity of Trp homo-sequence is 
conceivable with respect to Phe one. This unexpected behavior can be 
related to a worse packaging of W4 consequent to the different Van der 
Waals volume of Trp and Phe (that are 163 and 135 Å3, respectively). 
 
3.10.2 Secondary structure assignment 
A detailed analysis of PEG6-W4 structure was performed by circular 
dichroism (CD) and FTIR to unravel the supramolecular organization of 
PEGylated tetra-tryptophan monomers.  
Amide chromophores present in the protein backbone generate 
characteristic spectra with multiple transitions that can be ascribed to 
specific secondary structure motifs.253 CD spectra of PEG6-W4 
solutions, reported in Figure 89, show the dichroic signature of the 
peptide between 280 and 190 nm at several concentrations (0.1, 0.34, 
1.35, 3.5 and 5 mg /mL). 
For concentration below (0.1 mg/mL) and close to the CAC value (0.34 
mg/mL), dichroic trends are dominated by a negative peak (Figure 
89a). This signal is characterized by a progressive bathochromic shift 
from 225 nm to 230 nm while increasing concentration that can be 
attributed to a β-sheet structuration (Figure 89b).254 
A substantial conformational transition to Trp-zipper organization was 
detected at higher concentrations (1.35, 3.5 and 5.0 mg /mL).  
The structural change is revealed by an intense Trp-Trp exciton-
coupled band, resulting in a negative peak at 217 nm and a positive 
signal at 233 nm with a zero isobestic cross-over point at 224 nm. No 
differences emerge from the comparison of the CD spectrum profiles at 
the three analyzed concentrations; however the increase of 
concentration is associated with a progressive decrease in intensity. 
This experimental evidence can be related to an increase in the 
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concentration of W4 aggregates that progressively subtracts detectable 
chromophores from the solution. The positive Cotton effect and the 233 
nm zero are consistent with a backbone right handed helical twist.255,256 
Moreover, the weak peak around 274 nm is indicative of a zipper type 
arrangement, made it possible by the interaction of Trp chromophores 
(insert in Figure 89b).257 Given these experimental evidences, a Trp-
Trp cross-strand indole-mediated interaction can be referenced (or 
considered) as the stabilizing factor of the supramolecular aggregates 
and as mechanism for the β-structure organization by hydrophobic 
collapse.  
The β-sheet arrangement of the peptide was further confirmed by FTIR 
spectroscopy. In Figure 89c it is reported the deconvolution in 
absorbance for the secondary structure prediction of the amide I 
spectral region (1600-1700 cm-1). FTIR spectrum shows two peaks at 
1638 and 1680 cm-1. This profile is normally observed for β-sheet with 
antiparallel orientation of the β-strands.205,206 
 
a) 
 
b) 
 
c) 
 
 
Figure 89. Secondary structure characterization of PEG6-W4 aromatic 
peptides: a) CD spectra below (0.1 mg/mL) and close (0.34 mg/mL) to the 
CAC value, b) CD spectra above the CAC (1.35, 3.5 and 5 mg/mL), c) FTIR 
spectra at 5.0 mg/mL in the amide I region. 
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3.10.3 Structural characterization at the solid state  
PEGylated tetra-tryptophan nanostructures were also characterized at 
solid state by WAXS/SAXS and TEM measurements. 2D WAXS data of 
PEG6-W4 reported in Figure 90a (right) have been collected on the air 
dried fibers. 2D WAXS data of the PEG6-F4 are also reported for 
comparison in Figure 90a (left). 
 
a) 
 
 
b) 
 
 
 
Figure 90. a) 2D WAXS data (upper row) and 1D WAXS meridional and 
equatorial profiles (lower row). b) Selected TEM images for PEG6-W4 
nanostructures. 
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For both the peptides, the WAXS data present the characteristic 
diffraction pattern of a amyloid-like fiber, with two main axes of 
symmetry: the meridional axis along the fiber direction and the 
equatorial axis perpendicular to it.124 These axes were marked as white 
dotted arrows in each figure. The 2D data were integrated along these 
orthogonal directions and the corresponding 1D profiles were displayed 
in Figure 90a (lower row).  
The most intense meridional and equatorial peaks were summarized in 
Table 11, where the diffraction peak at q=1.26-1.35 Å-1 (d=4.6-4.9Å) 
corresponds to the distance between adjacent peptide backbones 
organized into β-strands along the fiber axis.199 2D SAXS data, 
recorded on the same nanofibers (data not shown) do not display 
diffraction contributions at the nanoscale, thus indicating the absence of 
a hierarchical organization of the fiber. The presence of fibers at the 
solid state was also confirmed by TEM images (5.0 mg/mL), reported in 
Figure 90b. 
 
Table 11: Meridional and equatorial peaks position in q (Å-1) and 
corresponding distance d=2/q (Å). The distances between adjacent peptide 
backbones (β-strands distance) along the fiber axis are marked in bold. 
 
 PEG6-W4 PEG6-F6 
M
er
id
io
n
al
 
q(Å-1) ± 0.02 d(Å) ± 0.5 q(Å-1) ± 0.02 d(Å) ± 0.5 
1.35 4.6 1.26 4.9 
-- -- 1.23 5.1 
-- -- 1.52 4.1 
Eq
u
at
o
ri
al
 
0.37 17.0 0.42 15.0 
-- -- 0.56 11.2 
0.72 8.7 0.79 7.9 
1.08 5.8 0.99 6.4 
1.42 3.5 1.42 4.4 
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3.10.4 Dynamic simulations 
In order to gain atomic-level structural information on the peptide spine 
of the W4 system it were performed MD simulations on different 
assemblies characterized by a different number of facing β-sheets (two 
to four) each composed of fifty β-strands (SH2_ST50_W4, 
SH3_ST50_W4, and SH4_ST50_W4).  
Simulations carried out on SH2_ST50_W4 indicate that the system is 
highly unstable as it rapidly loses its starting structure (data not shown). 
This behavior is somewhat different from that exhibited by a similar 
model of the peptide made by six Phe residues (F6).231 
 
 
Figure 91:. Time evolution of structural parameters in the MD simulation 
performed starting from the flat model of W4_ST50_SH4: a) two different 
views of the starting model, b) secondary structure, c) RMSD values 
computed on the Cα atoms of MD trajectory structures against the starting 
model, and d) gyration radius. Secondary structure is reported only for the 
residues belonging to the central region and to both terminal ends depicted in 
red in panel a.  
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This observation may be explained by considering the reduced inter-
sheet interface of the tetrapeptide W4 compared to the hexapeptide F6. 
In this framework, we generated larger and more realistic models of the 
W4 fiber by increasing the number of the β-sheets of the assemblies. 
Simulation carried out on the system made of three sheets indicates 
that, although more stable than SH2_ST50_W4, it also undergoes a 
substantial disassembly (data not shown). On the other hand, the model 
composed of four β-sheets (SH4_ST50_W4) (Figure 91a) is endowed 
with a significantly higher stability. Indeed, an 80-ns MD simulation 
indicates that this system, after an initial transition, reaches a stable 
state that persists in the 20-80 ns interval as highlighted by the gyration 
radius and the Root Mean Square Deviation (RMSD) values of the 
trajectory structures against the starting model (Figures 91c and 91d). 
Figure 91b also indicates that this system retains a significant level of 
secondary structure. It is worth mentioning that the high value (0.79) of 
the RMSIP calculated on two halves of the equilibrated trajectory (20-50 
and 50-80 ns) suggests that the system reached a good level of 
convergence. 
 The inspection of the structural and dynamic features of the models 
detected in the equilibrated region of the trajectory indicates that the 
major transition of SH4_ST50_W4 corresponds to a twisting of the 
assembly (Figure 92a).  
 
 
Figure 92. Structural features of W4_ST50_SH4: a) two views of a representative 
model of the equilibrated portion of the MD trajectory, b) representative example of 
the time evolution of the inter-sheet distance. 
 
The inspection of the Room Mean Square Fluctuation (RMSF) values 
indicates that the Cα atoms are endowed with a certain level of mobility 
(Figure 93a). 
Section III: PBMs obtained by punctual chemical modifications 
 
169 
Notably, the RMSF values corresponding to the atoms of the side chain 
are comparable to those exhibited by the Cα atoms (Figure 93b). This 
finding suggests that the intra-sheet and the inter-sheet interactions 
between Trp side chains limit their mobility. The analysis of the 
distances between facing sheets at the dry interface indicates that they 
are separated by approximately 15.0 Å (Figure 93b). This value, 
although larger than that found for the F6 system,231 is slightly lower 
than that experimentally derived from the WAXS data (17.0 Å) (Table 
11). This discrepancy may be ascribed to the finite size of 
SH4_ST50_W4 that, containing only four sheets, may favour an 
approaching of facing sheets.  
 
Figure 93: RMSF values computed on Cα (a) and on side chain atoms (b) in 
the equilibrated region of the trajectory.  
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4.1 Materials and Methods 
rotected Nα-Fmoc-amino acid derivatives orthogonally 
protected in side chain, coupling reagents (HOBt, PyBOP, 
HATU and DIEA), and Rink amide MBHA (4-
methylbenzhydrylamine) resin were purchased from 
Calbiochem-Novabiochem (Laufelfingen, Switzerland). The Fmoc-21-
amino-4,7,10,13,16,19-hexaoxahe-neicosanoic acid [Fmoc-Ahoh-OH, 
(L6)] and the Fmoc-8-amino-3,6-dioxaoctanoic acid [Fmoc-AdOO-OH, 
(L2)] were purchased from Neosystem (Strasbourg, France). 
DTPA(OtBu)4-OH and DOTA(OtBu)3-OH chelating agents were 
purchase from Chemateck (Dijon, France).  
All other chemicals and fluorophores were commercially available by 
Sigma-Aldrich, Fluka (Bucks, Switzerland) or LabScan (Stillorgan, 
Dublin, Ireland) and were used as received unless otherwise stated. All 
solutions were prepared by weight with doubly distilled water.  
Preparative RP-HPLCs were carried out on a LC8 Shimadzu HPLC 
system (Shimadzu Corporation, Kyoto, Japan) equipped with an UV 
lambda-Max Model 481 detector using Phenomenex (Torrance, CA) C18 
column. Elution solvents are H2O/0.1%TFA (A) and CH3CN/0.1% TFA 
(B). 
Purity and univocal identity of the products were assessed by analytical 
LC-MS analyses by using Finnigan Surveyor MSQ single quadrupole 
electrospray ionization (Finnigan/Thermo Electron Corporation San 
Jose, CA), column: C18-Phenomenex eluted with an H2O/0.1% TFA (A) 
and CH3CN/0.1% TFA (B), with a flow of 200 μL
-1. Analytical method of 
analysis are identified as: 
 
Method 1 :   5-70-15  (flow of 200 μL-1) 
Method 2 :   20-80-15 (flow of 200 μL-1) 
Method 3 :   5-70-15  (flow of 1 mL-1) 
Method 4 :   20-80-20  (flow of 1 mL-1) 
 
Times retentions, molecular mass values and 1HNMR characterization 
for all the synthetized compound are collected in the Appendix 1. 
 
4.2 Peptide and peptide conjugates synthesis 
Standard solid-phase peptide synthesis (SPPS) procedures with 
(fluorenylmethyloxycarbonyl) Fmoc/OtBu protection strategy were 
achieved to obtain peptide sequences and conjugates.215 
The Rink amide MBHA resin (substitution 0.65 mmolg-1) was used as 
the solid-phase support to provide the peptides as C-terminus amides. 
Synthesis was per-formed on a scale of 0.2 mmol using N,N-
P 
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dimethylformamide (DMF) as solvent. For high hydrophobic sequences, 
N-methyl-2-pyrrolidone (NMP) was associated to DMF.250  
Before starting with the elongation of the peptide, the resin was swelled 
for 30 min in DMF. Fmoc deprotection steps (two treatment of 7-10 
minutes) were realized with a solution of 30% (v/v) piperidine in DMF. 
Coupling steps were achieved via carbodiimide activation by adding 2-
fold molar excess of amino acid or PEG fragments, mixed with 
equimolar amounts of 1-hydroxybenzotriazole (HOBt), benzotriazol-1-yl-
oxy-tris-pyrrolidino-phosphonium (PyBop), and a 4-fold molar excess of 
diisopropylethylamine (DIPEA). Chelating agents and difficult couplings  
were carried out by using 1-[Bis(dimethylamino)methylene]-1H-1,2,3-
triazolo[4,5-b]pyridinium-3-oxid hexafluorophosphate (HATU) as 
activating agent and DIPEA as base. All couplings were performed 
twice for 1h.  
Selective removal of N-methyltrityl (Mtt) protecting group from the lysine 
epsilon amine function was realized with a solution of 1% triﬂuoroacetic 
acid (TFA)/5% tri-isopropylsilane (TIS) in dichloromethan (DCM).  
Qualitative ninhydrine test (called alternatively Kaiser test) was 
performed in order to check coupling and deprotection steps.258 
Final products were fully deprotected and cleavaged from the support 
with the TFA (triﬂuoroacetic acid)/TIS (triisopropylsilane)/H2O 
(92.5/5/2.5 v/v/v) mixture at room temperature for 3 hours. For peptide 
lacking in side chain protecting group, the cleavage mixture was TFA 
(triﬂuoroacetic acid)/ H2O (95/5) v/v.  
Peptides and peptide conjugates were precipitated with ice-cold ethyl 
ether, dissolved in H2O/CH3CN and freeze-dried.  
As previously mentioned, the puriﬁcation of the crude products was 
carried out by preparative RP-HPLC. Mass spectra and 1HNMR 
conﬁrmed the products identity. Full characterization of peptides 
derivatives is reported in Appendix I 
 
4.3 Preparation of peptide solutions and aggregates 
Peptide solution and aggregates were prepared using different 
methodologies according to the solubility of monomers: 
 
 Direct dissolution in water: solution of tetraphenylalanines 
(DOTA-L6-F4, DTPA-L6-F4, FF-DOTA-FF and ff-DOTA-FF, as 
free bases or as Gd complexes) derivatives, dinaphtylalanine  
peptide conjugates (DOTA-L6-2Nal2 and DOTA(Gd)-L6-2NAL2), 
peptide containing tyrosine (PEG8-Y6, PEG8-(FY)3) and of 
PEGylated hexaphenylalanine (PEG12-F6, PEG18-F6 and PEG24-
F6) were prepared  by dissolving the lyophilized powder in 
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double-distilled water. If required, samples were sonicated for 15 
min at 25°C. 
 Solvent switch method: this strategy was applied for PEG8-F6 
and PEG6-W4 derivatives. An initial solution (at 100 mgmL
-1) was 
prepared dissolving the lyophilized peptide powder in 1,1,1,3,3,3-
hexafluoro-2-propanol (HFIP). Subsequently, this solution was 
diluted in water. The organic solvent was removed with N2 flow. 
 
4.4 UV-Vis peptide quantification 
The final solution concentration was analytically assigned by 
absorbance on a UV/Vis Thermo FisherScientific Inc (Wilmington, 
Delaware USA) Nanodrop 2000c spectro-photometer equipped with a 
1.0 cm quartz cuvette (Hellma). Molar extinction coefficients of peptide 
conjugates were calculating using the following molar absorptivity (ε) 
and absorption wavelength for single chromophore residue: 
 
L,D-Phenylalanine  ε257= 195  M
-1cm-1 
L-2-Napthylalanine  ε280= 3035 M
-1cm-1 
L-Tyrosine   ε275= 1215  M
-1cm-1 
L-Tryptophan   ε280= 5600  M
-1cm-1 
 
4.5 Preparation of PEG8-F6 NBD-filled nanostructure 
PEG8-F6 NSs filled with 4-chloro-7-nitrobenzofurazan (NBD) were 
prepared according to solvent switch method, by dissolving fluorescent 
NBD dye and PEG8-F6 peptide in HFIP. The peptide and NBD 
concentrations in HFIP were 100 and 10 mg mL-1, respectively. This 
solution was ten-fold diluted in water, and the organic solvent was 
removed by a slow nitrogen flow.  
Then, the solution was centrifuged for 5 min at 13500 rpm, and the 
supernatant was purified from free NBD by gel-filtration with a 
Sephadex G-50 column pre-equilibrated with water.  
For the determination of the amount of NBD encapsulated in NSs, a 
sample was lyophilized and spectroscopically investigated by UV/Vis 
measurements at l = 340 nm on the powder dissolved in CH3OH. 
Themolar absorptivity (ε) at 340 nm (9352 M-1cm-1) was calculated by a 
calibration curve. The identity of NBD after loading in PEG8-F6was 
determined by LC–MS. 
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4.6 Preparation of gadolinium(III) and lanthanum (III) 
complexes  
 
The complexation has been carried out by adding 1:1 molar ratio of 
GdCl3 or LaCl3 salts to the aqueous solutions of the DOTA or DTPA 
derivatives at neutral pH and room temperature. The amount of residual 
free Gd3+/La3+ ions was assessed by the orange xylenol UV method259 
and complexed by further addition of the corresponding amount of each 
ligand. 
 
4.7 Fluorescence studies and determination of CAC 
Fluorescence spectra and values of critical aggregate concentration 
(CAC) were obtained by fluorescence measurements. Fluorescence 
spectra were recorded at room temperature on a Jasco Model FP-750 
spectrofluorophotometer in a 1.0 cm path length quartz cell. Equal 
excitation and emission bandwidths (5 nm) were used throughout the 
experiments with a recording speed of 125 nm/min and automatic 
selection of the time constant.  
The CAC values were measured by using 8-anilino-1-naphthalene 
sulfonic acid ammonium salt (ANS)260,261 and/or Pyrene (Pyr) as 
fluorescent probes.201  
Small aliquots of peptide conjugate in water solutions, were added to 
200 μL of aqueous solution of ANS (20 μM) or Pyr (1 μM). Final 
spectra, to be used for calculations, were obtained after blank 
correction and adjustment for dilution. The fluorescence intensity of 
ANS was followed as a function of the peptide concentration. The CAC 
values were determined by linear least-squares fitting of the 
fluorescence emission at 475 nm, upon excitation at 350 nm versus 
peptides derivatives concentration lower and higher than the change of 
slope. The excitation wavelength of Pyr was settled at 335 nm and 
spectra were recorded between 350 and 550 nm. 
 
4.8 Circular Dichroism characterization  
Far-UV CD spectra of the peptide conjugates were collected at room 
temperature on a Jasco J-810 spectropolarimeter equipped with a 
NesLab RTE111 thermal controller unit using a 0.1 mm quartz cell at 25 
°C. The spectra of samples at several concentrations were recorded 
from 280 to 190 nm. Other experimental settings were: scan speed, 10 
nm min-1; sensitivity, 50 mdeg; time constant, 16 s; bandwidth, 1 nm. 
Each spectrum was obtained by averaging three scans, corrected for 
the blank and adjusted for dilution. Ellipticities were reported as the 
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mean residue ellipticity (MRE), which is the ellipticity per mole of 
peptide divided by the number of amide bond in the building block. 
 
4.9 Fourier Transform Infrared spectroscopy (FT-IR) 
FT-IR spectra of samples (always at concentration higher than CAC) 
were collected on a Jasco FT/IR 4100 spectrometer (Easton, MD) in an 
attenuated total reflection (ATR) mode and using a Ge single-crystal at 
a resolution of 4 cm-1. All the spectral data were processed using built-in 
software. Spectra were collected in transmission mode and then 
converted in emission. FT-IR spectra were also collected on samples at 
the solid state. Each sample was recorded with a total of 100 scans with 
a rate of 2 mm·s-1 against a KBr background. 
 
4.10 Dynamic Light Scattering (DLS):  
DLS measurements were carried out using a Zetasizer Nano ZS 
(Malvern Instruments, Westborough, MA) that employs a 173° 
backscatter detector. Other instrumental settings (measurement 
position and attenuator) were automatically regulated by the instrument.  
 
4.11 Congo Red (CR) spectroscopic assay 
UV-Vis measurements of Congo Red (CR) alone or in presence of 
peptide self-assembling derivatives were carried out on Thermo Fisher 
Scientific Inc (Wilmington, Delaware USA) Nanodrop 2000c 
spectrophotometer equipped with a 1.0 cm quartz cuvette (Hellma). A 
stock solution of CR (3.5 mg in 500 μL) was freshly prepared in 10 mM 
phosphate buffer pH 7.4 and filtered through 0.2 μm syringe 
immediately prior to use. A small aliquot (5 μL) of this solution was 
diluted with the buffer at 12.5 μM final concentration and the UV-Vis 
spectrum was recorded between 400 and 700 nm at room temperature. 
Appropriate volume of peptide water solution were added to CR solution 
and samples were incubated for 30 min at room temperature. The 
spectra were recorded and background subtracted using a Congo Red 
spectrum in phosphate buffer as reference solution. 
 
4.12 Congo Red staining and polarized optical 
birefringence assay 
 
Dried film of peptide conjugates was prepared placing 30 L of the 
peptide solution (0.25 wt %) in deionized water, onto a glass slide and 
left drying at room temperature. The air-dried samples were stained 
with 25 L of CR solution just prepared adding a saturating amount of 
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CR in ethanol containing 20% of NaCl saturated water. After deposition, 
CR extra solution was detached from the glass slide with a filter paper. 
Fibers containing CR were prepared, according to the method 
described below in the Wide-Angle X-ray Scattering section, adding 4 
L of CR staining solution to 100 L of peptide solution (0.25 wt%). 
Both film and solid fiber were observed under bright field illumination 
and between crossed polars using a Nikon AZ100 microscope.  
 
4.13 Thioflavin T (ThT) spectroscopic assay 
Thioflavin T associates rapidly with β-aggregated peptides giving rise to 
an enhanced emission at 482 nm.[35] Fluorescence spectrum of an 
aqueous solution of ThT (25 μM) before and after the addition of tetra-
phenylalanine derivatives (2 mg/mL) was recorded at 25°C at regular 
intervals (each ten minutes) during two hours after the peptide addition 
into the cuvette. Samples were excited at 450 nm and fluorescence 
emission spectra were recorded between 460 and 650 nm. 
 
4.14 1HNMR spectra and experiments 
NMR experiments were acquired in the temperature range of 298–
303 K on either a Varian Unity Inova 600 MHz spectrometer provided 
with a cold probe or a 400 MHz Varian instrument provided with a 5-mm 
triple resonance probe and z-axis pulsed-field gradients. For 
identification, peptide conjugates were dissolved in CD3OD. Chemical 
shift and assigement are reported in Appendix1. 
For DOTA-L6-F2 and DOTA-L6-2Nal2 and their parental La complexes, 
samples were dissolved in a mixture H2O/D2O (98% D, Armar 
Chemicals, Dottingen, Switzerland) 90/10 v/v with a total volume equal 
to 600 μL. The DOTA-L6-F2 was analyzed in the concentration range 
0.3 mg/mL (i.e., 0.3 mM)–5.0 mg/mL (i.e., 4.8 mM); for the La-DOTA-L6-
F2 the examined concentration range was 0.3 mg/mL (i.e., 0.3 mM)–
10.0 mg/mL (i.e., 8.5 mM). The 2Nal2 compound was analyzed in the 
concentration range 0.1 mg/mL (i.e., 0.1 mM)–5.0 mg/mL (i.e., 4.4 mM) 
and La-2Nal2 in the range 0.2 mg/mL (i.e., 0.2 mM)–2.5 mg/mL (i.e., 
2 mM). 1D [1H] experiments along with a series of 2D experiments [(i.e., 
2D [1H, 1H] TOCSY (Total Correlation Spectroscopy)262 (70 ms mixing 
time), 2D [1H, 1H] NOESY (Nuclear Overhauser Enhancement 
Spectroscopy) 263(300 ms mixing time), and 2D [1H, 1H] ROESY 
(Rotating frame Overhauser Enhancement Spectroscopy) (200 and 
250 ms mixing times)] were recorded. 1D spectra were usually acquired 
with a relaxation delay d1 of 1.5 s and 32–512 scans; 2D experiments 
were recorded with 16–64 scans, 128–256 FIDs in t1, 1024 or 2048 
data points in t2.  
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Assignments of the DOTA-L6-F2 and 2Nal2-lacking the La (III) ion- were 
obtained at 1 mM concentration with a canonical protocol264 involving 
comparison of 2D [1H, 1H] TOCSY (70 ms mixing time), and 2D [1H, 1H] 
ROESY(200 ms mixing time). Water suppression was achieved by 
Excitation Sculpting265 Spectra were processed with VNMRJ (Varian by 
Agilent Technologies, Italy) and analyzed with NEASY266 comprised in 
the CARA software package (http://www.nmr.ch/). 
 
4.15 Transmission Electron Microscopy (TEM) images. 
TEM observations were performed with a transmission electron 
microscope FEI TECNAI G12 Spirit-Twin (LaB6 source) equipped with a 
bottom mounted FEI Eagle-4k CCD camera (Eindhoven, The 
Netherlands), operating with an acceleration voltage of 120 kV. (LaMest 
Pozzuoli, Italy). A droplet of the sample solution (5.0 mg/mL) was 
placed onto a 400 mesh holey-carbon coated copper grid, air-dried for 1 
hour, and then negatively stained with phosphotungstic acid in water 
solution (1wt%). Tomography holder with FEI Eagle 4K CCD camera 
and Xplore3D software were used to obtain digital images. 
 
4.16 Scanning Electron Miscroscopy (SEM) images. 
Morphological analysis of the nanostructures was carried out using field 
emission scanning electron microscope (Nova NanoSem 450-FEI). 
Samples were prepared using different samples concentration. Briefly, 
the samples were placed on an aluminum stub using a graphite 
adhesive tape. A thin coat of gold and palladium was sputtered at a 
current of 20 mA for 90 s. The sputter coated samples were then 
introduced into the specimen chamber and the images were acquired at 
an accelerating voltage of 2-5 kV, spot 3, through the Everhart Thornley 
Detector (ETD) and the Through the Lens Detector (TLD). 
 
4.17 Wide-Angle (WAXS) and Small-Angle X-ray 
Scattering (SAXS) 
 
Fiber diffraction WAXS and SAXS patterns were recorded from dried 
fibers prepared by the stretch frame method.243 Briefly, a droplet (10 L) 
of a high concentrated peptide aqueous solution (in the range 1-3 wt %) 
was suspended between the ends of a wax-coated capillary (spaced 2 
mm apart). The droplet was allowed to dry gently at room temperature 
overnight to obtain oriented fibers. WAXS and SAXS data were 
collected at the X-ray MicroImaging Laboratory (XMI-L@b) equipped 
with a Fr-E+ SuperBright rotating anode copper anode microsource (Cu 
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K, λ=0.15405 nm, 2475W), a multilayer focusing optics (Confocal 
Max-Flux; CMF 15-105) and a three-pinhole camera (Rigaku SMAX-
3000).267  
For WAXS in reflection mode (GIWAXS) some droplets of solutions 
were deposited on the top surface of Si substrate and left drying at 
room temperature.  
For WAXS data collection an image plate (IP) detector with 100 µm 
pixel size was placed at 10 cm from the sample and calibrated by 
means of the Si NIST standard reference material (SRM 640b); for 
SAXS data collection a Triton 20 gas-filled photon counter detector with 
~ 200 m pixel size was placed at 2.2 m from the sample and calibrated 
by means of silver behenate. A detailed description of the XMI-L@b 
performances can be found in Altamura et al.267 and Sibillano et al.268 
 
4.18 Fluorescence and confocal microscopy  
15-20 μL of sample in solution (10 mgmL-1) were deposited on a clean 
coverslip glass, dried and imaged with fluorescence and confocal 
microscopies. Immunofluorescence images were taken with a Leica 
DFC320 video-camera (Leica, Milan, Italy) connected to a LeicaDMRB 
microscope equipped with 10 V and 40 V objectives and the Image J 
Software (National Institutes of Health, Bethesda, MD) was used for 
images analysis. Confocal images were obtained with a Leica TCS-
SMD-SP5 confocal microscope (lex= 405 nm and lem= 490–510 nm). 0.8 
mm-thick optical slices were acquired with a 63V or 40 V/1.4 NA 
objective. 
 
4.19 Water proton relaxation measurements 
The longitudinal water proton relaxation rates were measured at 25°C 
by using a Stelar Spinmaster (Stelar, Mede, Pavia, Italy) spectrometer 
operating at 0.5 T (21.5 MHz Proton Larmor Frequency), by mean of 
the standard inversion-recovery technique. The temperature was 
controlled with a Stelar VTC-91 air-flow heater equipped with a copper 
constantan thermocouple (uncertainty 0.1°C). The proton 1/T1 NMRD 
profiles were measured at 25°C on a fast field-cycling Stelar 
relaxometer over a continuum of magnetic field strengths from 0.00024 
to 0.47 T (corresponding to 0.01-20 MHz proton Larmor frequencies). 
The relaxometer operates under computer control with an absolute 
uncertainty in 1/T1 of ± 1%. Additional data points in the range 21.5-70 
MHz were obtained on the Stelar Spinmaster spectrometer.  
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4.20 Rheological characterization of PEG8-(FY)3 gel 
Gels of PEG8-(FY)3 were prepared at 1.0 wt % concentration by 
suspending the peptide powder in water. A bath sonication was 
required for obtain homogeneous self-supporting gels. Inverted and 
sloping tube tests were performed with a sample volume of 500 μL. 
Rheological measurements for 1.0 wt % PEG8-(FY)3 self-supporting 
gels were performed on an AR-G2 controlled-stress rheometer (TA 
Instruments, USA). A parallel plate geometry was used. Oscillatory 
frequency (0.01-100 Hz) and strain sweep (0.01-100%) at 4°C were 
conducted with the aim to determine the linear viscoelastic region. 
Time-sweep oscillatory test was performed for one hour on 300 μL of 
fresh gel at temperature of 4°C with 0.1 % strain and 1Hz frequency. All 
the rheological data were reported in Pascal (Pa) as G' and G", the 
storage and loss moduli, respectively. 
 
4.21 In vitro cytotoxicity studies 
In vitro cytotoxicity was performed for DOTA(Gd)-L6-F4 and DTPA(Gd)-
L6-F4 aggregates and for PEG8-(FY)3 gel.  
In particular, the cytotoxicity of Gd(III) probes was investigated in a 
mouse macrophages cell line (J774A.1) and in a mouse embryonic 
fibroblast cell line (3T3). J774A.1 and 3T3 cells were seeded in DMEM 
culture medium, enriched with 10% fetal bovine serum and 1% 
glutamine, at 150,000 and 50,000 cells/well respectively, in 96-well 
plates the day before the incubation. The cells were incubated for 3 
hours (J774A.1) or overnight (3T3) at 37°C with the two Gd-based 
probes at different concentrations: 0.5, 1, 2, 3 and 5 mg/mL. After the 
incubation, cells were gently washed and re-incubated for 4 hours with 
20 μL of CellTiter-Blue® reagent for the viability test. The CellTiter-
Blue® reagent is a solution containing resazurin, an indicator dye, 
which has little intrinsic fluorescence with the maximum absorbance at 
605 nm. The reagent undergoes a “blue shift” upon reduction of 
resazurin to resorufin with a maximum peak at 573 nm. The 
fluorescence produced is proportional to the number of viable cells. The 
same amount of CellTiter-Blue® reagent was added to triplicate wells 
without cells (no-cell control) and with untreated cells (control cells) 
respectively. At the end of the incubation, the fluorescence at 560/590 
nm was measured using the fluorometric method. The experiments 
were carried out in triplicate. Obtained data were analysed subtracting 
the mean fluorescence value of the culture background from all 
fluorescence values of experimental wells. The percentage of viable 
cells was calculated according to the following equation: 
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% 𝑣𝑖𝑎𝑏𝑙𝑒 𝑐𝑒𝑙𝑙𝑠 =
𝑒𝑥𝑝𝑒𝑟𝑖𝑚𝑒𝑛𝑡𝑎𝑙 𝑐𝑒𝑙𝑙𝑠 𝑚𝑒𝑎𝑛 𝑣𝑎𝑙𝑢𝑒
𝑐𝑜𝑛𝑡𝑟𝑜𝑙 𝑐𝑒𝑙𝑙𝑠 𝑚𝑒𝑎𝑛 𝑣𝑎𝑙𝑢𝑒
 x 100 
 
Regarding PEG8-(FY)3 gels, the in vitro biocompatibility profile was 
studied performing elution test and live/dead assay. The cell line was 
Chinese Hamster Ovarian (CHO) cells, purchased from ATCC. CHO 
cell line was cultured in Dulbecco's Modified Eagle's medium (DMEM) 
supplemented with 100 U mL-1 penicillin, 100 U mL-1 streptomycin, 10% 
fetal calf serum, and 2 mmol L-1 of L-1 glutamine (all these materials are 
available at Biological Industries, Israel). The cells were stored in a wall-
plate in a 5% CO2 humidified atmosphere at the temperature of 37 °C.  
For elution test, 200 μL of PEG8-(FY)3 gel at 1.0wt % were prepared in 
sterile condition (with UV-sterilization) and incubated overnight with 1 
mL of DMEM (ratio gel-extracting media 1/5 v/v). No color change was 
detected for the media after the incubation and the tested pH value 
(7.5-7.8) was suitable for culturing. The efficient gel extraction and 
permeability was confirmed by its pink coloration. The extracted media 
was used to grow the cells for 6 hours and, after this time incubation, 
the viability was determined by MTT test. 20 μL of a MTT solution (5 
mg/mL) in phosphate buffer saline (PBS) was added to each well. After 
4 hour incubation, 100 μL of DMSO was added to extract the MTT 
reduced adduct (Formazan). All the samples were shacked for 20 
minute to allow a complete dissolution of the precipitated Formazan in 
DMSO. Absorbance was measured using Tecan Spark plate reader at 
570 nm. Background was measure at 680 nm. The viability was 
expressed as percentage. The live/dead assay was performed using a 
kit (Sigma Aldrich) containing FDA (6.6 μg/mL) and PI (5 μg/mL). After 
the addiction of the two fluorescent dyes, cells were incubated for ~10 
minutes in the same previously reported condition Labeled cells were 
immediately viewed using a Nikon Eclipse Tifluorescent microscope 
and images (reported as merged figure) were captured by a ZylascMOS 
camera using Nikon Intensilight C-HGFI fluorescent lamp. 
 
4.22 Cellular uptake studies 
Ca. 1106 J774A.1 cells, in DMEM medium, were incubated with 
different concentrations of DOTA(Gd)-L6-F4 and DTPA(Gd)-L6-F4 for 3h 
at 37 C. After this incubation time, the cells were washed three times 
with 5 mL ice-cold phosphate-buffered saline (PBS), detached with a 
scraper and, for the acquisition of the MR images, collected in 50μL of 
PBS, transferred into glass capillaries that were centrifuged at 1500 rpm 
for 5 min and placed in an agar phantom. The MR images were 
acquired by standard T1-weighted spin-echo sequence (TE = 2.6 ms, 
16 variable TR ranging from 50 to 8000 ms, NEX = 1, FOV = 1.1x1.1 
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cm2, 1 slice, slice thickness = 1 mm) and recorded on a Bruker 
Avance300 operating at 7 T. After imaging, the labeled cells were 
suspended in 200 μL PBS and sonicated to obtain cell lysates. Gd(III) 
content was measured by ICP-MS analysis (Element-2; Thermo-
Finnigan, Rodano Milan, Italy). The preparation of the samples for ICP-
MS analysis has been carried out as follows: i) 150 μL of each cell 
lysate was mineralized with 1 mL of concentrated HNO3 (65% v/v) 
under microwave heating at 160°C for 40 minutes (Milestone 
MicroSYNTH Microwave lab station equipped with an optical fiber 
temperature control and HPR-1000/6M six position high-pressure 
reactor, Bergamo, Italy); ii) after mineralization, the volume of each 
sample was brought to 2 mL with ultrapure water and the sample was 
analyzed by ICP-MS. The calibration curve was obtained using four 
gadolinium absorption standard solutions (Sigma-Aldrich) in the range 
0.005-0.2 μg/mL. The protein content of cells lysates was determined 
by the Bradford method using bovine serum albumin as standard.  
 
4.23 Doxorubicin loading and leakage 
A DOX solution (1·10−4M) was placed in the cuvette and titrated with 
small amount of DOTA(Gd)-L6-2Nal2 peptide conjugate at 50mg/mL. 
The fluorescence of each sample was monitored on Jasco Model FP-
750 spectroflurophotometer as above described. Excitation wavelength 
was settled at 480 and UV-Vis spectra were collected between 490 and 
700nm. At the end of the titration the DOX filled Gd-2Nal2 aggregates 
were 10-fold diluted and the DOX fluorescence was monitored up to 
72h. The extent of the DOX leakage was calculated as follows: Leakage 
(%)=100 (Fi−F0)/(F100−F0), where Fi represents the level of fluorescence 
measured for each time point, whereas F100 and F0 are the fluorescence 
levels before and after the peptide addition in cuvette, respectively. 
 
4.24 Molecular modelling and molecular dynamics 
simulation: systems and notations. 
 
A three-dimensional model for the F6 peptide was generated by using 
the steric zipper structure of the hexapeptide fragment KLVFFA of the 
amyloid-beta peptide.I n particular, the coordinates of the polymorph II 
(Protein Data Bank entry 3OW9269) refined at 1.80 Å resolution were 
considered. (Figure A3 in Appendix II) Monomers for the analyzed 
systems were generated using the structure of the hexapeptide 
fragment by replacing the non-Phe/non-Tyr/non-Trp residues of the 
model with Phe/Tyr/Trp.The asymmetric unit of this structure contains 
two copies of the peptide arranged as an antiparallel two-stranded β-
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sheet. Steric zipper pairs of β-sheets were built by using the symmetry 
operations of KLVFFA structure space groups (C2).  
Models here investigated were denoted as SHx_STy_AA, where x and 
y indicate the number of β-sheets and β-strands per sheet, respectively; 
and AA indicates the number and the type of amino acid residues per 
chain. 
MD simulations were performed using the GROMACS software 
package 4.5.7270 with the OPLS-AA force field.  Starting from these 
structures, models composed of a single β-sheet made of fifty strands 
were generated Steric zipper models were generated through the 
association of a pair of these sheets using the organization of the 
KLVFFA in the crystalline state.269 The energy of the structures 
generated by modeling was initially minimized in vacuo. Minimized 
models were then immersed in triclinic boxes filled with water molecules 
(TIP4P water model). Simulations were run by applying periodic 
boundary conditions. Equilibration of the system was conducted in order 
to stabilize the temperature (300 K) and the pressure (1 atm.). Energies 
were initially minimized by fixing the protein atoms and then without 
restraints. The Particle Mesh Ewald (PME) method (grid spacing of 0.12 
nm)271 was used to calculate the electrostatic interactions, whereas a 
cut off of 10 a was applied to treat Lennard–Jones interactions. The 
LINCS algorithm was used to constrain bond lengths. Trajectory 
structures were an-alyzed by using in-house programs, VMD,272 and 
GROMACS rou-tine.270 The achievement of an adequate convergence 
in the MD simulation has been checked by calculating the root-mean-
square inner product (RMSIP = 0.82) between the two halves of the 
equilibrated trajectory (20–60 ns and 60–100 ns). 
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5.1 General resume, outcomes and conclusions 
eptide materials based on the aggregation of amphiphilic 
peptides represent a rapidly growing field within materials 
science. Diphenylalanine (FF or F2) homodimer has showed 
stimulating potentialities for the development of novel materials 
in fabrication, industrial, biological and medical fields. However, due to 
their very low solubility, research on FF-based compounds as 
diagnostic tools remains largely unexplored.  
According to the design approach used in this thesis, it was 
demonstrated that water-soluble aromatic peptide building blocks could 
be prepared by modifying them with PEG moieties or by replacing the 
Phe amino acid with the more hydrophilic Tyr one. Rational design 
allowed also a chemical functionalization with chelating agent for MRI 
application. 
According to the characterization, the final functional properties of the 
supramolecular materials were found be strongly dependent by the 
chemical entity of the building blocks.  
The chemical features of the constituent building blocks affect also the 
physicochemical properties of the nanomaterials. Organization in β-
sheet rich materials generates blue PL phenomenon.  
MD simulation and molecular dynamics permitted a better 
understanding of how inner molecular organization governs the self-
aggregation process. These knowledges could allow the engineering of 
novel supramolecular materials with enhanced functionalities.  
A summary of these studies, divided in three fundamental section, is 
reported. 
 
Supramolecular contrast agents for MRI application can be prepared by 
self-assembling of a monomer based on FF sequence. They are 
composed of three different moieties: a hydrophobic peptide region 
containing an aromatic framework, a hydrophilic portion containing a 
stable Gd-complex (Gd-DOTA or Gd-DTPA) and a linker (eg. PEG) 
interposed between the aromatic framework and the Gd-complex. The 
insertion of the linker permits to increase the solubility and to distance 
the Gd-complex from the aggregating motif. Indeed, the spatial 
proximity of the bulk gadolinium complex to the aromatic FF framework 
causes the loss of the intermolecular π-π interactions.  
Results of this thesis demonstrate that the elongation of the peptide 
framework (F4 in place of F2) could restore the aromatic interactions. 
Nanostructures prepared according to this strategy showed common 
structural features ascribable to amyloid like structure rich in antiparallel 
β-sheet.  
P 
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As expected for supramolecular MRI CAs, these NSs present enhanced 
relaxivity properties with respect to the classical contrast agents at low 
molecular weight (Gd-DOTA and Gd-DTPA). Surprising the τR values 
extracted from the fitting procedure are quite short if compared to those 
usually found for nano-sized aggregates. These low τR values can be 
attributed to the occurrence of a quite fast internal motility of the Gd-
complexes along the linker spacer with respect to the overall fibril-like 
structures. 
Due to the significant internalization efficiency and to the high relaxivity 
values, these NSs are able to enhance the MRI cellular response on 
J774A.1 mouse macrophages cell line in which the cytotoxicity of the 
fibril nanoaggregates was negligible with an incubation time of 3h in the 
0.5-5.0 mg/mL concentration range 
Moreover, the different positioning of the chelating agent in to the 
aromatic framework (at the center or at the N-terminus of the F4-motif) 
can deeply affect both the structural behavior and the relaxivity 
properties of the supramolecular CAs.  
A lower tendency to self-assemble in derivatives having the Gd-
complex positionated at the center of the peptide aromatic framework 
was detected. Well structured fibrillary and intricate networks, appear at 
50 mg/mL. At this concentration relaxivity values are lower (11 mM-1s-1) 
than the relaxivity ones observed for analogues with the Gd-complex at 
the end of framework.  
This decrease is related to major flexibility of the Gd-complex on the 
supramolecular aggregate. The proposed model well explain as the Gd-
DOTA complex, pointing far from the spine of the aggregate, is free to 
move. Instead, peptide backbone folding in an antiparallel β-
arrangement allows the spacial approach of phenyl rings of the C and N 
termini permitting their T-shape staking. 
The replacement of Phe in the homodimer with non coded amino acids 
(such as 2Nal), having a more extended aromatic ring in its side chain, 
permit to restore in dipeptide π-π interactions and to prompt self-
assembly of Gd-conjugates.  
Gd-2Nal2 peptide derivative begins to self-aggregate at  0.1 mg/mL (75 
μM), forming stable amiloid like NSs when concentration is about 10-
fold higher (1.0 mg/mL). This CAC value, assessed by fluorescence 
and proton NMR spectroscopies, is higher than the value (0.076 
mg/mL) found for tetraphenylalanine Gd-complex Gd-DOTA-L6-F4. At 
the atomic level, the peptide conjugates in the aggregates assume a β 
sheet secondary structure with an antiparallel orientation of single 
strands and above 5.0 mg/mL, long fibrillary nanostructures appear. 
Moreover, above 20 mg/mL, gelification phenomena are observed.  
These gels are suitable reservoirs for the encapsulation of anticancer 
drugs like doxorubicin. The high values of r1p (12.3 mM
-1s-1 at 20 MHz) 
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and the capability to encapsulate the doxorubicin anticancer drug 
suggest a potential use of Gd-2Nal2 nanostructures as theranostic 
systems.  
However, before an in vivo applications of these novel class of 
theranostic agents, several issues have to be improved. For example, 
the insertion of structural elements able to confer rigidity to the 
molecules without to alter their solubility could lead to higher relaxivity 
values. Moreover, the achievement of lower CAC values could permit 
lowering the toxicity effects associated to these nanostructures. 
 
According to the literature, photoluminescence (PL) phenomena have 
been observed in fibrillary networks like amyloid fibrils and in others 
peptide based nanostructures, with a high content of cross-β structures. 
On the evidence that containing Phe peptides generate supramolecular 
systems rich in β-organization, a novel monomer, PEG8-F6, was 
designed and synthetized.  
As aspected,PEG8-F6 is able to self-organize in NSs, rich in β-sheet 
structures and show PL upon excitation at 370 or at 410 nm.  
However, the intensity of fluorescence emitted by these structures is 
almost weak and the signal remains confined in the near-Vis region.  
The development of biocompatible peptide nanostructures as 
bioimaging tools requires the improvement of their performance in 
terms of PL intensity and of wavelength range compatible with in vivo 
applications. 
A possible strategy to pursue could be the tight association 
(encapsulation, binding or absorption) of a small fluorescent dye like 
NBD to the photoluminescent NS.  
The close proximity, at the atomic level, between the dye and the 
nanostructure should promote the energy transfer. With this goal in the 
mind, 4-Chloro-7-nitrobenzofurazan (NBD) dye was incapsulated in 
PEG8-F6 NSs.  
The entrapment of NBD in these NSs effectively causes a red-shift from 
460 to 530 nm that was attributed to a FRET phenomenon.  
The comparison between the structural data of empty and NBD filled 
PEG8-F6 NSs suggests that NBD dye is arranged out from the dry 
interface of the NS, but it remains close enough to the origin of the PL 
to accept the energy transfer.  
The capability to transfer fluorescence between the NS and the dye is 
kept even when the dye is covalently bound to the peptide 
nanostructure. These evidences leave to envisage new stimulating 
feature applications for dye encapsulating peptides as innovative 
biomaterials. Encapsulation or conjugation of small molecule dyes in/to 
NSs, represent an alternative and complementary strategy for the 
detection of the aggregation process of endogenous proteins, which, in 
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their physio-pathological form, are known to adopt a cross-β structural 
motif.  
It was also demonstrated that the PEG length and its composition could 
alter the structural and optoelectronic properties of the final material. 
These findings arise from the compared study carried out along PEG 
series peptides (PEG8-F6, PEG12-F6, PEG18-F6, PEG24-F6, PEGMW1300-
F6).  
Independently from the PEG length and from the number of amide 
bonds, all the peptide NSs display cross-β like secondary structure with 
an antiparallel β-strand arrangement. However, a certain decrease of 
the fiber order was observed along the series 
(PEG8>PEG12>PEG18>PEG24). All the peptide nanostructures exhibit 
the aspected blue-PL emission at 460 nm upon excitation at 370 or at 
410 nm.  
Beyond this blue fluorescence emission, PEG24-F6 shows an additional 
green-PL emission at 530 nm when excited at 460 nm.  
This different optoelectronic behavior could be plausibly attributed to the 
higher number of amide bonds along the PEG chain, that may either 
produce a more extended electron delocalization via hydrogen bonds or 
a fine re-adjustment of the cross β-structure of the peptide spine.  
Due to ample debate on the origins of PL phenomenon, it is not possible 
to completely exclude that others factors that can affect the PL 
behavior. The interpretation of the PL properties of PEG24-F6 could 
represent an interesting challenge for future studies.  
 
The π-π stacking interactions between the side chains of aromatic 
amino acids were used as one of the main driving force towards to the 
self-assembling of aromatic oligopeptides or polymer-peptides.  
Ad hoc modifications of the peptide sequence or a derivatization of the 
sequence with PEG chains or with chelating agents can deeply affects 
the structural organization of the nanostructure.  
By a chemical prospective, it was explored and studied the replacement 
of the Phe residue with the two other coded aromatic amino acids, Trp 
and Tyr. 
As expected on the basis of the different solubility of these three amino 
acids (Trp, Tyr and Phe), Tyr containing peptides showed a higher 
solubility with respect to Phe containing peptides and their solubilization 
was achieved directly in water also at high concentrations. 
On the other hand, Trp containing peptide (PEG6-W4) showed a smaller 
water solubility with respect to the analog containing the same number 
of Phe residues (PEG6-F4).  
The structural characterization performed in solution highlights a similar 
behavior of all the studied peptide derivatives: at micromolar 
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concentration, these systems share a common mechanism of self-
assembling, hypnotized be an aromatic collapse.  
The novel peptide conjugates are characterized by the formation of 
nanostructures, rich in antiparallel β-sheets.  
However, at the solid state, significant structural differences were 
observed for the peptide containing Tyr and Trp. TEM, SEM, 
WAXS/SAXS studies and MD simulations confirmed these differences. 
Due to the different sizes of Trp and Phe residues, the distance of the 
dry interface between the two facing β-sheets of PEG6-W4 is larger 
than that observed in PEG6-F4.  
Instead, Tyr have a size similar to the Phe, but the phenolic group in its 
side chain favors a major number of hydrogen bonding interactions with 
water molecules or main chain carbonyls with respect to the Phe 
residue. In Tyr rich peptides (Y6), self-assembly occurs through the 
tight lateral association of Tyr side chains and networks of inter-sheet 
H-bonds contribute to the overall stability of the Tyr interface.  
However, the more polar and solvated interface with respect F6 oligo 
peptide partially limits the formation of large ordered fibers. Due to the 
limited self-assembly tendency, in PEG8-Y6, PEG moiety is able to 
induce crystallization effects.  
In (FY)3, MD simulations suggest the formation of two well-
distinguishable interfaces: a dry interface (Phe-interface) stabilized by 
inter-sheet π-stacking interaction and a wet interface (Tyr-interface) 
stabilized by both intra-sheet and inter-sheet H-bonds.  
At macroscopic level, only PEG8-(FY)3 showed stable soft hydrogels 
above 1.0 wt%.  
This evidence can be attributable to the higher tendency of Tyr to 
establish extended hydrogen bonding networks and to achievement in 
the molecule of an efficient compromise between 
hydrophobicity/hydrophilicity.  
The good water solubility and the low toxicity of PEG8-(FY)3 suggest 
that this polymer-peptide could be fruitfully exploited for generating self-
supporting biocompatible hydrogels. 
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6.1 Appendix I 
he Appendix I gathers together all the chemical shift and 
assignation from 1HNMR spectroscopy, retention time in HPLC, 
real and calculated conjugates masses and their molecular 
formulas. 
Some 1HNMR spectra, mass spectra and analytical HPLC profiles 
(channel 210 nm) are reported as identification and characterization 
examples.  
 
DTPA-F2: 
1
H-NMR (CD3OD) (chemical shifts in , CH3OH as internal 
standard 3.55) = 7.51-7.42 (m, 10 CH aromatic), 4.96-4.86 (m, 2H, CH Phe ), 
4.65-4.40 (dd, 2H, R2NCH2CONHR), 3.87 (s, 8H, R2NCH2COOH), 3.53-3.50 
(m, 4H, R2NCH2CH2NR2), 3.42-3.31 (m, 4H, R2NCH2CH2NR2), 3.24-2.99 (m, 
4H, CH2 Phe ). Retention time in Method 1, Rt = 10.34 min; MS (ESI+): m/z 
686.1 calcd. For C32H42N6O11: [M+H
+
] = 687.5. 
 
DOTA-F2:
 1
H-NMR (CD3OD) (chemical shifts in , CH3OH as internal 
standard 3.55) = 7.51-7.42 (m, 10 CH aromatic), 4.86-4.75 (m, 2H, CH Phe ), 
3.70 (s, 6H, R2NCH2COOH), 3.45 (s, 16H, R2N-CH2CH2NR2), 3.40-3.36 (m, 
2H, R2NCH2CONH), 3.16-2.90 (m, 4H, CH2 Phe ). Retention time in Method 
1, Rt = 10.65 min; MS (ESI+): m/z 698.3 calcd. For C34H46N6O10: [M+H
+
] = 
968.6. 
 
DTPA-L2-F2: 
1
H-NMR (CD3OD) (chemical shifts in , CH3OH as internal 
standard 3.55) = 7.51-7.42 (m, 10 CH aromatic), 4.96-4.86 (m, 2H, CH Phe ), 
4.55 (s, 2H, R2NCH2CONHR), 3.87 (s, 8H, R2NCH2COOH), 3.79 (s, 4H, 
OCH2CH2O), 3.75 (t, 2H, RNHCH2CH2O), 3.65 (s, 2H, OCH2COR), 3.60 (t, 
2H, RNHCH2CH2O), 3.53-3.50 (m, 4H, R2NCH2CH2N R2), 3.42-3.31 (m, 4H, 
R2NCH2CH2NR2), 3.24-2.99 (m, 4H, CH2 Phe ). ). Retention time in 
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Method 1, Rt = 11.19 min; MS (ESI+): m/z 831.2 calcd. For C38H53N7O14: 
[M+H
+
] = 831.7. 
 
DOTA-L2-F2:
 1
H-NMR (CD3OD) (chemical shifts in , CH3OH as internal 
standard 3.55) = 7.51-7.42 (m, 10 CH aromatic), 4.86-4.75 (m, 2H, CH Phe ), 
3.79 (s, 4H, OCH2CH2O), 3.75 (t, 2H, RNH-CH2CH2O), 3.70 (s, 6H, 
R2NCH2COOH), 3.65 (s, 2H, OCH2COR), 3.60 (t, 2H, RNH-CH2CH2O), 3.45 
(s, 16H, R2N-CH2CH2NR2), 3.40-3.36 (m, 2H, R2NCH2CONH), 3.16-2.90 (m, 
4H, CH2 Phe ). Retention time in Method 1, Rt = 11.42 min; MS (ESI+): m/z 
843.2 calcd. For C40H57N7O13: [M+H
+
] = 843.7. 
 
DTPA-L6-F2: 
1
H-NMR (CD3OD) (chemical shifts in , CH3OH as internal 
standard 3.55) = 7.51-7.42 (m, 10 CH aromatic), 4.86-4.75 (m, 2H, CH Phe ), 
4.55 (s, 2H, R2NCH2CONHR), 3.87 (s, 8H, R2NCH2COOH), 3.80 (s, 22H, 
OCH2CH2O), 3.75 (t, 2H, RNHCH2CH2O), 3.68 (t, 2H, RNHCH2CH2O), 3.40-
3.32 (m, 6H, R2NCH2CH2NR2), 3.27-3.20 (dd, 2H, R2NCH2CH2NR2), 3.16-
2.90 (m, 4H, CH2 Phe ). 2.58 (t, 2H, NHCOCH2CH2). Retention time in 
Method 1, Rt = 12.10 min; MS (ESI+): m/z 1020.0 calcd. For C47H70N7O18: 
[M+H
+
] = 1020.8. 
 
DOTA-L6-F2: 
1
H-NMR (CD3OD) (chemical shifts in , CH3OH as internal 
standard 3.55) = 7.51-7.42 (m, 10 CH aromatic), 4.86-4.75 (m, 2H, CH Phe ), 
3.80 (s, 22H, OCH2CH2O), 3.75 (t, 2H, RNHCH2CH2O), 3.70 (s, 6H, 
R2NCH2COOH), 3.60 (t, 2H, RNHCH2CH2O, 3.45 (s, 16H, R2NCH2CH2NR2), 
3.40-3.36 (m, 2H, R2NCH2CONH), 3.16-2.90 (m, 4H, CH2 Phe ), 2.58 (t, 2H, 
NHCOCH2CH2O). Retention time in Method 1, Rt = 12.33 min; MS (ESI+): 
m/z 1032.8 calcd. For C49H76N8O16: [M+H
+
] = 1233.1. 
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L6-F4: 
1
H-NMR (CD3OD) (chemical shifts in , CH3OH as internal standard 
3.55) = 7.51-7.42 (m, 20 CH aromatic), 4.86-4.75 (m, 4H, CH Phe ), 3.80 (s, 
22H, OCH2CH2O), 3.75 (t, 2H, RNHCH2CH2O), 3.60 (t, 2H, RNHCH2CH2O), 
3.16-2.90 (m, 8H, CH2 Phe ), 2.58 (t, 2H, NHCOCH2CH2O). Retention time 
in Method 1, Rt = 15.30 min; MS (ESI+): m/z 939.5 calcd. For C51H67N6O11: 
[M+H
+
] = 939.9 
 
DTPA-L6-F4: 
1
H-NMR (CD3OD) (chemical shifts in , CH3OH as internal 
standard 3.55) = 7.51-7.42 (m, 20 CH aromatic), 4.86-4.75 (m, 4H, CH Phe ), 
4.55 (s, 2H, R2NCH2CONHR), 3.87 (s, 8H, R2NCH2COOH), 3.80 (s, 22H, 
OCH2CH2O), 3.75 (t, 2H, RNHCH2CH2O), 3.68 (t, 2H, RNHCH2CH2O), 3.40-
3.32 (m, 6H, R2NCH2CH2NR2), 3.27-3.20 (dd, 2H, R2NCH2CH2NR2), 3.16-
2.90 (m, 8H, CH2 Phe ), 2.58 (t, 2H, NHCOCH2CH2). Retention time in 
Method 1, Rt = 14.54 min; MS (ESI+): m/z 1314.4 calcd. For C65H88N9O20: 
[M+H
+
] = 1315.1 
 
DOTA-L6-F4: 
1
H-NMR (CD3OD) (chemical shifts in , CH3OH as internal 
standard 3.55) = 7.51-7.42 (m, 20 CH aromatic), 4.86-4.75 (m, 4H, CH Phe ), 
3.80 (s, 22H, OCH2CH2O), 3.75 (t, 2H, RNHCH2CH2O), 3.70 (s, 6H, 
R2NCH2COOH), 3.60 (t, 2H, RNHCH2CH2O), 3.45 (s, 16H, 
R2NCH2CH2NR2), 3.40-3.36 (m, 2H, R2NCH2CONH), 3.16-2.90 (m, 8H, CH2 
Phe ), 2.58 (t, 2H, NHCOCH2CH2O). Retention time in Method 1, Rt = 14.59 
min; MS (ESI+): m/z 1326.8 calcd. For C65H88N9O20: [M+H
+
] = 1327.2 
 
DOTA-L6-(2Nal)2 [2Nal2]: 
1
H-NMR (CD3OD) (chemical shifts in δ, CH3OH 
as internal standard 3.55) = 7.51-7.42 (m, 10 CH aromatic), 4.86-4.75 (m, 2H, 
CH Phe α), 3.80 (s, 22H, OCH2CH2O), 3.75 (t, 2H, RNHCH2CH2O), 3.70 (s, 
6H, R2NCH2COOH), 3.60 (t, 2H, RNHCH2CH2O, 3.45 (s, 16H, 
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R2NCH2CH2NR2), 3.40-3.36 (m, 2H, R2NCH2CONH), 3.16-2.90 (m, 4H, CH2 
Phe β), 2.58 (t, 2H, NHCOCH2CH2O). Retention time in Method 1, Rt = 14.71 
min; MS (ESI+): m/z 1132.8 calcd. For C57H80N8O16: [M+H
+
] =1133.8; 
[M+Na
+
] =1155.7; [M+2H
+
]/2 =568.1 
 
FF-AdOO-Lys(DOTA)-AdOO-FF [FF-DOTA-FF] and ff-AdOO-
Lys(DOTA)-AdOO-FF [ff-DOTA-FF]:
 1
H-NMR (CD3OD) (chemical shifts 
in δ, CH3OH as internal standard 3.55) = 7.51-7.42 (m, 20 CH aromatic), 4.98-
4.76 (m, 4H, CH Phe α), 4.3 (dd, 1H, CH Lys α), 3.72 (s, 12H, OCH2CH2O), 
3.70 (s, 6H, R2NCH2COOH), 3.68 (t, 4H, RNH-CH2CH2O), 3.65 (s, 4H, 
OCH2COR), 3.45 (s, 16H, R2N-CH2CH2NR2), 3.40-3.36 (m, 2H, 
R2NCH2CONH), 3.36-3.25 (m, 8H, CH2 Phe β), 3.27-3.20 (dd, 2H, R2N-
CH2CH2NR2), 3.1(m 2H, CH2 Lys ε), 1.90 (m, 2H, CH2 Lys β), 1.6 (m, 2H, 
CH2 Lys δ), 1.45 (m, 2H, CH2 Lys γ). Retention time in Method 1 Rt = 12.65 
min; MS (ESI+): m/z 1407.5 calcd. For C70H99N13O18: [M+H
+
] =1408.5 
 
DOTA-L6-(2Nal)2 [2Nal2]: 
1
HNMR (CD3OD) (chemical shifts in δ, CH3OH 
as internal standard 3.55) = 7.51–7.42 (m, 10 CH aromatic), 4.86–4.75 (m, 
2H, CH Phe α), 3.80 (s, 22H, OCH2CH2O), 3.75 (t, 2H, RNHCH2CH2O), 
3.70 (s, 6H, R2NCH2COOH), 3.60 (t, 2H, RNHCH2CH2O, 3.45 (s, 16H, 
R2NCH2CH2NR2), 3.40–3.36 (m, 2H, R2NCH2CONH), 3.16–2.90 (m, 4H, 
CH2 Phe β), 2.58 (t, 2H, NHCOCH2CH2O). Retention time in Method 1 
Rt = 12.17 min; MS (ESI+): m/z 1132.8 calcd. For C57H80N8O16: 
[M + H+] = 1133.8; [M+Na+] = 1155.7; [M+2 H+]/2 = 568.1. 
 
PEG8-F6: 
1
H-NMR (CD3OD) (chemical shifts in , CH3OH as internal 
standard 3.55) = 7.51-7.42 (m, 30 CH aromatic), 4.86-4.75 (m, 6H, CH Phe ), 
3.80 (s, 16H, OCH2CH2O), 3.75 (t, 8H, RNH-CH2CH2O), 3.65 (s, 8H, 
OCH2COR), 3.60 (t, 8H, RNH-CH2CH2O), 3.16-2.90 (m, 12H, CH2 Phe β). 
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Retention time in Method 2 Rt = 14.05 MS (ESI+): m/z 1480.7 calcd. for 
C78H101N11O18: [M+H
+
] = 1480.9 
 
PEG12-F6: 
1
H-NMR (CD3OD) (chemical shifts in , CH3OH as internal 
standard 3.55) = 7.51-7.42 (m, 30 CH aromatic), 4.86-4.75 (m, 6H, CH Phe α), 
3.80 (s, 44H, OCH2CH2O), 3.75 (t, 4H, RNHCH2CH2O), 3.60 (t, 4H, 
RNHCH2CH2O), 3.16-2.90 (m, 12H, CH2 Phe β), 2.58 (t, 4H, 
NHCOCH2CH2O). Retention time in Method 1 Rt = 12.50 MS (ESI+): m/z 
1570.7 calcd. for C84H115N9O20: [M+H
+
] = 1572.1 
 
PEG18-F6: 
1
H-NMR (CD3OD) (chemical shifts in , CH3OH as internal 
standard 3.55) = 7.51-7.42 (m, 30 CH aromatic), 4.86-4.75 (m, 6H, CH Phe α), 
3.80 (s, 66H, OCH2CH2O), 3.75 (t, 6H, RNHCH2CH2O), 3.60 (t, 6H, 
RNHCH2CH2O), 3.16-2.90 (m, 12H, CH2 Phe β), 2.58 (t, 6H, 
NHCOCH2CH2O). Retention time in Method 1 Rt = 11.90 MS (ESI+): m/z 
1905.5 calcd. for C99H144N10O27: [M+H
+
] = 1906.6 
 
PEG24-F6: 
1
H-NMR (CD3OD) (chemical shifts in , CH3OH as internal 
standard 3.55) = 7.51-7.42 (m, 30 CH aromatic), 4.86-4.75 (m, 6H, CH Phe α), 
3.80 (s, 88H, OCH2CH2O), 3.75 (t, 8H, RNHCH2CH2O), 3.60 (t, 8H, 
RNHCH2CH2O), 3.16-2.90 (m, 12H, CH2 Phe β), 2.58 (t, 8H, 
NHCOCH2CH2O) Retention time in Method 1 Rt = 11.22 MS (ESI+): m/z 
2240.5 calcd. for C99H144N10O27: [M+H
+
] = 2243.0 
 
Y6: 
1
H-NMR (CD3OD) (chemical shifts in , CH3OH as internal standard 
3.55) = 7.26-7.14 (m, 6 CH aromatic Tyr), 6.88-6.85 (m, 6 CH aromatic 
Tyr), 4.77-4.58 (m, 6H, CH  of Tyr), 3.28-2.92 (m, 12H, CH2 β of Tyr). 
Retention time in Method 3 Rt = 13.30 min, MS (ESI+): m/z 966.1calcd. for 
C54H57N7O12:[M+H
+
] = 967.1 
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PEG8-Y6: 
1
H-NMR (CD3OD) (chemical shifts in , CH3OH as internal 
standard 3.55) = 7.18-7.10 (m, 6 CH aromatic Tyr), 6.91-6.82 (m, 6 CH 
aromatic Tyr), 4.73-4.51 (m, 6H, CHTyr), 3.87 (s, 16H, OCH2CH2O), 3.82 (t, 
8H, RNH-CH2CH2O), 3.74-3.71 (m, 8H, OCH2COR), 3.63 (t, 8H, RNH-
CH2CH2O), 3.31-2.92 (m, 12H, CH2 β of Tyr). Retention time in Method 3 Rt = 
11.56 min, MS (ESI+): m/z 1576.7 calcd. for C78H101N11O24:[M+H
+
] = 1577.7 
 
(FY)3: 
1
H-NMR (CD3OD) (chemical shifts in , CH3OH as internal standard 
3.55) = 7.48-7.35 (m, 15 CH aromatic Phe), 7.18-7.10 (m, 6 CH aromatic 
Tyr), 6.88-6.85 (m, 6 CH aromatic Tyr), 4.81-4.54 (m, 6H, CH of Phe and 
Tyr), 3.35-2.94 (m, 12H, CH2βof Phe and Tyr). Retention time in Method 3 Rt 
=14.52 min, MS (ESI+): m/z 948.1calcd. for C54H57N7O9:[M+H
+
] = 949.1 
 
PEG8-(FY)3: 
1
H-NMR (CD3OD) (chemical shifts in , CH3OH as internal 
standard 3.55) = 7.48-7.35 (m, 15 CH aromatic Phe), 7.18-7.10 (m, 6 
CHaromatic Tyr), 6.88-6.85 (m, 6 CH aromatic Tyr),4.81-4.54 (m, 6H, CH 
of Phe and Tyr), 3.83 (s, 16H, OCH2CH2O), 3.80 (t, 8H, RNH-CH2CH2O), 
3.75-3.72 (m, 8H, OCH2COR), 3.63 (t, 8H, RNH-CH2CH2O), 3.35-2.94 (m, 
12H, CH2β of Phe and Tyr). Retention time in Method 3 Rt = 12.21 min, MS 
(ESI+): m/z 1528.7 calcd. for C78H101N11O21:[M+H
+
] = 1526.7 
 
PEG6-W4: 
1
H-NMR (CD3OD) (chemical shifts in , CH3OH as internal 
standard 3.55) = 7.51-7.42 (m, 30 CH aromatic), 4.86-4.75 (m, 6H, CH Phe), 
3.80 (s, 16H, OCH2CH2O), 3.75 (t, 8H, RNH-CH2CH2O), 3.65 (s, 8H, 
OCH2COR), 3.60 (t, 8H, RNH-CH2CH2O), 3.16-2.90 (m, 12H, CH2 Phe β). 
Retention time in Method 4 Rt = 17.67 min, MS (ESI+): m/z 1096.5 calcd. for 
C78H101N11O18: [M+H
+
] = 1097.6 
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6.1.2 1HNMR spectra 
 
FF-AdOO-Lys(DOTA)-AdOO-FF [FF-DOTA-FF] and ff-AdOO-
Lys(DOTA)-AdOO-FF [ff-DOTA-FF] 
 
 
PEG8-F6 
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6.1.3 HPLC chromatograms and mass spectrometry 
 
 
LC-MS spectra for 2Nal2 
 
 
 
(FY)3 Method 3, Rt=14.52 
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6.2 Appendix II 
n the Appendix II are collected additional and supporting data for the 
Result and discussion chapter. Miller indices, d-spacing and unit cell 
measurements obtained with CLEARER softer for DOTA(Gd)-L6-F4 
and L6-F4 are inserted in Table A1 and A2. 
Biocompatibility study about Gd-2Nal2 in 10 mM phosphate buffer 0.9 
wt.% NaCl was conducted analizyng the HLPC profile of the compound 
in during the time. 
Assignation and chemical shift for protons in of F2-L6-DOTA and 2Nal2 
and TOCSY/NOESY spectra are reported in Table A3 and A4 and 
Figure A2, respectively. 
Parameter and initial crystal structure for F6 spine are in Table A5 and 
Figure A3. 
  
 
 
 
 
 
 
  
I 
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Table A1: Miller indices and d-spacings (calculated and observed) for 
DOTA(Gd)-L6-F4 fiber determined using the software CLEARER. The 
results provided an orthorhombic unit cell (α = β = ɣ = 90°), in which the 
axis values are a = 4.8 Å, b = 29.6 Å, c = 56.3 Å.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Miller Indices d-Spacings (Å) 
h k l calculated observed 
0 1 1 26.21967 26.144491 
0 2 11 4.8347726 4.8291917 
0 2 0 14.817239 14.834262 
0 2 3 11.626327 11.547104 
0 1 7 7.7571564 7.8169746 
0 2 8 6.3534093 6.3533344 
0 6 6 4.369945 4.3705463 
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Table A2: Miller indices and d-spacings (calculated and observed) for 
L6-F4 fiber determined using the software CLEARER. The results 
provided an orthorhombic unit cell (α = β = ɣ = 90°), in which the axis 
values are a = 4.8 Å, b = 27.6 Å, c = 46.4 Å. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Miller Indices d -Spacings (Å) 
h k l calculated observed 
0  1  1  23.725834  23.991104  
0  2  1  13.233081  13.298952  
0  6  0  4.602433  4.596377  
0  7  2  3.8890448  3.8920898  
0  2  0  13.8073  13.804399  
0  1  4  10.688595  10.701209  
0  3  6  5.9187117  5.9088035  
0  0  11  4.2153335  4.2161417  
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Figure A1: Reverse phase HPLC profiles of Gd-2Nal2 in 10 mM 
phosphate buffer 0.9 wt.% NaCl at pH 7.4 at time t=0 (a) and t=240 h 
(b).  
 
 
a) 
 
b) 
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Table A3: Chemical shifts of F2-L6-DOTA (1mM concentration) at 298 
K 
 
 
F2-L6-DOTA  
 
HN  Hα  Hβ  Others  
F1  8.12  4.51  2.94-2.87  
Aromatics 
7.14 
7.31 
F2 8.17  4.52  3.12-2.88  
Aromatics 
7.24 
7.34 
CONH2  
7.06-7.00  
L6  
NHCOCH2  2.43 
NHCOCH2CH2  3.62 
NHCH2CH2  3.58, 3.34 
NHCH2CH2 8.05 
OCH2CH2O 3.52, 3.57 
DOTA  3.77, 3.33, 3.11 
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Table A4: Chemical shifts of 2Nal2 (1mM concentration) at 298 K. 
 
 
2Nal2 
 
HN  Hα  Hβ  Others  
NAL1  7.97  4.53  2.94  
Aromatics: 
7.45, 7.18, 
7.75  
NAL2 8.15  4.63  3.32-3.00  
Aromatics: 
7.67, 7.38, 
7.85  
CONH2  
7.10-6.89  
L6  
NHCOCH2  2.19, 2.12 
NHCOCH2CH2  3.40, 3.30 
NHCH2CH2  3.52, 3.30 
NHCH2CH2 7.98 
OCH2CH2O 3.52, 3.57  
DOTA  3.69, 3.24, 3.03 
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Figure A2: A) TOCSY 70 (left panel) and ROESY 200 (right panel) 
spectra of DOTA-L6-F2 (1 mM concentration). B) TOCSY 70 (left panel) 
and ROESY 250 (right panel) NMR spectra of 2Nal2 (1 mM 
concentration).  
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Table A5: MD simulation parameters for F6 spine 
 
System Box dimensions 
 (nm3) 
Number of 
water 
molecules 
Timescale (ns) 
SH2_ST10_F6 5.384 x 7.644 x 4.916 5641 70 
SH2_ST26_F6 4.990 x 14.899 x 4.574 8899 200 
SH2_ST50_F6 4.545 x 25.700 x 4.021 11812 100 
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Figure A3: Generation of the F6 model used in the molecular dynamics 
studies. Panels (a) and (b) show two different views of the steric zipper 
structure of the hexapeptide fragment KLVFFA of the amyloid-beta 
peptide (PDB entry 3OW9). In panel (c) the model in which all side 
chains were replaced with Phe residues is shown (top view). 
 
 
(a) (b) 
 
 
(c)  
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R Reorientational time 
S  Electronic relaxation time 
1HNMR 
Å 
Hydrogen Nuclear Magnetic Resonance  
Angstrom 
ADNTs 
AdOO 
Ahoh 
ANS 
Boc 
Aromatic Dipeptide Nanotubes 
Fmoc-8-amino-3,6-dioxaoctanoic acid  
Fmoc-21-amino-4,7,10,13,16,19-hexaoxahe-neicosanoic acid  
8-anilino-1-naphthalene sulfonic acid ammonium salt 
tert-butyloxycarbonyl; 
CAC 
CAT 
CAs 
CD 
Critical Aggregation Concentration 
Computer-Assisted Tomography 
Contrast Agents 
Circular Dichroism 
CR Congo Red dye 
DIPEA  
DLS 
Diisopropylethylamine  
Dynamic Light Scattering 
DMF   N,N-dimethylformamide 
DOTA   1,4,7,10-tetraazacyclododecane- N,N,N,N- tetraacetic acid 
DTPA  
DOX 
F 
FF 
diethylenetriaminepentaacetic acid  
Doxorubicin 
(L)-Phenylalanine 
Diphenylalanine homopeptide 
Fmoc 
f 
FRET 
FT-IR 
Gd 
9-fluorenylmethyloxycarbonyl  
(D)-Phenylalanine 
Fӧrster resonance electron transfer 
Fourier Transform Infrared 
Gadolinium 
HATU  1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-
b]pyridinium-3-oxid hexafluorophosphate 
HFIP 1,1,1,3,3,3-hexafluoro-2-isopropanol 
HOBt 1-hydroxybenzotriazole  
L2 
L6 
LC/MS 
M 
Fmoc-8-amino-3,6-dioxaoctanoic acid 
Fmoc-21-amino-4,7,10,13,16,19-hexaoxahe-neicosanoic acid 
Liquid Chromatography-Mass spectrometry 
Molar 
MD 
MEG 
MRI 
Molecular Dynamics 
Magnetoencephalogram 
Magnetic Resonance Imaging 
Mtt  
Mw 
N-methyltrityl  
Molecular weight  
NBD 
NMs 
NMRD 
NMP 
4-Chloro-7-nitrobenzofurazan 
Nanomaterials 
Nuclear Magnetic Relaxation Dispersion 
N-methyl-2-pyrrolidone 
Abbreviations 
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NPs Nanoplatforms 
PBMs 
PEG 
PEG2 
PEG6 
PEO 
PET 
Phe 
Peptide-based materials 
Polyethylene glycol  
Fmoc-8-amino-3,6-dioxaoctanoic acid  
Fmoc-21-amino-4,7,10,13,16,19-hexaoxahe-neicosanoic acid 
Polyethylene oxide 
Positron Emission Tomography 
Phenylalanine 
PL 
POM 
Photoluminescence 
Polarized Optical Microscopy 
PyBop  benzotriazol-1-yl-oxy-tris-pyrrolidino-phosphonium 
Pyr Pyrene 
r1 
r2 
Longitudinal relaxivity 
Transverse relaxivity 
R1
obs  Measured Relaxivity 
R1p Relassività del protone dell’acqua 
Rt  
RP-HPLC  
RMSD 
RMSF 
RMSIP 
Ritention time 
Reverse Phase High Pressure Liquid Cromatography 
Root Mean Square Deviation 
Root Mean Square Fluctuation  
Root Mean Square Inner Product 
SAXS 
SEM 
SPIONs 
SPPS 
Small Angle X-Ray Scattering 
Scanning Electron Microscopy 
Superparamagnetic iron oxide 
Solid Phase Peptide Synthesis  
T1  Longitudinal relation time 
T2  Transversal  relation time 
TEM 
TFA  
Transmission Electron Microscopy 
Triﬂuoroacetic acid 
ThT Tioflavin T 
TIS tri-isopropylsilane 
TMS 
tBu 
Tetrametilsilano 
Tert-butyl 
Tyr 
Trp 
v/v 
WAXS 
Xe 
XRD 
(L)-Tyrosine 
(L)-Tryptophan 
Volume/volume concentration 
Wide Angle X-Ray Scattering 
Xenon 
X-Ray Diffraction  
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 1.  Introduction 
 In the last few years an explosion of interest has been focused 
on the design, synthesis, and characterization of peptide-based 
materials for nanomedicine and nanoscience. [ 1–3 ] The 
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advancement of knowledge about molec-
ular mechanism and forces that deter-
mine the growth of nanometric structures 
from basic peptide motifs from one side, 
and the applicative outcome in the obtain-
ment of peptide-based nanodevices for 
electronics, biosensing, coating for tissue 
engineering and cell adhesion, and drug 
delivery from the other side, have rapidly 
reached successful results. [ 4 ] 
 This has been achieved by mimicking 
the strategies that nature pursues in the 
construction of complex supramolecular 
aggregates, essentially based on self-
assembly and bottom-up procedures. 
 A large number of peptide-based 
building blocks, comprising cyclic 
peptides, amphiphile peptides, dendritic 
peptides, and aromatic dipeptides, have 
been considered for generating self-
assembled nanostructures. [ 5–8 ] 
 Among the different applications of 
peptide-based materials, there are several 
advantages, such as the intrinsic biological 
origin, low immunogenicity, biocompatibility, low cost, high 
stability, ability for specifi c molecular recognition, long-term 
storage, and easy handling, that make synthetic peptides useful 
and versatile building blocks for applications in biomedical 
fi eld. 
 The self-aggregation of short peptide sequences can be 
catalysed by the insertion of nonpeptidic hydrophobic groups, 
such as aliphatic chains [ 9,10 ] or cholesterol derivatives, [ 11 ] or 
introducing amino acids able to promote aromatic π-stacking 
interactions between their side chains, such as phenylalanine, 
tyrosine, and tryptophan. [ 6 ] 
 Intense stimulus in this research area was promoted 
by the identifi cation of some natural self-aggregation pat-
terns, such as diphenylalanine (FF) motive. Diphenylalanine, 
which constitutes the core recognition motif of Alzheimer’s 
β-amyloid peptide, is able to self-assemble into many different 
nanostructures from nanotubes to organogels. [ 12,13 ] 
 FF nanostructures have been investigated for their mechan-
ical, electrochemical, and optical properties. Many studies 
reported in literature are principally focused on clarifying 
the physicochemical aspects responsible for array stability in 
FF nanostructures, [ 14–16 ] whereas only few studies have been 
devoted in the investigation of FF aggregates for biomedical 
Adv. Funct. Mater. 2015, 25, 7003–7016
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applications, [ 17–19 ] essentially due to their intrinsic low water 
solubility. [ 20 ] 
 Very recently two examples of cationic diphenylalanine based 
microtubes (FF-MTs) and nanoparticles (CDPNCs) have been 
reported as potential vehicles for drug delivery. [ 21,22 ] However, 
research on FF-based compounds as diagnostic tools remains 
largely unexplored. Here, we describe new peptide materials 
based on poly-phenylalanine conjugates as potential contrast 
agents in magnetic resonance imaging (MRI). 
 The paramagnetic gadolinium complexes currently used in 
clinical diagnosis as MRI contrast agents are essentially low 
molecular weight compounds that rapidly equilibrate between 
the intra- and extravascular spaces after intravenous administra-
tion. However, gadolinium-based supramolecular aggregates, 
such as micelles, [ 23,24 ] liposomes, [ 25,26 ] and peptide amphiphile 
nanofi bers [ 27,28 ] have been proposed as MRI contrast agents in 
order to obtain enhanced contrast effi cacy and different phar-
macokinetic behavior. [ 29,30 ] It is known, in fact, that the ability 
of a MRI contrast agent to act as water proton relaxation agent 
is proportional to its molecular weight. [ 29,30 ] 
 Here we report the aggregation properties of phenylalanine 
derivatives displayed in  Figure  1 A, together with their relaxo-
metric behavior, cytotoxicity, and cellular uptake in J774A.1 and 
3T3 cells. 
 2.  Results and Discussion 
 2.1.  Design, Synthesis, and Aggregation Behavior 
 Various aromatic amino acids (phenylalanine, tryptophan, and 
tyrosine) and other aromatic moieties (naphthalene, azoben-
zene, and pyrene) have been proposed as building block for the 
synthesis of new nanomaterials. The structural properties of the 
resulting materials strongly depend from several parameters 
including hydrophilicity/hydrophobicity and extent of the 
aromatic ring. The self-asembling peptide derivatives here 
proposed as MRI contrast agents are based on poly-phenylala-
nine conjugates. Poly-phenylalanine conjugates, schematically 
represented in Figure  1 A, contain two (F2) or four (F4) phe-
nylalanine residues for self-assembly, a bifunctional chelating 
agent, 1,4,7,10-tetraazacyclododecane- N , N , N , N -tetraacetic acid 
(DOTA) or diethylenetriaminepentaacetic acid (DTPA), for 
achieving gadolinium coordination and an ethoxylic linker con-
sisting of two (L 2 ) or six (L 6 ) PEG units between the chelating 
group and peptide region. All compounds were obtained by 
Fmoc/tBu solid phase synthesis in good yield and high purity. 
The relative simple self-organization of di-phenylalanine 
depends on a combination of two kinds of not covalent inter-
actions: i) head-to-tail backbone hydrogen bonds and ii) π–π 
stacking between the aromatic ring of side chains. [ 14 ] Hydrogen 
bonds and π–π stacking are weak not covalent interactions that 
occur only if mutual guidance and directionality of the counter-
parts are kept. As a consequence, any modifi cation of the pep-
tide requires a careful design. First of all, it is well known that 
chemical modifi cations of Phe–Phe homo-dimer at C or N-ter-
minus may destroy the head-to-tail intermolecular hydrogen 
bonds, whereas π–π intermolecular interaction of the aromatic 
framework should be kept. However, independently from the 
chelating agent used, di-phenylalanine conjugates DOTA(Gd)-
F2 and DTPA(Gd)-F2 here reported do not show propensity to 
aggregate in water solution (data not shown), probably due to 
the steric hindrance of the bulk gadolinium complex, even with 
the insertion of L 2 ethoxylic spacer between the peptide frame-
work and the chelating agent. 
 Differently, UV–vis and fl uorescence measurements suggest 
a weak aggregation tendency for DOTA-L 6 -F2 and DTPA-L 6 -F2 
conjugates, in which L 2 spacer is replaced with L 6 spacer at six 
ethoxylic units (Figure  1 A). UV–vis spectra show the typical 
maximum of Phe residue at 257 nm (n → π transition of the 
aromatic residue), and another maximum at 282 nm, distinctive 
of the Phe excimer formation (data not shown). [ 31 ] Accordingly, 
Adv. Funct. Mater. 2015, 25, 7003–7016
www.afm-journal.de
www.MaterialsViews.com
 Figure 1.  A) Schematic representation of diphenylalanine or tetraphenylalanine conjugates, obtained using L 2 or L 6 polyethoxylic linkers and the 
DTPA(Gd) or DOTA(Gd) gadolinium complexes. B) Putative aggregation pattern for polyphenylalanine conjugates.
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fl uorescence spectrum of DOTA-L 6 -F2 at 2.0 mg mL −1 reported 
in  Figure  2 A clearly shows the monomer emission at 282 nm 
and the conspicuous excimer emission around 310 nm. [ 32 ] 
However, the emission peak of phenylalanine excimer almost 
disappears after the gadolinium complexation (see Figure  2 A). 
 The same behavior is also displayed by DTPA-L 6 -F2. This 
outcome could be attributed to the higher steric effect of gad-
olinium complex with respect to the chelating agent as free 
base. In order to restore the interactions between the pheny-
lalanine side chains, the peptide framework was reinforced by 
increasing the number of the phenylalanine residues from two 
to four, keeping unaltered the length of the spacer. These opti-
mized conjugates DOTA(Gd)-L 6 -F4 and DTPA(Gd)-L 6 -F4 show 
high water solubility: their solutions appear perfectly clear up to 
35 mg mL −1 ; whereas higher concentration (50 mg mL −1 ) leads 
to a hydrogel formation. The same behavior is also observed for 
L 6 -F4 derivative lacking of chelating agent at the N-terminus. 
Fluorescence spectra of DOTA(Gd)-L 6 -F4 at three different con-
centrations (0.01, 0.1, and 2.0 mg mL −1 ) reported in Figure  2 B 
show both the Phe ( λ 282 ) and its excimer ( λ 310 ) emission peaks, 
thus confi rming the high propensity of the complex to aggre-
gate, also at low concentration. Furthermore, by increasing the 
concentration of DOTA(Gd)-L 6 -F4 from 0.01 to 2.0 mg mL −1 , 
a progressive increase (from 1.7 to 4.0) of the ratio between 
the fl uorescence intensities at  λ 310 and  λ 282 is observed. The 
potential of nanosized supramolecular systems in the fi eld of 
drug delivery and diagnostic biomedical applications has been 
investigated from many years. In particular, if MRI diagnostic 
systems are considered, the possibility to exploit large-sized 
macromolecules is favourable also from the contrast effi ciency 
point of view. For this reason, on the basis of the preliminary 
aggregation data, the Gd-complexes of the tetra-phenylalanine 
conjugates, endowed with the highest propensity to aggrega-
tion, were selected to be further investigated for a relaxometric 
and structural characterization. Moreover, their cytotoxicity and 
cellular uptake capacity were investigated in J774A.1 and 3T3 
cell lines. 
 2.2.  Fluorescence Spectroscopy 
 Critical aggregate concentration (CAC) values of tetrapheny-
lalanine derivatives as free basis or as gadolinium complexes 
were quantitatively estimated with a fl uorescence-based method 
using 8-anilinonaphthalene-1-sulfonate (ANS) as probe. ANS 
fl uorophore gives fl uorescence emission at 460–480 nm only in 
a hydrophobic environment, such as in the micelle core. [ 33 ] The 
fl uorescence intensity of an ANS solutions (20 × 10 −6  M in water) 
at 475 nm as function of tetra-phenylalanine derivatives con-
centration are reported in  Figure  3 , and the CAC values of the 
aggregates were determined at the break point ( Table  1 ). During 
the titration experiment, the fl uorescence emission of DOTA-
L 6 -F4 remains unchanged until 75 × 10 −6  M (≈0.099 mg mL −1 ), 
whereas an increase in the signal at 475 nm was detected above 
this concentration value, indicating the self-organization of 
the tetraphenylalanine derivative (Figure  3 A). Usually, in the 
molecules containing chelating agents, aggregation properties 
can be infl uenced by two different phenomena: electrostatic 
repulsions and/or steric hindrance. [ 29 ] However, only a slight 
decrease in the CAC value is observed after the gadolinium 
complexation that reduces the negative charge from −3 to 0 
(CAC = 0.076 mg mL −1 for DOTA(Gd)-L 6 -F4). On the contrary, 
a signifi cant change has been observed when DOTA is replaced 
by the branched chelator DTPA (CAC = 0.59 mg mL −1 ) or by 
its gadolinium complex DTPA(Gd) (CAC = 0.51 mg mL −1 ) (see 
Figure  3 B and Table  1 ). These results suggest that the infl uence 
of electrostatic repulsions is almost negligible, whereas the 
replacement of the macrocycle DOTA with the branched and 
bulky DTPA produces an increase of the CAC values. 
 Aggregation of tetraphenylalanine derivatives was also 
investigated by monitoring fl uorescence behavior of pyrene 
(Pyr). 1 × 10 −6  M Pyr solution was titrated by adding increasing 
amounts of tetraphenylalanine derivatives. Fluorescence spectra 
of Pyr/DOTA(Gd)-L 6 -F4 solutions are reported in  Figure  4 A,B. 
Pyr is a poorly soluble water molecule that shows an emission 
spectrum in water with fi ve vibrational bands when excited at 
 λ = 335 nm: the fi rst (I 1 at 373 nm) and the third (I 3 at 383 nm) 
of them are strongly affected by the polarity of the surrounding 
environment. Moreover, at high concentration Pyr gives stacking 
phenomena resulting in excimer’s formation that can be diag-
nosed by the appearance of a maximum at around 480 nm. [ 10 ] 
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 Figure 2.  Fluorescence spectra of A) DOTA-L 6 -F2 and its gadolinium 
complex DOTA(Gd)-L 6 -F2 in water solution at 2.0 mg mL −1 and 
B) DOTA(Gd)-L 6 -F4 tetra-phenylalanine at a concentration of 0.01, 
0.1, and 2.0 mg mL −1 . All emission spectra were recorded at 25 °C 
between 265 and 400 nm with excitation at 258 nm.
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 The addition of small amounts of DOTA(Gd)-L 6 -F4 to 
Pyr solution causes a progressive decrease of fl uorescence 
signal (Figure  4 A). This effect was observed until concentra-
tion 14.3 × 10 −6  M of tetra-phenylalanine derivative, in which 
Pyr/DOTA(Gd)-L 6 -F4 molar ratio is 1/10. On the contrary, at 
concentration of 167 × 10 −6  M and higher, an increase of the 
fl uorescence intensities occurs. These data indicate that the 
aggregation phenomenon occurs at concentration within the 
14.3 × 10 −6  M to 167 × 10 −6  M range, in agreement with the CAC 
value (51 × 10 −6  M ) found by ANS titration, suggesting that when 
DOTA(Gd)-L 6 -F4 concentration is lower than 14.3 × 10 −6  M , the 
predominant effect is a quenching due to the aromatic stacking 
between phenylalanine residues and pyrene, whereas above this 
concentration, a fl uorescence resonance energy transfer (FRET) 
effect occurs in which tetra-phenylalanines, in their aggregated 
form, act as donor for pyrene. 
 2.3.  Secondary Structure 
 The secondary structure of DOTA-L 6 -F4 and DTPA-L 6 -F4 pep-
tide derivatives, as free bases or as gadolinium complexes, 
was assessed using circular dichroism (CD in  Figure  5 and 
Figures S1–S5, Supporting Information) and Fourier transform 
infrared spectroscopies (FTIR in  Figure  6 A). 
 CD spectra of solutions at several concentrations were 
recorded between 280 and 195 nm. CD spectra at con-
centrations below or close to CAC values clearly show two 
maxima around 205 and 220 nm, due to aromatic side-chains 
stacking, and pronounced minimum at 232 nm, which can be 
associated with a β-structure. [ 31,34 ] Signifi cant conformational 
transition was observed at higher concentrations, where the 
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 Figure 3.  Fluorescence intensity emission of the ANS fl uorophore at 
475 nm versus the concentration of A) DTPA-L 6 -F4 and B) DOTA-L 6 -F4 
as free bases or as gadolinium complexes. CAC values are established 
from the break points.
 Table 1.  Critical aggregate concentration (CAC) values of tetraphenylala-
nine derivatives measured by titration of the ANS fl uorophore. 
Sample CAC [ M ] CAC [mg mL −1 ]
DOTA-L 6 -F4 7.5 × 10 −5 9.9 × 10 −2 
DOTA(Gd)-L 6 -F4 5.1 × 10 −5 7.6 × 10 −2 
DTPA-L 6 -F4 4.5 × 10 −4 59 × 10 −2 
DTPA(Gd)-L 6 -F4 3.5 × 10 −4 51 × 10 −2 
 Figure 4.  Fluorescence spectra of a 1 × 10 −6  M pyrene solution titrated 
with DOTA(Gd)-L 6 -F4. Pyr emission spectra were recorded at 25 °C 
between 350 and 550 nm with excitation at 335 nm.
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main minimum at 230 nm and the absence of the maxima 
above reported can be interpreted as a signature for the 
dominant β-sheet arrangements. [ 31,34 ] From the inspection of 
Figure  5 , the CD spectra of peptide derivatives show similar 
trend irrespective of chelating agent. However, the confor-
mational transition described above was detected at higher 
concentration for DTPA-L 6 -F4 than DOTA-L 6 -F4, in agree-
ment with the difference in CAC values between these conju-
gates. Dichroic tendency of DOTA(Gd)-L 6 -F4 at 20 mg mL −1 
(well above the CAC value determined by fl uorescence) was 
also evaluated as function of the temperature between 10 and 
80 °C. At low temperature, it was observed a distinct min-
imum around 235 nm, typical of the polyphenylalanine in 
β-aggregate form (Figure S5A, Supporting Information). By 
increasing the temperature, the shape of the spectra remains 
unchanged, but a progressive decrease of the signal intensi-
ties with a red-shift effect occurs probably due to a progres-
sive unfolding of the peptide conjugate with higher molec-
ular mobility. However, the conformational features are kept 
almost until 80 °C, thus indicating a good thermal stability 
of the aggregate. [ 35 ] The integrity of the gadolinium complex 
in DOTA(Gd)-L 6 -F4 at the fi nal temperature (80 °C) was con-
fi rmed by the mass peak reported in Figure S5B of the Sup-
porting Information. 
 IR spectroscopy is often employed to probe the secondary 
structure assumed by di- or tetraphenylalanine derivatives. [ 17,36 ] 
Usually, the attention is focused on the amide I bands able 
to provide information on the secondary structure adopted. 
FTIR spectra in the amide I region are shown in Figure  6 A for 
DTPA(Gd)-L 6 -F4 and DOTA(Gd)-L 6 -F4 solutions at 2.0 mg mL −1 . 
Both the spectra show a principal peak at 1637 cm −1 and a 
minor peak at 1680 cm −1 . The peak at 1637 cm −1 is strongly 
indicative of β-sheet formation, whereas the fewer intensity of 
the second peak at 1680 cm −1 is indicative of an antiparallel 
orientation of the β-sheets. [ 37 ] FTIR spectra were also recorded 
on a dried fi lm of DTPA(Gd)-L 6 -F4 and DOTA(Gd)-L 6 -F4 (see 
Figure S6, Supporting Information). These spectra reported a 
similar profi le with respect to samples in solution. 
 Amyloid type fi bril formation was also confi rmed by using 
the typical Thiofl avin T and Congo Red spectroscopic assays. 
Fluorescence spectra of ThT, before and after the addition of 
DOTA-L 6 -F4, are reported in Figure S7 of the Supporting Infor-
mation. Spectra of DOTA-L 6 -F4 and its gadolinium complex in 
absence of ThT are also reported for comparison. 
 As shown in Figure S7 of the Supporting Information, 
DOTA(Gd)-L 6 -F4 gadolinium complex alone gives an emission 
peak in the same region in which the emission of ThT-β aggre-
gate is expected. 
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 Figure 5.  Selected Far-UV CD spectra of A) DOTA-L 6 -F4, B) DOTA(Gd)-L 6 -F4, C) DTPA-L 6 -F4, and D) DTPA(Gd)-L 6 -F4 in a concentration range of 
0.1–35 mg mL −1 .
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 As a consequence, in this sample we cannot attribute the 
peak at 482 nm to the interaction between ThT and the tetra-
phenylalanine aggregate. On the contrary, in its uncomplexed 
form, DOTA chelating agent did not provide fl uorescence 
signals. The sudden appearance of an emission peak at 
482 nm after the addition of DOTA-L 6 -F4 (2.0 mg mL −1 as 
fi nal concentration) indicates unambiguously the binding of 
the ThT to the peptide derivatives. [ 38 ] The fl uorescence signal 
remains unchanged until 2 h from the incubation, thus con-
fi rming the immediate interaction of ThT with peptides. The 
same behavior was also observed for tetra-phenylalanine ana-
logues containing DTPA chelating agent and its gadolinium 
complex (data not shown). According to the ThT assay, Congo 
Red staining (both UV–vis spectroscopy and polarized optical 
microscopy) confi rms the amyloid type fi bril formation. UV–vis 
spectra, reported in Figure  6 B, show the spectral shift of the 
conventional CR band from 488 to 540 nm after the addition 
of DOTA(Gd)-L 6 -F4 in the couvette for two different concentra-
tions (0.1 and 1.0 mg mL −1 ). At the same time, air-dried fi lms of 
gadolinium poly-phenylalanine derivatives stained with Congo 
Red and tetra-phenylalanine peptide dried fi bers containing CR 
exhibit intense green birefringence when imaged with polar-
ized optical microscopy (see Figure  6 C and Figure S8, Sup-
porting Information). 
 2.4.  TEM and X-Ray Diffraction 
 The morphology of the self-assembled nanostructures was 
also assessed by TEM and X-ray diffraction. Selected images 
of DTPA(Gd)-L 6 -F4 and DOTA(Gd)-L 6 -F4 gadolinium com-
plexes in water solution at 5.0 mg mL −1 show the presence 
of long nanofi bers with a minimum thickness around 10 nm 
( Figure  7 ). The recorded XRD patterns from DOTA(Gd)-L 6 -F4 
and L 6 -F4 peptide dried stalks are shown in  Figure  8 A,B, 
respectively. 
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 Figure 6.  A) FTIR spectra of DOTA(Gd)-L 6 -F4 and DTPA(Gd)-L 6 -F4 in the 
amide I region at 2.0 mg mL −1 concentration. B) The UV–vis spectra of 
DOTA(Gd)-L 6 -F4, stained with Congo Red, at 0.1 and 1.0 mg mL −1 . The 
spectrum of Congo Red is also reported for comparison. Insets: The spectra 
of DOTA(Gd)-L 6 -F4 0.1 mg () and 1.0 mg mL −1 () after the subtraction of 
the CR spectrum. C) Polarized optical microscopy image of dried DOTA(Gd)-
L 6 -F4 on a glass microscopy slide stained with Congo Red solution.
 Figure 7.  Selected TEM images for A,B) DOTA(Gd)-L 6 -F4 at 5.0 mg mL −1 
and C,D) DTPA(Gd)-L 6 -F4 at 5.0 mg mL −1 . Scale bars are 200 nm for 
(A,D), 100 nm for (B), and 500 nm for (C).
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 Miller indices and d-spacings for both fi ber types were 
determined using the software  CLEARER and are reported in 
Tables S1 and S2 of the Supporting Information. As clearly indi-
cated from the diffraction pattern, the structural arrangement of 
the peghylated cationic tetra-phenylalanine was not signifi cantly 
affected from the functionalization of the N-terminus with the 
DOTA (or DTPA, data not shown) chelating agents. Both the 
X-ray diffractions show the typical “cross-β” diffraction pattern 
of amyloid fi bers, with a Bragg spacing of 4.8–4.9 Å along the 
meridian, generally attributed to the interchain distance between 
the hydrogen-bonded strands oriented perpendicularly to the 
fi ber axis, and a more diffuse periodicity of ≈10 Å in the equato-
rial direction, usually ascribed to the staking of these β-sheets 
perpendicularly to the fi ber axis. [ 39,40 ] These XRD results are in 
agreement with the above reported CD (Figure  5 ) and IR data 
(Figure  6 A and Figure S6, Supporting Information) indicating 
a β-sheet conformation of DOTA(Gd)-L 6 -F4 in a dried fi lm. 
In Figure  8 it is also reported a simplifi ed model in extended 
conformation of DOTA(Gd)-L 6 -F4 based on our experimental 
results to better appreciate the monomer dimension (about 
50 Å), the antiparallel two-stranded β-disposition of the dimer 
with the fi ber axis pointing up the plane of the paper, and the 
stacked-dimers with the fi ber axis pointing toward the observer. 
 2.5.  Relaxometry 
 Gd-complexes are used as positive MRI con-
trast agents (CAs) as they are able to strongly 
enhance the water protons relaxation rate in 
aqueous solutions thanks to the magnetic 
dipolar interaction between unpaired elec-
trons on the gadolinium ions and the water 
protons. Their effi cacy as MRI CAs is thus 
measured on the basis of this ability, which 
is usually defi ned as longitudinal “relaxivity” 
(r 1p ) and is referred to the water proton relax-
ation rate of a solution containing one milli-
molar concentration of the Gd-complex. 
 The relaxivity of a Gd-containing 
system depends on the complex interplay 
among structural, dynamic, and electronic 
parameters. [ 41 ] At the frequencies most com-
monly used in commercial tomographs 
(20–60 MHz), r 1p is generally determined by 
the reorientational correlation time (τ R ) of 
the chelate so that high molecular weight sys-
tems display higher relaxivity. Based on this 
property, it is possible to follow the occur-
rence of an aggregation process involving 
a Gd-complex through the measure of the 
water proton longitudinal relaxation rate 
of its aqueous solution. The relaxivities 
of DOTA(Gd)-L 6 -F4 and DTPA(Gd)-L 6 -F4, 
measured at 21.5 MHz (0.5 T) and 298 K as 
a function of the complex concentration, are 
reported in  Figure  9 A. The observed progres-
sive enhancement in relaxivity is indicative of 
the self-aggregation of the two Gd-complexes. 
The inset in Figure  9 A shows an amplifi ca-
tion of the graph at low concentration values 
from which it is possible to observe that DTPA(Gd)-L 6 -F4 
starts to aggregate at higher concentrations than DOTA(Gd)-
L 6 -F4, refl ecting the CAC values determined by fl uorescence 
spectroscopy. 
 The analysis of the magnetic fi eld dependence of the 
relaxivity, obtained through the registration of the so-called 
nuclear magnetic resonance dispersion (NMRD) profi les, 
allows the determination of the principal parameters char-
acterising the relaxivity of a Gd(III) chelate. The NMRD pro-
fi les of DOTA(Gd)-L 6 -F4 and DTPA(Gd)-L 6 -F4, measured at 
40 mg mL −1 concentration, are reported in Figure  9 B. The 
shape of both the profi les, with the characteristic peak of relax-
ivity in the region of Proton Larmor Frequencies 10–70 MHz, is 
a clear indication that, at this concentration, the Gd-complexes 
are in an aggregated form. Data were fi tted to the conventional 
Solomon–Bloembergen–Morgan theory [ 42,43 ] and the relative 
fi tting parameters are reported in  Table  2 . 
 The high fi eld relaxivity of the two complexes are quite 
similar, being, at 20 MHz, 14.8 × 10 −3 and 14.0 × 10 −3  M −1 s −1 
for DOTA(Gd)-L 6 -F4 and DTPA(Gd)-L 6 -F4, respectively. The τ R 
values found for the two complexes are in fact very close. On the 
other hand, the big difference in relaxivity observed in the low 
fi eld region has to be ascribed to the difference in the electronic 
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 Figure 8.  Selected X-ray fi ber diffraction for A) DOTA-L 6 -F4 and B) L 6 -F4. The patterns show 
the diffraction features associated with the β-structure. Based on our experimental results, on 
the right side, a model of DOTA(Gd)-L 6 -F4 as monomer, dimer and stacked-dimers is reported.
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relaxation time (τ s0 ) of the two Gd-complexes (Table  2 ). It is 
in fact known, that highly symmetric and rigid DOTA-type 
chelates generally have longer τ s0 values than DTPA-like, and 
this physically translates to a higher low-fi eld relaxivity. [ 44 ] It is 
worth to note that the τ R values extracted from the fi tting pro-
cedure for DOTA(Gd)-L 6 -F4 and DTPA(Gd)-L 6 -F4 in the aggre-
gated form are quite short if compared to those usually found 
for nanosized aggregates (1–30 ns). Likely, this fi nding can be 
explained with the occurrence of a quite fast internal motility 
of the Gd-complexes along the linker spacer with respect to the 
overall fi bril-like structures, as evidenced in the model arrange-
ment proposed in Figure  8 . 
 2.6.  Cytotoxicity and MRI Evaluation of the Cellular Uptake 
 The cytotoxicity of the fi bril nanoaggregates of DOTA(Gd)-L 6 -F4 
and DTPA(Gd)-L 6 -F4 has been initially tested in the mouse 
embryonic fi broblast cell line 3T3 in the concentration range 
0.5–5.0 mg mL −1 ( Figure  10 A). With a view to the subsequent 
experiments on the evaluation of the MRI cellular response, 
given that the particles, in this preliminary stage, are not func-
tionalized for a target-specifi c cellular internalization, it was 
necessary to push the uptake experiment with an overnight incu-
bation. The cytotoxicity assay revealed a signifi cant reduction in 
fi broblast viability along with the increase of the Gd-complexes 
concentration, with a higher effect in the case of DOTA(Gd)-
L 6 -F4 particles. The cytotoxicity appears to be higher than that 
reported in the case of analogous di-phenylalanine microtubes 
in the same cell line [ 21 ] because of the longer incubation time 
(overnight in our experiments vs 2 h in the literature data. [ 21 ] 
 A recent work on the assessment of the cellular response 
to dissolution and degradation products from self-assembled 
Fmoc-FF gels revealed that the critical factor affecting cell via-
bility is the time a gel is allowed to degrade and leach into the 
media. [ 45 ] We taught that a way to elude a long incubation time 
while maintaining a suffi cient amount of internalized probes 
to test their ability to enhance the MRI cellular response would 
be to use a macrophagic cell line which attitude is to phago-
cytize a huge amounts of particles in short times. Thus, the 
cytotoxicity of the fi bril nanoaggregates of DOTA(Gd)-L 6 -F4 
and DTPA(Gd)-L 6 -F4 was investigated in J774A.1 mouse 
macrophages (Figure  10 B) in the same concentration range 
(0.5–5.0 mg mL −1 ) but with an incubation time of 3 h. In this 
case, the treated cells showed the same viability of the con-
trol cells even at the higher concentrations. Next, the uptake 
effi ciency of DOTA(Gd)-L 6 -F4 and DTPA(Gd)-L 6 -F4 nano-
aggregates and their effi cacy in enhancing the MR-signal upon 
internalization, were investigated in J774A.1 cells and com-
pared to those of the parents Gd-DOTA (Dotarem, Guerbert 
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 Table 2 Main relaxometric parameters derived from fi tting of NMRD profi les at 21.5 MHz reported in Figure  10 B. 
System r 1p a) 
[×10 −3  M −1 s −1 ]
Δ 2b) 
[s −2 ]
τ V c) 
[ps]
τ s0 d) 
[ps]
τ R e) 
[ps]
DOTA(Gd)-L 6 -F4 14.8 8.0 × 10 18 49 212 490
DTPA(Gd)-L 6 -F4 14.0 1.25 × 10 19 52 127 457
 a) On carrying out the fi tting procedure, some parameters were fi xed to reasonable values: r Gd–H (distance between Gd and protons of the inner sphere water molecule) = 
3.1 Å; a (distance of minimum approach of solvent water molecules to Gd 3+ ion) = 3.8 Å; D (solvent diffusion coeffi cient) = 2.2 × 10 −5 cm 2 s −1 ;  b) Squared mean transient 
zero-fi eld splitting (ZFS) energy;  c) Correlation time for the collision-related modulation of the ZFS Hamiltonian;  d) Electronic relaxation time at zero fi eld (calculated as 
1/τ s0 = 12Δ 2 × τ v );  e) Reorientational correlation time. 
 Figure 9.  A) Longitudinal proton relaxivity of DOTA(Gd)-L 6 -F4 and DTPA(Gd)-L 6 -F4 measured at 21.5 MHz (0.5 T) and 298 K as a function of the con-
centration of the poly-phenylalanine Gd-complexes. B) Nuclear magnetic resonance dispersion (NMRD) profi les of the 40 mg mL −1 aqueous solutions 
of the two polyphenylalanine Gd-complexes at 298 K. The data refer to 1 × 10 −3  M concentration of the paramagnetic complexes.
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SA, France) and Gd-DTPA (Magnevist, Schering AG, Germany) 
complexes. The cells were incubated with increasing concen-
trations of DOTA(Gd)-L 6 -F4 and DTPA(Gd)-L 6 -F4 for 3 h at 
37 °C and the amount of internalized gadolinium determined 
through ICP-MS analysis ( Figure  11 A). 
 Both the tetraphenylalanine functionalized Gd-complexes, 
being under the form of aggregates, displayed internalization 
effi ciency far higher than that of the control complexes. The cel-
lular MRI-signal response to labelling with the Gd-complexes 
was investigated at 7.1 T (Figure  11 B). The T 1w images of the 
cellular pellets, and the corresponding R 1 (1/T 1 ) values, refl ect 
the trend of higher cellular internalization for F4-Gd complexes 
displayed in Figure  11 A, being the signal intensity remarkably 
higher than that observed when J774A.1 cells were incubated 
with Gd-DOTA and Gd-DTPA. The comparison between the 
two F4-Gd complexes reveals a higher effi ciency of DOTA(Gd)-
L 6 -F4 in enhancing the water proton MR-signal with respect to 
DTPA(Gd)-L 6 -F4. The reason for this, likely, relies in the dif-
ferent aggregation state of the two Gd-complexes in the con-
centration used for this experiment. Both at 1.5 × 10 −3 and 
3.5 × 10 −3  M −1 (corresponding to 2.0 and 5.0 mg mL −1 ), in fact, as 
can be appreciated in Figure  9 A, DOTA(Gd)-L 6 -F4 is endowed 
with an higher relaxivity due to its higher aggregation tendency, 
while for DTPA(Gd)-L 6 -F4 the relaxivity is lower. An accurate 
analysis of the observed relaxation rates of the pellets of cells, 
incubated with DOTA(Gd)-L 6 -F4 and DTPA(Gd)-L 6 -F4 with 
reference to the amount of internalized Gd-complexes, reveals 
that the increase in the uptake extent observed by passing 
from 1.5 × 10 −3 to 3.5 × 10 −3  M −1 concentration in the incuba-
tion media, is not accompanied by the corresponding enhance-
ment in the relaxation rate (signal intensity) for each Gd-con-
taining system. This behavior can be explained on the basis 
of the previously observed “quenching” effect on the relaxivity 
taking place when cells are labelled with high amounts of Gd-
complexes and is related to the confi nement of the probe in the 
sub-cellular or cellular compartments. [ 46,47 ] The MRI contrast 
effect is not limited by insuffi cient loading with paramagnetic 
material, but by the exchange rate of water molecules across the 
endosomal or cellular membrane. 
 3.  Conclusions 
 The synthesis and the structural characterization of novel 
potential MRI contrast agents based on the aggregation of poly-
phenylalanine conjugates have been reported. The insertion of 
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 Figure 10.  Cell viability percentage, evaluated by a CellTiter-Blue reagent test, after A) overnight treatment of the 3T3 fi broblasts and B) 3 h treatment 
of J774A.1 macrophages with various concentrations of DOTA(Gd)-L 6 -F4 and DTPA(Gd)-L 6 -F4. Data are expressed as the mean ± SD ( n = 3).
 Figure 11.  A) Amount of internalized gadolinium ions, evaluated by ICP-MS, in J774A.1 cells incubated with increasing concentrations of DOTA(Gd)-
L 6 -F4, DTPA(Gd)-L 6 -F4, Gd-DOTA, and Gd-DTPA for 3 h. B) T 1 -weighted MR-images, and relative observed relaxation rates, of pellets of J774A.1 cells 
labelled with 1.5 and 3.5 × 10 −3  M DOTA(Gd)-L 6 -F4, DTPA(Gd)-L 6 -F4, Gd-DOTA, and Gd-DTPA.
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a DTPA or a DOTA gadolinium complex on the N-terminus 
FF homodimer destroys both the head-to-tail interaction and 
the π–π intermolecular interaction of the aromatic framework. 
This effect can be probably attributed to the steric hindrance 
of the gadolinium complex. Hence, the peptide framework 
was reinforced by increasing the number of the phenylalanine 
residues from two to four. Both the DOTA and DTPA tetra-
phenylalanine derivatives are able to self-aggregate at very low 
concentration, also after gadolinium coordination. Moreover, 
Gd(III) complexes are completely soluble in water, whereas a 
previously reported N-terminus-methoxy and C-terminus-ethyl 
protected F4-L 7 derivative showed a poor water solubility. [ 36 ] The 
structural characterization aimed to defi ne the secondary struc-
ture of the peptide fragment confi rms the amyloid type fi bril 
formation in which, as expected, an antiparallel alignment is 
preferred. Amyloid type fi bril formation was also confi rmed by 
TEM images and X-ray diffraction patterns. Moreover, the self-
aggregation of DOTA(Gd)-L 6 -F4 and DTPA(Gd)-L 6 -F4 has been 
proved by the progressive enhancement in relaxivity observed 
increasing the Gd complex concentration and by the typical 
shape of the NMRD profi les in the region of Proton Larmor 
Frequencies 10–70 MHz. The relaxivity values of the two com-
plexes at 20 MHz are 14.8 × 10 −3 and 14.0 × 10 −3  M −1 s −1 for 
DOTA(Gd)-L 6 -F4 and DTPA(Gd)-L 6 -F4, respectively. These 
values are higher than the classical contrast agents at low 
molecular weight. On the other hand, these values are com-
parable or lower than many examples of Gd(III)-based micelle 
or liposome contrast agents. [ 23–30 ] Surprising the τ R values 
extracted from the fi tting procedure are quite short if compared 
to those usually found for nano-sized aggregates (1–30 ns). In 
our opinion, these low τ R values can be attributed to the occur-
rence of a quite fast internal motility of the Gd-complexes along 
the linker spacer with respect to the overall fi bril-like structures. 
Preliminary studies aimed to defi ne the ability of DOTA(Gd)-
L 6 -F4 and DTPA(Gd)-L 6 -F4 to enhance the MRI cellular 
response was achieved on J774A.1 mouse macrophages cell line 
in which the cytotoxicity of the fi bril nanoaggregates was neg-
ligible with an incubation time of 3 h in 0.5–5.0 mg mL −1 con-
centration range. The in vitro MRI behavior of nanoaggregates 
was also compared to those of the parents Gd-DOTA and Gd-
DTPA complexes. Both the tetra-phenylalanine Gd-complexes 
showed a signifi cant internalization effi ciency and a remarkably 
enhance of the water proton MR-signal with respect to the con-
trol complexes. Moreover, the higher effi ciency of DOTA(Gd)-
L 6 -F4 in enhancing the water proton MR-signal with respect 
to DTPA(Gd)-L 6 -F4 probably refl ects the different aggregation 
state of the two Gd-complexes in the concentration used for 
this experiment. At the best of our knowledge, this is the fi rst 
example of aromatic framework based nanoaggregates as MRI 
contrast agent. However, several issues have to improve before 
their in vivo applications as diagnostic tools. For example, the 
insertion of structural elements able to confer rigidity to the 
molecules without to alter their solubility could lead to higher 
relaxivity values. At the same time, synthetic modifi cations of 
the peptide framework, e.g., the replacement of natural amino 
acids with uncoded ones, could improve the stability of the 
fi brillary aggregates, thus reducing the extent of degradation 
products that are invocated as the critical factor affecting cell 
viability into the cellular media. 
 4.  Materials and Methods 
 Protected N α -Fmoc-amino acid derivatives, coupling reagents, 
and Rink amide MBHA (4-methylbenzhydrylamine) resin 
were purchased from Calbiochem-Novabiochem (Laufelfi ngen, 
Switzerland). The Fmoc-21-amino-4,7,10,13,16,19-hexaoxahe-
neicosanoic acid [Fmoc-Ahoh-OH, (L 6 )] and the Fmoc-8-amino-
3,6-dioxaoctanoic acid [Fmoc-AdOO-OH, (L 2 )] were purchased 
from Neosystem (Strasbourg, France). DTPA(OtBu) 4 -OH 
and DOTA(OtBu) 3 -OH chelating agents were purchase from 
Chemateck (Dijon, France). All other chemicals were com-
mercially available by Sigma-Aldrich (Milan, Italy) or Fluka 
(Bucks, Switzerland) or LabScan (Stillorgan, Dublin, Ireland) 
and were used as received unless otherwise stated. All solu-
tions were prepared by weight with doubly distilled water. Pre-
parative RP-HPLCs were carried out on a LC8 Shimadzu HPLC 
system (Shimadzu Corporation, Kyoto, Japan) equipped with 
an UV lambda-Max Model 481detector using Phenomenex 
(Torrance, CA) C18 column. Elution solvents are H 2 O/0.1% 
TFA (A) and CH 3 CN/0.1% TFA (B), from 5% to 70% over 
30 min at 20 mL min −1 fl ow rate. Purity and identity of the 
products were assessed by analytical LC-MS analyses by using 
Finnigan Surveyor MSQ single quadrupole electrospray ioni-
zation (Finnigan/Thermo Electron Corporation San Jose, CA), 
column: C18-Phenomenex eluted with an H 2 O/0.1% TFA (A) 
and CH 3 CN/0.1% TFA (B) from 5% to 70% over 15 min at 
200 µL min −1 fl ow rate. 
 Synthesis of Peptide Derivatives : Peptides and peptide con-
jugates were synthesized by using standard solid-phase 
9-fl uorenylmethoxycarbonyl (Fmoc) procedures. The Rink 
amide MBHA resin (substitution 0.65 mmol g −1 ) was used 
as the solid phase support to provide the peptides as C-ter-
minus amide, and synthesis was performed on a scale of 
0.2 mmol. The resin was swelled in DMF for 30 min and the 
Fmoc deprotection reaction (10 min) was performed twice 
with 30% (v/v) piperidine in DMF. The amino acid coupling 
was achieved by adding twofold molar excess of amino acid, 
mixed with equimolar amounts of 1-hydroxybenzotriazole 
(HOBt), benzotriazol-1-yl-oxy-tris-pyrrolidino-phosphonium 
(PyBop), and fourfold molar excess of diisopropylethyl-
amine (DIPEA) in DMF. All couplings were performed twice 
for 1 h. Chelating agents and the ethoxylic spacers (Fmoc-
AdOO-OH and Fmoc-Ahoh-OH) were coupled as previously 
described. [ 48,49 ] Peptides were fully deprotected and from the 
resin with the TFA (trifl uoroacetic acid)/ TIS (triisopropylsi-
lane)/ H 2 O (95.5/2.0/2.5 v/v/v) mixture at room temperature. 
Peptides and peptide conjugates were precipitated with ice-
cold ethyl ether, dissolved in H 2 O/CH 3 CN and freeze-dried. 
The purifi cation of the crude products was carried out by RP-
HPLC. Mass spectra confi rm the products identity. Retention 
times ( R t ) and molecular weight ( M w ) of the peptide deriva-
tives are reported in  Table  3 . 
 DTPA-F2:  1 H-NMR (CD 3 OD) (chemical shifts in  δ , 
CH 3 OH as internal standard 3.55) = 7.51-7.42 (m, 10 C H 
aromatic), 4.96-4.86 (m, 2H, C H Phe α), 4.65-4.61 (d,  J = 
16 Hz, 1H, R 2 NC H 2 CONHR), 4.44-4.40 (d,  J = 16 Hz, 1H, 
R 2 NC H 2 CONHR), 3.87 (s, 8H, R 2 NC H 2 COOH), 3.53-3.50 (m, 
4H, R 2 NC H 2 CH 2 NR 2 ), 3.42-3.31 (m, 4H, R 2 NCH 2 C H 2 NR 2 ), 
3.24-2.99 (m, 4H, C H 2 Phe β). 
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 DOTA-F2:  1 H-NMR (CD 3 OD) (chemical shifts in  δ , CH 3 OH 
as internal standard 3.55) = 7.51-7.42 (m, 10 C H aromatic), 
4.86-4.75 (m, 2H, C H Phe α), 3.70 (s, 6H, R 2 NC H 2 COOH), 3.45 
(s, 16H, R 2 N-C H 2 C H 2 NR 2 ), 3.40-3.36 (m, 2H, R 2 NC H 2 CONH), 
3.16-2.90 (m, 4H, C H 2 Phe β). 
 DTPA-L 2 -F2:  1 H-NMR (CD 3 OD) (chemical shifts in  δ , CH 3 OH 
as internal standard 3.55) = 7.51-7.42 (m, 10 C H aromatic), 
4.96-4.86 (m, 2H, C H Phe α), 4.55 (s, 2H, R 2 NC H 2 CONHR), 
3.87 (s, 8H, R 2 NC H 2 COOH), 3.79 (s, 4H, OC H 2 C H 2 O), 3.75 
(t,  J = 4 Hz, 2H, RNHCH 2 C H 2 O), 3.65 (s, 2H, OC H 2 COR), 
3.60 (t,  J = 7 Hz, 2H, RNHC H 2 CH 2 O), 3.53-3.50 (m, 4H, 
R 2 NC H 2 CH 2 N R 2 ), 3.42-3.31 (m, 4H, R 2 NCH 2 C H 2 NR 2 ), 3.24-
2.99 (m, 4H, C H 2 Phe β). 
 DOTA-L 2 -F2:  1 H-NMR (CD 3 OD) (chemical shifts in  δ , 
CH 3 OH as internal standard 3.55) = 7.51-7.42 (m, 10 C H aro-
matic), 4.86-4.75 (m, 2H, C H Phe α), 3.79 (s, 4H, OC H 2 C H 2 O), 
3.75 (t,  J = 4  Hz , 2H, RNH-CH 2 C H 2 O), 3.70 (s, 6H, R 2 NC H-
 2 COOH), 3.65 (s, 2H, OC H 2 COR), 3.60 (t,  J = 6  Hz , 2H, RNH-
C H 2 CH 2 O), 3.45 (s, 16H, R 2 N-C H 2 C H 2 NR 2 ), 3.40-3.36 (m, 2H, 
R 2 NC H 2 CONH), 3.16-2.90 (m, 4H, C H 2 Phe β). 
 DTPA-L 6 -F2:  1 H-NMR (CD 3 OD) (chemical shifts in  δ , 
CH 3 OH as internal standard 3.55) = 7.51-7.42 (m, 10 C H aro-
matic), 4.86-4.75 (m, 2H, C H Phe α), 4.55 (s, 2H, R 2 NC H-
 2 CONHR), 3.87 (s, 8H, R 2 NC H 2 COOH), 3.80 (s, 22H, 
OC H 2 C H 2 O), 3.75 (t,  J = 8 Hz, 2H, RNHCH 2 C H 2 O), 
3.68 (t,  J = 7 Hz, 2H, RNHC H 2 CH 2 O), 3.40-3.32 (m, 6H, 
R 2 NC H 2 C H 2 NR 2 ), 3.27-3.20 (dd,  J = 7 Hz,  J = 14 Hz, 2H, 
R 2 NCH 2 C H 2 NR 2 ), 3.16-2.90 (m, 4H, C H 2 Phe β). 2.58 (t,  J = 6 
Hz, 2H, NHCOC H 2 CH 2 ). 
 DOTA-L 6 -F2:  1 H-NMR (CD 3 OD) (chemical shifts in  δ , 
CH 3 OH as internal standard 3.55) = 7.51-7.42 (m, 10 C H 
aromatic), 4.86-4.75 (m, 2H, C H Phe α), 3.80 (s, 22H, 
OC H 2 C H 2 O), 3.75 (t,  J = 4  Hz , 2H, RNHCH 2 C H 2 O), 3.70 (s, 
6H, R 2 NC H 2 COOH), 3.60 (t,  J = 6  Hz , 2H, RNHC H 2 CH 2 O, 
3.45 (s, 16H, R 2 NC H 2 C H 2 NR 2 ), 3.40-3.36 (m, 2H, R 2 NC H-
 2 CONH), 3.16-2.90 (m, 4H, C H 2 Phe β), 2.58 (t,  J = 6  Hz , 2H, 
NHCOC H 2 CH 2 O). 
 L 6 -F4:  1 H-NMR (CD 3 OD) (chemical shifts in  δ , CH 3 OH 
as internal standard 3.55) = 7.51-7.42 (m, 20 C H aromatic), 
4.86-4.75 (m, 4H, C H Phe α), 3.80 (s, 22H, OC H 2 C H 2 O), 
3.75 (t,  J = 4  Hz , 2H, RNHCH 2 C H 2 O), 3.60 (t,  J = 6  Hz , 2H, 
RNHC H 2 CH 2 O), 3.16-2.90 (m, 8H, C H 2 Phe β), 2.58 (t,  J = 6  Hz , 
2H, NHCOC H 2 CH 2 O). 
 DTPA-L 6 -F4:  1 H-NMR (CD 3 OD) (chemical shifts in  δ , 
CH 3 OH as internal standard 3.55) = 7.51-7.42 (m, 20 C H aro-
matic), 4.86-4.75 (m, 4H, C H Phe α), 4.55 (s, 2H, R 2 NC H-
 2 CONHR), 3.87 (s, 8H, R 2 NC H 2 COOH), 3.80 (s, 22H, 
OC H 2 C H 2 O), 3.75 (t,  J = 4 Hz, 2H, RNHCH 2 C H 2 O), 3.68 (t,  J = 
6 Hz, 2H, RNHC H 2 CH 2 O), 3.40-3.32 (m, 6H, R 2 NC H 2 C H 2 NR 2 ), 
3.27-3.20 (dd,  J = 7 Hz,  J = 14 Hz, 2H, R 2 NCH 2 C H 2 NR 2 ), 3.16-
2.90 (m, 8H, C H 2 Phe β), 2.58 (t,  J = 6  Hz , 2H, NHCOC H 2 CH 2 ). 
 DOTA-L 6 -F4:  1 H-NMR (CD 3 OD) (chemical shifts in  δ , 
CH 3 OH as internal standard 3.55) = 7.51-7.42 (m, 20 C H aro-
matic), 4.86-4.75 (m, 4H, C H Phe α), 3.80 (s, 22H, OC H 2 C H 2 O), 
3.75 (t,  J = 4  Hz , 2H, RNHCH 2 C H 2 O), 3.70 (s, 6H, R 2 NC H-
 2 COOH), 3.60 (t,  J = 6  Hz , 2H, RNHC H 2 CH 2 O), 3.45 (s, 16H, 
R 2 NC H 2 C H 2 NR 2 ), 3.40-3.36 (m, 2H, R 2 NC H 2 CONH), 3.16-2.90 
(m, 8H, C H 2 Phe β), 2.58 (t,  J = 6  Hz , 2H, NHCOC H 2 CH 2 O). 
 Preparation of Gadolinium Complexes : The complexation 
has been carried out by adding 1:1 molar ratio of GdCl 3 to the 
aqueous solutions of the DOTA or DTPA derivatives at neutral 
pH and room temperature. The amount of residual free Gd 3+ 
ions was assessed by the orange xylenol UV method [ 50 ] and 
complexed by further addition of the corresponding amount of 
each ligand. 
 Fluorescence Studies : The values of critical aggregate concen-
tration (CAC) were obtained by fl uorescence measurements. 
Fluorescence spectra were recorded at room temperature on a 
Jasco Model FP-750 spectrofl uorophotometer in a 1.0 cm path 
length quartz cell. Equal excitation and emission bandwidths 
(5 nm) were used throughout the experiments with a recording 
speed of 125 nm min −1 and automatic selection of the time 
constant. The CAC values were measured by using 8-anilino-
1-naphthalene sulfonic acid ammonium salt (ANS) [ 51,52 ] and 
pyrene (Pyr) as fl uorescent probes. [ 53 ] 
 Small aliquots of peptide conjugate in water solutions, as 
free bases or as gadolinium complexes, were added to 1.0 mL of 
aqueous solution of ANS (20 × 10 −6  M ) or Pyr (1 × 10 −6  M ). Final 
spectra, to be used for calculations, were obtained after blank 
correction and adjustment for dilution. The fl uorescence inten-
sity of ANS was followed as a function of the peptide concentra-
tion. The CAC values were determined by linear least-squares 
fi tting of the fl uorescence emission at 470 nm, upon excitation 
at 350 nm versus the polyphenylalanine concentration lower 
and higher than the change of slope. The excitation wavelength 
of Pyr was settled at 335 nm and spectra were recorded between 
350 and 550 nm. 
 Thiofl avin T (ThT) Spectroscopic Assay : Aggregation behavior 
of DOTA-L 6 -F4 and DTPA-L 6 -F4 as free bases or as gadolinium 
complexes was assessed by using Thiofl avin T (ThT). Thiofl avin 
T associates rapidly with β-aggregated peptides giving rise to 
an enhanced emission at 482 nm. [ 54 ] Fluorescence spectrum 
of an aqueous solution of ThT (25 × 10 −6  M ) before and after 
the addition of tetraphenylalanine derivatives (2 mg mL −1 ) was 
recorded at 25 °C at regular intervals (each 10 min) during 2 h 
after the peptide addition into the cuvette. Samples were excited 
at 450 nm and fl uorescence emission spectra were recorded 
between 460 and 650 nm. 
 Congo Red Spectroscopic Assay : UV–vis measurements of 
Congo Red (CR) alone or in presence of poly-phenylalanine 
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 Table 3.  Retention time ( R t ) and theoretical molecular weight ( M W ) 
of investigated polyphenylalanine conjugates. RP-HPLC method and 
column details are reported in the Materials and Methods Section. 
Sample Formula  R t 
[min]
 M W 
[u.m.a.]
DTPA-F2 C 32 H 42 N 6 O 11 10.34 686
DOTA-F2 C 34 H 46 N 6 O 10 10.65 698
DTPA-L 2 -F2 C 38 H 53 N 7 O 14 11.19 831
DOTA-L 2 -F2 C 40 H 57 N 7 O 13 11.42 843
DTPA-L 6 -F2 C 47 H 70 N 7 O 18 12.10 1020
DOTA-L 6 -F2 C 49 H 76 N 8 O 16 12.33 1032
L 6 -F4 C 51 H 67 N 6 O 11 15.30 939
DTPA-L 6 -F4 C 65 H 88 N 9 O 20 14.54 1314
DOTA-L 6 -F4 C 67 H 94 N 10 O 18 14.59 1326
FU
LL
 P
A
P
ER
7014 wileyonlinelibrary.com © 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim Adv. Funct. Mater. 2015, 25, 7003–7016
www.afm-journal.de
www.MaterialsViews.com
derivatives were carried out on Thermo Fisher Scientifi c Inc 
(Wilmington, Delaware, USA) Nanodrop 2000c spectropho-
tometer equipped with a 1.0 cm quartz cuvette (Hellma). A 
stock solution of CR (3.5 mg in 500 µL) was freshly prepared 
in 10 × 10 −3  M phosphate buffer pH 7.4 and fi ltered through 
0.2 µm syringe immediately prior to use. A small aliquot (5 µL) 
of this solution was diluted with the buffer at 12.5 × 10 −6  M fi nal 
concentration and the UV–vis spectrum was recorded between 
400 and 700 nm at room temperature. 50 µL of DTPA(Gd)-L 6 -F4 
or DOTA(Gd)-L 6 -F4 (20 mg mL −1 ) were added to CR solution 
and samples were incubated for 30 min at room temperature. 
The spectra were recorded and background subtracted using a 
Congo Red spectrum in phosphate buffer as reference solution. 
 Circular Dichroism : Far-UV CD spectra of the peptide conju-
gates in aqueous solution were collected on a Jasco J-810 spec-
tropolarimeter equipped with a NesLab RTE111 thermal con-
troller unit using a 0.1 mm quartz cell at 25 °C. The spectra 
of samples at several concentrations (35, 20, 15, 10, 5, 2.0, 1.0, 
0.5, and 0.1 mg mL −1 ) are recorded from 280 to 195 nm. Other 
experimental settings were: scan speed, 10 nm min −1 ; sen-
sitivity, 50 mdeg; time constant, 16 s; bandwidth, 1 nm. Each 
spectrum was obtained by averaging three scans and corrected 
for the blank. Here Θ represents the mean residue ellipticity 
(MRE), i.e., the ellipticity per mole of peptide divided by the 
number of amino acid residues in the peptide. Thermal profi les 
(CD vs temperature, in the 10–80 °C range) of the tetrapheny-
lalanine derivatives at 20 mg mL −1 were recorded every 10 °C, 
equilibrating for 10 min before next measurement. 
 Fourier Transform Infrared Spectroscopy (FTIR) : FTIR spectra 
of samples (2.0 mg mL −1 ) were collected on a Jasco FT/IR 4100 
spectrometer (Easton, MD) in an attenuated total refl ection 
(ATR) mode and using a Ge single-crystal at a resolution of 
4 cm −1 . All the spectral data were processed using built-in soft-
ware. Spectra were collected in transmission mode and then 
converted in emission. Each sample was recorded with a total 
of 100 scans with a rate of 2 mm s −1 against a KBr background. 
 Transmission Electron Microscopy (TEM) Images : TEM obser-
vation were performed with a transmission electron micro-
scope FEI TECNAI G12 Spirit-Twin (LaB6 source) equipped 
with a bottom mounted FEI Eagle-4k CCD camera (Eindhoven, 
The Netherlands), operating with an acceleration voltage of 120 
kV (LaMest Pozzuoli, Italy). A droplet of the sample solution 
(5 mg mL −1 ) was placed onto a 400 mesh holey-carbon coated 
copper grid, air-dried for 1 h, and then negatively stained with 
phosphotungstic acid in water solution (1 wt%). Tomography 
holder with FEI Eagle 4K CCD camera and Xplore 3D software 
were used to obtain digital images. 
 X-ray Fiber Diffraction (XRD) : Diffraction patterns were 
obtained for stalks prepared by the stretch frame method. [ 55 ] 
Briefl y, a droplet (10 µL) of peptide aqueous solution (3 wt%) 
was suspended between the ends of a wax-coated capillary 
(spaced 2 mm apart). The droplet was allowed to dry gently 
at room temperatures overnight to obtain oriented fi bers. The 
stalk was mounted vertically onto the four axis goniometer of 
an R-AXIS IV++ X-ray diffractometer (Rigaku) equipped with 
a rotating anode generator. The XRD data were collected using 
a Saturn 944 CCD camera (CuKα high intensity X-ray micro-
focus source,  λ = 1.5418 Å). The specimen-to-fi lm distance was 
set at 90 mm and the exposure time was set to 60 s. The X-ray 
patterns were processed using the analysis and simulation 
 CLEARER software. [ 56 ] 
 Congo Red Staining and Polarized Optical Microscopy : Dried 
fi lm of polyphenylalanine was obtained placing 10 µL of the 
peptide aqueous solution (3 wt%) onto a glass slide and left 
drying at room temperature. Then, the air-dried samples were 
stained with 150 µL of freshly prepared CR solution, obtained 
adding a saturating amount of CR in ethanol containing 20% of 
NaCl saturated water. After the application of the CR solution, 
the excess was rapidly removed from the glass slide with a fi lter 
paper. CR containing fi bers were prepared, as above described 
with stretch frame method, adding 2 µL of CR staining solution 
to 50 µL of poly-phenylalanine solution. Samples dried on glass 
slide or CR containing fi bers were observed under bright fi eld 
illumination and between crossed polars using a Nikon AZ100 
microscope. 
 Water Proton Relaxation Measurements : The longitudinal 
water proton relaxation rates were measured at 25 °C by using 
a Stelar Spinmaster (Stelar, Mede, Pavia, Italy) spectrometer 
operating at 0.5 T (21.5 MHz Proton Larmor Frequency), by 
mean of the standard inversion-recovery technique. The tem-
perature was controlled with a Stelar VTC-91 air-fl ow heater 
equipped with a copper constantan thermocouple (uncer-
tainty 0.1 °C). The proton 1/T 1 NMRD profi les were meas-
ured at 25 °C on a fast fi eld-cycling Stelar relaxometer over 
a continuum of magnetic fi eld strengths from 0.00024 to 
0.47 T (corresponding to 0.01–20 MHz proton Larmor fre-
quencies). The relaxometer operates under computer control 
with an absolute uncertainty in 1/T 1 of ±1%. Additional data 
points in the range 21.5–70 MHz were obtained on the Stelar 
Spinmaster spectrometer. The concentration of the solutions 
used for the relaxometric characterization was determined 
according to a previously reported relaxometric method. [ 57 ] 
Data were fi tted to the conventional Solomon–Bloembergen–
Morgan theory. 
 Cytotoxicity Studies : The cytotoxicity of DOTA(Gd)-L 6 -F4 and 
DTPA(Gd)-L 6 -F4 probes was investigated in a mouse mac-
rophages cell line (J774A.1) and in a mouse embryonic fi bro-
blast cell line (3T3). J774A.1 and 3T3 cells were seeded in 
DMEM culture medium, enriched with 10% fetal bovine serum 
and 1% glutamine, at 150 000 and 50 000 cells per well, respec-
tively, in 96-well plates the day before the incubation. The cells 
were incubated for 3 h (J774A.1) or overnight (3T3) at 37 °C 
with the two Gd-based probes at different concentrations: 0.5, 
1, 2, 3, and 5 mg mL −1 . After the incubation, cells were gently 
washed and re-incubated for 4 h with 20 µL of CellTiter-Blue 
reagent for the viability test. The CellTiter-Blue reagent is a 
solution containing resazurin, an indicator dye, which has little 
intrinsic fl uorescence with the maximum absorbance at 605 
nm. The reagent undergoes a “blue shift” upon reduction of 
resazurin to resorufi n with a maximum peak at 573 nm. The 
fl uorescence produced is proportional to the number of viable 
cells. The same amount of CellTiter-Blue reagent was added to 
triplicate wells without cells (no-cell control) and with untreated 
cells (control cells), respectively. At the end of the incubation, 
the fl uorescence at 560/590 nm was measured using the fl uoro-
metric method. The experiments were carried out in triplicate. 
Obtained data were analysed subtracting the mean fl uorescence 
value of the culture background from all fl uorescence values of 
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experimental wells. The percentage of viable cells was calcu-
lated according to the following equation:
 
% viable cell
experimental cells mean value
control cells mean value
100= ×
 
 (1)
 
 Cellular Uptake Studies : Approximately 1 × 10 6 J774A.1 cells, 
in DMEM medium, were incubated with different concentra-
tions of DOTA(Gd)-L 6 -F4 and DTPA(Gd)-L 6 -F4 for 3 h at 37 °C. 
After this incubation time, the cells were washed three times 
with 5 mL ice-cold phosphate-buffered saline (PBS), detached 
with a scraper and, for the acquisition of the MR images, col-
lected in 50 µL of PBS, transferred into glass capillaries that 
were centrifuged at 1500 rpm for 5 min and placed in an 
agar phantom. The MR images were acquired by standard 
T 1 -weighted spin-echo sequence (TE = 2.6 ms, 16 variable TR 
ranging from 50 to 8000 ms, NEX = 1, FOV = 1.1 × 1.1 cm 2 , 
1 slice, slice thickness = 1 mm) and recorded on a Bruker 
Avance300 operating at 7 T. After imaging, the labeled cells 
were suspended in 200 µL PBS and sonicated to obtain cell 
lysates. Gd(III) content was measured by ICP-MS analysis (Ele-
ment-2; Thermo-Finnigan, Rodano Milan, Italy). The prepara-
tion of the samples for ICP-MS analysis has been carried out as 
follows: i) 150 µL of each cell lysate was mineralized with 1 mL 
of concentrated HNO 3 (65% v/v) under microwave heating at 
160 °C for 40 min (Milestone MicroSYNTH Microwave lab sta-
tion equipped with an optical fi ber temperature control and 
HPR-1000/6M six position high-pressure reactor, Bergamo, 
Italy); ii) after mineralization, the volume of each sample was 
brought to 2 mL with ultrapure water and the sample was ana-
lyzed by ICP-MS. The calibration curve was obtained using 
four gadolinium absorption standard solutions (Sigma-Aldrich) 
in the range 0.005–0.2 µg mL −1 . The protein content of cells 
lysates was determined by the Bradford method using bovine 
serum albumin as standard. 
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 Supporting Information is available from the Wiley Online Library or 
from the author. 
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Liposomal doxorubicin doubly
functionalized with CCK8 and R8
peptide sequences for selective
intracellular drug delivery‡
Paola Ringhieri,a Carlo Diaferia,a Stefania Galdiero,a Rosanna Palumbo,b
Giancarlo Morellia and Antonella Accardoa*
A new dual-ligand liposomal doxorubicin delivery system, which couples targeting to enhanced cellular uptake andmay lead to a
more efficient drug delivery system, is here designed and synthetized. Liposomes based on the composition 1,2-dioleoyl-sn-
glycero-3-phosphocholine/1,2-distearoyl-sn-glycero-3-phosphoethanolamine-Peg2000-R8/(C18)2-L5-SS-CCK8 (87/8/5 mol/mol/mol)
were prepared and loaded with doxorubicin. Presence of the two peptides on the external surface is demonstrated by fluores-
cence resonance energy transfer assay. The combination of the R8 cell-penetrating peptide and of the CCK8 targeting peptide
(homing peptide) on the liposome surface is obtained by combining pre-modification and post-modification methods. In the
dual-ligand system, the CCK8 peptide is anchored to the liposome surface by using a disulfide bond. This chemical function
is inserted in order to promote the selective cleavage of the homing peptide under the reductive conditions expected in
proximity of the tumor site, thus allowing targeting and internalization of the liposomal drug. Copyright © 2015 European
Peptide Society and John Wiley & Sons, Ltd.
Additional supporting information may be found in the online version of this article at the publisher’s web site.
Keywords: liposomes; homing peptides; cell-penetrating peptides; click chemistry; drug delivery systems
Introduction
The therapeutic effectiveness of many pharmaceutical compounds
currently proposed for the treatment of cancer diseases is low, be-
cause a large amount of the administered drug is also delivered to
normal tissues. Inefficient delivery reduces the total dose of drug
reaching the target and is responsible of severe adverse effects
on non-target organs. Consequently, researchers are focusing their
attention on the development of novel sophisticated systems able
to enhance the therapeutic index of anticancer drugs by improving
delivery and allowing the drug to reach the intended target organ
at full concentration [1–3]. Recently, several examples of supramo-
lecular systems, includingmicelles [4,5], liposomes, [6,7] dendrimers
[8] and nanoparticles [9,10], loaded with anticancer drugs such as
doxorubicin, paclitaxel or cisplatin have been proposed as innova-
tive delivery vehicles. For example, pegylated liposomal doxorubi-
cin (PLD), commercially available as Doxil/Caelyx, is routinely
administered in ovarian andmetastatic breast cancers [11], and sev-
eral other liposomal drugs are under development in clinical
phases. Although liposomal formulations allow to reduce severe
cardiotoxicity associatedwith free doxorubicin and to increase drug
delivery to target cells exploiting the enhanced permeability and
retention effect, the therapeutic efficacy of PLD remains low be-
cause mainly of poor cell penetration and slow drug release from
liposomes [11–13].
In order to accumulate the drug only to target organs and inside
malignant cells, new delivery systems based on micelles or
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liposomes externally modified with bioactive ligands, such as pep-
tides, have been recently proposed.
Two different strategies have been followed: the first is based on
the use of bioactive peptides able to target the entire system on re-
ceptors overexpressed by cancer cells, while the second exploits
cell-penetrating peptides (CPPs) to allow cell penetration of the full
delivery system that releases the drug in the inner cell compart-
ments [14]. Examples of the first strategies are micelles and lipo-
somes externally modified with homing peptides (HPs) [15,16],
while examples of the second strategy are nanosystems modified
with CPPs [17–19]. In both cases, peptides should remain well
exposed on the external surface of the delivery system and should
maintain the right conformation to perform their biological
functions. Therefore, different strategies have been developed to
efficiently bind the peptide sequence to the supramolecular aggre-
gate surface and to study the conformational and structural proper-
ties of the exposed peptide along with that of the entire aggregate.
Hence, in order to couple the targeting properties of a HP with
the cell-penetrating efficacy of a peptide sequence, we describe
the preparation of a prototype of a 1,2-dioleoyl-sn-glycero-3-
phosphocholine (DOPG)-based liposomal doxorubicin delivery sys-
tem externally functionalized with two different peptides (Figure 1).
CCK8 has been chosen as HP, while thewell-known polyarginine-
based sequence (octa-arginine, R8) as CCP. The C-terminal chole-
cystokinin octapeptide amide (CCK 26-33 or CCK8) [20] displays
high affinity and selectivity for CCK2-R cholecystokinin receptor,
whereas the same peptide in its sulfated form (sCCK8) presents
high affinity for both CCK1-R and CCK2-R cholecystokinin receptors
[21,22]. Both cholecystokinin receptors are normally present on the
cell surface, but result overexpressed in many malignant transfor-
mations: CCK1-R is overexpressed by pancreatic cancer cells while
CCK2-R is found in small cell lung cancer, colon and gastric cancers,
medullary thyroid carcinomas, astrocitomas and stromal ovarian
tumors [23]. The high specificity of the CCK8 peptide toward the
cholecystokinin receptors is also kept when the peptide sequence
is modified at the N-terminus with chelating agents [24] or alkyl
chains [25,26] allowing the development of target selective contrast
agents or cargo systems for selective drug delivery, respectively.
CPPs provide a promising solution to the problems commonly
related with drug delivery of conventional cancer chemotherapeu-
tics. CPPs are peptide sequences that, interacting with charged
phospholipids on the outer surface of the cell membrane and
destabilizing the bilayer, assist the intracellular delivery of various
biomolecules including proteins, small molecules, nucleic acids
therapeutics and liposomes [27,28]. R8 is a well-known CPP able
to promote delivery of a cargo into the cytoplasm [29,30]. The
two peptides were bound to the liposomal surface using two
different strategies: pre-liposome formulation and post-liposome
formulation methods.
In the design of the dual-ligand system, the CCK8 peptide was
anchored to the liposome surface by using a disulfide bond. This
chemical function was inserted in order to promote the selective
cleavage of the HP under the reductive conditions expected in
proximity of the tumor site [31].
In fact, in our strategy, the dual-peptide cargo should reach the
overexpressed receptors present on tumor site driven by the
homing CCK8 peptide; then, the reductive conditions should free
the liposomal vehicle that is subsequently internalized in the target
cell by means of the R8 peptide. As a consequence, doxorubicin
should be released only in the target cells, as schematized in
Figure 1.
Materials and Methods
Fmoc-protected amino acid derivatives, coupling reagents and Rink
amide p-methylbenzhydrylamine 4-methylbenzhydrylamine resin
(MBHA resin) were purchased from Calbiochem-Novabiochem
Figure 1. Schematic representation of a liposomal doxorubicin simultaneously functionalized with CCK8 homing peptide ligand and R8 cell-penetrating
peptide ligand (DOPG/DSPE-Peg2000-R8/(C18)2-L5-SS-CCK8, 87/8/5 mol/mol/mol, Doxo-loaded liposomes), and, below, the sketch of a presumed
mechanism for cellular uptake and internalization. The first step concerns the selective binding between the CCK8 homing peptides on the liposome
surface and the cholecystokinin receptors. In a second step, the cleavage of the thiol bond, under the reducing conditions expected in proximity of the
tumor site, should free the liposomal vehicle that, in a third step, is internalized in the target cell by means of the R8 peptide.
RINGHIERI ET AL.
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(Laufelfingen, Switzerland). Fmoc-L-propargylglycine (Fmoc-Pra-OH)
was purchased from Neosystem (Strasbourg, France). N3-Peg(9)-
COOHwas purchased by Iris BiotechGmbH (Marktredwitz, Germany).
Doxorubicin hydrochloride, fluorescein isothiocyanate (FITC) isomer I
and 3-(2-pyridyldithio)propionic acid N-hydroxysuccinimide ester
(SPDP-NHS) were purchased from Sigma-Aldrich (Milan, Italy). DOPG,
DSPE-Peg2000-Mal (4) and Rho-PE were purchased by Avanti Polar
Lipids (Alabaster, AL, USA). N,N-dioctadecylsuccinamic acid was syn-
thesized according to a published procedure [32]. All other chemicals
were commercially available by Sigma-Aldrich and were used as re-
ceived, unless otherwise stated. UV-Vis measurements were carried
out on Thermo Fisher Scientific Inc (Wilmington, Delaware USA)
Nanodrop 2000c spectrophotometer equipped with a 1.0 cm quartz
cuvette (Hellma). The fluorescence emission spectra were recorded
using a Jasco Model FP-750 spectrofluorimeter (Easton, MD)
equipped with a Peltier temperature controller in 1.0 cm path length
quartz cell at 25 °C. 1H NMR spectra were recorded on a Varian
400MHz spectrometer (Palo Alto, CA).
Solid-Phase Synthesis
Azide-Peg9-Lys(C(O)CH2CH2C(O)N-(C18H37)2)-amide ((C18)2-Peg9-N3)
(3) was synthesized according to the experimental procedures
elsewhere reported [33].
Synthesis of the Octa-Arginine Derivatives
Fmoc-R8-OH was synthesized according to standard solid-phase
techniques with Fmoc/tBu procedures by using a Syro I
MultiSynThec GmbH (Wullener, Germany) automatic synthesizer.
The Rink amide MBHA resin (substitution 0.65mmol/g, scale
0.5mmol, 0.770g) was used as solid-phase support. Peptide chain was
elongated by sequential addition of Fmoc-AA-OH with benzotriazol-1-
yl-oxytris(pyrrolidino)phosphonium/1-hydroxybenzotriazole/N,
N-diisopropylethylamine (PyBOP/HOBt/DIPEA) (1 : 1 : 2) as cou-
pling reagents, in dimethylformamide (DMF) in pre-activation
mode. After each coupling, the Fmoc protecting group was re-
moved from the N-terminus by treating the peptidyl resin with
fewmilliliters of DMF/piperidine solution (70/30 v/v). Each coupling
was performed twice for 1 h. Then, the peptide-resin was shared in
four reactors (each one containing 0.1mmol of peptide-resin), and
the syntheses were completed manually to obtain the R8-Pra (2a)
and R8-Cys (2b) peptide derivatives or their fluorescent analogues
R8PraFITC (2c) and R8CysFITC (2d). The FITC coupling was
performed overnight at room temperature by using o-(7-
azabenzotriazol-1-yl)-1,1,3,3-tetramethyluronium/DIPEA (1/2 with
respect to FITC) as activating agents. Peptides were fully
deprotected and cleaved from the resin with trifluoracetic acid
(TFA) with 2.5% (v/v) water, 2.0% (v/v) anisole, 2.0% (v/v) thioanisole
as scavengers, at room temperature, and then precipitated with
ice-cold ethyl ether, filtered, dissolved in water and lyophilized.
The crude peptides were purified by reversed-phase high-
performance liquid chromatography (RP-HPLC) on a LC8 Shimadzu
HPLC system (Shimadzu Corporation, Kyoto, Japan) equipped with
a UV Lambda-Max Model 481 detector using a Phenomenex
(Torrance, CA) C18 (300Å, 250× 21.20mm, 5μ) column eluted with
H2O/0.1% TFA (A) and CH3CN/0.1% TFA (B) from 5 to 70% over
30min at a flow rate of 20ml/min. Purity and identity were assessed
by analytical LC-MS analyses by using Finnigan Surveyor MSQ sin-
gle quadrupole electrospray ionization (Finnigan/Thermo Electron
Corporation San Jose, CA), column: C18-Phenomenex eluted with
H2O/0.1% TFA (A) and CH3CN/0.1% TFA (B) from 5 to 70% over
15min at 250μl/min flow rate. The final yields of purified peptides
ranged between 60 and 80%. Characteristics of the peptides
(formula and molecular mass) are collected in Table 1.
Synthesis of CCK8 Derivatives
(C18)2-L5-SPDP (5)
(C18)2-L5-SPDP monomer was synthesized on solid phase by using
standard Fmoc protocols. The amphiphilic monomer was synthe-
sized on Rink amide MBHA resin (substitution 0.65mmol/g,
0.2mmol, 0.308g). The Fmoc protecting group on the resin was
removed by a DMF/piperidine (70 : 30) mixture. All coupling reac-
tions were activated by using PyBOP/HOBt/DIPEA (1/1/2) in DMF.
Fmoc-Lys(Mtt)-OH (0.50 g, 0.8mmol) was coupled on the resin for
1 h. The solution was filtered, and the resin was washed several
times with dichloromethane (DCM); the Mtt protecting group on
the Nε amino function of the lysine was removed by various treat-
ment of 2min each, with a DCM/triisopropylsilane (TIS)/TFA
(94 : 5 : 1 v/v/v) mixture. This procedure was repeated until the
solution became colorless. The resin was washed three times with
DCM and three times with DMF. After the Mtt removal, 0.498 g of
N,N-dioctadecylsuccinamic acid (0.8mmol) were coupled for 1 h
as previously described [34]. Then, the Fmoc protecting group from
the main chain was removed, and five Fmoc-8-amino-3,6-
dioxaoctanoic acid (AdOO)-OH ethoxylic linkers (two equivalents
for each coupling) were sequentially coupled under standard con-
dition in DMF for 1 h. After the Fmoc removal from the Nα-terminus
of the last ethoxylic linker, two equivalents of heterobifunctional
peptide crosslinker SPDP-NHS and four equivalents of DIPEA were
added in DFM for 1h to the resin. The crude product was cleaved
from the resin by treatment under stirring for 2 h with 5ml of a
TFA solution containing TIS (2.5%) and water (2.5%). The product
was slowly precipitated at 0 °C by adding water dropwise, washed
several times with small portions of water and lyophilized. The
white solid was recrystallized from MeOH/H2O and recovered
with high yields (>80%). The product was identified by mass
spectra [electrospray ionization (ESI)] and NMR spectroscopy. 1H
NMR spectrum was recorded on a Varian 400MHz spectrometer
(Palo Alto, CA).
1H NMR (400MHz, CDCl3) (chemical shifts in δ, CDCl3 internal
standard=7.26) = 8.50 (d, 1H, H aromatic), 7.6 (m, 2H, H aromatic),
7.1 (m, 1H H aromatic), 4.4 (m, 1H, CH Lysα), 4.04 (m, 1H,
OCH2CONH), 3.67 (s, 20H, OCH2CH2O), 3.59 (m, 10H OCH2CH2N),
3.25–3.20 (m, 14H, N–CH2), 3.2 (m, 2H, CH2 Lys
ε), 2,80 (m, 2H
SCH2), 2.64–2.49 (m, 4H, NHCOCH2CH2CO), 1.74 (m, 2H, CH2Lys
β),
Table 1. Characteristics of investigated peptides and lipopeptides
Peptide Formula Molecular mass [g/mol]
Calculated Determined
R8-Pra (2a) C53H103N34O9 1360.64 1361.62
R8-Cys (2b) C51H103N34O9S 1367.60 1368.6
R8-Pra-βAla-FITC (2c) C77H118N36O14S 1802.22 902.1
R8-Cys-βAla-FITC (2d) C75H118N36O14S2 1810.21 906.1
(C18)2-Peg9-N3 (3) C68H132N8O14 1284.5 1285.6
(C18)2-L5-SPDP (5) C83H154N10O19S2 1673.0 1674.1
(C18)2-L5-SS-CCK8 (1) C132H219N21O33S4 2753.6 918.7
DUAL-LABELED LIPOSOMES
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1.55 (m, 2H, CH2Lys
γ), 1.45 (m, 2H, CH2Lys
γ), 1.40 (m, 4H, RCH2CH3),
1.25 (m, 60 CH2 aliphatic), 0.88 (t, 6H, CH3).
(C18)2-L5-SS-CCK8 (1)
Fmoc-Cys(Trt)-CCK8 peptide was synthesized on Rink amide MBHA
resin (substitution 0.65mmol/g, scale of 50μmol) by using
automatic synthesizer as described in the preceding texts. Fmoc
and Trt protecting groups from the Nα-terminus and the Nε-terminus
of the cysteine residue were removed with DMF/piperidine
(70/30) and DCM/TIS/TFA (94/5/1), respectively. Then, the resin
was washed several times with DCM and DFM, and (C18)2-L5-
SPDP (5) amphiphile (1 equiv.) was coupled in DMF over weekend.
The crude product was cleaved from the resin as previously de-
scribed for (C18)2-L5-SPDP (5). Purity and identity were assessed
by analytical LC-MS analyses as previously reported.
Liposome Preparation and Structural Characterization
All liposomal solutions were prepared in 10mM 4-2-hydroxyethyl
piperazino-ethanesulfonic acid (HEPES) buffer at pH 7.4 by using
the thin film method. Briefly, the amphiphiles were dissolved in a
small amount of MeOH/CHCl3 (50/50); subsequently, a thin film of
amphiphiles was obtained by evaporating the solvent by slowly ro-
tating the tube containing the solution under a stream of nitrogen.
Lipid film was hydrated in HEPES buffer, sonicated for 30min and
extruded 10 times at room temperature, using a thermobarrel
extruder system (Northern Lipids Inc, Vancouver, BC, Canada) under
nitrogen through a polycarbonate membrane (Nucleopore Track
Membrane 25mm, Whatman, Brentford, UK) with 0.1μm pore size.
DOPG/(C18)2-Peg9-N3/(C18)2-L5-SS-CCK8 and DOPG/DSPE-
Peg2000-Mal/(C18)2-L5-SS-CCK8 (both at 87 : 8 : 5 molar ratio) lipo-
somes were prepared, according to pre-liposome formulation
method, as previously described, by including the CCK8 amphi-
philic derivative in liposome formulation.
Fluorescent-labeled liposomes were prepared by adding 1%mol
of Rho-PE in the phospholipid mixture, during the lipid film
preparation.
Hydrodynamic radii (RH), polydispersity index (PI) and zeta poten-
tial (ζ) of liposomes were measured by dynamic light scattering
(DLS). DLS measurements were carried out using a Zetasizer Nano
ZS (Malvern Instruments, Westborough, MA) that employs a 173°
backscatter detector. Other instrumental settings are measurement
position (mm): 4.65, attenuator: 8, temperature 25 °C and cell: dis-
posable sizing cuvette. Before starting with DLS measurements,
samples previously prepared were diluted at final concentration
of 2.0·104M and centrifuged at room temperature at 13 000 rpm
for 5min. For each formulation, RH and PI were calculated as the
mean of three measurements on three different batches.
Doxorubicin Loading
Doxorubicin was remote-loaded in liposomes, by using the well-
assessed ammonium sulfate gradient method [35]. Briefly, a liposo-
mal solution (10mM) was prepared as previously reported in
250mM (NH4)2SO4 solution at pH 5.5. After preparation, the outer
solution was removed by gel filtration, eluting liposomes on a
Sephadex G-50 (Amersham Biosciences) column pre-equilibrated
with HEPES buffer. After filtration, liposomes were immediately
incubated with doxorubicin and stirred for 1 h at 60 °C. The drug
weight/lipid weight ratio chosen for the incubation was 0.2.
Unloaded doxorubicin was subsequently separated from loaded
doxorubicin by gel filtration on a Sephadex column. The amount
of doxorubicin loaded in the inner compartment of liposomes
was determined by UV-Vis spectroscopy using calibration curves
obtained bymeasuring absorbance at λ=480nm. The drug loading
content (DLC%, defined as the weight ratio of encapsulated
doxorubicin vs the amphiphilic molecules forming liposomes) was
quantified by subtraction of the amount of removed doxorubicin
from the total amount of loaded doxorubicin.
Post-Liposomal Modification
Two post-liposomal modification strategies were used to bind R8
peptide on the outer liposome surface: copper-catalyzed azide-
alkyne cycloaddition (CuAAC) and the reaction betweenmaleimide
and sulfhydryl group (SH).
For CuAAC reaction-mixed liposomes, DOPG/(C18)2-Peg9-N3 (at
92 : 8 molar ratio) and DOPG/(C18)2-Peg9-N3/(C18)2-L5-SS-CCK8
(at 87 : 8 : 5molar ratio) were prepared at 1·103M lipid concentration
in 10mM HEPES buffer at pH 7.4. Then, 1.0 equiv. of the peptide
derivative (R8-Pra (2a) or R8PraFITC (2c)), 2.0 equivs. of sodium
ascorbate and 0.5 equivs. of CuCl2 with respect to the azido
moiety were added. The reaction mixture was stirred at 40 °C for
30min and successively stored overnight at room temperature.
Free peptide and copper ions were removed by gel filtration
chromatography by using Sephadex G-50 column. For reaction
betweenmaleimide and sulfhydryl group (SH) mixed liposomes,
DOPG/DSPE-Peg2000-Mal (at 92 : 8 molar ratio) and DOPG/DSPE-
Peg2000-Mal/(C18)2-L5-SS-CCK8 (at 87 : 8 : 5 molar ratio) were
prepared at 1·103M lipid concentration in 10mM HEPES buffer
at pH 7.4. Then, 110μl of a stock solution (1mg/ml in HEPES) of
the peptide derivative (R8-Cys (2b) or R8CysFITC (2d)) was
added, and the reaction was left under stirring at room tem-
perature for 1 h. Free peptide was eliminated as described in
the preceding texts. The amount of the unreacted fluorescent
peptide was spectroscopically estimated using UV-Vis measure-
ments at λ= 490 nm.
Fluorescence Resonance Energy Transfer
R8 conjugation on the outer liposomal surfacewasmonitored using
the fluorescence resonance energy transfer assay (FRET). According
to the experimental procedures described in the previous section,
CuAAC and maleimido reactions were carried out on DOPG lipo-
somes made fluorescent by adding 1mol% of Rho-PE during the
formulation. After reactions, liposomes were purified by gel filtra-
tion in order to remove unbound peptide derivatives. Fluorescence
spectra of liposomal solutions before and after the reactions were
recorded at room temperature. Equal excitation and emission
bandwidths were used throughout the experiments, with a record-
ing speed of 125nm/min and automatic selection of the time
constant. Excitation wavelengths of FITC and Rho were set at 490
and 520nm, respectively. Emission spectra of samples were
recorded between 500 and 700nm.
Fluorescence Spectroscopy
Emission spectra of tryptophane were recorded in 290–450nm
range exciting at 280 nm the solutions at a CCK8 concentration
of 1.0·105M. Equal excitation and emission bandwidths were
used throughout the experiments, with a recording speed of
125 nm/min and automatic selection of the time constant.
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DTT Reductive Cleavage
The reductive cleavage of the disulfide bond of (C18)2-L5-SS-CCK8
(1) monomer in the dual-ligand-based liposomes (DOPG/(C18)2-
L5-SS-CCK8/R8) was performed adding 750μl of 100mM dithio-
threitol (DTT) solution to 3.0ml of 1mM liposomes. Reaction was
stirred under a nitrogen atmosphere for 2 h at room temperature.
Then, liposomes were eluted on Sephadex G-50 column pre-
equilibrated with HEPES buffer, and free peptide detached from
the liposome was identified by LC-MS spectrometry.
Cell Culture and Flow Cytometry
Cellular uptake of liposomes (LP, R8-LP, CCK8-LP and R8/CCK8-LP)
was studied by flow cytometry on A431 cells overexpressing the
CCK2-R by stable transfection [36]. Cells were cultured as an expo-
nential growing sub-confluent monolayer on 100mm plates in
DMEM supplemented with 10% FCS, 2mM L-glutamine and
250mg/ml G418 in a humidified atmosphere containing 5% CO2
at 37 °C. Cell aliquots (3·105) were incubatedwith 0.1mM liposomes
(1μM Rho-PE) at RT for 30min. After the incubation, cells were
washed and permeabilized with 0.1% Triton X-100 in 33mM
sodium citrate and analyzed with a flow cytometer equipped with
a 488nm argon laser (FACScan, Becton Dickinson, CA, USA). A total
of 30000 events per sample were collected. Values of fluorescence
intensity were obtained from histogram statistic of CellQuest
software.
Results and Discussion
Dual-ligand DOPG-based liposomes were prepared using simulta-
neously two different strategies of functionalization (pre-liposomal
and post-liposomal formulation methods). The CCK8 HP was
introduced on the outer liposomal surface, according to the pre-
liposome formulation method, by inserting its amphiphilic deriva-
tive ((C18)2-L5-SS-CCK8 (1), shown in Figure 2A), directly during
the liposome formulation step. The (C18)2-L5-SS-CCK8 (1) amphi-
phile contains the CCK8 sequence, modified at N-terminus with
two saturated alkyl chains at 18 carbon atoms, a polyethoxylic
spacer and a cleavable disulfide bond between the CCK8 and alkyl
moiety. The polyethoxylic spacer was used both to improve the
bioavailability of the peptide on the outer liposomal surface and
to increase the intrinsic water solubility of the amphiphilic peptide.
On the other hand, a disulfide bond was inserted in order to
promote a selective cleavage of the CCK8 under the reductive con-
ditions expected in proximity of tumor sites.
The post-liposomal formulation method was used to bind the
CPP, R8, to the liposome surface. This coupling strategy involves
the insertion onto the liposomal surface of an appropriate
functional group able to selectively react with the peptide deriva-
tive. Several functional groups such as (i) azides for Cu(I)-catalyzed
Huisgen cycloaddition (CuAAC), (ii) biotin for non-covalent interac-
tion with avidin (iii) amines for the amine-N-hydroxysuccinimide
coupling method, (iv) maleimide for Michael addition or (v)
triphosphines for Staudinger ligation are ordinarily used [37]. The
synthetic approach should be conveniently selected in order to
increase the reproducibility and the yield of the coupling reaction.
In order to perform the selective coupling of the R8 peptide on
the liposomal surface, both Michael addition and Huisgen cycload-
dition strategies were investigated. For Huisgen cycloaddition, R8-
Pra derivative (Figure 2B – compound 2a) and (C18)2-Peg9-N3
(Figure 2C, compound 3) were used, whereas for Michael addition,
R8-Cys (Figure 2B – compound 2b) and DSPE-Peg2000-Mal
(Figure 2D, compound 4) were employed.
Peptide Syntheses
Both peptide derivatives and peptide amphiphiles (refer to Figure 2)
were synthesized by solid-phase methods according to standard
solid-phase peptide synthesis (SPPS) protocols with Fmoc/tBu
chemistry. The synthesis of the cleavable peptide amphiphile
(C18)2-L5-SS-CCK8 (1) was achieved in two stages. In the first one,
the (C18)2-L5-SPDP (5) amphiphilic monomer (Figure 3A) was
synthesized on the Rink amide resin according to the modified
protocol sketched in Figure 3B. Fmoc-Lys(Mtt)-OH, in which the
two amino functions are orthogonally protected, was anchored to
the solid support. After removal of the Mtt group from the Nε of
the lysine, the fragment containing the two alkyl chains was con-
densed using N,N-dioctadecylsuccinamic acid. Then, the Fmoc
protecting group on the principal chain was removed, and five
ethoxylic linkers and the SPDP-NHS crosslinker were sequentially in-
troduced. SPDP-NHS is an amino and thiol (sulfhydryl) reactive
heterobifunctional peptide crosslinker that contains an NHS
reactive moiety able to react with primary amines and a
pyridinyldisulfide group able to react with sulfhydryl groups to yield
a reversible disulfide bond. NHS group was hence used to bind
crosslinker at the last ethoxylic linker. At the end of the synthesis,
the amphiphilic derivative was cleaved from the resin under acidic
conditions, precipitated by adding cold water dropwise. The crude
product was dissolved in H2O/acetonitrile mixture and lyophilized,
and its identity was confirmed by ESI mass spectrometry and 1H
NMR characterization. In the second stage, Fmoc-Cys(Trt)-CCK8
was synthesized on the Rink amide resin, and after removal of Trt
and Fmoc protecting groups of the cysteine, the crude monomer
(C18)2-L5-SPDP (5) was added to the peptidyl resin and left under
stirring for 48h at room temperature. SPDP pyridinyldisulfide group
reacts with the SH group of the cysteine residue at the N-terminus
of the CCK8 peptide to yield a reversible disulfide bond.
R8-Pra and R8-Cys peptides (compounds 2a and 2b in Figure 2B)
and their fluoresceinate analogues R8PraFITC and R8CysFITC
(compounds 2c and 2d in Figure 2B) were obtained by SPPS and
subsequently purified by RP-HPLC. In details, peptide derivatives were
prepared by adding an L-propargylglycine or a cysteine residue at the
N-terminus of the peptide sequence. For the syntheses of their
fluoresceinate derivatives, the Fmoc protecting group from the princi-
pal chain was removed and Fmoc-β-Ala-OH and FITC-isothiocianate
were coupled in sequence. The β-alanine residue was introduced
before the coupling step of FITC chromophore to avoid classical FITC
elimination by the Edman degradation mechanism [38]. All the R8
peptide derivatives previously describedwere obtained in good yields
and high purity (HPLC profiles are reported as Supplementary
Materials). Parameters of peptide derivatives are reported in Table 1.
Preparation of Dual-Ligand Liposomes
Untargeted and targeted DOPG-based liposomes containing the
CCK8 derivative were prepared in 10mM HEPES buffer at pH 7.4
using the thin film method (Figure 4). Lipid films were hydrated in
HEPES buffer, sonicated and extruded under nitrogen. Subse-
quently, the functionalization of pre-formed liposomes with R8
peptide was carried out using the Cu(I)-catalyzed Huisgen cycload-
dition. This reaction presents several advantages such as rapidity,
versatility and high product yields. Moreover, several examples of
liposome functionalization by click reaction in the presence of
DUAL-LABELED LIPOSOMES
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disulfide bonds are also reported [39,40]. Anyway, several evi-
dences of the ability of ascorbate to reduce disulfide bridges in a
mixture containing physiological low-molecular weight disulfides
(GS-SG, CyS-S and CyS-SGly) [41] or in proteins (tubulin, tau and
microtubule-associated protein-2) [42], in function of the incuba-
tion time, have been recently reported. These evidences pose
doubts about the feasibility of the functionalization of liposomes,
containing S–S bonds, using reactions that require the addition of
Figure 2. Schematic representation of (A) (C18)2-L5-SS-Cys-CCK8 (1) amphiphilic monomer; (B) R8 peptide derivatives R8-Pra (2a) and R8-Cys (2b) and
their fluoresceinate analogues R8PraFITC (2c) and R8CysFITC (2d); (C) (C18)2-Peg9-N3 (3) amphiphilic monomer functionalized with azido group and (D)
DSPE-Peg2000-Mal (4) phospholipid derivatized with maleimido reactive group.
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ascorbate, such as click chemistry procedures. Thus, at the end of
the click chemistry reaction, we investigated the integrity of the di-
sulfide bond by LC-MS and fluorescence spectroscopy. Liposomes
were purified with a Sephadex G-50 gel filtration column and the
elutes characterized. Only few amounts of the unreacted R8-Pra
(2a) peptide were found, indicating that R8 peptide was covalently
bound on the liposomal surface, but chromatographic and ESI
spectroscopy analyses (refer to Figure 5A) showed a peak at
Figure 4. Schematic representation of the procedure used to prepare the dual-ligand liposomes. CCK8 liposomes containing few amounts of azido or
maleimido moieties ((C18)2-Peg9-N3 (3) or DSPE-Peg2000-Mal (4)) were obtained by the film method. Subsequently, liposomes were externally
functionalized with R8 cell-penetrating peptide by CuAAC or Michael addition.
Figure 3. (A) Schematic representation of the synthetic monomer (C18)2-L5-SPDP (5). (B) Scheme for the solid-phase synthesis of the (C18)2-L5-SPDP (5)
monomer. The Rink amide resin is represented as an empty circle. Fmoc, 9-fluorenylmethoxycarbonyl; Pip, piperidine; Mtt, 4-methyltrityl;
DCM, dichloromethane; DIPEA, N,N-diisopropylethyl-amine; DTT, dithiothreitol; Fmoc-AdOO-OH, Fmoc-8-amino-3,6-dioxaoctanoic acid; HOBt, 1-
hydroxybenzotriazole; PyBOP, benzotriazole-1-yl-oxytrispyrrolidinophosphonium hexafluorophosphonate; TFA, trifluoroacetic acid; TIS, triisopropylsilane.
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12.59min with a mass profile attributable to the reduced CCK8-Cys
peptide fragment. Moreover, the comparison of the tryptophan
fluorescence spectra recorded on the liposomal suspension before
and after the reaction showed a dramatic decrease of the emission
peak of the indole group at 360nm. Our results further support the
view that the addition of the ascorbate causes the reductive cleav-
age of the CCK8 from the liposomal surface (Figure 5B) during the
click chemistry reaction. As a consequence, Michael addition
seemed to be the most suitable alternative strategy for the peptide
functionalization of the liposomal surface. According to this
procedure, (C18)2-Peg9-N3 (3) monomer was replaced with an
equivalent amount of DSPE-Peg2000-Mal (4) (8%mol/mol) in the li-
posome formulation step. Maleimide group is widely employed in
bioconjugation reactions for its specificity for thiols, fast aqueous
reaction kinetics, lack of byproducts and the ability to form a stable
thioether bond. The pre-formed liposomes DOPG/DSPE-Peg2000-
Mal/(C18)2-L5-SS-CCK8were reactedwith the R8-Cys for 1 h at room
temperature at pH 7.4 to give DOPG/DSPE-Peg2000-R8/(C18)2-L5-
SS-CCK8 (87/8/5 mol/mol/mol) liposomes; then liposomes were
separated from unreacted peptide by gel filtration. Both fluores-
cence spectroscopy (refer to Figure 5B) and LC-MS analyses
indicated that no side reaction involving the CCK8 cleavable mono-
mer occurs during the reaction confirming the efficiency of this pro-
cedure compared with the strategy involving click chemistry.
Fluorescence Resonance Energy Transfer (FRET)
Post-liposomal formulation using maleimido or CuAAC reactives
were also studied by using FRET. For the experimental procedures,
liposomes were doped with 1% (molar ratio) of Rho-PE and R8 pep-
tide was labeled with FITC fluorofore (R8CysFITC or R8PraFITC, indi-
cated as compound 2c and 2d in Figure 2B). FITC and rhodamine
(Rho) is a well-known donor–acceptor couple. FITC fluorophore ab-
sorbs at 490 nm and emits at 520 nm, whereas rhodamine absorbs
at 520 and emits at 590nm. When the FITC derivative is covalently
bound on the liposomal surface, acceptor and donor are spatially
close to each other and the rhodamine absorbs light at the donor
emission wavelength. Fluorescence spectra of Rho-PE-labeled lipo-
somes before (Rho/CCK8-LP) and after (Rho/R8CysFITC/CCK8-LP)
functionalization with R8-FITC derivative were recorded after
gel filtration of liposomes performed to remove unbound pep-
tide derivatives. Spectra are reported in Figure 6A. Fluorescence
spectrum of unlabeled liposomes plus R8CysFITC (2d) peptide
(R8CysFITC+CCK8-LP), at the same FITC concentration, is also
reported for comparison. The fluorescence spectrum of this formu-
lation shows a peak centered at 520 nm as a result of the emission
of FITC, whereas liposomes doped with Rho-PE show a peak at
590 nm. After the post-modification reaction, the intensity of the
peak at 590nm associated with Rho emission increases, whereas
Figure 5. (A) Chromatographic and ESI spectroscopy analyses of gel
filtration elute after click chemistry reaction; peak at 12.59min is
attributable to the reduced CCK8-Cys peptide fragment. (B) Fluorescence
spectra of tryptophan residue of CCK8 liposomes after post-liposomal
formulation strategy by CuAAC and maleimido reaction at 25 °C and
1.0·105M CCK8 concentration. Spectrum of CCK8 liposomes before
reactions is also reported for comparison. Spectra were excited at 280 nm
and recorded between 290 and 450 nm.
Figure 6. (A) Fluorescence measurements of Rho-PE-labeled liposomes
before and after Michael reaction. Fluorescence spectrum of unlabeled
liposomes in the presence of R8-FITC not covalently bound (emission peak
at 520 nm), at the same concentration, is also reported for comparison.
(B) Unlabeled and labeled rhodamine CCK8 liposomes before (vials 1 and 2)
and after (vials 3 and 4) conjugation of R8-FITC by post-liposomal formulation.
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the intensity of the peak at 520 nm, corresponding to the FITC
emission, decreases. This behavior indicates that a covalent bond
occurs between the R8-FITC derivative and the functional group
on the liposomal surface. As a consequence of the post-formulation
reaction, a visible colorimetric change attributable to FRET
phenomenon between FITC donor fluorofore and Rho acceptor
can be also observed in liposomal solution (refer to Figure 6B).
Structural Characterization
Size, diffusion coefficients and PI of DOPG-based liposomes, before
and after post-liposomal formulation reaction with R8 peptide,
were measured by DLS at θ=173°, and data are reported in Table 2.
According to literature, mean diameter of DOPG liposomes
containing small amount of (C18)2-Peg9-N3 (3) monomer or of
DSPE-Peg2000-Mal (4) phospholipid is ≈90nm. The introduction
of the (C18)2-L5-SS-CCK8 (1) peptide amphiphile (5% mol/mol)
does not cause significant variations in the size of the liposomes.
On the contrary, an increase of about 25% in diameter (from 91
to 122nm) is observed after post-liposomal modification with R8
peptide, as reported in Table 2 and depicted in Figure 7. This result
can be attributed to the R8 peptide, in which the eight arginine res-
idues at pH 7.4 are in their protonated form. The high number of
positive charges probably produces a distancing of the peptide
from the outer shell of the liposomes with a consequent increase
of the aggregate size.
Doxorubicin Loading
The anticancer drug doxorubicin (Doxo) was loaded into
mixed liposomes DOPG/DSPE-Peg2000-Mal (92/8 mol/mol) and
DOPG/DSPE-Peg2000-Mal/(C18)2-L5-SS-CCK8 (87/8/5 mol/mol/
mol) using the well-known ammonium gradient method [35].
The initial amount of doxorubicin used to perform the loading
was drug(wt)/lipid(wt) ratio of 0.200. Free Doxo was eliminated
by gel filtration. The Doxo loading content (DLC), defined as
the weight ratio of the encapsulated Doxo versus the amount
of the amphiphilic molecules, was calculated by fluorescence
measurements with subtraction of the amount of free doxorubi-
cin, eluted by gel filtration, from the total amount of initial doxo-
rubicin. DLC values were 0.090 for both liposomal formulations
and correspond to 90% of the starting doxorubicin. The Doxo
loading does not influence the post-liposomal modification with
R8 peptide derivatives as evidenced by experiments of liposome
functionalization with R8 derivatives according to the maleimido
method (data not shown).
Even if, in principle, doxorubicin loading could be efficiently
performed on CCK8-labeled liposomes (CCK8-LP) or on the dual-
peptide liposomes (R8/CCK8-LP), we proved that the strategy based
on the following steps: (i) liposome formulation with the CCK8 pep-
tide derivative; (ii) Doxo loading and (iii) R8 labelling by maleimido
reaction, seems a straightforward way to prepare doxorubicin
encapsulated dual-labeled liposomes.
DTT Reductive Cleavage
Reductive conditions expected on tumor cells were simulated by
adding DTT reductive agent on liposomes. Reaction was stirred un-
der a nitrogen atmosphere for 2 h at room temperature. Then, lipo-
somes were eluted on gel filtration, and possible products of the
reductive cleavage were examined by LC-MS spectrometry. The
chromatographic profile of the elute shows a retention peak at
12.59min with a mass of 1220Da, exactly superimposable to the
LC-MS previously reported for the CuAAC post-formulation reaction
(refer to Figure 5A). This LC-MS profile, corresponding to the CCK8-
Cys peptide, indicates that by treating our liposomal solution (R8/
CCK8-LP) with DTT, disulfide bonds between CCK8 peptide frag-
ment and the liposomal surface have been reduced. On the other
hand, any presence of the octa-arginine peptide was found in the
elutes, thus suggesting that the thioether linkage used to anchor
R8 on liposomes is completely stable under this reductive condition.
Flow Cytometric Analysis
The cell labeling efficiency of each liposomal formulation on A431
cell line was assessed by using flow cytometry analysis at room
temperature. Liposomes were made fluorescent by insertion of a
small amount of Rho-PE. CCK8 liposomes should bind the receptor
Table 2. Structural parameters of liposomes: diffusion coefficients (D),
mean diameter and polydispersity index (PI)
Systems D*1012/m2/s Diameter (nm) ± SD PI
LP 2.7 ± 1.3 91 ± 43 0.25
R8-LP 2.0 ± 0.8 122 ± 46 0.22
CCK8-LP 2.68 ± 0.5 92 ± 16 0.20
R8/CCK8-LP 2.02 ± 1.4 122 ± 86 0.22
Figure 7. DLS spectra of DOPG/DSPE-Peg2000-Mal/(C18)2-L5-SS-CCK8
liposomes before and after thioether linkage at 25 °C and 1.0·104M
concentration.
Figure 8. Representative flow cytometry histograms illustrating liposomes
binding to A431 cells. Measurements were performed at least three times,
and typical results are showed.
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remaining confined on the outer of the cell, whereas R8, acting as
CPP, should promote the liposome entering in the cells by using
an endocytosis mechanism. After incubation with liposomes for
30min, cells were treated with a permeabilizing agent in order to
take in account the total fluorescence (internalized and bound).
Flow cytometry histograms illustrating liposomes binding to A431
cells are shown in Figure 8 as preliminary binding results. Values
of median of the fluorescence intensity are also reported in the
figure insert. Liposomes externally modified with both HP (CCK8)
and CPP (R8) peptides showed a slightly higher fluorescence inten-
sity than the R8-LPs and CCK8-LPs in which only one peptide is
bound and higher than the untargeted LPs. This result suggests a
synergic effect of the two peptides.
Conclusions
Even if the preparation of liposomes derivatized with two different
peptides has been already described [2,43,44], we have here
reported on the feasibility of a dual peptide-ligand liposome
(DOPG/DSPE-Peg2000-R8/(C18)2-L5-SS-CCK8, 87/8/5 mol/mol/mol)
loaded with doxorubicin and containing a disulfide bond between
the liposome surface and one of the two external peptides. The
presence of the disulfide bond prevents the use of click chemistry
reaction and forces to develop appropriate synthetic strategies for
the obtainment of liposomes modified with two different peptides
in a stable manner. In our case, the CCK8 peptide linked to an hy-
drophilic moiety thought that the disulfide bond is incorporated
in liposome during formulation, according to the pre-liposomal for-
mulation strategy, while the R8 peptide derivative is coupled by
using the Michael addition method, following the post-liposomal
formulation approach. A complete characterization by different
spectroscopic methods confirms the obtainment of liposomes in
which both peptides are durably linked to the external liposome
surface, while reducing conditions, used to simulate tumor environ-
ment, efficiently cut the disulfide bond between CCK8 peptide and
the R8 liposome. Doxorubicin is efficiently loaded in the inner water
liposome compartment, independently by the peptide(s) presence,
leaving unaltered liposome structural parameters. The obtained
doxorubicin-loaded liposomes could target cancer cells overexpress-
ing CCK receptors driven by the CCK8 HP; therefore, reductive
conditions free the liposomes that could internalize by means of the
R8 CPP, thus releasing the active drug only in the target tumor cells.
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Self-assembly of PEGylated 
tetra-phenylalanine derivatives: 
structural insights from solution 
and solid state studies
Carlo Diaferia1,2, Flavia Anna Mercurio2, Cinzia Giannini3, Teresa Sibillano3, 
Giancarlo Morelli1,2, Marilisa Leone2 & Antonella Accardo1,2,†
Water soluble fibers of PEGylated tetra-phenylalanine (F4), chemically modified at the N-terminus 
with the DOTA chelating agent, have been proposed as innovative contrast agent (CA) in Magnetic 
Resonance Imaging (MRI) upon complexation of the gadolinium ion. An in-depth structural 
characterization of PEGylated F4-fibers, in presence (DOTA-L6-F4) and in absence of DOTA (L6-F4), is 
reported in solution and at the solid state, by a multiplicity of techniques including CD, FTIR, NMR, 
DLS, WAXS and SAXS. This study aims to better understand how the aggregation process influences 
the performance of nanostructures as MRI CAs. Critical aggregation concentrations for L6-F4 (43 μM) 
and DOTA-L6-F4 (75 μM) indicate that self-aggregation process occurs in the same concentration 
range, independently of the presence of the CA. The driving force for the aggregation is the π-stacking 
between the side chains of the aromatic framework. CD, FTIR and WAXS measurements indicate an 
antiparallel β-sheet organization of the monomers in the resulting fibers. Moreover, WAXS and FTIR 
experiments point out that in solution the nanomaterials retain the same morphology and monomer 
organizations of the solid state, although the addition of the DOTA chelating agent affects the size and 
the degree of order of the fibers.
Peptide materials based on the aggregation of amphiphilic peptides represent a rapidly growing field within 
materials science1–3. They have been considered for several applications in different fields from electronic to 
nanomedicine. Amphiphilic peptides self-assemble in well-structured supramolecular materials as the result of 
an intricate network of interactions between hydrophobic and hydrophilic regions. The interaction mode can 
strongly influence both morphology and properties of the final peptide-based materials. Special interest was 
recently devoted to peptide self-assembling materials in which aggregation is promoted by aromatic amino acids, 
such as phenylalanine, tyrosine or tryptophan, where π -stacking interactions occur4–6. To this regard, a paradig-
matic example is represented by the diphenylalanine (FF or F2) peptide, which constitutes the core recognition 
motif of Alzheimer’s β -amyloid peptide. FF is able to self-assemble into many different nanostructures from 
nanotubes to vesicles and organogels. Peptide nanostructures containing the FF motif or more extended aro-
matic sequences have been investigated for their mechanical, electrochemical and optical properties, and more 
recently for some nanomedicine applications7,8. Despite the growing literature about FF, only a few examples of 
new materials obtained by the self-assembling of tetraphenylalanines have been reported until now9–12. In order 
to get a deeper understanding of the molecular interactions involved in their self-assembly process, theoretical 
calculations for FFFF (also called F4) and Fmoc-FFFF aggregates have been recently reported9. Moreover, a few 
examples of tetraphenylalanine-polymer conjugates, in which the aromatic framework has been elongated at 
the N-terminus with addition of polymeric chains, have been proposed. The F4-PEG5000 derivative, synthe-
tized by Hamley and coworkers, is able to self-aggregate in water solution at low concentrations (0.095 wt.%), 
whereas well-developed β -sheet structures occur only at higher concentration10. Others examples of F4-polymer 
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conjugates (mPEO-F4-OEt), containing variable length of PEO chain (350, 1200 and 1800 Da) were synthe-
sized by a click-chemistry reaction between an alkyne modified tetraphenylalanine (alkyne-F4-OEt) and the 
azide-terminated PEO oligomer (mPEO-N3). In a water/tetrahydrofuran mixture, mPEO-F4-OEt self-assembles 
initially in nanotubes (between 2 and 10 mg/mL) and successively, at higher concentration, the entanglement 
between adjacent nanotubes leads to the hydrogel formation11. The length of the hydrophilic block PEO influ-
ences significantly the assembling process by favouring fibers formation and worm-like micelles12. Very recently, 
we proposed the first example of PEGylated di-phenylalanine [DOTA(Gd)-L6-F2 and DTPA(Gd)-L6-F2] and 
tetra-phenylalanine [DOTA(Gd)-L6-F4 and DTPA(Gd)-L6-F4] conjugates as potential MRI CAs13. These conju-
gates contain two (F2) or four (F4) phenylalanine residues for self-assembly, a chelating agent, DOTA (1,4,7,10-tet
raazacyclododecane-N,N,N,N-tetraacetic acid) or DTPA (diethylenetriamine pentaacetate), for achieving gad-
olinium coordination and an ethoxylic linker at six PEG units (L6) between the chelating group and the peptide 
region. All of these phenylalanine conjugates have been structurally characterized by CD, FTIR, fluorescence 
spectroscopies and X-ray diffraction on the dried fibers. Due to the steric hindrance of the bulk gadolinium 
complex, F2 conjugates were not able to keep their propensity to aggregate in water solution. On the contrary F4 
adducts, with a more extended aromatic framework, kept their capability to aggregate after the synthetic modifi-
cation with the Gd-complex. The replacement of the paramagnetic Gd(III) ion with others radioactive metal ions 
(111In, 67/68Ga) could open novel perspective for these nanostructures in others diagnostic fields. As an alternative, 
the chelating agent could be also replaced with an active pharmaceutical ingredient (API). However, at the best of 
our knowledge, until now it has not been fully explored how modifications on the flexible PEG chain could affect 
the molecular interactions governing the overall structural organization of the conjugates in aqueous solution. To 
this aim, here we report an in-depth comparative structural study of PEGylated tetra-phenylalanine nanostruc-
tures, in presence (DOTA-L6-F4) and in absence of DOTA (L6-F4), in solution and at the solid state. The work 
relies on a multidisciplinary approach including a variety of techniques such as Circular Dichroism (CD), Fourier 
Transform Infrared (FTIR), Dynamic Light Scattering (DLS), NMR, Wide-Angle (WAXS) and Small-Angle X-ray 
Scattering (SAXS). The combination of these techniques allows a full characterization of nanostructures both at 
the solid-state and in solution, clarifying their molecular organization also in solution at concentrations useful 
for MRI applications. These findings can help to improve the performance of poly-phenylalanine conjugates as 
contrast agents.
Results and Discussion
Synthesis and fluorescence spectroscopy. PEGylated tetra-phenylalanine derivatives, L6-F4 and 
DOTA-L6-F4, are schematically reported in Fig. 1A. In DOTA-L6-F4, the DOTA bifunctional chelating agent, 
added at the N-terminus of the PEG moiety, can allow kinetically and thermodynamically stable coordination of 
radioactive or paramagnetic metal ions (111In, 67/68Ga, Gd(III)) for diagnostic applications in Nuclear Medicine 
or Magnetic Resonance Imaging14,15. Both peptides were obtained by Fmoc/tBu solid phase synthesis and sub-
sequently purified by RP-HPLC chromatography. Critical aggregate concentration (CAC) values of L6-F4 and 
DOTA-L6-F4 were determined with a fluorescence-based method, in which 8-anilinonaphthalene-1-sulfonate 
ammonium salt (ANS) was used as fluorescent probe. Fluorescence emission of ANS is commonly observed at 
460–480 nm only when this fluorophore is surrounded by a hydrophobic environment, such as in the micelle 
core16,17. The fluorescence intensity of an ANS solution (20 μ M in aqueous solution) at 470 nm, as function of 
both tetra-phenylalanines concentration, is reported in Fig. 1B. The CAC values determined by Fig. 1B are 75 μ M 
(~0.099 mg/mL) and 43 μ M (~0.040 mg/mL) for DOTA-L6-F4 and L6-F4, respectively. For L6-F4 the CAC value 
is in good agreement with that of ~167 μ M, 0.095 wt.%, previously measured by Hamley et al., through pyrene 
fluorescence assays, for another PEGylated tetra-phenylalanine (F4-PEG5000)10. As expected, the CAC of L6-F4 
is slightly lower than the CAC of F4-PEG5000, in which the hydrophobic/hydrophilic ratio is more unbalanced 
towards hydrophilic share. Moreover, the CAC values for L6-F4 and DOTA-L6-F4 are quite similar, thus indicating 
that the self-aggregation process occurs in the same range of concentration, independently of the presence of the 
chelating agent at the N-terminus. Undoubtedly, the driving force for the aggregation is the π -stacking between 
the side chains of the aromatic framework. In this perspective, it does not surprise that the two peptides, con-
taining the same aromatic portion, show a very close CAC value. However, it is also well-known that chelating 
agents such as DOTA and DTPA, can cause a steric and/or electrostatic hindrance, thus providing an increase of 
the CAC value13,18. In our case, we can ascribe the low incidence of DOTA macrocycle on the fibrillary process 
in presence of the PEG chain; the latter being long enough to act as a spacer between the chelating agent and the 
aromatic framework.
NMR spectroscopy. NMR spectroscopy was implemented to better investigate the conformational proper-
ties of DOTA-L6-F4 in solution. Due to the high tendency of the compound to aggregate, experiments at differ-
ent concentrations were conducted to get an estimate of the critical aggregation concentration (CAC). 1D [1H] 
experiments were first acquired (Fig. 1C). At a concentration equal to 0.9 mg/mL (680 μ M) or higher, aggregation 
phenomena resulted so relevant that extensive line broadening dominated the NMR spectra causing loss of sig-
nal intensity (Fig. 1C). The sensitivity of the NMR experiments highly improved by lowering the concentration 
from 0.9 mg/mL (680 μ M) to 0.3 mg/mL (230 μ M). A further dilution to 0.15 mg/mL (110 μ M) caused only a 
slight enhancement of the spectrum. These results allowed us to set the CAC below 0.15 mg/mL. In addition, this 
aggregation propensity was confirmed by means of 2D [1H, 1H] spectroscopy. 2D [1H, 1H] NOESY experiments19 
were collected at three different concentrations (Fig. 2): spectra of diluted F4-L6-DOTA samples (concentrations 
equal or below 110 μ M) (Fig. 2A) contained only a few cross-peaks and reflected the almost complete absence 
of aggregation phenomena and the presence in solution of small, fast tumbling flexible species (Fig. 2A). On the 
contrary, at a concentration equal to 1.25 mg/mL (0.94 mM), NOESY spectra were characterized by extensive 
signal enlargement, due to the occurrence of large size aggregates in solution (Fig. 2B). The consequent low signal 
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intensity, caused by high aggregation levels, did not allow conducting a detailed structural characterization of the 
concentrated DOTA-L6-F4 samples containing large size aggregates.
To get insights into the secondary structure elements characterizing small size aggregates formed by 
DOTA-L6-F4, NMR spectra were recorded at concentrations between 300 and 500 μ M, because under these 
experimental conditions good quality solution NMR spectra could be collected (Fig. 2C). Proton resonance 
assignments for DOTA-L6-F4 were obtained by means of a canonical protocol based on comparison of 2D 
TOCSY and NOESY experiments20 (Supporting Table S1). Sequential assignments for the four phenylalanine 
residues were further confirmed by means of heteronuclear 2D and 3D experiments (Figs 3 and 4) recorded with 
double labeled 15N/13C DOTA-L6-F4 containing either selective F(2,4) or uniformly F(1,2,3,4) labeling.
The HN chemical shifts for the four phenylalanine residues are distributed in a very narrow chemical shift 
range centered around 8 ppm, while, Hα protons resonate at almost identical chemical shifts (Fig. 3 and Table S1). 
Differences between observed Hα chemical shifts and random coil values were small (Supporting Figure S1)21, 
thus indicating that at the concentration used to run the experiments (i.e., 0.3–0.5 mM range) random coil species 
were prevalent. Extensive chemical shifts degeneracy could be revealed also for 13Cα , 13Cβ and aromatic carbon 
atoms of the four phenylalanine residues (Fig. 4). Previous studies have demonstrated that, in the solid state, 
DOTA-L6-F4 forms ordered aggregates, characterized by an antiparallel β -sheet structure13. We carefully analyzed 
Figure 1. (A) Schematic representation of L6-F4 and DOTA-L6-F4 derivatives. (B) Fluorescence intensity 
emission of ANS fluorophore at 470 nm vs. concentration of L6-F4 and DOTA-L6-F4, CAC values are 
established from the break points. (C) 1D 1H NMR spectra of DOTA-L6-F4 recorded at 400 MHz and 298 K with 
samples dissolved in H2O/D2O 90/10 v/v at different concentrations.
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2D [1H, 1H] NOESY (Fig. 2C), 3D 15N resolved-[1H, 1H] NOESY-HSQC (250 ms mixing time) (Fig. 3B), and 3D 
13C resolved-[1H, 1H] NOESY-HSQC (200 ms mixing time) (Fig. 4B), trying to confirm the presence of such 
ordered species in the solution state. However, as already specified, at the concentrations exploited by NMR, the 
aggregation level was possibly low and the equilibrium between ordered and disordered species in solution was 
moved towards the latter forms as clearly indicated by Hα CSD values (Figure S1)21.
It’s also worth noting that Zanuy and coworkers22 have previously reported a computational conformational 
study on polyphenylalanine containing peptides and on their PEG adducts. Theoretical quantum mechanical 
calculations indicated a low tendency of the isolated tetra-phenylalanine (F4) peptide to adopt a fully extended 
β -conformation whereas pointed out the highest stability of ribbon-like organizations, made up of regular propa-
gation of γ -turns motives through residues 1 to 4, or helical-like structures composed of alternated repetitions of 
canonical and reverse γ -turns22. Once the PEG unit was added to the F4 peptide, molecular dynamics simulations 
performed in water starting from a fully extended F4 conformation, indicated that the peptide unit of the result-
ing material tended to maintain the conformational preferences of the isolated F4 portion and thus to assume 
a more folded structural organization similar to the pseudo-ribbon or helical arrangements described above. 
However, this previous computational analysis22 was carried out on monomeric peptide units without taking into 
account aggregation effects in solution, that even at low extent, may indeed stabilize the fully extended structures.
For our DOTA-L6-F4 compound, chemical shifts degeneracy among atoms in the four phenylalanine residues 
made also impossible to unambiguously distinguish intra- from inter-molecular contacts as well as intra- from 
inter-residue NOEs (Figs 3B and 4B) that could have clearly witnessed the presence of an organized β -structure. 
Nevertheless, we can only realistically speculate that the DOTA-L6-F4 molecules preferentially adopt an extended 
Figure 2. Comparison of 2D [1H, 1H] NOESY 300 spectra of DOTA-L6-F4 at concentrations equal to 0.11 mM 
(0.15 mg/mL) (A) and 0.94 mM (1.25 mg/mL) (B). 2D NOESY 300 spectrum of DOTA-L6-F4 (0.34 mM, 
0.45 mg/mL) (C). NOE contacts involving HN protons with side chain protons are included in the red rectangle 
whereas correlations arising from aromatic protons are incorporated in the green box. The * indicates a 
correlation between the HN amide proton of F1 and close linker (L6) protons (C).
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structure. Indeed, NOE effects between linker L6 protons and phenylalanine atoms are limited to short range contact 
involving primarily F1 and the closest -NHCOCH2CH2O- protons of the linker L6 (Figs 1A and 2C). 2D [1H, 1H] 
spectra were recorded also to compare the conformational behavior of DOTA-L6-F4 and L6-F4 (Supporting 
Figures S2). In detail, no chemical shifts changes in the 4F- portion of the two molecules could be revealed by 
analysis of TOCSY spectra (Figure S2). This indicates that the addition of a chelating agent -like DOTA- does not 
influence the conformational behavior.
DLS characterization. Hydrodynamic radii (RH) and diffusion coefficients (D) of L6-F4 and DOTA-L6-F4 
in water solution were measured by DLS at 2.0 mg/mL. Both samples show a mono-modal distribution due to 
translational diffusion process of nanostructures (data not shown). The time correlation functions of the scattered 
intensity g(2)(t)-1 for both tetra-phenylalanine derivatives are reported in Supporting Figure S3A. DLS measure-
ments for L6-F4 and DOTA-L6-F4 nanostructures at different concentrations (2.0, 5.0 and 10 mg/mL) were also 
performed in order to investigate the effect of the concentration on the size of nanostructures and the intensity 
correlation functions for L6-F4 are reported in Figure S3B.
Data reveal a translation of the correlation function for DOTA-L6-F4 at longer decay time with respect to 
L6-F4, with apparent translational diffusion coefficients D = (1.8 ± 0.1) × 10−12 and (7.2 ± 0.3) × 10−12 m2 s−1 
respectively. These data were directly correlated to the apparent hydrodynamic radii (77 and 300 nm for L6-F4 
and for DOTA-L6-F4) through the Stokes-Einstein equation. These RH values are compatible with supramolecu-
lar aggregates with elongated shape23 such as open bilayers, worm-like micelles or nanofibers as in this case. The 
slower motion of DOTA-L6-F4 with respect to L6-F4 suggests that, at a similar concentration, nanostructures 
containing the DOTA chelating agent have a higher propensity to self-aggregate, with respect to the correspond-
ing derivative in absence of DOTA. This hypothesis is also supported by the DLS analysis of nanostructures at 
different concentration (Figure S3B).
Secondary structure. Structural characterization of these nanostructures by NMR spectroscopy fails in a 
range of concentration above 500 μ M. In order to deeply investigate the aggregation properties in this range of 
concentrations, we studied the secondary structure of these peptide derivatives by CD and FTIR spectroscopies. 
CD spectra of L6-F4 in solution, recorded between 280 and 195 nm, are reported in Fig. 5A. For comparison, the 
dichroic tendency of DOTA-L6-F4, previously studied by us13 in the same experimental conditions and concen-
trations has been also reported. CD spectra of PEGylated tetra-phenylalanine L6-F4, at concentrations close to 
the CAC value (0.1 mg/mL), show two maxima (at 205 and 220 nm) and a minimum at 232 nm. The two maxima 
can be attributed to aromatic side-chains stacking, whereas the minimum can be associated with a β -structure13. 
Significant variations of the dichroic signal can be observed at 5 mg/mL, which corresponds to a concentration 
higher than the CAC value: the main minimum at 230 nm and the complete absence of the maximum at 205 nm 
can be ascribed to a dominant β -sheet arrangement10–12. For each concentration, CD spectra of tetra- phenylala-
nine in presence of the DOTA macrocycle did not show significant differences in the dichroic tendency. However, 
according to literature11, the spectrum of L6-F4 at 0.1 mg/mL shows a higher intensity of the maximum at 205 nm 
with respect to DOTA-L6-F4. However, the spectra of the two aromatic molecules here described show high 
Figure 3. Overlay of [1H,15N] HSQC spectra of DOTA-L6-F4 (100 μ M concentration) with 15N/13C double-
labeled F(1,2,3,4) (red) or F(2,4) (blue) (A). Strips from 1H/1HN slices of the 3D 15N resolved-[1H, 1H] NOESY-
HSQC spectrum of 15N,13C F(1,2,3,4) labeled DOTA-L6-F4 (500 μ M concentration). Each strip corresponds to 
a single Phe residue as indicated at the top of each slice. Aromatic protons are reported as Hδ ε ζ . The #highlights 
unambiguous NOEs between the backbone HN of F1 and F2 and the closest -NHCOCH2CH2O- protons of the 
L6 linker portion (B). Spectra were recorded at 600 MHz and 298 K.
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similitude, thus suggesting that the addition of the chelating agent at the N-terminus of the sequence does not 
affect their assembling properties in solution. Further information on the secondary structure adopted by L6-F4 
and DOTA-L6-F4 in solution (2.0 mg/mL) was obtained using FTIR spectroscopy in the amide I region (see 
Fig. 5B). Both spectra show two peaks at 1637 cm−1 and 1680 cm−1, respectively. The peak at 1637 cm−1 is strongly 
indicative of β -sheet formation, whereas the lower intensity of the second peak at 1680 cm−1 is indicative of an 
antiparallel orientation of the β -sheets24. FTIR spectra recorded on dried film of both peptides showed a similar 
profile with respect to samples in solution (data not shown).
Wide-Angle and Small-Angle X-ray Scattering. Figure 6(A,B) present the two-dimensional (2D) 
WAXS pattern collected on the L6-F4 and DOTA-L6-F4 dried samples, respectively. The 2D patterns, once 
centered, calibrated and radially folded into 1D profiles by integrating along the azimuth, are displayed in 
Fig. 6(C,D) in the 0.8–1.8 Å−1 and 0.08–0.8 Å−1 q-ranges, respectively (black corresponding to the L6-F4 and red 
to DOTA-L6-F4). The 2D patterns both display the typical cross-β fiber diffraction pattern which contains, along 
the meridional and equatorial directions, the following fingerprints:
i) the meridional reflection at dβ1 = 4.9 ± 0.3 Å, marked by the white arrow in Fig. 6(A,B), which corresponds 
to the highest peak in Fig. 6(C). The meridional reflections are due to the separation between adjacent peptide 
backbones organized into β -strands along the fiber axis. In the meridional direction we have not measured any 
diffraction reflection at 2dβ1 = 9.8 Å. This absence could be either due to the predominance of parallel β -strands 
organization or to the 21 symmetry of antiparallel β sheets25. However, the presence of the peak at 1680 cm−1 in 
the FTIR spectra, recorded on both tetra-phenylalanines in solution (Fig. 5) and dried sample, led us to hypothe-
size an antiparallel β sheet with 21 symmetry.
ii) A series of equatorial reflections were marked by the dotted lines labelled as 1, 2 3, 4, 5. The most intense 
equatorial lines (1, 2, 3) correspond to the spacing: d1 = 31 ± 1 Å, d2 = 15 ± 1 Å = d1/2, d3 = 11 ± 0.3 Å, indicating 
Figure 4. [1H, 13C] HSQC spectra of DOTA-L6-F4 (100 μ M), recorded with a sample containing 15N/13C 
double-labeled F(1,2,3,4) (A). The Cα , Cβ and aromatic region of the [1H, 13C] HSQC spectrum are reported 
in the left, middle and right panels respectively (B). A few [1H, 1Hα ] (left side) and [1H, 1Hβ ] (right side) strips 
from the 3D 13C resolved-[1H, 1H] NOESY-HSQC spectrum of double 15N/13C F(1,2,3,4) labeled DOTA-L6-F4 
are shown. Assignments are reported for each Phe residue.
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the presence of a lamellar phase along the fiber cross-section. Only in the case of the DOTA-L6-F4, another 
equatorial reflection is measured at very small q value, labelled as 0 in the red pattern of Fig. 6D. This reflection 
corresponds to a spacing d0 = 54 ± 4 Å, although this evaluation is less accurate being the reflection on the tail of 
the primary beam. The d0 and d1 could match with the lengths of the backbones for the DOTA-L6-F4 and L6-F4, 
respectively (http://pubchem.ncbi.nlm.nih.gov), taking into account a possible folding of the PEG chain.
iii) For both samples the 2D WAXS data are due to oriented fibers, as evidenced by the presence of arcs 
instead of fully rings. Diffraction patterns, made up of longer arcs, indicate higher fiber disorder (mosaicity 
effect). Indeed, Figure S4 of the Supporting Information displays four fiber diffraction 2D patterns, simulated by 
the CLEARER program26, for increasing fiber disorder: 0.1 rad (5.7°) in (A), 0.2 rad (11.4°) in (B), 0.5 rad (28.6°) 
in (C) and 0.75 rad (43°) in (D). The longer arcs of the L6-F4 sample with respect to the DOTA-L6-F4 prove the 
presence of a larger disorder for the L6-F4 sample. Comparing with the simulated patterns, data registered for the 
DOTA-L6-F4 can be well described by a fiber disorder as small as 0.1 rad, while for the L6-F4 sample the longer 
arcs can be explained by a disorder of about 0.2 rad. This is confirmed also by the full-width-at-half-maximum 
of the meridional and equatorial peaks which decreases for the DOTA-L6-F4, proving how the additional DOTA 
produces fibers with a higher order degree. It is worth noting that a very large disorder in the fiber would cause 
the diffraction pattern to lose the typical characteristic arcs which degenerate in the full rings of a powder-like 
sample (Figure S4D). This behavior was observed by Hamley et al.10 for F4-PEG5000, in which the long PEG 
moiety causes crystallization effects.
2D SAXS data were also collected on the same L6-F4 and DOTA-L6-F4 dried fibers and shown in Figure S5A,B 
of the Supporting Information, respectively. The data were centered, calibrated and folded in the 1D patterns of 
Fig. 5C,D, respectively. The SAXS data confirm and reinforce the previous findings. Indeed, while the L6-F4 sam-
ple does not present any SAXS diffraction, the pattern registered on DOTA-L6-F4 clearly shows fiber diffraction 
partial rings. This is a distinct indication that the DOTA chelating agent increases the fiber order, extending it 
from atomic to nanoscale.
Finally, Fig. 7(A,B) show the WAXS profiles collected on the L6-F4 and DOTA-L6-F4 solutions (25 mg/mL), 
respectively, after subtraction of the water contribution (red profiles). In each of them the pattern was compared 
with the analogous measured in the dried samples (black profiles). The comparison allows identifying exactly the 
same fingerprints measured for the dried fibers, bringing to the same conclusions. Also in the case of solutions the 
DOTA-L6-F4 sample shows sharpest peaks, with respect to the L6-F4 one, and therefore a more ordered lattice.
Structure and relaxometric properties. DOTA-L6-F4, and its analogue DTPA-L6-F4, have been previ-
ously complexed with the paramagnetic gadolinium ion and studied for their relaxometric behavior with the aim 
Figure 5. Spectroscopic characterization of L6-F4 and DOTA-L6-F4 peptide derivatives by CD and FTIR. 
(A) Far-UV CD spectra of both peptides in aqueous solution at (5.0 and 0.1 mg/mL) recorded between 280 and 
195 nm; (B) FTIR spectra in the amide I region at 2.0 mg/mL concentration.
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to be used as positive MRI contrast agents (CAs)13. In principle, the efficacy of a MRI CAs depends on the ability 
to enhance the water protons relaxation rate in aqueous solutions due to the magnetic dipolar interaction between 
unpaired electrons on the gadolinium ions and the water protons, which is usually defined as longitudinal “relax-
ivity” (r1p) and is referred to the water proton relaxation rate of a solution containing the Gd-complex at one 
millimolar concentration. The relaxivity of a Gd-containing system depends on the complex interplay of struc-
tural, dynamic and electronic parameters. At the frequencies most commonly used in commercial tomographs 
(20–60 MHz), r1p is generally determined by the reorientational correlation time (τ R) of the chelate so that high 
molecular weight systems display higher relaxivity. Moreover, when the gadolinium containing adduct is organ-
ized in a supramolecular structure with a well-defined three-dimensional order, slow reorientational correlation 
times and, consequently, high relaxivity values are expected.
Figure 6. (A,B) show the two-dimensional (2D) WAXS pattern collected on the L6-F4 and DOTA-L6-F4 dried 
samples, respectively; (C,D) show the 1D profiles corresponding to the L6-F4 (black) and DOTA-L6-F4 (red).
Figure 7. (A,B) show the WAXS profiles, displayed in red, collected on the L6-F4 and DOTA-L6-F4 solutions 
(25 mg/mL) to be compared with the profiles obtained on the analogous dried samples (black line).
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This is the case for DOTA(Gd)-L6-F4, and its analogue DTPA(Gd)-L6-F4 that present relaxivity values, 
measured at 21.5 MHz (0.5 T) and 298 K, of 14.8 and 14.0 mM−1s−1, respectively13. These values, that are about 
three times higher the ones measured for the free monomeric DOTA(Gd) and DTPA(Gd) complexes in water 
solutions under the same experimental conditions, could be related to the structural organization observed for 
DOTA-L6-F4. Under the experimental conditions of the MRI studies, DOTA-L6-F4 monomers aggregate in 
well-ordered and very stable fibers and the driving force of aggregation is represented by the π -stacking contacts 
between the side chains of the aromatic framework. CD, FTIR, NMR and WAXS measurements, here reported, 
confirm the capability of the monomers to self-aggregate in fibers with an antiparallel β -sheet organization both 
in solution and at the solid state. In particular, NMR and WAXS results highlight the presence of highly stable 
nanofibers yet in solution, thus suggesting a potential application of these compounds as MRI contrast agents. 
Moreover, the herein reported in deep physicochemical characterization of these materials allows to unequivo-
cally define the structural parameters characterizing the fibers, such as the inter-planar distances and the L6 fold-
ing around the fibers. The knowledge of these parameters can help clarifying important aspects to improve the 
performances of the final MRI contrast agent, in term of relaxivity values. For example, the mobility of the DOTA 
chelating agent along the linker spacer, with respect to the overall fibril-like structure, influences the τ R values that 
result quite short if compared to those usually found for nano-sized aggregates27,28. Our data clearly indicate that 
to enhance the performances of DOTA(Gd)-L6-F4 fibers as MRI contrast agents, an increase of the rigidity of the 
DOTA moiety, pending from the fiber organization of DOTA-L6-F4 should be achieved.
Conclusions
Extraordinary interest was recently devoted to peptide materials containing aromatic amino acids in which the 
aggregation process is promoted by π -stacking interactions. Very recently, we proposed novel PEGylated-F4 fib-
ers, highly soluble in water solution, as potential CAs in MRI. The PEGylated-F4 was chemically modified at the 
N-terminus with branched DTPA or macrocyclic DOTA chelating agents, both of them able to allow kinetically 
and thermodynamically stable coordination of metal ions for diagnostic purpose. The comparative structural 
study of PEGylated tetra-phenylalanine fibers, in presence (DOTA-L6-F4) and in absence of DOTA (L6-F4), 
points out the high similitude between the resulting nanomaterials. Both nanofibers show an antiparallel β -sheets 
organization, although in DOTA-L6-F4 fibers an increase in the size and in the order degree was observed. This 
result suggests the low incidence of the DOTA macrocycle on the β -sheets organization, as a consequence of 
the PEG chain, the latter being long enough to place a distance between the chelating agent and the aromatic 
framework. Nevertheless it remains to understand, at the molecular level, what is the rationale for the higher 
inner order of DOTA-L6-F4 nanostructures with respect to L6-F4 ones. The organization in well-ordered and 
stable fibers of the DOTA-L6-F4 monomers, observed by comparing structural data from a multiplicity of exper-
imental techniques (CD, FTIR, NMR, DLS, WAXS and SAXS) is responsible of the three-fold increase in the 
relaxivity value of DOTA(Gd) complex. As a consequence, a potential use of these nanofibers as MRI contrast 
agent can be realistically envisioned. On the other hand, the structural characterization here reported confirms 
and reinforces our previous hypothesis about the high flexibility of the DOTA moiety, bound to a quite long 
PEG chain. A more rigid organization should be advantageous to increase the relaxometric performance of the 
contrast agent. Despite this issue remains to be improved, the structural similitude of these nanofibers with the 
fibrillary oligomers (Aβ Os) or plaques commonly observed during the progression of several neurodegenerative 
disorders (Alzheimer’s, Parkinson’s and prion-related diseases) open new perspectives towards the development 
of diagnostic tools for their early detection. Moreover, we can realistically suppose that the replacement of DOTA 
with another active pharmaceutical ingredient, characterized by a comparable steric and electrostatic hindrance, 
would not cause significant structural differences. Based on these findings we can conclude that L6-F4, for its 
handily preparation and high water solubility, can represent a promising building block for the synthesis of novel 
materials for therapeutic or diagnostic applications.
Materials and Methods
Peptide synthesis. L6-F4 and DOTA-L6-F4 peptides were synthesized by solid phase synthesis and puri-
fied by RP-HPLC chromatography, according to the procedure previously described13. Similarly, double labeled 
15N/13C DOTA-L6-F4 containing either selective (Phe 2,4) or uniformly Phe(1,2,3,4) labeling were synthesized by 
replacing Fmoc-Phe-OH with Fmoc-Phe-OH-13C9,15N. Double labeled phenylalanine was purchased by Sigma 
Aldrich (Milan, Italy).
Fluorescence studies. CAC values were obtained by fluorescence measurements. Fluorescence spectra were 
recorded at room temperature on a Jasco Model FP-750 spectrofluorophotometer in a 1.0 cm path length quartz 
cell. Equal excitation and emission bandwidths (5 nm) were used throughout the experiments with a recording 
speed of 125 nm/min and automatic selection of the time constant. The CAC values were measured by using 
8-anilino-1-naphthalene sulfonic acid ammonium salt (ANS) as fluorescent probe29,30. Small aliquots of peptide 
derivatives in water solutions were added to 1.0 mL of aqueous solution of ANS (20 μ M). Final spectra, to be used 
for calculations, were obtained after blank correction and adjustment for dilution. The ANS fluorescence inten-
sity was followed as a function of the peptide concentration. The CAC values were determined, upon excitation 
at 350 nm, by linear least-squares fitting of the fluorescence emission at 470 nm versus the poly-phenylalanine 
concentration, as the crossing point between the changes of slope.
NMR experiments. NMR experiments were acquired at 298 K on either a Varian Unity Inova 600 MHz 
spectrometer equipped with a cold probe or a 400 MHz Varian instrument provided with a 5-mm triple res-
onance probe and z-axis pulsed-field gradients. All samples were dissolved in a mixture H2O/D2O (98% D, 
Armar Chemicals, Dottingen, Switzerland) 90/10 v/v with a total volume equal to 600 μ L. The L6-F4 sample 
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(0.05–1.5 mM concentration range) was analyzed through a set of 2D experiments: 2D [1H, 1H] TOCSY31 (70 ms 
mixing time), 2D [1H, 1H] NOESY19 (300 ms mixing time), and 2D [1H, 1H] ROESY (Rotating frame Overhauser 
Enhancement Spectroscopy)32 (150 and 250 ms mixing times). For the DOTA conjugated molecule DOTA-L6-F4 
1D [1H] experiments were registered at the following concentrations: 1.9, 0.9, 0.7, 0.4, 0.2, 0.1 mM; whereas 2D 
[1H, 1H] TOCSY (70 ms mixing time), and 2D [1H, 1H] NOESY (300 ms mixing time) were acquired at 0.1, 0.3, 
and 0.9 mM.
1D spectra were usually acquired with a relaxation delay d1 of 1.5 s and 32–512 scans; 2D experiments were 
recorded with 16–64 scans, 128–256 FIDs in t1, 1024 or 2048 data points in t2. Further 3D and 2D heteronuclear 
correlation experiments33,34 (i.e., 2D [1H, 15N] HSQC (Heteronuclear Single Quantum Correlation Spectroscopy), 
and 2D [1H, 13C] HSQC, 3D 15N resolved-[1H, 1H] NOESY-HSQC (250 ms mixing time), 3D 13C resolved-[1H, 
1H] NOESY-HSQC (200 ms mixing time), were set up with two different 15N/13C Phe labeled DOTA-L6-F4 sam-
ples (concentration range 0.1–1 mM): sample A) containing all phenylalanine residues uniformly labeled with 13C 
and 15N and sample B) containing instead only 15N/13C double labeled F2 and F4 (Fig. 1A). The process of proton 
resonance assignment was performed by following a canonical protocol based on comparison of TOCSY, NOESY 
and ROESY experiments (See Table S1)20.
Water suppression was achieved by Excitation Sculpting35. Spectra were processed with VNMRJ (Varian by 
Agilent Technologies, Italy) and analyzed with NEASY36 comprised in the CARA software package (http://www.
nmr.ch/). 2D HSQC spectra were compared with the program Sparky (T. D. Goddard and D. G. Kneller, SPARKY 3, 
University of California, San Francisco). Chemical shift deviations from random coil values for Hα protons 
(CSD) were calculated with the protocol suggested by Kjaergaard and collaborators by keeping into account the 
influence of neighboring amino acids21,37,38.
DLS measurements. Hydrodynamic radii (RH) and diffusion coefficients (D) of tetra-phenylalanine nano-
structures were measured by Dynamic Light Scattering technique (DLS). DLS measurements were carried out 
using a Zetasizer Nano ZS (Malvern Instruments, Westborough, MA) that employs a 173° backscatter detector. 
Other instrumental settings are measurement position (mm): 4.65; attenuator: 8; temperature: 25 °C; cell: dis-
posable sizing cuvette. DLS measurements in triplicate were carried out on aqueous samples at 2.0 mg/mL, after 
centrifugation at room temperature at 13,000 rpm for 5 minutes.
Circular Dichroism. Far-UV CD spectra of the peptide derivatives in aqueous solution were collected on a 
Jasco J-810 spectropolarimeter equipped with a NesLab RTE111 thermal controller unit using a 0.1 mm quartz 
cell at 25 °C. The spectra of samples at (0.1 and 5.0 mg/mL) are recorded from 280 to 195 nm. Other experimen-
tal settings were: scan speed = 10 nm/min; sensitivity = 50 mdeg; time constant = 16 s; bandwidth = 1 nm. Each 
spectrum was obtained by averaging three scans and corrected for the blank. Here Θ represents the mean residue 
ellipticity (MRE), i.e. the ellipticity per mole of peptide divided by the number of amino acid residues in the 
peptide.
Fourier Transform Infrared spectroscopy (FTIR). FTIR spectra of samples dried film (2.0 mg/mL) or 
in solution (2.0 mg/mL) were collected on a Jasco FT/IR 4100 spectrometer (Easton, MD) in an attenuated total 
reflection (ATR) mode and using a Ge single-crystal at a resolution of 4 cm−1. All the spectral data were processed 
using built-in software. Spectra were collected in transmission mode and then converted in emission. Each sam-
ple was recorded with a total of 100 scans with a rate of 2 mm·s−1 against a KBr background.
Wide-Angle and Small-Angle X-ray Scattering. Fiber diffraction WAXS and SAXS patterns were 
recorded from dried fibers; WAXS data were measured from water diluted peptide solutions (10–25 mg/mL). 
Stalks were prepared by the stretch frame method39. Briefly, a droplet (10 μ L) of peptide aqueous solution (3 wt%) 
was suspended between the ends of a wax-coated capillary (spaced 2 mm apart). The droplet was allowed to dry 
gently at room temperature overnight to obtain oriented fibers. Peptide solutions were loaded into Lindemann 
capillaries and measured, in the same experimental conditions adopted for the dried fibers, at room temperature. 
WAXS/SAXS data were collected at the X-ray MicroImaging Laboratory (XMI-L@b) equipped with a Fr-E+ 
SuperBright rotating anode copper anode microsource (Cu Kα, λ = 0.15405 nm, 2475 W), a multilayer focusing 
optics (Confocal Max-Flux; CMF 15–105) and a SAXS/WAXS three-pinhole camera (Rigaku SMAX-3000)40. For 
WAXS data collection an image plate (IP) detector with 100 μ m pixel size was placed at 8.5 cm from the sample 
and calibrated by means of the Si NIST standard reference material (SRM 640 b); for SAXS data collection a Triton 
20 gas-filled photon counter detector with 200 μ m pixel size was placed at 2.2 m from the sample and calibrated 
by means of silver behenate. A detailed description of the XMI-L@b performances can be found in Altamura 
et al.40 and Sibillano et al.41.
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Hierarchical Analysis of Self-Assembled PEGylated
Hexaphenylalanine Photoluminescent Nanostructures
Carlo Diaferia,[a] Teresa Sibillano,[b] Nicole Balasco,[c] Cinzia Giannini,[b] Valentina Roviello,[d]
Luigi Vitagliano,[c] Giancarlo Morelli,[a] and Antonella Accardo*[a]
Abstract: Despite the growing literature about diphenylala-
nine-based peptide materials, it still remains a challenge to
delineate the theoretical insight into peptide nanostructure
formation and the structural features that could permit ma-
terials with enhanced properties to be engineered. Herein,
we report the synthesis of a novel peptide building block
composed of six phenylalanine residues and eight PEG units,
PEG8-F6. This aromatic peptide self-assembles in water in
stable and well-ordered nanostructures with optoelectronic
properties. A variety of techniques, such as fluorescence,
FTIR, CD, DLS, SEM, SAXS, and WAXS allowed us to correlate
the photoluminescence properties of the self-assembled
nanostructures with the structural organization of the pep-
tide building block at the micro- and nanoscale. Finally,
a model of hexaphenylalanine in aqueous solution by molec-
ular dynamics simulations is presented to suggest structural
and energetic factors controlling the formation of nanostruc-
tures.
Introduction
Self-assembly is an increasingly attractive tool for the fabrica-
tion of novel nanomaterials.[1] In this field, self-assembled pep-
tides have received considerable interest because of their in-
trinsic biocompatibility, relative simple synthesis and prepara-
tion, versatility, and functional diversity.[2] In 2003, diphenylala-
nine (FF) was identified by Gazit as a recognition motif of the
Alzheimer’s b-amyloid peptide[3] and since then it has been ex-
tensively studied.[4] Diphenylalanine homodimers show a very
high morphological variability[5] depending on the experimen-
tal preparation conditions, such as solvent,[6] pH,[7] or tempera-
ture.[8] Moreover, chemical modifications of the aromatic dipep-
tide (e.g. the introduction of a thiol group or of a fluorenylme-
thyloxycarbonyl (Fmoc) group) can alter the self-assembling
phenomena.[5] Nanotubes, nanowires, nanofibrils, spherical
vesicles, and organogels are just a few examples of the new
peptide materials, based on FF self-assembly. These materials
exhibit mechanical,[9] electrical,[10] electrochemical,[11] or optical
(photoluminescence[12] and optical waveguide[13]) properties.
All these physicochemical characteristics make them suitable
for several applications in biology, nanomedicine, and nano-
fabrication fields (for tissue engineering, drug delivery, bio-
imaging, and fabrication of biosensors).[5] Moreover, their high
thermal, chemical,[14] and proteolytic stability[15] provides them
with the features for potential applications in the industrial
field. The functional properties of self-assembled materials
seem strictly correlated with their morphological features, thus
suggesting the existence of a direct relationship between the
structural organization of the building blocks and the physico-
chemical properties of the nanomaterials. For these fundamen-
tal reasons, a deep study into the peptide nanostructure for-
mation (control of the morphological diversity, rational modifi-
cation of the peptide motifs, and prediction for the resulting
self-assembled structures) and on the structural features of the
nanostructures could permit new materials with enhanced
properties to be engineered. Crystallographic studies showed
that FF crystals contain ringlike networks with a hexagonal
symmetry, promoted by head-to-tail hydrogen-bonding inter-
actions between the charged termini of neighboring dipepti-
des and by the „T-shaped“ contacts between the aromatic side
chains.[16] Molecular dynamic simulations confirmed the forma-
tion of open and ringlike peptide networks also for FF pep-
tides in aqueous solution.[17] Concurrently to these networks,
more-complex structures, arranged in parallel or antiparallel b-
sheets, were also observed.[17] Analogous structures character-
ized by higher stability and peptide-network propensity were
observed in the triphenylalanine (FFF) simulations, thus sug-
gesting that stacking interactions could contribute to the sta-
bility of the nanostructure. In contrast to FF dipeptide, it was
noted that FFF tripeptide forms planar nanostructures.[18] In-
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stead, a different aggregative behavior was observed for its an-
alogues Fmoc-FFF and Boc-FFF that preferentially gives forma-
tion of nanosphere[19] and hydrogels, respectively.[20] Despite
the growing literature about FF, only a few examples of nano-
materials obtained by the self-assembling of others aromatic
analogues (naphthylalanine, tyrosine, tryptophan) or of long
polyphenylalanines have been reported until now.[21] In order
to get a deeper understanding of the molecular interactions
involved in their self-assembly process, theoretical calculations
for tetraphenylalane (FFFF or F4) and Fmoc-FFFF aggregates
have been recently reported.[21] Analogously hybrid materials,
in which the aromatic framework is chemically modified with
polymeric chains (polyethylene glycol, polycaprolactone or
polyethylene oxide) remain largely unexplored. Some examples
of F4-polymer conjugates, containing PEO or PEG chains with
a variable length, have been synthesized, and their aggrega-
tion properties in water or in water/tetrahydrofuran mixtures
have been described. Very recently, we proposed PEGylated-F4
functionalized with contrast agents for potential diagnostic ap-
plications in magnetic resonance imaging.[21e] The longer Phe-
based building block reported until now is the pentaphenylala-
nine, which, thanks to its high hydrophobicity, displayed inter-
esting properties for the surface coating.[22] With the aim of im-
proving the knowledge in this field, at the molecular level, we
herein investigate the effect of the elongation of the aromatic
framework in the aggregation process. We have synthesized
a novel peptide building block composed of six phenylalanine
residues and eight PEG units (PEG8-F6) (see Figure 1a). PEG8-F6
is able to aggregate in water in nanostructures producing
novel b-rich peptide materials. The photoluminescence (PL)
properties of the self-assembled material are investigated and
correlated with the structural organization of the peptide
building block at the micro- and nanoscale. A variety of tech-
niques, such as fluorescence, FTIR, CD, DLS, SEM, SAXS, and
WAXS has allowed us to 1) investigate the aggregation behav-
ior, 2) study the secondary structure, and 3) visualize the mor-
phology of the final aggregates. Finally, a model of hexapheny-
lalanine in aqueous solution by molecular dynamics (MD) simu-
lations is presented to suggest structural and energetic factors
controlling the formation of nanostructures.
Results and Discussion
Synthesis and fluorescence spectroscopy
PEGylated hexaphenylalanine PEG8-F6, reported in Figure 1a,
was obtained by Fmoc/tBu solid-phase synthesis in good yield
and high purity. LCMS and 1H NMR are reported in Figure S1,
Supporting Information. PEG8-F6 is formed by two blocks: an
aromatic one, formed by the repetition of six phenylalanine
residues (F6), and a hydrophilic one composed of eight ethox-
ylic repetitions, here indicated as PEG8 (MW~600 Da). This PEG
chain was coupled at the N-terminus of the peptide sequence.
The PEG chain was inserted with the aim of producing
a water-soluble material for a large field of applications and
does not preclude its potential usage in nanomedicine for the
delivery of drugs or contrast agents. Nonetheless, PEG8-F6
shows very limited solubility in water, whereas it shows an ex-
cellent solubility in 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP).
After dissolution, the peptide solution appeared to clear up to
a concentration of 100 mgmL@1. According to the procedure
described for cationic diphenylalanine, this stock solution in
HFIP was diluted five-fold in water. After dilution and removal
Figure 1. a) Schematic representation of hexaphenylalanine PEG8-F6. b) Fluo-
rescence spectra of PEG8-F6 in water solution at 0.1 (*), 1.0 (*), and
2.5 mgmL@1 (~). In the insert, fluorescence spectra of PEG8-F6 at 0.02 and
0.05 mgmL@1. All emission spectra were recorded at 25 8C between 265 and
400 nm with an excitation at 258 nm. c) Fluorescence intensity emission of
ANS fluorophore at 470 nm versus concentration of PEG8-F6. CAC values are
established from the break point.
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of HFIP, the peptide solution remains perfectly limpid until
20 mgmL@1. The UV/Vis spectrum of PEG8-F6, reported in Fig-
ure S2, Supporting Information, shows the typical spectral pro-
file of Phe residue (B band). The tendency of PEG8-F6 to self-
aggregate was evaluated with fluorescence spectroscopy, by
exciting the sample at 257 nm (Figure 1b). At all the concen-
trations here studied, the expected emission peak at 282 nm,
ascribed to the phenylalanine residue, appears weakly out-
lined, whereas it is well observable that the peak at 310 nm is
typical of p-stacking phenomena observed during the excimer
Phe formation. This result suggests the high tendency of PEGy-
lated peptide PEG8-F6 to self-aggregate and indicates that the
critical aggregate concentration (CAC) value of this compound
is lower than 0.02 mgmL@1. However, two different trends can
be identified for the maximum as a function of the concentra-
tion. At very low concentrations (0.02 and 0.05 mgmL@1), the
fluorescence intensity at 310 nm increases gradually, whereas
at high concentrations (0.1, 1.0, and 2.5 mgmL@1) an opposite
behavior was observed. The decrease of the signal intensity for
concentrations above 0.1 mgmL@1 can be attributed to
quenching that arises from the stacking of the aromatic rings.
A more accurate determination of the critical aggregation con-
centration (CAC) was carried out by using a fluorescence-
based method, in which 8-anilinonaphthalene-1-sulfonate am-
monium salt (ANS) was used as the fluorescent probe.
It is well-known that ANS fluorofore is able to emit in the
range of 460–480 nm only when it is surrounded by a hydro-
phobic environment, such as in the micelle core.[23] On the
contrary, no fluorescence intensity is observed in water solu-
tion. Figure 2 reports the fluorescence intensity of an ANS solu-
tion (20 mm in cuvette) at 470 nm, as a function of hexapheny-
lalanine concentration. From the graphical break point, the
CAC value (7.5 mm, 0.01 mgmL@1) can be established (7.5 mm,
0.01 mgmL@1). This value is significantly lower (around one
order of magnitude) than the value found for the polymeric
tetraphenylalanine analogues previously studied.[21b–e] In detail,
all the polymeric F4-peptides showed CAC values ranging be-
tween 43 and 167 mm.
As expected, the elongation of the aromatic framework from
four to six F residues permits the CAC value to be reduced and
in turn to increase the stability of the aggregate upon dilution.
Structural characterization: Secondary structure
Secondary structure of PEGylated hexapeptide in water solu-
tion was assessed by CD and FTIR spectroscopies. These spec-
troscopic methods are typically employed for monitoring the
conformational behavior of peptide-based nanostructures and
mainly for revealing secondary structural features, such as b-
sheet structures, accompanying the formation of amyloid
fibers.
CD spectra of PEG8-F6 at 0.1, 1.0, and 10.0 mgmL
@1, well-
above the CAC value, were recorded between 280 and 195 nm
and the dichroic behavior was reported in Figure 2a. Due to
the very low CAC value of this aromatic derivative, we were
not able to record CD spectra of acceptable quality for solution
concentration below CAC (<0.01 mgmL@1). All the spectra
show two peaks: a maximum around 205 nm, attributable to
aromatic side-chain stacking, and a minimum around 230 nm,
Figure 2. Spectroscopic characterization of PEG8-F6 by CD and FTIR. a) Far-
UV CD spectra of hexaphenylalanine in aqueous solution at
0.1 mgmL@1 (~), 1.0 mgmL@1 (&), and 10.0 mgmL@1 (&). Spectra are re-
corded between 280 and 195 nm. In the insert, a zoom of the PEG8-F6 spec-
trum at 10 mgmL@1 is presented. b) FTIR spectra of PEG8-F6 in solution and
at the solid state, in the amide I region. c) UV/Vis spectra of PEG8-F6, stained
with Congo Red at 0.1 and 1.0 mgmL@1. The spectrum of Congo Red is also
reported for comparison.
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associated with a b-structure. However, the relative ratio be-
tween the intensity of the two peaks decreases progressively
as function of the concentration (from 5.8 to 1.2). This de-
crease indicates the progressive formation of supramolecular
aggregates in solution.
According to CD data, the presence of b-sheet structures is
supported by FTIR analysis in the region of the amide I vibra-
tional band (1600–1700 cm@1). This region is considered the
most sensitive spectral region for the revelation of secondary
peptide arrangement.[24] FTIR spectra for PEG8-F6, as a dried
film or in solution (2.0 mgmL@1), are reported in Figure 2b.
Both spectra show a dominant peak at 1637 and 1640 cm@1
for the dried film and sample in solution, respectively. Peaks at
these wavenumbers are strongly indicative of b-sheet forma-
tion. In addition, both spectra show a secondary broad peak at
around 1680 cm@1 that appears better defined for the solid-
state sample (1672 cm@1). The occurrence of this peak indicates
an antiparallel orientation of the b-sheet. The FTIR spectrum of
PEG8-F6 also shows a peak at 3280 cm
@1 corresponding to the
NH stretching in fibrillary assembly (see Figure S3, Supporting
Information) As expected, in HFIP the FTIR spectrum does not
present peaks in the amide I region, thus confirming the disag-
gregation of PEG8-F6 in this solvent (data not shown).
Congo Red spectroscopic assay
Further confirmation of PEG8-F6’s ability to aggregate in amy-
loid-like fibers was obtained with a Congo Red (CR) staining
assay. CR is an azoic dye, frequently used as an indicator of the
occurrence of amyloid like fibrils.[25] UV/Vis spectra of CR alone
and after incubation with 0.1 or 1.0 mgmL@1 of peptide are re-
ported in Figure 2c. As expected, CR absorbs at 490 nm,
whereas a spectral shift of the CR band from 490 to 540 nm
was observed for solutions containing 1.0 mgmL@1. Instead,
only a negligible shift can be invocated for the sample contain-
ing 0.1 mgmL@1 of PEG8-F6. At the same time, air-dried film
and solid-state PEG8-F6 were stained with Congo Red and vi-
sualized by optical microscopy under cross-polarized light.
From the inspection of Figure 3, both air-dried film (Figure 3a)
and solid-state sample (Figure 3c) exhibit the characteristic
blue–green birefringence.
Dynamic light scattering (DLS)
DLS measurements were performed in order to reveal the
presence of peptide aggregation in solution and to monitor
the system evolution as a function of the concentration and
time.
The intensity profiles of PEG8-F6 in water solution, in the
0.05–5.0 mgmL@1 range, are reported in Figure 4 and structural
data (mean diameter and diffusion coefficients, D) are collected
in Table 1.
From the inspection of Figure 4, monomodal and bimodal
distributions were observed for peptide solutions at high con-
centration (until 0.5 mgmL@1) and low concentration (0.1 and
0.05 mgmL@1), respectively. These results indicate that PEG8-F6
nanostructures remain stable upon dilution until 0.5 mgmL@1.
Below this concentration a second population arises. At the
same time, the size of the nanostructures in solution remains
unaltered for up to one month (data not shown). It is well-
known that b-sheet-rich peptides tend to aggregate, according
to their kinetics, in oligomers, protofibrils, and finally in
fibers.[26] However, PEGylation of amyloid fragments, such as
Figure 3. Polarized optical microscopy: a) images of PEG8-F6 dried onto
a glass slide and stained with Congo Red solution; b,c) PEG8-F6 fibers
stained with CR and observed with a Nikon microscope under bright-field il-
lumination and between crossed polars, respectively.
Figure 4. Mean diameter distribution as function of the concentration.
Table 1. Mean diameter and diffusion coefficient for PEG8-F6 in water at
different concentration. Each measure is in triplicate.
PEG8-F6 concentration [mgmL
@1] Mean diameter [nm] DV10@12 [m2 s@1]
5.0 56.87:0.48 8.66:0.08
2.0 56.70:0.15 8.68:0.04
1.0 56.93:0.63 8.65:0.08
0.5 58.81:0.61 8.37:0.09
0.1 67.84:2.13 7.28:0.22
0.05 74.52:0.77 6.60:0.06
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Ab(10-35) peptide induces the inhibition of the fibrillation pro-
cess, as compared to the peptide alone.[27]
Scanning electron microscopy
Scanning electron microscopy (SEM) images confirmed the ca-
pability of the aromatic peptide to assemble with a high mor-
phological variability (Figure 5). PEG8-F6 self-assembles at very
low concentration (0.05 mgmL@1) giving several amorphous
conglomerates (Figure 5a and b). These data are in good
agreement with the critical aggregation concentration experi-
mentally determined (~0.01 mgmL@1). The increase of the con-
centration causes changes of the morphology to give long and
well-ordered nanostructures at 2 mgmL@1 (Figure 5). At
0.2 mgmL@1, crystallization effects are observed (Figure 5c and
d). In FF dipeptide, the crystal structure is due to hydrogen-
bonded head-to-tail chains, which form hydrophilic channels
embedded in a hydrophobic matrix created by the peptide
side chains. However, in this case, in which head-to-tail interac-
tions are absent, the crystallization can be attributed to the
PEG chain on the N-terminus. At 0.5 mgmL@1, formation of
highly ordered tree-like multibranch nanostructures is shown.
Several nucleation centers are visible on these multibranch
nanostructures (Figure 5e and f). Finally, at 1.0 and
2.0 mgmL@1, small conglomerated fibers and very long nano-
structures can be observed together on the plate (Figure 5g
and h). Many sheafs of fibers with variable length (between 1.5
and 12.5 mm) and thickness (between 250 and 5000 nm)
appear. Each sheaf is formed by small fibers of 65–350 nm
width, placed side by side. Beside them, also the long nano-
structures (from 150 to 4000 mm) present a high morphological
variability: some nanostructures with a flat ribbon shape (Fig-
ures S4a and S4c, Supporting Information) and others with
a twisted ribbon shape (Figures S4b and S4d, Supporting Infor-
mation). Twisted ribbons are expected for amyloid peptides
functionalized with short PEG chains.[28]
In tubular nanoaggregates (Figures S4a and S4c, Supporting
Information), the width maintains a homogeneous size (~10–
15 mm) along its full length, whereas in the twisted nanostruc-
tures thickness changes of 20 mm are measured along the dif-
ferent parts of the aggregate. From these images we can real-
istically speculate that above 1.0 or 2.0 mgmL@1, the small
fibers begin to collapse to give stacks. These stacks aggregate
beyond in long nanostructures. DLS and SEM measures indi-
cate different sizes for self-assembled PEG8-F6 at the same con-
centration (for instance at 2.0 mgmL@1). However, this mis-
match depends on different physical states of the sample,
which is in solution and at the solid state for DLS and SEM, re-
spectively.
Wide- and small-angle X-ray scattering
To gain better insight into the assembly process and molecular
organizations, we prepared ordered fibers by the stretch frame
method[29] and acquired wide- and small-angle X-ray scattering
(WAXS/SAXS) data. Figure 6a shows PEG8-F6 dried fibers as
placed under the micro-focused X-ray beam. Four different re-
gions were explored, at a relative distance of 0.2 mm, marked
as 1 (red), 2 (green), 3 (blue), and 4 (orange) in Figure 6a, to
control the lateral homogeneity of the fiber. The WAXS and
SAXS detectors, placed at 10 mm and 2.2 m from the sample
(see Figure 6b), allowed us to collect the diffraction in two dif-
ferent slightly overlapped Dq ranges: Dq(WAXS)=0.006–
2.5 a@1 and Dq(SAXS)=0.007–0.189 a@1. The 2D WAXS and
SAXS diffraction patterns are displayed for each sample posi-
tion in Figure 6a.
Several diffraction peaks were measured either along the
meridional (along the fiber) and equatorial direction (perpen-
dicular to the fiber) and no difference was found moving
across the different positions, proving a high lateral homoge-
neity of the fiber, either at the atomic- (WAXS) or at the nano-
scale (SAXS). The 2D WAXS and SAXS patterns were centered,
calibrated, and folded into 1D profiles, by integrating along
the equatorial and meridional directions (white arrows) of Fig-
ure 7a and b, respectively. The corresponding 1D patterns
were reported, as blue (SAXS) and black (WAXS) profiles, in Fig-
Figure 5. Selected SEM microphotos for PEG8-F6: a,b) 50 mgmL
@1 (16000V ,
10 mm and 60000V , 2 mm scale bar, respectively) ; c,d) 0.2 mgmL@1 (30000V ,
5 mm and 60000V , 2 mm scale bar, respectively), e, f) 0.5 mgmL@1 (26000V ,
10 mm and 60000V , 4 mm scale bar, respectively), g,h) 2 mgmL@1 (1000V ,
100 mm and 12000V , 10 mm scale bar, respectively).
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ure 7c and d for the meridional and equatorial direction, re-
spectively. Table 2 summarizes the peak positions (in q) of the
most intense SAXS and WAXS peaks, measured along the
equatorial and meridional directions. The same meridional re-
flections were measured either in SAXS and WAXS, marked as
m1 and m2 in Figure 7c. No equatorial SAXS peak was detect-
ed in the explored range. Therefore, the equatorial profile con-
tains only morphological information.
The experimental data were fitted with the GNOM pro-
gram,[30] as reported in Figure S5a (Supporting Information,
dotted curve corresponds to the experimental data, red line to
the fitted profile). The pair distribution function extracted by
this analysis, reported in Figure S5b (Supporting Information),
is a typical distribution of elongated scattering objects. The gy-
ration radius, determined by this analysis, is Rg=69:1 nm.
The diffraction peak positions in Table 2 were converted in lat-
tice spacings (d). Three relevant distances can be distinguish-
ed: the typical b-strands distance at dm4=4.8:0.3 a, more rep-
resented along the meridional direction; the sharp peak at
de1=12.2:0.3 a, with its replica at half lattice spacing (de2=
6.1:0.3 a), which corresponds to the b-sheet distance; and
the meridional peak at dm1=48:0.3 a, which corresponds to
10-times the b-strands distance. This meridional reflection with
the spacing of 48 a may be indicative of additional regularities
along this direction. The presence of a clear fiber diffraction
pattern either in SAXS and in WAXS is fingerprint of a hierarchi-
cal organization of the molecules in fibers from the atomic to
the nanoscale, the latter footprint of the quaternary level of
the fiber.
Photoluminescence in peptide nanostructures
Recently, Rosenman et al. have described the appearance of
blue/green photoluminescence (PL) in FF and FFF nanostruc-
tures, upon the thermally induced phase.[12b,31] This PL phe-
nomenon has been observed by exciting self-assembled oligo-
peptides at 370 or 410 nm, only after heating the sample at
140–180 8C, as a consequence of an irreversible reconstructive
phase transition in the nanostructure.[12b,31] A similar effect of
PL has been also observed for amyloid-like fibrils[32] considering
the nanofiber morphology with antiparallel b-sheet structures.
The origin of this fluorescence is truly attributed to the elec-
tron delocalization through hydrogen bonds in the b-sheet-
rich structures. According to these findings, also our PEG8-F6
nanoaggregates that contain a high content of b-sheet struc-
tures exhibit optoelectronic PL properties in water solution
when excited in the same spectral region to those that have
been studied recently by Rosenman[12b,31] (see Figure 8).
PEG8-F6 at a concentration of 10 mgmL
@1 shows a blue PL
between 420–460 nm when the sample is excited at a wave-
Figure 6. a) PEG8-F6 sample, as placed under the micro-focused X-ray beam,
with the regions explored marked in red (1), green (2), blue, (3), and
orange (4), placed at a relative distance of 0.2 mm; b) WAXS and SAXS data
with different slightly overlapped Dq ranges: Dq(WAXS)=0.006–2.5 a@1 and
Dq(SAXS)=0.007–0.189 a@1; c) 2D WAXS and SAXS diffraction patterns col-
lected for each sample position in (a).
Figure 7. a) 2D WAXS and b) SAXS patterns, recorded for sample position 3;
c) meridional and d) equatorial 1D SAXS (blue) and WAXS (black) as obtained
once the 2D WAXS (a) and SAXS patterns (b) are centered, calibrated, and
folded into uni-dimensional (1D) profiles by integrating along the equatorial
and meridional directions (white arrows).
Table 2. Equatorial and meridional reflections for PEG8-F6 fibers.
Meridional reflections
Label q [a@1] d [a]
m1 0.132 48.0
m2 0.171 37.0
m3 0.514 12.2
m4 (b strand) 1.32 4.8
Equatorial reflections
e1 0.514 12.2
e2 1.026 6.1
e3 (b strand) 1.319 4.8
e4 1.536 4.1
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length of 370 or 410 nm. The narrow peak at l=420 nm that
appears upon excitation at 370 nm can be associated to the
Raman scattering in water.[33] PEG8-F6 keeps a PL effect also in
the solid state. Figure 8 reports the immunofluorescence and
confocal images of the sample deposited on a clean coverslip
glass and slowly dried at room temperature.
Molecular modeling and dynamics
To gain insights into the atomic structure of these supramolec-
ular aggregates, we performed molecular dynamics simula-
tions. Although, in principle, PEG moieties could influence the
PEG8-F6 structure, we assumed that the self-assembling is es-
sentially dictated by the aromatic peptide region, as PEG is
completely disordered, even in the crystal state, in the only 3D
structure available of a highly PEGylated protein.[34] According-
ly, MD simulations were performed on distinct F6 models gen-
erated using the steric zipper structure of the KLVFFA hexapep-
tide as the template (see Materials and Methods and Table S1
for modeling and notations, Supporting Information). These as-
semblies were characterized by a different number of b-strands
per b-sheet. Models here investigated were denoted as SHx_
STy_F6, in which x and y indicate the number of b-sheets and
b-strands per sheet, respectively ; F6 indicates the number of
Phe residues per chain. Preliminary simulations carried out on
the smaller systems (SH2_ST10_F6 and SH2_ST26_F6) suggest-
ed that these steric zipper models were rather stable in the
simulation timescale (data not shown). However, to reduce the
impact of the assembly termination effects, most extensive
analyses were conducted on the larger SH2_ST50_F6 system
(Figure 9a).The inspection of the root mean square values
(RMSD) of SH2_ST50_F6 trajectory structures versus the initial
structure clearly shows that the starting model undergoes
a major transition during the simulation (Figure S6a,b, Support-
ing Information). The analysis of the evolution of the trajectory
also indicates that the structural transition is followed by
states characterized by rather constant RMSD values (Fig-
ure S6a, Supporting Information). This behavior suggests that
the system adopts a novel structural state in the equilibrated
region of the trajectory (20–100 ns). This transition is also cou-
pled with a significant variation of the assembly gyration
radius (Figure S6b, Supporting Information). Notably, the sec-
ondary structure of SH2_ST50_F6 is well preserved in the simu-
Figure 8. PL of PEG8-F6 nanostructures at 10 mgmL
@1. a) Blue PL emission spectra for the sample in solution upon excitation at ~370 nm (blue line) and at
~410 nm (red line). b) Fluorescence microscopy images of a dried film of PEG8-F6 obtained by exciting in the UV spectral region (DAPI filter). c) Confocal mi-
croscopy images of a dried film of PEG8-F6: Fluorescence images (on the left), bright field images (on the right) and the merge of fluorescence and bright
field images (at the center). Scale bar=50 mm.
Figure 9. Evolution of the SH2_ST50_F6 model during the simulation.
Panel (a) shows the starting flat model, whereas panels (b) and (c) show two
different views of the average structure calculated in the equilibrated region
of the trajectory.
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lation (Figure S6c, Supporting Information). The visual analysis
of trajectory structures clearly indicates that the initially flat
SH2_ST50_F6 b-sheet motif undergoes a significant twist.
This is also evident when the average structure calculated in
the equilibrated region of the trajectory is visualized (Fig-
ure 9b,c). This behavior has been observed for several other
peptides forming cross-beta structures.[35] It has been suggest-
ed that the b-sheet twisting is better suited for fiber formation,
whereas the growth of single crystals forces the b-sheets to
adopt flat states[35] However, no twisting has been observed
for the Gln homopeptides.[36] In this latter case, the strong in-
terdigitation of the Gln side chains has likely prevented the b-
sheet twisting.
The analysis of the evolution of the intersheet distance
shows that the two facing sheets are more separated in the
equilibrated region compared to their relative position in the
KLVFFA structure (Figure 10). Indeed, in the starting crystallo-
graphic KLVFFA structure, the distances between facing Ca
atoms belonging to the two distinct b-sheets are on average
10.5 a (range 9.4–11.6 a). The modeling in this scaffold of the
F6 homopeptide produces some steric hindrance. As a conse-
quence, we observe an increase of the b-sheet separation
during the simulation (Figure 10). The shortest distances be-
tween Ca atoms of the two b-sheets are approximately 12.5 a.
This indicates a close agreement between the intersheet dis-
tance of the equilibrated model and the WAXS data. The good
agreement between the resulting model and the experimental
WAXS data corroborate our assumption that the PEG moiety
has a limited impact on PEG8-F6 structure, which is essentially
dictated by the peptide region. The structural transition occur-
ring in the simulation leads to the staggering of the facing
strands of the two b-sheets along the fiber axis.
The examination of the flexibility of this novel state, carried
out by computing root mean square fluctuation (RMSF) values,
demonstrates that, with the exception of terminal residues
within each strand, the backbone atoms are rather rigid (Fig-
ure S7a, Supporting Information). A limited level of flexibility is
also shown by Phe side chains. Indeed, the flexibility of Phe
side chain located in the intersheet dry interface is comparable
to the mobility of the backbone atoms (Figure S7b, Supporting
Information). Phe side chains of the solvent-exposed interface,
although displaying larger RMSF values, still retain a restricted
mobility. The limited flexibility of Phe side chains is also high-
lighted by the analysis of their rotameric states. Each strand
presents rather recurrent values of the c1 dihedral angle (Fig-
ure S8, Supporting Information). All residues within the same
strand adopt predominantly the same c1 value. Furthermore,
strands with all gauche+ (g+) Phe side chains alternate with
strands showing all-trans (t) rotameric states. This trend does
not depend on the location of the Phe residue in terms of dry
interface or exposed surface. The inspection of the Phe side
chain interactions clearly indicates that this recurrent rotameric
motif plays an important role in the stabilizations of the SH2_
ST50_F6 assembly. Indeed, the juxtaposition of alternating anti-
parallel F6 strands with side chains presenting either g+ or t
states leads to the formation of staggered p-stacking interac-
tions within the same b-sheet (Figure 11a). In line with litera-
ture classification of these interactions,[37] the distance between
the centers of mass of the stacking aromatic rings is on aver-
age close to 5.0 a. This particular configuration of the Phe side
chains within the individual sheets is suitable for the formation
of stabilizing interactions at the intersheet level. As shown in
Figure 11b, the dry interface is characterized by the presence
of recurrent T-shaped aromatic interactions. These findings
provide a clear structural pattern for the stabilization of anti-
parallel b-sheets by Phe side chains. They also indicate that in-
dividual Phe-rich b-sheets are preorganized to form steric
zipper assemblies.
Figure 10. Evolution of the distance between two representative Ca atoms
of the facing sheets along the trajectory. The values of the monitored distan-
ces for both the flat starting model and the twisted average structure are
shown in the insets.
Figure 11. Conformations of the Phe side chains and their interactions at the
exposed interface and at the dry interface. The interstrand interaction within
the same sheet are reported in panel (a) whereas the intersheet interactions
are reported in panel (b). The rotameric states of Phe residues are shown in
both panels. The T-shaped interactions established at the dry interface are
also indicated in panel (b).
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However, Phe side chains, although closely packed through
the formation of hydrophobic and steric interactions, do not
lead to the interdigitation that frequently characterizes amy-
loid-like peptides.[26,35]
Conclusion
Diphenylalanine homodimer has showed stimulating potential-
ity for the development of novel peptide-based materials. The
mechanical, electrical, electrochemical, or optical properties of
the supramolecular materials are strongly dependent on the
structural organization of the building blocks and on the physi-
cochemical properties of the nanomaterials. A better under-
standing of how their inner molecular organization governs
their self-aggregation process could allow the engineering of
novel supramolecular materials with enhanced functionalities.
Nevertheless, the literature lacks studies that explain how the
supramolecular organization of the material can be affected by
chemical modifications, such as the replacement of phenylala-
nine with naphthylalanine, tyrosine, or tryptophan residues, or
the elongation of the aromatic framework. Herein, we showed
the effect of elongating the aromatic portion of FF on the ag-
gregation process. The PEG8-F6 building block is able to self-
assemble in water solution after five-fold dilution of a stock so-
lution in HFIP. The structural characterization in solution pro-
vides evidence for the high tendency of the aromatic peptide
to self-assemble at very low concentration (~0.01 mgmL@1) in
nanostructures with a hydrodynamic diameter of ~60 nm.
Moreover, their size does not seem to be affected significantly
by the concentration and the time. The spectroscopic charac-
terization of the aggregates, both in solution and in the solid
state, clearly indicated an arrangement of the peptide in anti-
parallel b-sheets. As expected for b-sheet-rich structures, PEG8-
F6 shows blue photoluminescence both in solution and at the
solid state. Structural features of nanostructures were deeply
investigated at the atomic- (WAXS), nano- (SAXS), and micro-
scale (SEM) to gain a full study of the different hierarchical or-
ganization of the aggregates. SEM images indicate that PEG8-
F6 at 2.0 mgmL@1 assembles in a sheaf of fibers, each of them
formed by small fibers of 65–350 nm width, placed side by
side. Beside them, long nanostructures (up to 4000 mm) with
high morphological variability (flat or twisted ribbon shape)
were observed. The hypothesis that arises from the SEM
images is that large and long supramolecular nanostructures
are obtained from the aggregation of small fibers. Wide-angle
X-ray scattering data, recorded on dried fibers, reveal a typical
„cross-b“ diffraction pattern of amyloid-like fibers, with a diffrac-
tion peak of 4.8 a along the meridian, representing the inter-
chain distance between the hydrogen-bonded strands, and
a diffraction peak of 12.5 a along the equatorial direction, dis-
tinctive of the stacking of b-sheets perpendicularly to the fiber
axis. The value of equatorial d-spacing is higher than the value
usually expected (~10 a). No differences in diffraction pattern
were found moving across fiber in the different positions,
proving a high lateral homogeneity of the fiber. Present molec-
ular dynamics data suggest that the F6 spine is likely constitut-
ed by facing twisted b-sheets separated by a dry interface. This
follows the aggregation scheme experimentally shown for a va-
riety of amyloid-like peptides.[26] The model is endowed with
a remarkable rigidity and stability in the simulation timescale.
The intersheet separation observed in these twisted models is
in line with the detection in the WAXS data of a strong equato-
rial reflection at ~12.5 a. Although the observed twisting of
the SH2_ST50_F6 may be biased by a number of factors (limi-
tations of the force field accuracy, omission of the PEG moiet-
ies, and reduction of the fiber spine to a pair of sheets), it is
suggestive of the presence of long-range regularities in this
system that may be experimentally characterized by future
SAXS experiments at very small angles. Thanks to their photo-
luminescence properties, hexaphenylalanine-based nanostruc-
tures herein described can be used for the fabrication of novel
optoelectronic nanomaterials. However, the high stability and
water solubility of these supramolecular aggregates, attributa-
ble to the PEG chain, make these materials potentially suitable
for applications in nanomedicine for the delivery of bioactive
molecules as drugs or contrast agents.
Experimental Section
Materials
Protected Na-Fmoc-Phe-OH, coupling reagents, and Rink amide
MBHA (4-methylbenzhydrylamine) resin, commercially available
from Calbiochem-Novabiochem (Laufelfingen, Switzerland), were
used. The Fmoc-8-amino-3,6-dioxaoctanoic acid, Fmoc-AdOO-OH,
was purchased from Neosystem (Strasbourg, France). All other
chemicals commercially available by Sigma–Aldrich (Milan, Italy),
Fluka (Bucks, Switzerland), or LabScan (Stillorgan, Dublin, Ireland)
were used as received unless otherwise stated. All solutions were
prepared by weight with doubly distilled water. The purifications
by preparative RP-HPLCs were carried out on a LC8 Shimadzu
HPLC system (Shimadzu Corporation, Kyoto, Japan) equipped with
a UV lambda-Max Model 481detector using a Phenomenex (Tor-
rance, CA) C18 column. Elution solvents are H2O/0.1% TFA (A) and
CH3CN/0.1% TFA (B), from 20 to 80% over 30 min at 20 mLmin
@1
flow rate. Purity and identity of the products were assessed by an-
alytical LCMS analyses by using Finnigan Surveyor MSQ single
quadrupole electrospray ionization (Finnigan/Thermo Electron Cor-
poration San Jose, CA), column: C18-Phenomenex eluted with an
H2O/0.1% TFA (A) and CH3CN/0.1% TFA (B) from 20 to 80% over
15 min at 200 mLmin@1 flow rate.
Synthesis of PEGylated peptide PEG8-F6
PEGylated peptide PEG8-F6 was synthesized according to standard
solid-phase Fmoc procedures. The Rink amide MBHA resin (substi-
tution 0.65 mmolg@1) was used as the solid-phase support to pro-
vide the peptides as C-terminus amides, and synthesis was per-
formed on a scale of 0.2 mmol. The synthesis was carried out in
DMF/NMP (1:1, v/v).[38] Before starting with the elongation of the
peptide, the resin was swelled for 30 min. Fmoc deprotection was
performed twice (each treatment for 10 min) using 30% (v/v) pi-
peridine in DMF/NMP. The amino acid coupling was achieved by
adding 2-fold molar excess of amino acid, mixed with equimolar
amounts of 1-hydroxybenzotriazole (HOBt), benzotriazol-1-yl-oxy-
tris-pyrrolidino-phosphonium (PyBop), and a 4-fold molar excess of
diisopropylethylamine (DIPEA) in DMF/NMP. All couplings were per-
formed twice for 1 h. Four residues of Fmoc-AdOO-OH were se-
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quentially coupled as previously described.[39] Crude peptide was
fully cleaved from the resin with TFA (trifluoroacetic acid)/H2O (95/
5 v/v) mixture at room temperature for 2 h. PEGylated peptide was
precipitated with ice-cold water and freeze-dried. The purification
of the crude products was carried out by RP-HPLC. Mass spectra
and 1H NMR spectrum confirm the products identity.
PEG8-F6 characterization
tR=14.05 min, MS (ESI+): m/z : 1480.7 calcd for C78H101N11O18 :
[M+H+]=1480.9; 1H NMR (CD3OD) (chemical shifts in d, CH3OH as
internal standard 3.55)=7.51–7.42 (m, 30 CH aromatic), 4.86–4.75
(m, 6H, CH Phe a), 3.80 (s, 16H, OCH2CH2O), 3.75 (t, 8H, RNH-
CH2CH2O), 3.65 (s, 8H, OCH2COR), 3.60 (t, 8H, RNH-CH2CH2O), 3.16–
2.90 ppm (m, 12H, CH2 Phe b).
Preparation of PEG8-F6 solutions
PEG8-F6 peptide was dissolved in HFIP at 100 mgmL
@1.[40] Subse-
quently, this solution was ten-fold diluted in water and the organic
solvent was removed with N2 flow. The concentration of the final
solution was determined by absorbance on a UV/Vis Thermo Fisher
Scientific Inc (Wilmington, Delaware USA) Nanodrop 2000c spectro-
photometer equipped with a 1.0 cm quartz cuvette (Hellma) by
using a molar absorptivity (e257) of 1170m
@1cm@1.
Fluorescence studies
Critical aggregate concentration (CAC) of PEG8-F6 was determined
by fluorescence measurements using 8-anilino-1-naphthalene sul-
fonic acid ammonium salt (ANS) as the fluorescent probe.[41] Fluo-
rescence spectra were recorded at room temperature by a Jasco
Model FP-750 spectrofluorophotometer in a 1.0 cm path length
quartz cell. Equal excitation and emission bandwidths (5 nm) were
used throughout the experiments with a recording speed of
125 nmmin@1 and automatic selection of the time constant. Small
aliquots of PEG8-F6 solutions, at several concentrations, were
added to 200 mL of aqueous solution of ANS (20 mm). Data analysis
was performed on spectra after blank correction. The fluorescence
intensity of ANS was followed as a function of the peptide concen-
tration. The CAC values were determined by linear least-squares fit-
ting of the fluorescence emission at 470 nm, upon excitation at
350 nm, versus the hexaphenylalanine concentration.
Circular dichroism
Far-UV CD spectra of the PEG8-F6 in aqueous solution were collect-
ed on a Jasco J-810 spectropolarimeter equipped with a NesLab
RTE111 thermal controller unit using a 0.1 mm quartz cell at 25 8C.
The spectra were recorded from 280 to 195 nm using samples at
several concentrations (10.0, 5.0, 2.5, 1.0, 0.5, and 0.1 mgmL@1).
Other experimental settings were: scan speed, 10 nmmin@1; sensi-
tivity, 50 mdeg; time constant, 16 s; bandwidth, 1 nm. Each spec-
trum was obtained by averaging three scans and corrected for the
blank contribute. Here V represents the mean residue ellipticity
(MRE), that is, the ellipticity per mole of peptide divided by the
number of amino acid residues in the peptide.
FTIR spectroscopy
FTIR spectra of PEG8-F6 (2.0 mgmL
@1) were collected on a Jasco
FT/IR 4100 spectrometer (Easton, MD) in an attenuated total reflec-
tion (ATR) mode using a Ge single-crystal at a resolution of 4 cm@1.
All the spectral data were processed using built-in software. Spec-
tra were collected in transmission mode and then converted in
emission. Each sample was recorded with a total of 100 scans with
a rate of 2 mms@1 against a KBr background.
Dynamic light scattering
Mean diameter and diffusion coefficient (D) of supramolecular ag-
gregates were measured by DLS. DLS measurements were carried
out using a Zetasizer Nano ZS (Malvern Instruments, Westborough,
MA) that employs a 1738 backscatter detector. Other instrumental
settings were: measurement position (mm) of 4.65; attenuator of
9; temperature of 25 8C; disposable sizing cuvette as the cell. DLS
measurements in triplicate were carried out on aqueous samples
at 5.0, 2.0, 1.0, 0.5, 0.1, and 0.05 mgmL@1, after room temperature
centrifugation at 13,000 rpm for 5 min. Measurements were record-
ed each week for up to one month.
Congo Red spectroscopic assay
Congo Red (CR) spectroscopy assay was carried out by UV/Vis
measurements. A stock solution of CR (3.5 mg in 500 mL) was fresh-
ly prepared in 10 mm phosphate buffer, at pH 7.4 and filtered
through 0.2 mm syringe immediately prior to use. A small aliquot
(5 mL) of this solution was diluted with water at 12.5 mm final con-
centration and the UV/Vis spectrum was recorded between 400
and 700 nm at room temperature. 5 or 50 mL of PEG8-F6 solution
(20 mgmL@1) were added to CR solution to obtain a final peptide
concentration of 0.1 or 1.0 mgmL@1. After incubation for 30 min at
room temperature, the spectra were recorded and background
subtracted using a Congo Red spectrum in phosphate buffer as
a reference solution.
CR staining and polarized optical microscopy
A dried film of PEG8-F6 was prepared by placing 30 mL of the pep-
tide solution (0.25 wt%) in deionized water onto a glass slide,
which was then left to dry at room temperature. The air-dried sam-
ples were stained with 25 mL of CR solution just prepared adding
a saturating amount of CR in ethanol containing 20% of NaCl satu-
rated water. After deposition, CR extra solution was detached from
the glass slide with a filter paper. Fibers containing CR were pre-
pared, according to the method described below in the wide-
angle X-ray scattering section, adding 4 mL of CR staining solution
to 100 mL of peptide solution (0.25 wt%). Both film and solid fiber
were observed under bright-field illumination and between
crossed polars by using a Nikon AZ100 microscope.
Scanning electron microscopy
Morphological analysis of the nanostructures was carried out using
field emission scanning electron microscope (Nova NanoSem 450-
FEI). Samples, at several concentrations (0.05, 0.2, 0.5, 1.0, and
2.0 mgmL@1), were prepared for sequential dilution from a stock
solution (20 mgmL@1) obtained as above described. Briefly, the
samples were placed on an aluminum stub by using a graphite ad-
hesive tape. A thin coat of gold and palladium was sputtered at
a current of 20 mA for 90 s. The sputter-coated samples were then
introduced into the specimen chamber and the images were ac-
quired at an accelerating voltage of 2–5 kV, spot 3, through the Ev-
erhart Thornley Detector (ETD) and the Through the Lens Detector
(TLD).
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Wide- and small-angle X-ray scattering
Fiber diffraction WAXS and SAXS patterns were recorded from
dried fibers prepared by the stretch-frame method.[29] Briefly,
a droplet (10 mL) of peptide aqueous solution (3 wt%) was sus-
pended between the ends of a wax-coated capillary (spaced 2 mm
apart). The droplet was allowed to dry gently at room temperature
overnight to obtain oriented fibers. WAXS and SAXS data were col-
lected at the X-ray MicroImaging Laboratory (XMI-L@b) equipped
with a Fr-E+ SuperBright rotating anode copper anode micro-
source (CuKa, l=0.15405 nm, 2475 W), a multilayer focusing optics
(Confocal Max-Flux; CMF 15–105) and a three-pinhole camera
(Rigaku SMAX-3000).[42] For WAXS data collection an image plate
(IP) detector with 100 mm pixel size was placed at 10 cm from the
sample and calibrated by means of the Si NIST standard reference
material (SRM 640b); for SAXS data collection a Triton 20 gas-filled
photon counter detector with ~200 mm pixel size was placed at
2.2 m from the sample and calibrated by means of silver behenate.
A detailed description of the XMI-L@b performances can be found
in Altamura et al.[42] and Sibillano et al.[43]
Optical spectrofluorometry
Measurements of PL were performed using Jasco Model FP-750
spectrofluorophotometer in a 1.0 cm path length quartz cell. Aque-
ous PEG8-F6 nanostructures (10 mgmL
@1) were prepared as previ-
ously described, diluting HFIP in water. PL was measured on freshly
prepared samples excited at 370 or 410 nm.
Fluorescence and confocal microscopy
15 mL of PEG8-F6 solution at 10 mgmL
@1 were deposited on a clean
coverslip glass, dried and imaged with fluorescence and confocal
microscopies. Immunofluorescence images were taken with a Leica
DFC320 video-camera (Leica, Milan, Italy) connected to a Leica
DMRB microscope equipped with 10V and 40V objectives and the
Image J Software (National Institutes of Health, Bethesda, MD) was
used for analysis. Confocal images were obtained with a Leica TCS-
SMD-SP5 confocal microscope (lex=405 nm and lem=490–
510 nm). 0.8 mm-thick optical slices were acquired with a 63V or
40V /1.4 NA objective.
Molecular modeling and molecular dynamics simulation:
Systems and notations
A 3D model for the F6 peptide was generated by using the steric
zipper structure of the hexapeptide fragment KLVFFA of the amy-
loid-beta peptide.[44] In particular, the coordinates of the poly-
morph II (Protein Data Bank entry 3OW9) refined at 1.80 a resolu-
tion were considered (Figure S9a,b, Supporting Information). The
asymmetric unit of this structure contains two copies of the pep-
tide arranged as an antiparallel two-stranded b-sheet. Steric zipper
pairs of b-sheets were built by using the symmetry operations of
KLVFFA structure space groups (C2). The side chains of non-Phe
residues of the model were replaced by Phe to generate a 3D
structure of F6 (Figure S9c). Models with a different number of b-
strands per b-sheet were generated. Following our previous nota-
tion[36,45] these models were denoted as SHx_STy_F6, in which
x and y indicate the number of b-sheets and b-strands per sheet,
respectively. Preliminary analyses were conducted on SH2_ST10_F6
and SH2_ST26_F6. More extensive analyses were, however, con-
ducted on SH2_ST50_F6.
Molecular dynamics protocol
MD simulations were performed using the GROMACS software
package 4.5.7[46] with the OPLS-AA force field. The energy of the
structures generated by modeling was initially minimized in vacuo.
Minimized models were then immersed in triclinic boxes filled with
water molecules (TIP4P water model). The number of the water
molecules along with other simulation parameters (box dimensions
and simulation timescale) for the different systems are reported in
Table S1, Supporting Information. Simulations were run by apply-
ing periodic boundary conditions. Equilibration of the system was
conducted in order to stabilize the temperature (300 K) and the
pressure (1 atm.). Energies were initially minimized by fixing the
protein atoms and then without restraints. The Particle Mesh
Ewald (PME) method (grid spacing of 0.12 nm)[47] was used to cal-
culate the electrostatic interactions, whereas a cutoff of 10 a was
applied to treat Lennard–Jones interactions. The LINCS algorithm
was used to constrain bond lengths. Trajectory structures were an-
alyzed by using in-house programs, VMD,[48] and Gromacs rou-
tine.[46] The achievement of an adequate convergence in the MD
simulation of SH2_ST50_F6 has been checked by calculating the
root-mean-square inner product (RMSIP=0.82) between the two
halves of the equilibrated trajectory (20–60 ns and 60–100 ns).[49]
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Gadolinium containing telechelic
PEG-polymers end-capped by di-
phenylalanine motives as potential
supramolecular MRI contrast agents
Carlo Diaferia,a Eliana Gianolio,b Antonella Accardoa and Giancarlo Morellia*
Telechelic PEG-polymers end-capped by diphenylalanine (FF) motives and containing a DOTA-Gd complex, bound on a lysine side
chain at the centre of peptidemoiety, are studied for their assembling properties and for the relaxometric behavior. The observed
variations in terms of relaxivity are correlated to the assembling properties of the aggregates by using several techniques:
fluorescence, Circular Dichroism (CD) and Fourier Transform Infrared (FTIR) for aggregation tendency and secondary structure
determination; Dynamic Light Scattering (DLS) and Transmission Electron Microscopy (TEM) for morphological definition.
Self-aggregation in water solution of the peptide conjugates, due to interaction of the phenylalanine frameworks, starts at
concentration around 1mg/ml with a first evidence of the coexistence of fibrillary networks and hydrogels at 10mg/ml. Definitive
presence of well-structured fibrillary networks, dominated by an antiparallel β-sheet arrangement, occurs at 50mg/ml. At the
latter concentration relaxivity values measured at 20MHz and 298K, are around 11mM1 s1, in line with a possible use of the
these aggregates as MRI contrast agents. Copyright © 2016 European Peptide Society and John Wiley & Sons, Ltd.
Additional supporting information may be found in the online version of this article at the publisher’s web site.
Keywords: oligo-phenylalanines; telechelic polimers; MRI contrast agents; nanofibers; self-assembling
Introduction
The self-assembling of hydrophobic, amphiphilic, and aromatic
peptides is a promising route for the obtainment of new
nanomaterials displaying a wide range of properties and applica-
tions [1–3]. Peptide-based self-assembled compounds organized
in a high ordered architecture are able to give new functional
materials that open application in emerging fields such as optical
devices [4], artificial photosynthesis [5], rechargeable batteries [6],
biosensors/chips [7], coating for tissue engineering and cell
adhesion [8], and healthcare (regenerative medicine and drug
delivery) [8,9].
However, the knowledge of the forces that permit to obtain an
ordered organization of the nanostructure at micro-scale and
nano-scale could help in projecting new peptide based materials
for more attractive applications.
Peptide materials based on diphenylalanine (FF) motif [10] and
all its analogues (Fmoc-FF, Fmoc-FFF, Boc-FFF, FFFF, Fmoc-FFFF,
and polymeric polyethylene oxide, PEO, and polyethylene glycol,
PEG conjugates) have been strongly studied for their ability to give
a wide range of structures (nanotubes, nanowires, nanofibrils,
spherical vesicles, and organogels) with physiochemical properties
suitable for several applications in the earlier mentioned emerging
fields [11–13]. Many studies reported in literature are principally
focused on clarifying the physicochemical aspects responsible for
array stability in these nanostructures [14–16] and on the study of
relationship between the structural organization of the building
blocks, the preparation method of the samples and the physico-
chemical properties of the nanomaterials [17,18].
However, only few studies have been devoted in the investiga-
tion of FF aggregates for biomedical applications, essentially due
to their intrinsic low water solubility [19]. To increase their solubility,
hydrophilic polymers of appropriate lengths can be bound to the
aromatic framework.
We have recently developed new potential Magnetic Reso-
nance Imaging (MRI) contrast agents (CAs) based on oligo-
phenylalanine aggregates derivatized with oxoethylene linkers
and a chelating agent (DTPA or DOTA) able to complex the para-
magnetic gadolinium(III) ion [20]. In particular, tetraphenylalanine
peptides modified on the N-terminus with the 21-amino-
4,7,10,13,16,19-hexaoxaheneicosanoic acid [Ahoh-OH, (L6)] spacer
and with the DOTA(Gd) or DTPA(Gd) complexes [DOTA(Gd)-L6-F4
and DTPA(Gd)-L6-F4] self-assemble in water solution, also at low
concentration, giving well soluble nanoaggregates. Single pep-
tides in the aggregates are in a beta-sheet conformation with an
antiparallel alignment along the fiber axis, and aggregating forces
essentially are due to the interactions between phenylalanine
aromatic frameworks. Both compounds have been also fully
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characterized for their relaxometric properties and cell uptake and
internalization in view of a potential use as MRI CAs. Even if the
relaxometric parameters are in line with other examples of Gd
(III) based supramolecular (micelles or liposomes) CAs [21,22],
and more performing respect to classical low molecular weight
CAs, the τR values extracted from the fitting procedure are quite
short if compared with those usually found for nano-sized aggre-
gates (1–30ns) [20]. The low τR values we found can be attributed
to the occurrence of a quite fast internal motility of the Gd-
complexes along the linker spacer with respect to the overall
fibril-like structures.
Here, we report the design and the synthesis of a novel supramo-
lecular CA based on the self-assembling of FF-AdOO-Lys(DOTA-
Gd)-AdOO-FF [FF-DOTA(Gd)-FF], a telechelic-polymer end-capped
by FF motives (Figure 1), in which the Gd-complex is placed at
the centre of F4-motive. The objective of this study is aimed to
evaluate how the relaxivity properties of the self-assembled CA
can be affected by the different position having the gadolinium
complex in the aromatic framework. The effect of the phenylala-
nine chirality on assembled structure and therefore on the relaxivity
properties, are also evaluated by replacing two L-Phe with two
D-Phe residues at the N-teminus [ff-DOTA(Gd)-FF]. On the basis of
the literature, the building block based on the D-amino acid
analogue of the FF dipeptide should self-assemble into highly
persistent discrete nanotubes having the same structural features
as the corresponding L-amino acid peptide [23]. The observed
variations in terms of relaxometric performances are analyzed and
correlated to the structural morphology of the aggregate using
several techniques: fluorescence, Circular Dichroism (CD), and
Fourier Transform Infrared (FTIR) spectroscopies for aggregation
Figure 1. Schematic representation of (A) FF-DOTA-FF and (B) ff-DOTA-FF. (C) 1H-NMR spectrum of FF-DOTA-FF registered at 600MHz in CD3OD.
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tendency and secondary structure determination; Dynamic Light
Scattering (DLS) and Transmission Electron Microscopy (TEM) for
morphological definition.
Materials and Method
Protected Nα-Fmoc-amino acid derivatives, coupling reagents,
and Rink amide MBHA (4-methylbenzhydrylamine) resin were pur-
chased fromCalbiochem-Novabiochem (Laufelfingen, Switzerland).
The Fmoc-8-amino-3,6-dioxaoctanoic acid (Fmoc-AdOO-OH) was
purchased from Neosystem (Strasbourg, France). DOTA(OtBu)3-OH
chelating agent was purchased from Chemateck (Dijon, France).
All other chemicals were commercially available by Sigma-Aldrich
or Fluka (Bucks, Switzerland) or LabScan (Stillorgan, Dublin,
Ireland) and were used as received unless otherwise stated. All
solutions were prepared by weight with doubly distilled water.
Preparative RP-HPLCs were carried out on a LC8 Shimadzu HPLC
system (Shimadzu Corporation, Kyoto, Japan) equipped with a UV
lambda-Max Model 481 detector using Phenomenex (Torrance,
CA) C18 column. Elution solvents are H2O/0.1% trifluoroacetic acid
(TFA) (A) and CH3CN/0.1% TFA (B), from 5% to 70% over 30min at
20mlmin1 flow rate. Purity and identity were assessed by
analytical LC-MS analyses by using Finnigan Surveyor MSQ single
quadrupole electrospray ionization (Finnigan/Thermo Electron
Corporation San Jose, CA), column: C18-Phenomenex eluted with
an H2O/0.1% TFA (A) and CH3CN/0.1% TFA (B) from 5% to 70% over
15min at 200μLmin1 flow rate.
Synthesis of peptide derivative
Peptide conjugates were synthesized by using standard solid-
phase 9-fluorenylmethoxycarbonyl (Fmoc) procedures [24]. The
Rink amide MBHA resin (substitution 0.65mmolg1) was used as
the solid phase support to provide the peptides as C-terminus
amide, and synthesis was performed on a scale of 0.2mmol. The
resin was swelled in dimethylformamide (DMF) for 30min and the
Fmoc deprotection reaction was performed twice with 30%
piperidine in DMF. The amino acid coupling was achieved by
adding twofold molar excess of amino acid, mixed with equimolar
amounts of 1-hydroxybenzotriazole (HOBt), benzotriazol-1-yl-oxy-
tris-pyrrolidino-phosphonium (PyBop), and fourfold molar excess
of diisopropylethylamine (DIPEA) in DMF. All couplings were per-
formed twice for 1 h. Fmoc-AdOO-OH ethoxylic spacer was coupled
as previously described [21,25]. DOTA(OtBu)3-OH was coupled to
the Lys side chain after selective removal of Mtt protecting group
from the lysine epsilon amine function. Peptide-DOTA derivatives
were fully deprotected and cleaved from the resin with the
TFA/TIS (triisopropylsilane)/H2O (92.5/5.0/2.5) mixture for 2 h at
room temperature. Peptide conjugates were precipitated with
ice-cold ethyl ether, dissolved in H2O/CH3CN, and lyophilized. Puri-
fication of the crude products was carried out by RP-HPLC. Mass
spectra confirm the product identities. 1H-NMR spectra, registered
on Varian 600MHz, present identical patterns for both compounds,
with principal signals as reported below.
FF-AdOO-Lys(DOTA)-AdOO-FF [FF-DOTA-FF] and ff-AdOO-Lys(DOTA)-
AdOO-FF [ff-DOTA-FF]
1H-NMR (CD3OD) (chemical shifts in δ, CH3OH as internal standard
3.55) = 7.51–7.42 (m, 20 CH aromatic), 4.98–4.76 (m, 4H, CH Phe α),
4.3 (dd, 1H, CH Lys α), 3.72 (s, 12H, OCH2CH2O), 3.70 (s, 6H,
R2NCH2COOH), 3.68 (t, 4H, RNH-CH2CH2O), 3.65 (s, 4H, OCH2COR),
3.45 (s, 16H, R2N-CH2CH2NR2), 3.40–3.36 (m, 2H, R2NCH2CONH),
3.36–3.25 (m, 8H, CH2 Phe β), 3.27–3.20 (dd, 2H, R2N-CH2CH2NR2),
3.1(m 2H, CH2 Lys ε), 1.90 (m, 2H, CH2 Lys β), 1.6 (m, 2H, CH2 Lys
δ), 1.45 (m, 2H, CH2 Lys γ).
Retention time, Rt = 12.65min; MS (ESI+): m/z 1407.5 calcd. For
C70H99N13O18: [M+H
+] =1408.5
Preparation of Gadolinium Complex
The complexation of gadolinium(III) ions to the DOTA containing
peptide conjugate has been carried out by adding 1 : 1 molar ratio
of GdCl3 to the aqueous solutions of the DOTAderivatives at neutral
pH and room temperature. The amount of residual free Gd3+ ions
was assessed by the orange xylenol UV method [26] and removed
by complexing it upon addition of the corresponding amount of
each ligand.
Preparation of Peptide Solutions
Peptide solutions were prepared by dissolving the lyophilized
powder in double distilled water and the concentration was
experimentally determined by absorbance on UV–Vis Thermo
Fisher Scientific Inc (Wilmington, Delaware USA) Nanodrop 2000c
spectrophotometer equipped with a 1.0 cm quartz cuvette (Hellma)
using a molar absorptivity (ε257) of 780M
1 cm1.
Water Proton Relaxation Measurements
The proton 1/T1 nuclear magnetic relaxation dispersion (NMRD)
profiles (field dependence of the longitudinal water proton relaxa-
tion rates) were measured at 25 °C on a fast field-cycling Stelar
relaxometer over a continuum of magnetic field strengths from
0.00024 to 0.47 T (corresponding to 0.01–20MHz proton Larmor
frequencies). The relaxometer operates under computer control
with an absolute uncertainty in 1/T1 of 1%. Additional data points
in the range 21.5–70MHz were obtained on the Stelar Spinmaster
spectrometer. The temperature was controlled with a Stelar VTC-
91 air-flow heater equipped with a copper constantan thermocou-
ple (uncertainty 0.1 °C). The concentration of the solutions used for
the relaxometric characterization was determined according to a
previously reported relaxometric method [27].
Fluorescence Studies
The values of critical aggregate concentration (CAC) were obtained
by fluorescence measurements. Fluorescence spectra were
recorded at room temperature on a Jasco Model FP-750
spectrofluorophotometer in a 1.0 cm path length quartz cell. Equal
excitation and emission bandwidths (5nm) were used throughout
the experiments with a recording speed of 125 nmmin1 and
automatic selection of the time constant. The CAC values were
measured by using 8-anilino-1-naphthalene sulfonic acid ammo-
nium salt (ANS) as the fluorescent probe [28,29]. Small aliquots of
peptide conjugate aqueous solutions, as free bases or as gadolin-
ium complexes, were added to a fixed volume (1.0ml) of ANS
(20μM) dissolved in water. Final spectra, to be used for calculations,
were obtained after blank correction and adjustment for dilution.
The intensity was followed as a function of the peptide concentra-
tion. The CAC values were determined by linear least-squares fitting
of the fluorescence emission at 460 nm, upon excitation at 350 nm
versus the oligo-phenylalanine concentration lower and higher than
the change of slope, as previously reported [20,30].
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Dynamic Light Scattering
Mean diameter and diffusion coefficient (D) of oligo-phenylalanine
nanostructures were measured by DLS using a Zetasizer Nano ZS
(Malvern Instruments, Westborough, MA) that employs a 173° back-
scatter detector. Other instrumental settings were: measurement
position (mm) of 4.65; attenuator of 8; temperature of 25 °C; dispos-
able sizing cuvette as cell. Each measurement was performed in
triplicate on aqueous samples at 10.0mg/ml, after centrifugation
at 13 000 rpm for 5min.
Transmission Electron Microscopy Images
Transmission electron microscopy observations were performed
with a transmission electronmicroscope FEI TECNAI G12 Spirit-Twin
(LaB6 source) equipped with a bottom mounted FEI Eagle-4 k CCD
camera (Eindhoven, The Netherlands), operating with an accelera-
tion voltage of 120 kV. (LaMest Pozzuoli, Italy). A droplet of the
sample solution (10mg/ml) was placed onto a 400mesh holey-
carbon coated copper grid, air-dried for 1 h, and then negatively
stained with phosphotungstic acid in water solution (1wt%).
Tomography holder with FEI Eagle 4 K CCD camera and Xplore3D
software were used to obtain digital images.
Circular Dichroism
Far-UV CD spectra of the peptide conjugates in aqueous solution
were collected at room temperature on a Jasco J-810 spectropolar-
imeter equipped with a NesLab RTE111 thermal controller unit
using a 0.1mmquartz cell at 25 °C. The spectra of samples at several
concentrations ranged between 0.5 and 20mg/ml were recorded
from 280 to 195nm. Other experimental settings were: scan speed,
10nmmin1; sensitivity, 50 mdeg; time constant, 16 s; bandwidth,
1 nm. Each spectrum, run in duplicate, was obtained by averaging
three scans, corrected for the blank and adjusted for dilution.
Ellipticities are reported as themean residue ellipticity (MRE), which
is the ellipticity per mole of peptide divided by the number of
amino acid residues in the peptide.
Fourier Transform Infrared Spectroscopy
Fourier transform infrared spectra of samples, as free bases and as
Gd-complexes at 10mg/ml, were collected on a Jasco FT/IR 4100
spectrometer (Easton, MD) in an attenuated total reflection (ATR)
mode and using a Ge single-crystal at a resolution of 4 cm1. All
the spectral data were processed using built-in software. Spectra
were collected in transmission mode and then converted in
emission. Each sample was recorded with a total of 100 scans with
a rate of 2mm·s1 against a KBr background.
Results
Synthesis
Schematic representation of FF-AdOO-Lys(DOTA-Gd)-AdOO-FF
[FF-DOTA(Gd)-FF] peptide conjugate and its analogue ff-AdOO-
Lys(DOTA-Gd)-AdOO-FF [ff-DOTA(Gd)-FF] is reported in Figure 1A
and 1B. Peptide synthesis of the two gadolinium free compounds
was performed by using solid phase methods as reported in
Scheme 1 in supporting information. In agreement with our
previous synthesis of F4-conjugate, Rink amide MBHA resin, which
releases peptide adducts as amide on the C-terminus, was used.
After the coupling of two phenylalanine residues and of
Fmoc-AdOO-OH ethoxylic spacer on the solid support, a lysine
residue orthogonally protectedwithMtt on the epsilon amino func-
tion was added. The removal of the Mtt protecting group allowed
introduction of DOTA(OtBu)3-OH on the Lys side chain. The synthe-
sis was completed by introducing the second ethoxylic spacer and
the other two phenylalanine residues; therefore, the peptide-DOTA
derivatives were fully deprotected, cleaved from the resin and puri-
fied by RP-HPLC. Purity (>95%) and identity of the products were
confirmed by HPLC and mass spectra. 1H-NMR studies were also
performed in CD3OD solution at 600MHz and the mono-
dimensional spectrum is reported in Figure 1C. The complexation
of gadolinium(III) ions to the DOTA containing peptide conjugates
to obtain FF-DOTA(Gd)-FF and ff-DOTA(Gd)-FF has been carried
Figure 2. The magnetic-field dependence of the relaxivity (r1) measured
over an extended range of magnetic field strengths (from 0.01 to 70MHz).
The nuclear magnetic relaxation dispersion (NMRD) profiles were obtained
for the aqueous suspensions of FF-DOTA(Gd)-FF at 5mg/ml (□) and
50mg/ml (■) and ff-DOTA(Gd)-FF at 5mg/ml (△) and 50mg/ml (▲). The
temperature was set to 298 K and data were normalized to 1mM
concentration of Gd3+.
Table 1. Main relaxometric parameters derived from fitting of NMRD
profiles reported in Figure 2.a
System r1p
(mM1 s1)
Δ2(s2)b τV
(ps)c
τs0
(ps)d
τR (ps)
e
LLLL isomer monomer 7.1 1.66×1019 32.8 153 190
aggregate 10.1 1.86×1019 41.0 109 270
LLDD isomer monomer 7.9 1.06×1019 41.7 188 227
aggregate 11.5 2.21×1019 35.0 108 341
aOn carrying out the fitting procedure, some parameters were fixed to
reasonable values: rGd–H (distance between Gd and protons of the
inner sphere water molecule) = 3.1 Å; a (distance of minimum
approach of solvent water molecules to Gd3+ ion) = 3.8 Å; D (solvent
diffusion coefficient) = 2.2°105 cm2 s1.
bSquared mean transient zero-field splitting (ZFS) energy.
cCorrelation time for the collision-related modulation of the ZFS
Hamiltonian.
dElectronic relaxation time at zero field (calculated as 1/τs0 = 12Δ
2×τv)
eReorientational correlation time.
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out by adding equimolar amounts of GdCl3 to the aqueous solu-
tions of the DOTA derivatives at neutral pH and room temperature,
as already reported [25].
Relaxivity Measurements
The relaxivity of a Gd-containing system, which is directly related to
its efficacy as potential MRI contrast agent, depends on the com-
plex interplay of structural, dynamic, and electronic parameters
[31]. At the frequencies most commonly used in commercial
tomographs (20–60MHz), r1p is generally determined by the
reorientational correlation time (τR) of the chelate so that high mo-
lecular weight systems display higher relaxivity. For this reason, a
wide range of high-molecular weight supramolecular systems, in-
cluding dendrimers [32], micelles and liposomes [33], proteins
[34], gold [35], and silica [36] nanoparticles, have been applied as
slowly moving carriers for Gd(III)-complexes. The analysis of the
magnetic field dependence of the relaxivity, obtained through
the registration of the NMRD profiles, allows the determination of
the principal parameters characterizing the relaxivity of a Gd(III)
chelate. The NMRD profiles of FF-DOTA(Gd)-FF and ff-DOTA(Gd)-
FF, measured at 50 and 5mg/ml concentrations, are reported in
Figure 2. From a qualitative point of view, the shape of the profiles
gives information on the aggregation state of the system: low mo-
lecular weight Gd-complexes, in fact, show NMRD profiles with a
dispersion in the region 1–10MHz, while a characteristic peak of
relaxivity appears, in the region of proton Larmor frequencies
10–70MHz, in the case of high molecular weight Gd-containing
systems. Inspection into Figure 2 reveals that both FF-DOTA(Gd)-
FF and ff-DOTA(Gd)-FF are mostly in monomeric form at a
concentration of 5mg/ml, while, at a concentration ten times
higher, the aggregation process is definitively completed, particu-
larly in the case of ff-DOTA(Gd)-FF where the high field relaxivity
peak is better evidenced. Data were fitted to the conventional
Solomon-Bloembergen-Morgan theory [37,38] and the relative
fitting parameters are reported in Table 1. The high field relaxivity
of the two complexes are quite similar, being, at 20MHz and
298K, 10.1 and 11.5mM1 s1 in the aggregated form and 7.1
and 7.9mM1 s1 in the monomeric form, for FF-DOTA(Gd)-FF
and ff-DOTA(Gd)-FF, respectively. The τR values found for the two
complexes reflect the slight increase in relaxivity passing from LLLL
isomer to the DDLL one.
Structural Characterization
Critical aggregation concentration values of peptide conjugate FF-
DOTA-FF and of its corresponding Gd-complex were determined
using the fluorescence spectroscopy. ANS is a well-known
fluorescent probe able to emit between 460 and 480nmonly when
immersed in a hydrophobic environment, such as in the hydro-
phobic core of micelles [39]. On the contrary, no fluorescence is
observed for ANS in water solution. Upon titration of ANS (20μM
in cuvette) with increasing amounts of our peptide conjugates a
distinctive emission peak at 460nm appears. The CAC values have
been determined from the graphical break points of the plot in
Figure 3A, in which is reported the variation of the ANS fluores-
cence intensity as function of peptide concentration. The CAC
values of FF-DOTA-FF peptide conjugate and its Gd-complex are
7.7·104 M (1.1mg/ml) and 5.8·104 M (0.9mg/ml), respectively.
Figure 3. (A) Fluorescence intensity emission of ANS fluorophore at
470 nm versus concentration of FF-DOTA-FF as free basis and as
gadolinium complex. CAC values are established from the break point; (B)
DLS intensity profiles of FF-DOTA(Gd)-FF at 5mg/ml.
Figure 4. Selected TEM images for FF-DOTA(Gd)-FF at 10.0mg/ml.
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The same values were found for ff-DOTA-FF and ff-DOTA(Gd)-FF
analogues (Figure S1). Self-assembled aggregates were further
characterized from the structural and morphological point of view.
Mean diameters and diffusion coefficients of the gadolinium
self-assembled CAs in water solution were measured by DLS at
10mg/ml. The intensity profile of FF-DOTA(Gd)-FF, reported in
Figure 3B shows a mono-modal distribution due to translational
diffusion process of aggregate (Figure S2) with an apparent
translational diffusion coefficient D=2.2×1012m2 s1. Through
the Stokes-Einstein equation, we calculate a mean diameter of
~ 230nm, which is compatible with supramolecular aggregates.
The morphology of the self-assembled nanostructures assessed
by TEM is reported in Figure 4 and S3. Images of the Gd-complex
in water solution at 10mg/ml1 show coexistence of fibrillary
networks.
Secondary Structure
The secondary structure of the peptide conjugates in water solution
was achieved by CD and FTIR spectroscopies (Figure 5). CD
measurements of the peptides were recorded between 280 and
195nm at several concentrations in 2.5–20mg/ml range and
spectra are reported in Figure 5A. CD spectrum of FF-DOTA(Gd)-
FF, recorded at 2.5mg/ml, show two maxima at 202 and 221nm.
These maxima can be attributed to the stacking of the aromatic
side chains. The mainmaximum at 221nm undergoes to a red-shift
as function of the concentration, indicating an increase of the
β-sheet content. In Figure 5B, CD spectrum of ff-DOTA(Gd)-FF at
2.5mg/ml reveals a minimum at 218nm, consistent with a substan-
tial β-sheet content. As for FF-DOTA(Gd)-FF analogue, a progressive
red-shift of the minimum, due to the increase of concentration, was
observed. Further information on the secondary structure adopted
by peptide conjugates and their Gd-complexes was obtained inves-
tigating the amide I region of FTIR spectra in aqueous solution
(10mg/ml). FTIR spectra of LLLL isomer and DDLL one showed a
similar profile, with very slight differences between the free bases
and the Gd-complexes. From the inspection of the spectra of
FF-DOTA-FF and FF-DOTA(Gd)-FF, reported in Figure 5C, it is possi-
ble to detect with three peaks at 1637, 1674, and 1680 cm1. The
peak at 1674 cm1 is associated with residual trifluoroacetate
counterions, deriving from the peptide chromatographic purifica-
tion. Instead, both 1637 and 1680 cm1 are indicatives of β-sheet
formation with an antiparallel orientation [40]. CD and FTIR results,
together with TEM images, indicate the ability of the peptide
Gd-complex to self-aggregate in fibrillary and intricate network
dominated by an antiparallel β-shift arrangement.
Discussion
Analysis of the results here described allows several interesting
observations regarding the synthesized telechelic-polymers end
capped by FF-motives. FF-DOTA(Gd)-FF peptide contains a hydro-
philic gadolinium complex as central core of a symmetric telechelic
polymer decorated with hydrophobic FF end groups that, thanks to
their high tendency to associate via non covalent interactions, pro-
mote self-assembly phenomena. This peptide conjugate has been
designed with the idea to confer higher rigidity to the DOTA(Gd)
complex with respect to the already studied tetraphenylyalanine
DOTA(Gd)-L6-F4, in which the chelating agent is anchored to a long
and flexible oxoethylene linker. The two phenylalanine residues on
the N and C termini of the lysine residue bearing the gadolinium
complex should guarantee aggregating properties for the final
adducts. In order to investigate the effect of the phenylalanine
Figure 5. Selected Far-UV CD spectra of (A) FF-DOTA-FF and of (B) ff-DOTA-
FF in a concentration range of 2.5–20mgml1. Spectra are recorded
between 280 and 195 nm. In the insert it is reported the variation of the
wavelength as function of the peptide concentration. (C) FTIR amide I
region for FF-DOTA-FF and FF-DOTA(Gd)-FF.
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containing Phe in D configuration, the aromatic framework com-
posed of four Phe residues is interrupted by the -AdOO-Lys[DOTA
(Gd)]-AdOO- motif. At high concentration, it is feasible that a fold-
ing of the peptide backbone occurs as reported in Figure 6. This
folding should favor the approach of phenyl rings of the C and N
termini and permits their T-shape staking. As suggested by CD
and FTIR data, the peptide conjugates interact with an antiparallel
β-arrangement and the Gd-DOTA complexes point far from the
spine of the aggregate.
Conclusions
Self-aggregation of the telechelic-polymer end-capped by FF
motives in water solution starts at concentration around 1mg/ml
with a first evidence of the coexistence of fibrillary networks and
long hydrogels at 10mg/ml and definitive presence of well-
structured fibrillary and intricate networks dominated by an
antiparallel β-shift arrangement at 50mg/ml. At the latter concen-
tration relaxivity values measured at 20MHz and 298K, are around
11mM1 s1, in line for a possible use of the these aggregates as
MRI CAs. However, these peptide conjugates, in which the Gd-
complex is placed at the centre of F4-motive show lower relaxivity
values with respect to DOTA(Gd)-tetraphenylalanine conjugates
previously published [20]. The decrease of the relaxivity can be
directly related to the τR values, which are affected both by the
rigidity and the size of the gadolinium based CA. In principle an
higher τR value was expected for FF-DOTA(Gd)-FF respect to
DOTA(Gd)-tetraphenylalanine, in which the Gd-complex is an-
chored at the end of a long oxoethylene spacer. However, the
experimental data suggest that the low tendency of the telechelic
compound to aggregate, more than the flexibility, affects signifi-
cantly the relaxivity value of the contrast agent. The proposed
model well explain as the Gd-DOTA complex, pointing far from
the spine of the aggregate, is free to move, while the folding of
the peptide backbone allows the approach of phenyl rings of the
C andN termini, permits their T-shape staking as well an antiparallel
β-arrangement of the peptide chains.
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Nucleophosmin (NPM1) is a multifunctional protein involved in a variety of biological processes including the
pathogenesis of several human malignancies and is the most frequently mutated gene in Acute Myeloid Leuke-
mia (AML). To deepen the role of protein regions in its biological activities, lately we reported on the structural
behavior of dissected C-terminal domain (CTD) helical fragments. Unexpectedly the H2 (residues 264–277)
andH3AML-mutated regions showed a remarkable tendency to form amyloid-like assemblieswith ﬁbrillarmor-
phology and β-sheet structure that resulted as toxicwhen exposed to human neuroblastoma cells. More recently
NPM1 was found to be highly expressed and toxic in neurons of mouse models of Huntington's disease (HD).
Here we investigate the role of each residue in the β-strand aggregation process of H2 region of NPM1 by
performing a systematic alanine scan of its sequence and structural and kinetic analyses of aggregation of derived
peptides by means of Circular Dichorism (CD) and Thioﬂavin T (Th-T) assay. These solution state investigations
pointed out the crucial role exerted by the basic amyloidogenic stretch of H2 (264–271) and to shed light on the
initial andmain interactions involved inﬁbril formationwe performed studies onﬁbrils deriving from the related
Ala peptides through the analysis of ﬁbrils with birefringence of polarized optical microscopy and wide-angle X-
ray scattering (WAXS). This analysis suggested that the presence of branched Ile269 conferred preferential pack-
ing patterns that, instead, appeared geometrically hampered by the aromatic side-chain of Phe268. Present inves-
tigations could be useful to deepen the knowledge of AML molecular mechanisms and the role of cytoplasmatic
aggregates of NPM1c+.
© 2016 Elsevier B.V. All rights reserved.
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1. Introduction
In processes of protein misfolding the amyloid ﬁbrillization is a
unique ordered state governed by speciﬁc patterns ofmolecular interac-
tions and not an aspeciﬁc aggregation [1,2]. The process that leads to the
formation of amyloid aggregates is a heterogeneous multistep reaction
with many parallel events [3] and, nevertheless the common structural
features of ﬁnal ﬁbrils [4,5], initiation steps of the aggregation by differ-
ent proteins can be signiﬁcantly diverse. Even if the primary sequences
do not determine uniquely the structures of ﬁnalﬁbrils [6–8], the details
of structural variations can be markedly sequence-dependent [9]. The
determination of conformational elements that underlaymolecular rec-
ognition and self-assembly is crucial to understand amyloid formation
[10]. Normally folded proteins can access to amyloidogenic states as a
result of thermal ﬂuctuations of the native state [11] or disruption of
the quaternary structure [12] and the amyloidogenic state is often con-
sidered as anensemble of native-like conformationswith locally unfold-
ed elements [13,14]. The characterization of these amyloidogenic
species is crucial to elucidate potential aggregation under native condi-
tions and for in vivo aggregation events [15]. Many peptides and pro-
teins convert in vitro into highly organized amyloid structures and the
investigations of the effects of sequence changes on the aggregation
can help the development of therapeutical strategies for amyloid-asso-
ciated diseases [16].
Nucleophosmin (NPM1, B23, No38 and numatrin) is a multifunc-
tional protein, present in the granular region of nucleoli [17,18], belong-
ing to the nucleoplasmin family of nuclear chaperones [19] that shuttles
between the nucleus and cytoplasm [20]. In human cells this protein is
expressed in three distinct isoforms: B23.1, the longest and the most
abundant (294 residues), B23.2 and B23.3 splicing variants lacking the
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C-terminal 35 amino-acids and a 29 amino-acid stretch (residues 195–
223) in the basic region, respectively [21]. Structural investigations
showed that the protein is endowed with a modular structure: i) the
N-terminal region is an oligomerization domain crucial for chaperone
function [22,23], the central portion presents two IDRs (Intrinsically
Disordered Regions) [24] and is crucial for DNA/RNA recognitionmech-
anism [25–27] and the C-terminal domain (CTD)with a three helix bun-
dle tertiary structure [28]. A NMR structural study allowed to delineate
the ﬁrst helix, H1, (243–259), the second, H2, (264–277), and the third
H3 (280–294), within the wt CTD that demonstrated to fold through a
compact transition state with an extended nucleus and unfolds keeping
a malleable residual secondary structure at the interface between H2
and H3 helices [29–31].
NPM1 is overexpressed in solid tumors correlating with mitotic
index and metastatization [32] and is the most frequently mutated
gene in Acute Myeloid Leukemia (AML) patients: speciﬁc mutations in
the exon 12 of the NPM1 gene occur, accounting for approximately
30% of cases [19,33–39]. Mutations in the H3 region of the CTD cause
its unfolding [28,40], the impairment of several functions such as
DNA/RNA recognition [39] and the aberrant accumulation of the protein
in the cytoplasm of the leukemic cells (thus the term NPM cytoplasmic
positive NPMc+AML) [36]. AML NPM1mutations revealed involved in
leukemia cell viability and invasion and, in this process, Matrixmetallo-
proteinases MMPs (regulated by the K-Ras/ERKMAPK signaling path-
way) play a key role [41]. The aberrant cytoplasmatic accumulation of
AML mutated protein is due both to the loss of the NoLS (nucleolar lo-
calization signal) and to the oligomerization level of the protein de-
pending on N-terminal and/or C-terminal domains. Recently a study
focused on the role of NPM1 in neurons of mouse models of
Huntington's disease (HD) was reported. It demonstrated that NPM1
has complex roles in the regulation of neuronal survival in dependence
on its levels of expression, oligomerization and subcellular localization:
in particular NPM1 resulted highly expressed and toxic with a
cytoplasmatic localization [42].
Lately, following a structure-based protein dissection approach, we
demonstrated that the H2 [43] and H3 AML mutated regions [44] of
the CTD of NPM1 form amyloid-like assemblies endowed with ﬁbrillar
morphology andβ-sheet structure that resulted toxic in cell viability as-
says. Actually, our mechanistic hypothesis is that the AML-associated
mutations destabilize theα-helical structure of the H3 region in the na-
tive NPM1 and disrupts the CTD tertiary structure predisposing it to the
formation of toxic aggregates since it induces the exposure of the H2 re-
gion, which is the most amyloidogenic region of the whole NPM1-CTD.
Here we investigate the role of each residue in the aggregation pro-
cess of H2 region of NPM1 through the characterization of a series of
peptides deriving from a systematic alanine scan [45] of its sequence.
Bioinformatics analyses pointed out the chameleon nature of this region
and that Alanine-substitutions deeply affect the “basic amyloidogenic
unit” (264–271) as conﬁrmed by structural and kinetic analyses of ag-
gregation processes by means of Circular Dichorism, Infrared spectros-
copies and Th-T assay. Further, to shed light on the initial and main
interactions in ﬁbril formation, we analyzed amyloid ﬁbrils of H2 wt
and several sequences bearing Ala substitutions with birefringence of
polarized optical microscopy and wide-angle X-ray scattering (WAXS).
2. Results and discussion
2.1. Chameleon behavior of H2-Ala scan peptides
To investigate the speciﬁc role of the residues of the region H2 of
NPM1-CTD (264–277), we performed a systematic alanine scan of the
sequence and thirteen peptides (Table 1)were synthesized and puriﬁed
with good yields (N90%).
A bioinformatic analysis of each primary sequence of the H2 Ala-
scan peptides was carried out using the PASTA server [46]. Their ten-
dencies to assume β-strand secondary structure and to aggregate in
an amyloid-like way respect to disorder were analyzed and probability
proﬁles were reported in Figs. S1 and S2, respectively. Notably a similar
analysis, carried out on the NPM1-CTDwt outlined the chameleon char-
acter of H2 sequence and deﬁned a shorter region as the “basic
amyloidogenic unit” (named H2 short265–272) [43]. Here PASTA analysis
indicates that Alaninepoint substitutionsdonot alterβ secondary struc-
ture preferences respect to H2 wt. Exceptions were for the Ala/Asn270
(H2A7) and Ala/Lys273 (H2A10) (to a lesser extend) replacements
(Fig. S1G,J) for which the probability to assume a beta conformation
seems comparable to aggregation. Similarly the greater probability to
aggregate respect to disorder is not affected by substitutions except
for Ala/Ile269 (H2A6) (Fig. S2F) that seemed, in turn, to decrease the ten-
dency of the related sequence to aggregate.
The effects of Ala substitutions on conformational features were ex-
perimentally evaluated by CD spectra over time. H2 wt sequence re-
vealed able to self-assemble in an amyloid-like way at physiological
pH but basic pHs demonstrated to speed this process and in order to
compare the β-sheet aggregating propensities of Ala sequences in the
absence of net positive charges, we performed studies at pH 10, that is
the closest value to theoretical pIs (Table 1) [43]. H2 Ala derived pep-
tides freshly dissolved in 10mMborate buffer, at pH 10.0, exhibited dif-
ferent far-UV CD spectra (Fig. 1). Each spectrum was followed within
24–48 h. Most spectra presented decreases over time in the overall sig-
nal, resulting from the formation of large aggregates that escape exper-
imental detection. The large mean residue ellipticity in the 215–220 nm
range indicated a β-structure content [47]. This feature was mainly de-
tected in H2A9, H2A11, H2A12 and H2A14 sequences: notably all of
them, except H2A9, present Ala substitutions outside the indicated
basic amyloidogenic stretch (Fig. 1H,J,K,M). Visually H2A9 did not
formed ﬁbrils in the explored time-course (differently from several
other sequences), presumably the substitution Ala/Val272 allowed a
major solubility of preﬁbrillar oligomers suggesting that Val272 is not
determinant in the oligomerizationmechanism and could only enhance
insolubility of wt sequence as conﬁrmed by the solubility proﬁle report-
ed in Fig. S3-I, see below. Conversely, spectra of H2A5, H2A6 and H2A8
did not assumeβ-strand proﬁles within 24–48 h:while H2A5 andH2A8
showed only decreased Cotton effects with a substantial random proﬁle
H2A6 presented a transition from random to α+β mixed conforma-
tion, as predicted by PASTA analysis (Fig. 1D,E,G). Aromatic interactions
can greatly affect to the self-assembly process: indeed stacking interac-
tions can provide energetic contributions, as well as order and direc-
tionality in the aggregation [48]. H2 sequence contains three aromatic
residues: two inside the shortest amyloidogenic region, Phe268 and
Tyr271, and one outside it, Phe276. Their Ala substitutions caused that
none of related peptides presented β-like CD spectra (Fig. 1D,G,L) atmi-
cromolar concentrations: notably this effect is more evident for Phe268
with respect to Phe276, pointing out the dependence of the local context
on conformational behavior. This dependence is also evident in the
Table 1
Sequences and names of analyzed peptides derived from Ala scan of H2 wt. Molecular
weight (MW) and isoelectronic point (pI) for each peptide sequence are also reported.
Name Sequence MW (amu) pI
H2wt VEAKFINYVKNCFR 1772 10.15
H2A1, Ala/Val264 AEAKFINYVKNCFR 1744 10.15
H2A2, Ala/Glu265 VAAKFINYVKNCFR 1714 10.76
H2A4, Ala/Lys267 VEAAFINYVKNCFR 1715 9.06
H2A5, Ala/Phe268 VEAKAINYVKNCFR 1696 10.15
H2A6, Ala/Ile269 VEAKFANYVKNCFR 1730 10.15
H2A7, Ala/Asn270 VEAKFIAYVKNCFR 1729 10.15
H2A8, Ala/Tyr271 VEAKFINAVKNCFR 1680 10.64
H2A9, Ala/Val272 VEAKFINYAKNCFR 1744 10.15
H2A10, Ala/Lys273 VEAKFINYVANCFR 1715 9.06
H2A11, Ala/Asn274 VEAKFINYVKACFR 1729 10.15
H2A12, Ala/Cys275 VEAKFINYVKNAFR 1740 10.78
H2A13, Ala/Phe276 VEAKFINYVKNCAR 1696 10.15
H2A14, Ala/Arg277 VEAKFINYVKNCFA 1687 9.01
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comparison of CD features of Ala/Asn substituted peptides at different
positions: at 270, inside, and 274 positions, outside the amyloidogenic
core. CD spectra analyses and of H2A7 and H2A11 suggest that the
Ala/Asn substitution caused a transition to β-like structure after long
time (24 h) (Fig. 1F, conﬁrming PASTA prediction). Similarly for charged
residues inside and outside the shortest amyloidogenic fragment.
Fig. 1. CD analysis of H2 Ala derived peptides. Overlay of CD spectra recorded at indicated time (h) from freshly prepared samples at 100 μM in 10 mM borate buffer, pH 10. For a better
comprehension substituted residue in parenthesis is reported above each panel CD spectrum of H2 wt (at t = 0) is also showed [43].
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Fig. 2. Kinetic of oligomers formation at indicated H2 Ala peptides, determined by ThT ﬂuorescence assay, at 100 μM at pH 10. They were grouped in: upper “not aggregating” (full line);
central “slow aggregating” (dashed line), lower panel as “aggregated” (dotted line) sequences, respectively. For a better comprehension substituted residue in parenthesis is reported
above each panel, H2 wt kinetic proﬁle is also reported [43].
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Indeed H2A12 and H2A14 CD spectra (Fig. 1K,M), showed a β-like pro-
ﬁle, while H2A2 CD spectra (Fig. 1B), did not show transition toward β-
sheet conformation, suggesting a primary role for Glu265 to create ionic
interactions stabilizing β-structure.
2.2. Kinetic aggregation studies of H2-Ala scan peptides
The effects of Ala-substitution in the H2 region of NPM1 were also
investigated with respect to the kinetic of aggregation. To this purpose,
the time course of ThT ﬂuorescence intensity of freshly prepared solu-
tions was monitored, at 100 μM and pH 10.0, under stirring and report-
ed in Fig. 2 [49]. In general a sigmoidal shape of ﬂuorescence intensity
versus time is typical of a nucleation-dependent growth mechanism of
amyloid ﬁbril formation, while H2 wt was almost fully aggregated at
t=0, as here shown (Fig. 2N) and previously reported [43]. For amatter
of clarity we have grouped Ala-scan sequences into: “not aggregating”,
“slow aggregating” and “aggregated” peptides in three panels of Fig. 2.
The members of ﬁrst group are peptides with Ala replacement in the
264–271 fragment, that show very low ﬂuorescence intensity that did
not increase in 300min (Fig. 2A-E). An interesting group is represented
by the “slow aggregating sequences” inwhich the replacement of native
residue signiﬁcantly delay aggregation. To this group H2A1 sequence
belongs (Fig. 2F) suggesting an important role exerted by the N-termi-
nal Val264 in the aggregation process. Most of the sequences bearing
Ala substitution outside amyloidogenic stretch showed a high ﬂuores-
cence signal even at t = 0 and were deﬁned as “aggregated sequences”
(Fig. 2J–M). But this behavior was not shown by H2A12, A13, A14 for
which native amino acids, Cys, Phe and Arg, gave a contribution to the
aggregation process (Fig. 2G–I). The substitutions of Lys268 and Cys275
(H2A4, H2A12) showed a fast kinetic aggregation (time of saturation
~10 and 20 min, respectively) suggesting electrostatic contributions to
the self-recognition. These considerations were corroborated by the
total suppression of aggregation showed fromH2A2 (Fig. 2A), indicating
that Glu266 can create favourable electrostatic interactions. Sequences
H2A9 andH2A14 (Fig. 2K,I) appeared themost intense at t= 0 suggest-
ing higher soluble aggregated states with respect to others. This ﬁnding
was also conﬁrmed by an additional progressive slow aggregation of
H2A14 sequence.
The lag times of ﬁbril growth is strictly dependent on the solubility
of each sequence as evidenced by different solubility proﬁles reported
in Fig. S3 obtained with CamSol program [50]. Changes in amyloid pro-
pensity through mutational analyses require to be evaluated also in the
light of reduced/enhanced solubility caused bymutations. Indeed small
sequence variations can produce dramatic effects on the solubility and
the lag times of amyloid formation of amyloidogenic proteins and pep-
tides [51–52]. Several residues including proline, arginine and lysine in-
crease solubility and their incorporations in the ﬂanking regions of
aggregation- prone sequences reduce aggregation propensity and amy-
loid formation [53]. Solubility proﬁles of Ala-H2 peptides (Fig. S3) con-
ﬁrmed these indications since the Ala substitution of two of these
residues in H2A10 and H2A14, that cause lower solubility respect to
the wt sequence, exhibited Tht assays in which sequences resulted al-
ready aggregated at t = 0 (Fig. 2I,L).
2.3. Fibrils characterization of H2-Ala scan peptides
With the aim to gain deeper insights into the role exerted by resi-
dues in the amyloidogenic core of H2 wt we selected three sequences
(H2A5, H2A6 and H2A8) bearing the Ala substitution of aromatic
(Phe268, Tyr271) and branched (Ile 269) residues. Their β-structures
were further analyzed at millimolar concentrations by FTIR and VIS CR
spectroscopies. Subsequently ﬁbrils deriving from these peptides were
analyzed at solid state by polarized optical microscopy (with CR stain-
ing) and WAXS techniques.
FTIR spectra of peptide solutions (~2.3 mM) were recorder in trans-
mission conﬁguration. In Fig. 3A FTIR spectra in the amide I region are
reported for H2 wt, H2A5, H2A6 and H2A8. They show two bands: a
principal maximum at 1637 cm−1 and a minor peak at ~1675 cm−1.
The maximum at 1637 cm−1 is typical of peptides in a β-sheet confor-
mation,whereas the lower peak (~1675 cm−1) indicated an antiparallel
orientation of the β-sheets [54]. From the deconvolution of the FTIR
data, it results that all four peptides have high β-sheet content (~80%
for H2 andH2A5 and ~60% for H2A6 and H2A8 analogs) [55]. FTIR spec-
tra of dried ﬁlms of these peptides resulted quite similar to spectra of
samples in solution (data not shown).
While the UV–vis spectrumof CR alone showed its typicalmaximum
at 490 nm, after the incubation with 1.0 mg/mL of H2A5, H2A6 and
H2A8 peptides for 30 min a signiﬁcant shift of the CR band from 490
to 540 nm was observed for all sequences (see Fig. 3B). The shift of
the maximum clearly indicates the presence in solution of ﬁbrillar ag-
gregates, a similar behavior was previously showed by H2 wt [43].
To speculate on potential differences in themorphology of ﬁbrils we
analyzed those deriving from H2 wt, H2A5 and H2A6 ﬁbrils through
solid state techniques. Notably the sequence H2A8 (Ala/Tyr271) demon-
strated not able to ﬁbril in the same explored conditions conﬁrming the
major aromatic contribution to self-recognition in the ﬁbrillar process.
Both air-dried ﬁlms of peptides stainedwith CR and peptide dried ﬁbrils
containing CR exhibited intense green birefringence when analyzed
with polarized optical microscopy (Fig. 4). Moreover, the dried ﬁbrils,
reported in Fig. S4, show a dendritic spherulite arrangement of category
1 [56] in which they grown radially from the nucleation site, branching
intermittently to maintain a space ﬁlling character. The interference of
growth from the neighboring spherulites resulted in structures with
high density and small size. These spherulites did not shown the typical
“Maltese cross” pattern exhibited for amyloid ﬁbrils of bovine insulin
[57] or of pro-islet amyloid polypeptide (ProIAPP1–48) [58] but a pattern
similar to those observed for crystallizing polymers such as polyethyl-
ene glycol (PEG) or PEG peptides derivatives able to form ﬁbril [59].
Usually spherulites are observed on a long length scale (N1 μm)with di-
ameters generally between 6 and 12nm [57]. Accordingly previousAFM
analysis for H2 wt revealed that the ﬁbril reaches a height of 9.5 ±
0.5 nm after 1 h aggregation [43].
The same ﬁbrils were also analyzed through WAXS investigations
[60] and in Fig. 5 the results of experiments related to H2 wt, H2A5
and H2A6 are summarized: in the top the investigated ﬁbrils are
shown; the collected 2DWAXS patterns, are reported in the middle of
Fig. 5. TheseWAXS proﬁles display the typical “cross-β” diffraction pat-
tern of amyloid ﬁbrils, with a Bragg spacing of 4.8–4.9 Å along the me-
ridional direction and a more diffuse periodicity of ~10 Å in the
equatorial direction, usually ascribed to the staking of these β-sheets
perpendicularly to the ﬁbril axis [61,62]. The 2DWAXS data were cen-
tered, calibrated and radially folded into unidimensional (1D) proﬁles.
Two 1DWAXS patternswere integrated separately along the equatorial
andmeridional directions (white arrows of the 2DWAXS data), report-
ed as red (meridional) and black (equatorial) proﬁles at the bottom of
Fig. 5. The most intense peak of the meridional proﬁles corresponds to
the β-strands distance of 4.76 ± 0.3 Å.
Despite similar morphology of ﬁbrils we investigated potential dif-
ferent orders of amyloids caused by Ala substitutions, to this purpose
the analysis of azimuthal data was carried out. The alignment of the ﬁ-
bers in the X-ray beam was carried out with a photodiode close to the
sample to monitor the transmitted primary beam intensity. The sample
position inwhichwe collectedWAXS data coincides with theminimum
transmitted intensity (center of the ﬁber).
Each 2DWAXS pattern (Fig. 6A) was transformed into polar coordi-
nates (Fig. 6B) with q and azimuth as new axes. Two computing win-
dows were selected and displayed in Fig. 6A as yellow (Δq = 0.65–
0.85 Å-1) and red (Δq=1.25–1.45Å-1) rectangular areas, in correspon-
dence of themost intense equatorial andmeridional reﬂections, respec-
tively. The 2D WAXS data were integrated along each Δq, and the
resulting 1D WAXS azimuthal proﬁles were plotted for each sample in
Fig. 6C (Δq = 0.65–0.85 Å-1) and in Fig. 6D (Δq = 1.25–1.45 Å-1),
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respectively. The full-width-at-half maximum (FWHM) was ﬁtted for
all 1DWAXS azimuthal proﬁles, reported in Fig. 6C–D, and summarized
in Table 2. The analysis of FWHMvalues support an increasing order for
ﬁbrils as follows H2A5 N H2 wtN H2A6 [63].
3. Conclusions
Both in natively unfolded and globular proteins, very short amino
acid stretches are primarily responsible of ﬁbrillation process and are
deﬁned as “hot spots” [64–66]. In the wt NPM1-CTD [67] the core of
the three helix bundle is mainly supported by aromatic interactions by
residues belonging both to the H2 and H3 regions (Tyr271, Phe268,
Phe276, Trp288 and Trp290). On the basis of previous studies we hypoth-
esized that an aggregation could occur upon the structural destabiliza-
tion of the bundle primarily at the interface of H2 and mutated H3
regions and both bioinformatic and experimental investigations sug-
gested a prominent role exerted by H2 as “hot sequence” in the aggre-
gation. Herein we present novel investigations, at solution as well as
ﬁbrillar states, by exploring the entire H2 sequence through a systemat-
ic alanine scanning approach. Solution studies revealed that the frag-
ment 264–271 is crucial for the initial steps of self-recognition
process. Substitutions within this stretch dramatically affect the β-con-
formations and the tendency to aggregate of the H2 region: indeed the
Ala mutations of related amino acids hampered, almost completely, the
aggregation of H2 fragment at micromolar concentrations. In particular
the absence of aromatic residues in this fragment (Phe268 and Tyr271)
enhanced this feature. Circular dichroism and IR spectroscopic analyses
conﬁrmed the concentration dependent conformational changes of the
peptides. To deepen this aspect we structurally characterized ﬁbrils of
H2 wt and other derived peptides bearing Ala in the smallest stretch
268–271. The analysis of amyloid ﬁbrils indicated the formation of
spherulites, that are common structures both for synthetic peptides
[67,68], including a helix–turn–helix peptide [69] and in tissues of pa-
tients with amyloid disorders [57]. They contain a large quantity of
well-deﬁned amyloid ﬁbrils, suggesting that they are formed at least
in part as a consequence of the self-assembly of pre-formed ﬁbrils.
Fig. 3. (A) FTIR spectra in the amide I region (B) UV Vis spectra of H2 wt, H2A5, H2A6 and H2A8 peptides (1.0 mg/mL) with Congo Red. The spectrum of Congo Red is also reported for
comparison.
Fig. 4. Polarized optical microscopy H2A5 ﬁbers images containing CR (A, B) and dried H2 wt (C, D) stained with Congo Red solution onto a glass slide and observed with a Nikon
microscope under bring ﬁeld illumination (A, C) and between crossed polars (B, D).
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WAXS analyses of ﬁbrils of H2 wt, H2A5 and H2A6 Ala conﬁrmed the
presence of themain amyloid structural feature i.e. the cross-β architec-
ture constituted by intermolecular β-sheets with β-strands oriented
perpendicular to the ﬁbril axis [70,71] while azimuthal data of the dif-
fraction patterns [72] were employed allowed to establish a lower
order of the ﬁbril associated to the H2A6 sequence with respect to H2
wt suggesting that the presence of branched Ile269 conferred preferen-
tial packing patterns that, instead, appeared geometrically hampered by
the aromatic side-chain of Phe268. These results conﬁrm that the inter-
digitation of the side chains between β-sheets is crucial for ordered am-
yloid fold. It is likely that the antiparallel arrangement of β-strands
would allow proper orientation of aromatic residues to permit π-inter-
actions and stacking of the side chains. Most probably aromatic resi-
dues, for H2 in antiparallel orientation, are not favorably positioned
thereby reducing the order of amylodogenic state [73]. Recently a direct
correlation between amyloid-like aggregation and cancer was demon-
strated for p53/p73 mutants [74,75], with relevant therapeutic ap-
proaches [76]. With the aim to investigate a potential link between
aggregation of NPM1 and AML and the molecular mechanisms of this
severe and widespread pathology, work is now in progress in our labo-
ratory on the biophysical characterization of other AML-mutated se-
quences in the H3 region and are preparing by chemical synthesis the
entire mutated-CTDs of NPM1. In conclusion our investigations could
be useful to deepen the knowledge of AML molecular mechanisms
and the role of cytoplasmatic aggregates of NPM1c+. Indeed interfering
with the levels or the oligomerization status of NPM1may inﬂuence its
capability to properly build up the nucleolus in NPM1- mutated AML
cells. Many therapeutical approaches targetingNPM1 propose the iden-
tiﬁcation of molecules able to interfere with its biological functions: its
subcellular localization, its oligomerization properties or ways driving
to its degradation [39].
3.1. Experimental procedures
3.1.1. Peptide synthesis
Reagents for peptide synthesis were from Iris Biotech (Germany).
Solvents for peptide synthesis and HPLC analyses were from Romil
(Dublin, Ireland); reversed phase columns for peptide analysis and the
LC-MS system were from ThermoFisher (Waltham, MA). Solid phase
peptide syntheses were performed on an automated multichannel syn-
thesizer Syro I (Multisynthech, Germany). Preparative RP-HPLC was
carried out on a Shimadzu LC-8A, equippedwith a SPD-M10AVdetector
and with a Phenomenex C18 Jupiter column (50 × 22 mm ID; 10 μm).
LC-MS analyses were carried out on a LCQ DECA XP Ion Trapmass spec-
trometer equipped with an OPTON ESI source, operating at 4.2 kV nee-
dle voltage and 320 °C with a complete Surveyor HPLC system,
comprised of MS pump, an autosampler and a photo diode array
(PDA). The peptides reported in Table 1 were synthesized following
standard Fmoc strategies on a 50 μmol scale [77]. To better mime pro-
tein regions the peptides investigated in this study were acetylated
and amidated at the extremities. Rink-amide resin (substitution
0.5 mmol/g) was used as solid support. Activation of amino acids was
achieved using HBTU/HOBt/DIEA (1:1:2), whereas Fmoc deprotection
was carried out using a 20% (v/v) piperidine solution in DMF. Peptides
Fig. 5.WAXS analysis of H2wt, H2 A5 and H2A6: Top: picture of the analyzed ﬁbers; Middle: 2DWAXS ﬁber diffraction data; Bottom: 1DWAXS ﬁber diffraction proﬁles (red: meridional
proﬁle; black equatorial proﬁle).
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were removed from the resin by treatment with a TFA:TIS:H2O (90:5:5,
v/v/v) mixture for 90 min at room temperature; then crude peptides
were precipitated in cold ether, dissolved in a water/acetonitrile (1:1,
v/v) mixture and lyophilized.
Productswere puriﬁed by RP-HPLC applying a linear gradient of 0.1%
TFA CH3CN in 0.1% TFA water from 5% to 65% over 12min using a semi-
preparative 2.2 × 5 cmC18 column at a ﬂow rate of 20mL/min. Peptides
and purity and identity were conﬁrmed by LC-MS. Puriﬁed peptides
were lyophilized and stored at−20 °C until use.
3.1.2. Far-UV CD spectroscopy
Samples were prepared by dilution of freshly prepared stock solu-
tions (2 mM peptide on average), whose peptide concentrations were
determined by UV absorbance employing a ε275 value of 1390 cm−1
M−1 (except for H2A8). CD spectrawere recorded on a Jasco J-815 spec-
tropolarimeter (JASCO, Tokyo, Japan). CD spectra were registered at
25 °C in the far-UV region from 190 to 260 nm. Other experimental set-
tings were: 20 nm/min scan speed, 2.0 nm band width, 0.2 nm resolu-
tion, 50 mdeg sensitivity, and 4 s response. Each spectrum was
obtained averaging three scans, subtracting contributions from corre-
sponding blanks and converting the signal to mean residue ellipticity
([Θ]res) in units of deg cm2 dmol−1. Peptide concentration was
100 μM and a 0.1 cm path-length quartz cuvette was used. CD spectra
were acquired in 10 mM borate buffers pH 10.0 [78,79].
3.1.3. ThT ﬂuorescence assay
Tht assays were carried out at 100 μM of both ThT and peptides at
25 °C. ThT ﬂuorescence wasmeasured using a Varian Cary Eclipse spec-
troﬂuorimeter (Varian, California, USA) and a cell of 10mmpath-length
quartz cuvette, under magnetic stirring. Measurements were collected
every 1–5 minfor 300–400 min, using excitation and emission wave-
lengths of 440 and 450–600 nm, respectively.
3.1.4. Fourier transform infrared spectroscopy (FTIR)
FT-IR characterization was performed on peptides in solution
(~2 mM) and at the solid state. FT-IR spectra were collected with a
Jasco FT/IR 4100 spectrometer (Easton, MD) in an attenuated total re-
ﬂection (ATR) mode and using a Ge single-crystal at a resolution of
4 cm−1. All the spectral data were processed using built-in software.
Spectra were collected in transmission mode and then converted in
emission. Each sample was recorded with a total of 100 scans with a
rate of 2 mm·s−1 against a KBr background.
3.1.5. Congo Red spectroscopic assay
UV–vis spectra of Congo Red (CR) alone or incubated with a peptide
solution (1.0 mg/mL, ~500 μM) were carried out on Thermo Fisher Sci-
entiﬁc Inc (Wilmington, Delaware USA) Nanodrop 2000c spectropho-
tometer equipped with a 1.0 cm quartz cuvette (Hellma). A stock
solution of CR (3.5 mg in 500 μL) was freshly prepared in 10 mM phos-
phate buffer pH 7.4 and ﬁltered through 0.2 μm syringe immediately
prior to use. A small aliquot (5 μL) of this solution was diluted with
the buffer at 12.5 μM ﬁnal concentration or with H2A5, H2A6 or H2A8
peptide solutions. These solutions were left under stirring for 30 min
Fig. 6. 2DWAXS analysis: (A) 2DWAXS ﬁber diffraction of H2A ﬁber; (B) same 2DWAXS ﬁber diffraction pattern shown in (A), here reported in polar coordinates (q, azimuth); (C) 1D
WAXS azimuthal proﬁles obtained by integration along Δq= 0.65–0.85 Å-1 of the rectangular region of the 2DWAXS pattern in (B), marked in yellow; (D) 1DWAXS azimuthal proﬁles
obtained by integration along Δq = 1.25–1.45 Å-1 of the rectangular region of the 2D WAXS pattern in (B), marked in red.
Table 2
FWHM of the 1DWAXS proﬁles, reported in Fig. 6C and D.
Fibril Equatorial (rad) Meridional (rad)
H2A5 0.63 0.54
H2 0.88 0.71
H2A6 1.04-1.55 0.73
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at room temperature and then the UV–vis spectra were recorded be-
tween 400 and 700 nm at room temperature and background was
subtracted.
3.1.6. Congo Red staining and polarized optical microscopy
Dried ﬁlms of H2, H2A5 and H2A6 peptides were obtained placing
30 μL of the peptide (0.25 wt.%), dissolved in deionized water, onto a
glass slide and left drying at room temperature.
The air-dried samples were stained with 50 μL of a freshly prepared
CR solution. This solution was prepared adding a saturating amount of
CR in ethanol containing 20% of NaCl saturated water. After the deposi-
tion of CR on the air-dried sample, the extra solution was quickly re-
moved from the glass slide with a ﬁlter paper. CR containing ﬁbrils
were prepared, according to the stretch frame method [80], described
in the Wide-Angle X-ray Scattering section, adding 4 μL of CR staining
solution to 100 μL of peptide solution. Both air-dried samples on glass
slide and CR containing ﬁbrils were observed under bright ﬁeld illumi-
nation and between crossed polars using a Nikon AZ100 microscope.
3.1.7. Wide-angle X-ray scattering
Fibril diffractionWAXS patternswere recorded from stalks prepared
by the stretch frame method [80]. Brieﬂy, a droplet (10 μL) of peptide
aqueous solution (3 wt.%) was suspended between the ends of a wax-
coated capillary (spaced 2 mm apart). The droplet was allowed to dry
gently at room temperature overnight to obtain oriented ﬁbrils.
The WAXS experiments were performed with the laboratory set-up
of the XMI-Lab1–2 equipped with Fr-E+ SuperBright rotating anode
copper anodemicrosource (Cu Kα, λ=0.15405 nm, 2475W),multilay-
er focusing optics (Confocal Max-Flux; CMF 15–105) and three-pinhole
camera (Rigaku SMAX-3000). An image plate (IP) detector with 100 μm
pixel size was placed at 10 cm from the sample and calibrated bymeans
of the Si NIST standard reference material (SRM 640b) [81,82].
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Cross-beta nanostructures based on 
dinaphthylalanine Gd-conjugates 
loaded with doxorubicin
Carlo Diaferia1, Eliana Gianolio2, Teresa Sibillano3, Flavia Anna Mercurio4, Marilisa Leone4, 
Cinzia Giannini3, Nicole Balasco4, Luigi Vitagliano4, Giancarlo Morelli1 & Antonella Accardo1
Very recently we proposed novel di- and tetra-phenylalanine peptides derivatized with gadolinium 
complexes as potentials supramolecular diagnostic agents for applications in MRI (Magnetic Resonance 
Imaging). It was observed that in very short FF dipeptide building blocks, the propensity to aggregate 
decreases significantly after modification with bulky moiety such as Gd-complexes, thus limiting their 
potential as CAs. We hypothesized that the replacement of the Phe side chain with more extended 
aromatic groups could improve the self-assembling. Here we describe the synthesis, structural and 
relaxometric behavior of a novel water soluble self-assembled peptide CA based on 2-naphthylalanine 
(2Nal). The peptide conjugate Gd-DOTA-L6-(2Nal)2 is able to self-assemble in long fibrillary 
nanostructures in water solution (up to 1.0 mg/mL). CD and FTIR spectroscopies indicate a β sheet 
secondary structure with an antiparallel orientation of single strands. All data are in good agreement 
with WAXS and SAXS characterizations that show the typical “cross-β pattern” for fibrils at the solid 
state. Molecular modeling indicates the three-dimensional structure of the peptide spine of aggregates 
is essentially constituted by extended β-sheet motifs stabilized by hydrogen bonds and hydrophobic 
interactions. The high relaxivity of nanoaggregates (12.3 mM−1 s−1 at 20 MHz) and their capability to 
encapsulate doxorubicin suggest their potential application as supramolecular theranostic agents.
Since its identification as recognition motif of the Alzheimer’s β-amyloid peptide, the aromatic homodimer 
diphenylalanine (FF) has been largely studied for its capability to self-organize into a large variety of nanos-
tructures (NSs) from nanotubes to nanofibrils, vesicles and organogels1, 2. The morphological variability of NSs 
structurally depends on the experimental procedure adopted for their preparation such as the polarity of the sol-
vent3, the pH value4 or temperature5. In addition, chemical modifications of the aromatic homodimer, including 
the introduction of a thiol group or of a fluorenylmethyloxycarbonyl (Fmoc) group, can cause variations in the 
morphology of the aggregate2. The morphology of the FF-NSs seems to be determinant for their physicochemical 
properties. Mechanical, electrochemical and optoelectronic properties of FF-NSs2 leave envisage a their potential 
application in nanofabrication and industrial fields. However, only a few studies have been devoted, until now on 
their potential abilities in the biomedical field2. Moreover, also their applications in the diagnostic field remains 
unexplored, overall for the low intrinsic water solubility of these derivatives. Very recently we described the first 
example of supramolecular aggregates based on PEGylated cationic di-phenylalanine and tetra-phenylalanine 
conjugates as enhanced contrast agents (CAs) for diagnostic applications in Magnetic Resonance Imaging (MRI)6. 
These conjugates contain two (FF or F2) or four (F4) phenylalanine residues for promoting the self-assembly, a 
branched or linear bifunctional chelating agent such as DOTA (1,4,7,10-tetraazacyclododecane-N,N,N,N-tetraa
cetic acid) or DTPA (diethylenetriamine penta-acetate), for achieving the kinetically stable and thermodynami-
cally inert coordination of the gadolinium paramagnetic ion and an ethoxylic linker at six PEG units (L6) between 
the chelating agent and the oligopeptide. In zwitterionic FF homodimer the self-assembling pathway is driven by 
head-to-tail hydrogen-bonding between the charged termini of neighbouring dipeptides and “T-shaped” con-
tacts between the amino acid side-chains7, 8. On the contrary, in capped uncharged dipeptide FF the loss of the 
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head-to-tail hydrogen-bonding occurs. Nevertheless, the aromatic stacking interactions allow for recovering the 
self-aggregation behaviour9. However, we observed that in very short peptide building blocks the propensity 
to aggregate decreases significantly after modification with bulky moiety such as Gd-complexes6. On the con-
trary F4 conjugates, with a more extended aromatic framework, keep their capability to self-aggregate giving 
well-structured nanofibres, also after the complexation of the gadolinium ions. These results point out that the 
elongation of the aromatic framework from two to four residues can represent a successful strategy to recover 
the aggregation propensity. As an alternative, the replacement of the Phe side chain with more extended aromatic 
groups could increase the self-assembling propensity of these compounds. Here, we report the synthesis of a 
novel peptide conjugate DOTA-L6-(2Nal)2 (Fig. 1a) obtained replacing the phenylalanine with the non-coded 
amino acid 2-naphthylalanine (2Nal). Both the aromatic conjugate DOTA-L6-(2Nal)2 (mentioned as 2Nal2) and 
its gadolinium complex Gd-DOTA-L6-(2Nal)2 (reported as Gd-2Nal2) are able to self-assemble spontaneously 
in water solution. The morphology of the supramolecular assemblies was evaluated with transmission electron 
microscopy (TEM). A deep characterization of nanostructures at the nano and atomic scale was achieved both in 
solution and at the solid state with SAXS/WAXS, fluorescence, 1HNMR, Fourier Transform Infrared (FTIR), cir-
cular dichroism (CD), and molecular modelling. The relaxivity properties of these nanostructures were studied. 
Moreover, fluorescence spectroscopy and 1HNMR studies and optical microscopy images provide the evidence 
for their capability to encapsulate anticancer drugs such as doxorubicin.
Results and Discussion
Design synthesis and fluorescence studies. The very short peptide conjugate Gd-DOTA-L6-F2 was 
previously synthesized and characterized in our previous work6. Physicochemical characterization pointed out 
that DOTA-L6-F2 is able to weakly self-aggregate and only before gadolinium coordination. The aggregation is 
mediated by π-stacking between the aromatic side chains of phenylalanine residues. Due to steric repulsion of 
the Gd-complex, after metal coordination, the dipeptide seems unable to keep π-π interactions. The replacement 
of the phenyl group with a more extended aromatic one (such as 2-naphthyl group) could in principle restore the 
stacking. In this perspective, we synthesized and fully characterizedDOTA-L6-(2Nal)2 (here indicated as 2Nal2), 
an analogue of the parental DOTA-L6-F2, in which the two phenylalanine residues were replaced with the non-
coded amino acid 2-naphthylalanine (2-Nal). Peptide synthesis of 2Nal2 was achieved according to the standard 
protocols of the solid phase synthesis with Fmoc/tBu strategy, the peptide was then characterized with LC-MS 
(see Figure S1A) and 1H-NMR. After purification, the DOTA chelating agent was complexed with lanthanide 
metal ions, i.e. gadolinium (Gd) or lanthanum (La) for MRI or NMR studies, respectively. Nevertheless in spite 
of the higher hydrophobicity of the naphthyl group with respect to the phenyl one, the Gd-2Nal2 derivative keeps 
high water solubility, and the solutions remain perfectly clear up to 50 mg/mL; whereas a further increase of the 
concentration causes its hydrogelation. Lowering the temperature below 5 °C, fast hydrogel formation occurs 
yet at 20 mg/mL. The peptide conjugate Gd-2Nal2 shows high stability also in physiological conditions (10 mM 
phosphate buffer 0.9 wt.% NaCl at pH 7.4) (see Figure S2). Self-organization of the peptide conjugates at the 
atomic level was further characterized also in solution with fluorescence, UV-Vis, 1HNMR, CD and FTIR spec-
troscopies. In Fig. 1b and c are reported fluorescence spectra of 2Nal2 and Gd-2Nal2 at several concentrations 
(from 0.025 to 20.0 mg/mL) obtained by exciting the samples at 280 nm, which corresponds to the wavelength of 
absorption for the 2-naphthylalanine (Figure S1B). From ispection of Fig. 1b, the typical emission spectrum of 
the 2-naphthyl group with three maxima at 325, 340 and 355 nm, respectively, can be detected. The fluorescence 
intensity of 2Nal2 (see Fig. 1b) increases gradually in the range of concentration between 0.025 and 0.2 mg/mL. 
After this concentration a progressive intensity decrease, attributable to the stacking of the aromatic rings, occurs. 
Since 2.0 mg/mL, the fluorescence intensity is very low. From ispection of the inset in Fig. 1b a weak peak, that 
is centered between 380–430 nm and indicative of excimer formation, is visible. These results suggest that the 
peptide derivative begins to undergo self-aggregation phenomena at 0.2–0.5 mg/mL (150–375 μM). However, the 
appearance of the excimer peak above 2.0 mg/mL leaves us to hypotize that very stable aggregates can be formed 
above 2.0 mg/mL. A similar behaviour was observed afterthe gadolinium coordination (see Fig. 1c). However in 
Gd-2Nal2, both the decrease of the fluorescence intensity (0.1 mg/mL) and the appearance of the excimeric peak 
(1.0 mg/mL) were observed at lower concentration with respect to 2Nal2, thus confirming that the neutralization 
of the negative charges on the chelating agent, after the Gd-coordination, induces a better self-assembling in these 
peptide conjugates. Determination of the critical aggregation concentration (CAC) value of Gd-2Nal2 was carried 
out using a fluorescence-based method, in which ANS was used as fluorescent probe. This dyeis completely silent 
at the fluorescence in aqueous solution, but emits in the range 460–480 nm when is surrounded by a hydrophobic 
environment10. A solution of ANS in cuvette (20 μM) was titrated with Gd-2Nal2 and the fluorescence intensities 
maximum measured at 470 nm have been plotted in Figure S3. CAC value, determined from the graphical break-
point, is ∼6.70 10−4 M (0.86 mg/mL). This value is 10-fold higher than the CAC value (5.1·10−5 M, 0.076 mg/
mL) previously found for tetraphenylalanine Gd-complex Gd-DOTA-L6-F4. This consideration suggests that the 
replacement of the phenyl ring with the naphthyl one allows to increase the aggregation propensity with respect 
to diphenylalanine conjugates (Gd-DOTA-L6-F2). However from the comparison of CAC values (Gd-DOTA-
L6-F2 > Gd-DOTA-L6-Nal2 > Gd-DOTA-L6-F4) it emerges that the increase of the number of aromatic residues6 
causes a better aggregation with respect to the replacement of Phe with more extended aromatic group.
NMR studies. This trend was also confirmed by 1HNMR measurements (see Figure S4). We have recently 
analyzed the conformational properties of DOTA-L6-F4 in aqueous solution by mono- and multi-dimensional, 
homo- and hetero-nuclear NMR techniques11. In the present work we have used a similar approach and thus 
implemented 1D [1H] and 2D [1H, 1H] NMR spectroscopy to study two different compounds: DOTA-L6-F2 
and 2Nal2 analogue in absence and in presence of the DOTA coordinated metal ion lanthanum (III), La. We 
used lanthanum (III) since it gives rise to a NMR “easy to handle” diamagnetic complex. Both DOTA-L6-F2 and 
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Figure 1. (a) Schematic representation of di-aromatic compounds obtained by SPPS with Fmoc chemistry. 
Conjugates contain an aromatic framework consisting of two 2-naphthylalanine (2-Nal) residues, an ethoxylic 
linker (L6) formed by six PEG units and bifunctional and macrociclic chelating agent (DOTA) for gadolinum 
(III) coordination. (b and c) Fluorescence spectra of 2Nal2 and Gd-2Nal2 in 0.025–20.0 mg/mL concentration 
range. Samples were excited at λ = 280 nm and recorded between 290 and 500 nm.
www.nature.com/scientificreports/
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2Nal2 present low aggregation propensities. The process of resonance assignments of the two molecules could 
be easily achieved at a concentration equal to 1 mM (see Supplemental Material Tables S1, S2 and Figure S5). 
For the DOTA-L6-F2 relevant changes in the spectra, indicating occurrence of potential aggregation processes, 
take place at a concentration higher than 1.2 mg/mL (Figure S4a-left panel). In detail by comparing spectra 
recorded at 0.3 mg/mL and 5.0 mg/mL chemical shift changes appear relevant in the spectral regions between 
8.0 and 8.2 ppm, where signals from HN amide protons are present and between 3.0 and 3.5 ppm where several 
peaks overlap (Table S1). However, even at the highest investigated concentrations, peaks in the NMR spectra 
remain rather sharp thus pointing towards formation of small size aggregates. Once complexed with La (III) the 
DOTA-L6-F2 presents similar weak aggregation propensity (Figure S4b-left panel). For 2Nal2 in the absence of 
coordinated metal ions, from 0.1 mg/mL till 5.0 mg/mL, we cannot reveal significant aggregation as the signals 
in the NMR spectra do not become broad or change their chemical shifts (Figure S4a-rigth panel). Once La (III) 
is inserted in 2Nal2 the aggregation tendency increases and line broadening starts to affect the spectra thus indi-
cating formation of aggregated species already at 0.8 mg/mL concentration; at 2.5 mg/mL concentration exten-
sive line broadening causes partial signal loss thus indicating the presence of larger aggregates (Figure S4b-right 
panel). Aggregation as witnessed by line broadening is affecting all signals in the NMR spectrum of 2Nal2 (See for 
instance the HN amide and aromatic protons regionin Figure S4b-right panel). This different aggregation property 
in presence and absence of the metal ion likely indicates that La (III) by neutralizing DOTA negative charges is 
favoring intermolecular interaction by lowering electrostatic repulsions. Moreover, NMR data show that La-2Nal2 
has a higher tendency to aggregate with respect to La-DOTA-L6-F2; this outcome can be easily explained by the 
larger aromatic patches present in the former molecule which are likely favoring larger intermolecular π-stacking 
interactions. These data indicate consequently that the Gd-2Nal2 may work better as a potential MRI contrast 
agent than Gd-DOTA-L6-F2.
Secondary structure characterization. Secondary structure assumed by 2Nal2 and Gd-2Nal2, was 
investigated by Circular Dichroism (CD) and by Fourier Transform Infrared (FTIR) spectroscopies. CD spectra, 
reported in Fig. 2a and b, were recorded both below and above the self-aggregation concentration. Independently 
from the coordination of the metal, 2Nal2 peptide shows a similar dichroic signature: at 0.5 mg/mL, there are two 
minima around 205 and 218 nm and a maximum at 232 nm. This dichroic signature is perfectly identical and 
Figure 2. Selected Far-UV CD spectra of 2Nal2 (a) and Gd-2Nal2 (b) in a concentration range of 0.5–20.0 mg 
mL−1. Spectra are recorded between 280 and 195 nm.
www.nature.com/scientificreports/
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symmetric to that previously observed for tetra-phenylalanine conjugates6. The two minima are attributable to 
the stacking between the 2-naphthyl aromatic rings, whereas the maximum is typically observed in presence of 
β-structure. Above this concentration value a progressive red-shift of the maximum (up to 340 nm), as function of 
the peptide concentration, occurs. This spectral shift is accompanied by the decrease of the maximum and by the 
presence of an isosbestic point. Both the shift and the decrease of the maximum indicate the formation in solution 
of nanostructures with a dominant β-sheet arrangement. Further information on the secondary structural organ-
ization of the peptide conjugates was achieved using FTIR spectroscopy in the region of the amide I vibrational 
band (1600–1700 cm−1). FTIR spectra of 2Nal2 and Gd-2Nal2 at 5.0 mg/mL in the amide I region are reported in 
Fig. 3a. Spectrum of Gd-2Nal2 as dried film is also reported. Gd-2Nal2 FTIR spectra, both at the solid state and 
in solution, show a dominant peak around 1638 cm−1, expected for β-sheet formation. In addition, both spectra 
have a secondary peak around 1680 cm−1, that is normally observed for antiparallel orientation of the β-sheet. By 
comparing these spectra with spectrum of 2Nal2, it appears a very broad peak at 1642 cm−1.
Congo Red spectroscopic assay. The high tendency of Gd-2Nal2 to self-aggregate in amyloid-like fibril-
lary nanostructures in solution was confirmed by Congo Red (CR) staining assay. CR is a well-known azoic 
dye, used as indicator of the occurrence of amyloid like fibrils12. CR alone exhibits in UV-Vis a typical absorb-
ance maximum at 490 nm (see Fig. 3b). When incubated with fibrillary aggregates, its spectral profile changes 
and a shift of the CR band from 490 to 540 nm is expected. In our experiment, depicted in Fig. 3b, CR UV-Vis 
Figure 3. (a) FTIR spectra of 2Nal2 and Gd-2Nal2 in the amide I region at 5.0 mg/mL. (b) UV-Vis spectra of 
2Nal2 and Gd-2Nal2, stained with Congo Red at 0.1 and 1.0 mg/mL. The spectrum of Congo Red is also reported 
for comparison.
www.nature.com/scientificreports/
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maximum undergoes a clear shift after incubation with Gd-2Nal2 at 2.5 mg/mL. Instead, any variation or a slight 
shift can be evidenced for CR incubated with 0.1 and 1.0 mg/mL, respectively.
Materials characterization and molecular modelling. Self-assembled peptide conjugate at 5.0 mg/mL, 
as free base or as metal complex, was initially characterized using TEM. TEM images reported in Fig. 4a and b 
demonstrate the assembling of both 2Nal2 and Gd-2Nal2 in long fibrillary nanostructures. On the other hand, 
TEM images of Gd-DOTA-L6-F2 do not show any supramolecular aggregate (data not shown). To further analyze 
the supramolecular morphology of 2Nal2 and Gd-2Nal2 at the micro and nano scale, WAXS and SAXS meas-
urements were performed on dried fibres prepared according to the stretch frame method13. Figures 5a,b and 
6a,b present the two-dimensional (2D) WAXS and SAXS patterns collected on the 2Nal2 and Gd-2Nal2 samples, 
respectively. The 2D patterns, once centered, calibrated and radially folded into 1D profiles, are shown in Figs 5c,d 
and 6c,d, respectively. The low-q region of each WAXS pattern is displayed separately in Figs 5e and 6e to better 
visualize the diffraction peaks. The red and black WAXS/SAXS profiles correspond to the meridional and equa-
torial directions marked by the red arrows in panels (b). The position of most intense meridional and equatorial 
diffraction peaks are reported in Table 1. Both fibers present the classic cross-β fiber 2D WAXS diffraction pattern 
with the β-strands distance at dβ1 = 4.7 ± 0.3 Å along the meridional direction (fiber axis). The 2D SAXS patterns 
display a clear diffraction structure. The most intense peaks lay along the equatorial direction, for both samples. 
The presence of a diffraction pattern both in SAXS and in WAXS is fingerprint of a hierarchical organization of 
the molecules in fibers from the atomic to the nanoscale. The most intense SAXS peak in the Gd-2Nal2 sample, 
labelled as e1 in Fig. 6d, corresponding to d = 57 Å, almost disappears in the 2Nal2, where the most intense SAXS 
peak occurs at d = 48 Å (e2 equatorial peak in Fig. 5d). We estimated the full-width-at-half-maximum along the 
azimuth angle for the e1 and e2 peaks in the insets of Figs 5d and 6d, which are FWHM (e1-Gd-2Nal2) = 27° and 
FWHM (e2-2Nal2) = 19°, respectively. Furthermore, for both aggregates intense equatorial peaks were observed 
in WAXS experiments (d range 21–25 Å). Although peaks in this region occur in both 2Nal2 and Gd-2Nal2 sam-
ples their location and intensity are not identical. This observation suggests that the metal complexation of 2Nal2 
induces some structural rearrangements. Altogether, SAXS and WAXS experiments provide some interesting 
clues on the organization of the peptide spine of these assemblies at different structural level. In particular, (a) the 
meridional peak at 4.7 Å atomic distance clearly indicates a cross-β structure in which the β-strands run perpen-
dicular to the fiber axis, (b) the equatorial reflections at 21–25 Å likely represent regularities within the inter-sheet 
distances, and (c) the peaks at d = 48 and 57 Å provide some preliminary information on the nanofiber organi-
zation. In this framework, we performed molecular modeling analyses to gain insights into the atomic structure 
of the peptide moiety of these assemblies using the programs Coot and Pymol14, 15. Accordingly, we generated 
antiparallel cross-β models, which were stabilized by four inter-strand hydrogen bonds, to check whether Nal 
side chains could contribute to the stabilization of this motif. In particular, we evaluated the interactions between 
Nal side chains of consecutive β-strands within the cross β-sheet by considering all its possible rotameric states. 
We found combinations of rotameric states that maximized hydrophobic interactions between side chains of 
consecutive strands (Fig. 7a). Then, we evaluated how different β-sheets could laterally interact. We found that 
optimal interactions between the Nal side chains of facing β-sheets could be established when the inter-sheet dis-
tance was about 16–17 Å (Fig. 7b). Notably, although as minor peaks, equatorial reflections with this spacing were 
observed for both samples (Figs 5e and 6e). However, as mentioned above, the largest equatorial peaks that likely 
correspond to inter-sheet distances present spacings with d = 21–25 Å. This observation suggests that there are 
multiple ways in which β-sheets interact in these assemblies and that other species may mediate these inter-sheet 
interactions. In this scenario, it cannot be excluded that the hydrophobic rings of individual Nal molecules inter-
calate within the hydrophobic surfaces of facing β-sheets (Figure S6). In conclusion, our observations suggest that 
the basic structural elements of these assemblies is a cross β-sheet that is stabilized by both the hydrogen bonding 
Figure 4. Selected TEM images for 2Nal2 (a) and Gd-2Nal2 (b) at 5.0 mg/mL.
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Figure 5. 2Nal2 fiber at solid state: (a,b) 2D WAXS and SAXS data; (c,d) 1D WAXS and SAXS profiles (red and 
black corresponding to the meridional and equatorial directions) as obtained once the corresponding 2D WAXS 
(a) and SAXS (b) data are centered, calibrated and radially folded; the inset in panel (d) refers to the equatorial 
e2 reflection, with an estimated FWHM (e2-2Nal2) = 19°; (e) expanded WAXS region marked by a dotted 
rectangle in (c).
Figure 6. Gd-2Nal2 fiber at solid state: (a,b) 2D WAXS and SAXS data; (c,d) 1D WAXS and SAXS profiles (red 
and black corresponding to the meridional and equatorial directions) as obtained once the corresponding 2D 
WAXS (a) and SAXS (b) data are centered, calibrated and radially folded; the inset in panel (d) refers to the 
equatorial e1 reflection, with an estimated FWHM (e1-Gd-2Nal2) = 27°; (e) expanded WAXS region marked by 
a dotted rectangle in (c).
www.nature.com/scientificreports/
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and hydrophobic interactions established by Nal aromatic side chains. The larger size of the Nal hydrophobic side 
chain compared to Phe makes dipeptide cross β-sheets formed by the former residues stable enough to generate 
well-defined aggregates at microscale level. Finally, individual β-sheets can then mutually interact in different 
ways to generate the structural variability of the lateral packing observed in these aggregates.
Water proton relaxation measurements. The paramagnetic relaxivity (r1p) of Gd (III) complexes is 
given by:
τ∝ =r 1
T
K f ( )
(1)
1p
1M
H R
where K is a constant related to the strength of the dipolar interaction between the protons and the electronic 
magnetic moment, and τR is the correlation time associated with the reorientation of the Gd-H magnetic vector. 
This means that slowly moving high molecular weight systems are endowed with higher relaxivity than rap-
idly reorienting low molecular weight ones. In the case of self assembling Gd-containing systems, the extent of 
aggregation may be evaluated through the measure of the water proton longitudinal relaxation rate of its aque-
ous solution. In Fig. 8 are reported the NMRD (Nuclear Magnetic Resonance Dispersion) profiles of Gd-2Nal2 
acquired at 21.5 MHz (0.5 T) and 298 K as a function of the complex concentration. The enhancement in relax-
ivity indicates that Gd-2Nal2 starts to self-aggregate at very low concentration (ca. 1.0 mg/mL), confirming the 
values determined by fluorescence spectroscopy and 1H-NMR. At concentrations higher than 10–15 mg/mL the 
relaxivity assumes an almost stable value which corresponds to the system in the completely aggregated form. By 
analyzing the profile of the relaxivity data as a function of the applied field strength (NMRD - Nuclear Magnetic 
Relaxation Dispersion) it is possible to obtain an accurate determination of the reorientational correlation time 
(τR)16, that is strictly related to the molecular size of the investigated system. NMRD profiles were acquired below 
(black circles) and above (white ones) the CAC values determined by ANS titration and 1HNMR. In Fig. 8b the 
NMRD profiles of Gd-2Nal2 at 1.0 and 25.0 mg/mL concentrations are reported and compared to those of the cor-
responding di-phenylalanine conjugate Gd-DOTA-L6-F2 at the same concentrations. Data were analyzed using 
the Solomon-Bloembergen-Morgan model17, 18, considering one water molecule in the inner coordination sphere 
(q = 1) and fixing the exchange lifetime (τM) to a reliable value (700 ps) on the basis of those previously reported 
for mono-amido DOTA derivatives19–22. The quantitative analysis of the NMRD profile of the aggregated form 
was not satisfactory when the simple inner- outer-sphere model was used, so the Lipari-Szabo approach was 
used for the description of the rotational dynamics. This model allows one to take into account the presence ofa 
certain degree of internal rotation superimposed on the overall tumbling motion23, 24. These two types ofmotion, a 
relatively fast local rotation of the coordination cage about the linker to the peptide scaffold superimposed on the 
global reorientation of the system, are characterized by different correlation times: τRl and τRg, respectively. The 
degree of correlation between global and local rotations is given by the parameter S2, which takes values between 
0 (completely independent motions) and 1 (entirely correlated motions). Both the shape of the profiles and the τR 
values determined from the fitting of the experimental results (Table 2) validate the hypothesis of the formation of 
aggregates for Gd-2Nal2 at 25.0 mg/mL. On the contrary, the system is in the monomeric state when it is dissolved 
in solution at 1 mg/mL concentration. In the case of Gd-DOTA-L6-F2, both qualitative and quantitative analysis 
confirm the inability of the system to self-aggregate even at high concentration. The quantitative analysis of the 
Label
2-Nal Gd-2Nal2
q (Å−1) d (Å) q (Å−1) d (Å)
e1 0.11 57 0.11 57
e2 0.13 48 0.18 35
e3 0.15 42 0.24 26
e4 0.26 24 0.26 24
e5 0.3 21 0.28 22.5
e6 0.4 16 0.29 22
e7 — 0.34 18.5
e8 — 0.40 16
e9 — 1.35 4.5
e10 1.94 3
2.23 2.8
m1 0.11 57 0.11 57
m2 0.125 50 0.17 37
m3 0.14 45 0.22 28.5
m4 1.28 5 0.26 24
m5 1.34 4.7 0.28 22.5
m6 — 1.32 4.75
m7 — 1.9 3.3
Table 1. q positions, and corresponding d = 2π/q values, of meridional and equatorial reflections for the 2-Nal 
and Gd-2Nal2 fibers. The error on the d values amounts to ±0.3 Å.
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Figure 7. Three-dimensional model of the assembly formed by the peptide moiety of 2Nal2/Gd-2Nal2. In panel 
(a) the cross β-structure of a single β-sheet is reported. In the inset the extensive hydrophobic interactions 
established by Nal side chains are highlighted. The possible direct interactions between two facing β-sheets is 
reported in panel (b).
Figure 8. (a) Longitudinal proton relaxivity of Gd-DOTA-L6-(2Nal)2 measured at 21.5 MHz (0.5 T) and 298 K 
as a function of the concentration of the Gd-complex. (b) NMRD profiles of Gd-DOTA-L6-(2Nal)2 (1.0 mg/
mL (●) and 25.0 mg/mL (○)) compared to those of Gd-DOTA-L6-F2 (1.0 mg/mL (■) and 25.0 mg/mL (□)). 
Experimental data points were measured on aqueous solutions of the Gd-complexes at 298 K. The data refer to 
1 mM concentration of the paramagnetic complexes.
www.nature.com/scientificreports/
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NMRD profiles indicates that both the local and the global rotational correlation times (Table 2) are significantly 
increased as compared to the τR value of the Gd-complex in the monomeric form, whereas the S2 value is rela-
tively low (S2 = 0.23), suggesting great flexibility of Gd-coordination cage around the oxoethylenic linker.
Doxorubicin loading and release. In order to prepare a potential theranostic agent, we assayed to incor-
porate cytotoxic doxorubicin (DOX) model drug in the Gd-2Nal2 paramagnetic nanostructures. DOX is an estab-
lished anticancer agent clinically effective for the treatment of many cancertypes (breast and ovarian cancers). The 
incorporation and release of DOX into nanostructures was estimated by fluorescence spectroscopy (Figures S7 
and S8). The addition of increasing amounts of the peptide conjugate to the DOX solution causes a progressive 
decrease of the fluorescence intensity of DOX (Figure S7a). This quenching effect is attributable to the electro-
static interaction between the aromatic ring of the anthracycline with the naphthylalanine one. By plotting the 
fluorescence intensity in the maximum at 590 nm as function of the Gd-2Nal2 concentration (Figure S7b) we 
estimated that gDrug/gPeptide is 0.028 (∼60 μg of DOX for ∼2.0 mg of peptide). The leakage assay, reported in Fig. 8 
indicate a very low efflux of DOX across the peptide aggregate (∼6% of drug released after 72 h).
The ability of 2Nal2 aggregates to encapsulate DOX was also checked by running 1D [1H] spectra of La-2Nal2 
(at 2.5 mg/mL)at increasing DOX concentrations (Fig. 9). At a concentration equal to 2.5 mg/mL, as indicated 
above, La-2Nal2 has formed relatively large aggregates (Fig. 9a). In absence of La-2Nal2, doxorubicin NMR spec-
trum in water (0.5 mg/mL concentration) contains sharp peaks (Fig. 9b). In presence of La-2Nal2 aggregates, dox-
orubicin signals are large and can be barely recognized in the spectrum, thus indicating the encapsulation of the 
drug inside the aggregates (Fig. 9c–i). The extensive line broadening and loss of signal is caused by the improved 
relaxation rate reflecting an increase of molecular weight with respect to the free doxorubicin. Once all the pores 
inside the supramolecular aggregates of La-2Nal2 are saturated, the drug starts to be released and this occurs at a 
concentration of doxorubicin close to 1.0 mg/mL (Fig. 9i). At this drug concentration signals are still affected by 
System
r1p 
(mM−1 s−1) Δ2 (s−2)[b]
τV 
(ps)[c] τR (ps)[e]
Gd-DOTA-L6-(2Nal)2 1 mg/mL 7.3 1.02 × 1019 50 184
25 mg/mL 12.3 8.10 × 1018 43 τRl τRg S2
423 4800 0.23
Gd-DOTA-L6-F2 1 mg/mL 5.7 2.97 × 1019 28 120
25 mg/mL 6.0 2.28 × 1019 35 127
Table 2. Relaxometric parameters extracted from the fitting of NMRD profiles reported in Fig. 8[a]. [a]On 
carrying out the fitting procedure, some parameters were fixed to reasonable values: rGd-H (distance between 
Gd and protons of the inner sphere water molecule) = 3.1 Å; a (distance of minimum approach of solvent 
water molecules to Gd3+ ion) = 3.8 Å; D (solvent diffusion coefficient) = 2.2∙10−5 cm2 s−1. [b]Squared mean 
transient zero-field splitting (ZFS) energy. [c]Correlation time for the collision-related modulation of the ZFS 
Hamiltonian. [d]Electronic relaxation time at zero field (calculated as 1/τs0 = 12Δ2 × τv). [e]Reorientational 
correlation time.
Figure 9. 1D 1H NMR spectra acquired at 298 K of (a) La-(2-Nal)2 at 2.5 mg/mL, (b) DOX 0.5 mg/mL, (c) La-
(2-Nal)2 at 2.5 mg/mL + DOX 0.05 mg/mL, (d) La-(2-Nal)2 at 2.5 mg/mL + DOX 0.1 mg/mL, (e) La-(2-Nal)2 
at 2.5 mg/mL + DOX 0.2 mg/mL, (f) La-(2-Nal)2 at 2.5 mg/mL + DOX 0.3 mg/mL, (g) La-(2-Nal)2 at 2.5 mg/
mL + DOX 0.4 mg/mL, (h) La-(2-Nal)2 at 2.5 mg/mL + DOX 0.5 mg/mL, (i) La-(2-Nal)2 at 2.5 mg/mL + DOX 
1 mg/mL. In the lowest spectrum a few peaks arising from doxorubicin appear, as indicated by the black lines.
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line broadening thus indicating that most of the molecules are still entrapped inside the aggregates. Incorporation 
of DOX in Gd-2Nal2 nanostructures was further examinedby optical microscopy. Figure 10 shows polarizing 
optical micrographs (POM) of empty Gd-2Nal2 nanostructures compared to DOX filled Gd-2Nal2 ones. Polarized 
light interacts strongly with both the birefringent samples, generating contrast with the background.
Conclusions
Diphenylalanine peptide remains the most largely studied peptide building block until now for self-aggregating 
peptide materials. Their capability to self-aggregate can considerable decrease hereafter the modification with 
bulky moiety such as Gd-complexes. This consideration is particularly true for the cationic FF peptide, in which 
the replacement of the carboxylic group at the C-terminus with the amidic one causes the loss of the head-to-tail 
hydrogen-bonding. In CAs based FF (Gd-DOTA-L6-F2 and Gd-DTPA-L6-F2), the steric repulsion between the 
Gd-complexes weakens the π-π interactions of the phenyl rings. Here we demonstrated that the replacement of 
the two phenylalanine residues in Gd-DOTA-L6-F2 with two 2-naphthylalanine ones allows restoring the stack-
ing interactions. TEM images, at 5.0 mg/mL, show that Gd-2Nal2 is able to aggregate in long fibrillary nanostruc-
tures, whereas Gd-DOTA-L6-F2 remains in an unaggregated form. At the atomic level, the peptide conjugates 
in the aggregates assume a β sheet secondary structure with an antiparallel orientation of single strands. WAXS/
SAXS characterization of the sample, at the solid state, confirms a fibrillary organization with a typical “cross-β 
pattern”. At the best of our knowledge, this di-naphthylalanine derivative is the most little linear peptide able to 
give cross-β interactions. Fluorescence studies suggest that Gd-2Nal2 peptide derivative begins to self-aggregate 
at ∼0.1 mg/mL (75 μM), forming stable aggregates when concentration is about 10-fold higher (∼1.0 mg/mL). 
This CAC value, assessed by fluorescence and proton NMR spectroscopies, is higher than the value (0.076 mg/
mL) previously found for tetraphenylalanine Gd-complex Gd-DOTA-L6-F4. In the Larmor region, the NMRD 
profile of Gd-2Nal2 (25.0 mg/mL) presents a peak of relaxivity typical of high molecular weight Gd-containing 
systems. POM images and 1HNMR spectra confirmed the incorporation of doxorubicin drug model inside 2Nal 
based nanostructures. The high values of r1p (12.3 mM−1 s−1 at 20 MHz) and the capability to encapsulate the 
doxorubicin anticancer drug suggest a potential use of Gd-2Nal2 nanostructures as theranostic systems.
Experimental section
Materials and chemicals. All chemical reagents for the peptide synthesis (amino acids, coupling rea-
gents, and the Rink amide 4-methylbenzhydrylamine resin) were available from Calbiochem-Novabiochem 
(Laufelfingen, Switzerland). Fmoc-Ahoh-OH (Fmoc-21-amino- 4,7,10,13,16,19-hexaoxaheneicosanoic acid) 
and DOTA (OtBu)3-OH were purchased from Neosystem (Strasbourg, France) and Chemateck (Dijon, France), 
respectively. All other chemical reagents and solvents were purchased by Sigma-Aldrich or Fluka (Bucks, 
Switzerland) and used as received unless otherwise stated. Purification of peptide conjugates was achieved by 
employing an HPLC LC8 Shimadzu (Kyoto, Japan) using an UV-detector (lambda-Max Model 481) and a C18-
Phenomenex (Torrance, CA) column. Samples were eluted with 0.1% TFA containing H2O (A) and 0.1% TFA 
containing CH3CN (B), with a flow rate of 20 mL min−1 and a gradient method that moves the B% from 5% to 
70% over 30 minutes. Analytical analyses, aimed to identify the products and to assess their purity, were per-
formed using a single quadrupole electrospray ionization, Finnigan Surveyor MSQ (San Jose, CA). Samples were 
eluted on an analytical C18-Phenomenex column with A and B, with a flow rate of 200 µL min−1 and a gradient 
method that moves the B% from 5% to 70% over 15 minutes.
Synthesis of peptide derivatives. DOTA-L6-F2 and DOTA-L6-(2Nal)2 were synthesized as previously 
reported6, 25, 26. Briefly, peptide conjugates were synthesized on Rink amide MBHA resin (scale 0.2 mmol, substitu-
tion grade 0.65 mmol/g). Deprotection of the 9-fluorenylmethoxycarbonyl group (Fmoc) was performed twice for 
10 minutes each by treating the peptidyl-resin with a piperidine/N, N-dimethylformamide (70/30, v/v) mixture. 
The couplings of the amino acids were performed in N, N-dimethylformamide by using 2 equivs. of the amino 
Figure 10. Polarized optical microscopy image of 1-cm vials containing (a) Gd-2Nal2 and (b) DOX 
encapsulating Gd-2Nal2 hydrogels. Images areobserved with a Nikon microscope.
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acid, 2 equivs. of 1-hydroxybenzotriazole (HOBt) and benzotriazol-1-yl-oxy-tris-pyrrolidino-phosphonium 
(PyBop) and 4 equivs. of diisopropylethylamine (DIPEA) respect to the synthetic scale. After the cleavage from 
the resin, the crude products were purified by RP-HPLC chromatography and their purity and the identity con-
firmed by ESI mass spectrometry and 1HNMR spectroscopy.
DOTA-L6-(2Nal)2 [2Nal2]. 1H-NMR (CD3OD) (chemical shifts in δ, CH3OH as internal standard 3.55) = 7.51–
7.42 (m, 10 CH aromatic), 4.86–4.75 (m, 2H, CH Phe α), 3.80 (s, 22H, OCH2CH2O), 3.75 (t, 2H, RNHCH2CH2O), 
3.70 (s, 6H, R2NCH2COOH), 3.60 (t, 2H, RNHCH2CH2O, 3.45 (s, 16H, R2NCH2CH2NR2), 3.40–3.36 (m, 2H, 
R2NCH2CONH), 3.16–2.90 (m, 4H, CH2 Phe β), 2.58 (t, 2H, NHCOCH2CH2O). Retention time, Rt = 12.17 min; 
MS (ESI+): m/z 1132.8 calcd. For C57H80N8O16: [M + H+] = 1133.8; [M + Na+] = 1155.7; [M + 2 H+]/2 = 568.1.
Preparation of gadolinium complexes. Gadolinium complexes were prepared through the addition of 
GdCl3 to the DOTA-functionalized ligands in a molar ratio 1:1 at room temperature and neutral pH. The absence 
of any residual free Gd3+ ions was checked by the well-known UV-Vis method of the orange xylenol27; the even-
tual residual was removed from the solution by adding a further amount of ligand corresponding to the Gd3+ 
excess.
Preparation of peptide solutions. 2Nal2 and Gd-2Nal2 peptide solutions were prepared by dissolving the 
lyophilized powder in double distilled water. The concentration of the final solution was determined by absorb-
ance on UV-vis Thermo Fisher Scientific Inc (Wilmington, Delaware USA) Nanodrop 2000c spectrophotometer 
using a 1.0 cm quartz cuvette (Hellma). The molar absorptivity (ε280) for 2Nal2 and Gd-2Nal2 peptide employed 
for the spectroscopic measurements was 6070 M−1 cm−1.
Fluorescence studies. The determination of CAC (critical aggregate concentration) values was determined 
as previously described6 by the titration of the fluorescent probe ANS (8-anilino-1-naphthalene sulfonic acid 
ammonium salt)28, 29 with the peptide conjugates30. Fluorescence spectra of 2Nal2 and Gd-2Nal2 were recorded at 
room temperature at several concentrations, exciting samples at 280 nm and recording spectra between 290 and 
500 nm.
NMR experiments. NMR experiments were acquired in the temperature range of 298–303 K on either a 
Varian Unity Inova 600 MHz spectrometer provided with a cold probe or a 400 MHz Varian instrument provided 
with a 5-mm triple resonance probe and z-axis pulsed-field gradients. All samples were dissolved in a mixture 
H2O/D2O (98% D, Armar Chemicals, Dottingen, Switzerland) 90/10 v/v with a total volume equal to 600 μL. The 
DOTA-L6-F2 was analyzed in the concentration range 0.3 mg/mL (i.e., 0.3 mM)–5.0 mg/mL (i.e., 4.8 mM); for the 
La-DOTA-L6-F2 the examined concentration range was 0.3 mg/mL (i.e., 0.3 mM)–10.0 mg/mL (i.e., 8.5 mM). The 
2Nal2 compound was analyzed in the concentration range 0.1 mg/mL (i.e., 0.1 mM)–5.0 mg/mL (i.e., 4.4 mM) and 
La-2Nal2 in the range 0.2 mg/mL (i.e., 0.2 mM)–2.5 mg/mL (i.e., 2 mM). 1D [1H] experiments along with a series 
of 2D experiments [(i.e., 2D [1H, 1H] TOCSY (Total Correlation Spectroscopy)31 (70 ms mixing time), 2D [1H, 
1H] NOESY (Nuclear Overhauser Enhancement Spectroscopy)32 (300 ms mixing time), and 2D [1H, 1H] ROESY 
(Rotating frame Overhauser Enhancement Spectroscopy)33 (200 and 250 ms mixing times)] were recorded. 1D 
spectra were usually acquired with a relaxation delay d1 of 1.5 s and 32–512 scans; 2D experiments were recorded 
with 16–64 scans, 128–256 FIDs in t1, 1024 or 2048 data points in t2. Assignments of the DOTA-L6-F2 and 
2Nal2-lacking the La (III) ion- were obtained at 1 mM concentration with a canonical protocol34 involving com-
parison of 2D [1H, 1H] TOCSY35 (70 ms mixing time), and 2D [1H, 1H] ROESY33 (200 ms mixing time). Water 
suppression was achieved by Excitation Sculpting35. Spectra were processed with VNMRJ (Varian by Agilent 
Technologies, Italy) and analyzed with NEASY36 comprised in the CARA software package (http://www.nmr.ch/).
Circular Dichroism. Far-UV CD spectra of the 2Nal2 and Gd-2Nal2, in 0.5–20 mg/mL concentration range, 
were recorder on the spectropolarimeter Jasco J-810 equipped with a NesLab RTE111 thermal controller unit. 
Spectra were recorded between 280 to 195 nm at room temperature, using a standard quartz cell with an path 
length of 0.1 mm, a scan speed of 10 nm/min a sensitivity of 50 mdeg, a time constant of 16 s and a bandwidth 
of 1 nm. All the spectra were obtained by averaging three scans, after correction for the solvent and for dilution. 
Ellipticities were reported as the mean residue ellipticity (MRE).
Fourier Transform Infrared spectroscopy (FTIR). Fourier Transform Infrared spectra of 2Nal2 and 
Gd-2Nal2 in solution at the concentration of 5.0 mg/mL and at the solid state were collected on the spectrometer 
Jasco FT/IR 4100 (Easton, MD) in ATR mode, using a Ge single-crystal at a resolution of 4 cm−1. All the spectra 
(100 scans with a rate of 2 mm · s−1 against a KBr background) were collected in transmission mode and then 
converted in emission.
Congo Red spectroscopic assay. Congo Red (CR) UV-Vis assay was carried out on aforementioned spectro-
photometer as previously described6. Briefly, 5, 50 and 125 μL of di-naphthylalanine stock solution (20 mg/mL) were 
added to a CR solution (12, 5 μM) prepared immediately before to use. The solutions containing peptide conjugate 
incubated with CR were left at room temperature for 30 min and then their UV-Vis spectra were recorded between 
400 and 700 nm. The spectrum of CR alone at the same concentration was also recorded in the this spectral region.
Transmission Electron Microscopy (TEM) images. TEM images were acquired by LaMest (Pozzuoli, 
Italy) with a FEI TECNAI G12 Spirit-Twin microscope (LaB6 source) endowed of a bottom mounted FEI Eagle-4k 
CCD camera (Eindhoven, The Netherlands), working at 120 kV. The samples for the observation were prepared 
by placing 10 µL of a solution (5.0 mg/mL) on a holey-carbon coated copper grid (400 mesh). The sample was left 
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to dry at room temperature for 1 hour and stained with a solution (1 wt%) of phosphotungstic acid. Digital images 
were obtained by FEI Eagle 4 K CCD camera and Xplore 3D software.
Wide-Angle and Small-Angle X-ray Scattering. Fiber diffraction WAXS and SAXS patterns were 
recorded from dried fibers prepared according to the well-known method of the stretch frame13, in which a drop-
let (10 μL) of 3 wt% peptide solution, hanged between two wax-coated capillary, was left to dry slowly overnight 
at room temperature. WAXS and SAXS data were collected at the X-ray MicroImaging Laboratory (XMI-L@b) 
equipped with a Fr-E+ Super Bright rotating anode copper anode microsource (Cu Kα, λ = 0.15405 nm, 2475 W), 
a multilayer focusing optics (Confocal Max-Flux; CMF 15-105) and a three-pinhole camera (Rigaku SMAX-
3000)37. For WAXS data collection an image plate (IP) detector with 100 µm pixel size was placed at 8.5 cm from 
the sample and calibrated by means of the Si NIST standard reference material (SRM 640b). For SAXS data col-
lection a Triton 20 gas-filled photon counter detector with ~200 µm pixel size was placed at 2.2 m from the sample 
and calibrated by means of silver behenate. A detailed description of the XMI-L@b performances can be found in 
Altamura et al.37 and Sibillano et al.38.
Water proton relaxation measurements. Measure of R1 (longitudinal water proton relaxation rates) 
of Gd-2Nal2 were carried out on a Stelar Spinmaster spectrometer (Pavia, Italy) operating at 0.5 T which corre-
sponds to 21.5 MHz Proton Larmor Frequency. R1 (1/T1) values were measured at 298 K by mean of the stand-
ard inversion-recovery technique. For the measure of the proton 1/T1 NMRD (Nuclear Magnetic Resonance 
Dispersion) profiles, a fast field-cycling Stelar relaxometer, operating over a continuum of magnetic field strengths 
from 0.00024 to 0.47 T (corresponding to 0.01–20 MHz proton Larmor frequencies) was used. The temperature 
was set at 298 K. The relaxometer is computer controlled and the absolute uncertainty is 1/T1 ± 1%. Additional 
data points were obtained on a Stelar Spinmaster spectrometer coupled to an electromagnet tunable at differ-
ent Larmor Frequencies between 21.5 and 70 MHz. Experimental temperature control was obtained with an 
air-flow heater (Stelar VTC-91) endowed of a copper constantan thermocouple (uncertainty 0.1 °C). A previously 
reported relaxometric method39 was used for the determination of the concentrations of the solutions used for 
the relaxometric characterization. The conventional Solomon-Bloembergen-Morgan theory was used for fitting 
of experimental data.
Doxorubicin loading and leakage. A DOX solution (1 · 10−4 M) was placed in the cuvette and titrated with 
small amount of Gd-2Nal2 peptide conjugate at 50 mg/mL. The fluorescence of each sample was monitored on Jasco 
Model FP-750 spectroflurophotometer as above described. Excitation wavelength was settled at 480 and UV-Vis 
spectra were collected between 490 and 700 nm. At the end of the titration the DOX filled Gd-2Nal2 aggregates were 
10-fold diluted and the DOX fluorescence was monitored up to 72 h. The extent of the DOX leakage was calculated as 
follows: Leakage (%) = 100 (Fi − F0)/(F100 − F0), where Fi represents the level of fluorescence measured for each time 
point, whereas F100 and F0 are the fluorescence levels before and after the peptide addition in cuvette, respectively.
Doxorubicin loading of by 1HNMR and polarized optical microscopy (POM). To explore encap-
sulation of doxorubicin in 2Nal2, a sample at a concentration of 2.5 mg/mL was used and 1D [1H] NMR spectra 
were recorded in absence and presence of doxorubicin (concentration going from 0.05 to 1 mg/mL). POM images 
of Gd-2Nal2 at 20 mg/mL and of Gd-2Nal2/DOX (20 and 1 mg/mL, respectively) in water solution were obtained 
observing samples with AZ100 microscope (Nikon) between crossed polars.
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Photoluminescent Peptide-Based Nanostructures as FRET Donor
for Fluorophore Dye
Carlo Diaferia,[a] Teresa Sibillano,[b] Cinzia Giannini,[b] Valentina Roviello,[c] Luigi Vitagliano,[d]
Giancarlo Morelli,[a] and Antonella Accardo*[a]
Abstract: A great interest has been recently generated by
the discovery that peptide-based nanostructures (NSs) en-
dowed with cross-b structure may show interesting photolu-
minescent (PL) properties. It was shown that NSs formed by
PEGylated hexaphenylalanine (PEG8-F6, PEG=polyethylene
glycol) are able to emit at 460 nm when excited at 370 or
410 nm. Here, the possibility to transfer the fluorescence of
these PEG8-F6-based NSs by foster resonance electron trans-
fer (FRET) phenomenon to a fluorescent dye was explored.
To achieve this aim, the 4-chloro-7-nitrobenzofurazan (NBD)
dye was encapsulated in these NSs. Structural data in solu-
tion and in solid state, obtained by a variety of techniques
(circular dichroism, Fourier-transform infrared spectroscopy,
wide-angle X-ray scattering, and small-angle X-ray scatter-
ing), indicated that the organization of the peptide spine of
PEG8-F6 NS, which consists of anti-parallel b-sheets separat-
ed by a dry interface made of interacting phenylalanine side
chains, was maintained upon NBD encapsulation. The spec-
troscopic characterization of these NSs clearly showed a red-
shift of the emission fluorescence peak both in solution and
in solid state. This shift from 460 to 530 nm indicated that
a FRET phenomenon from the peptide-based to the fluoro-
phore-encapsulated NS occurred. FRET could also be detect-
ed in the PEG8-F6 conjugate, in which the NBD was covalent-
ly bound to the amine of the compound. On the basis of
these results, it is suggested that the red-shift of the intrinsic
PL of NSs may be exploited in the bio-imaging field.
Introduction
In the last few years an explosion of interest has been focused
on peptide-based materials for interdisciplinary nanoscience
applications.[1] There are several advantages for using peptides
as building blocks, such as intrinsic biological origin, low cost,
high stability, ability for specific molecular recognition, long-
term storage, and easy handling. One of the most studied rep-
resentative building blocks, able to self-assemble in supra-
molecular nanostructures (NSs), is the diphenylalanine homodi-
mer (FF).[2] FF self-assembles in nanotubes that show notewor-
thy mechanical rigidity[3] along with a multiplicity of other
chemical and physical functionalities,[4] making it promising for
potential application in nanomedicine,[5] nanofabrication,[6]
tissue engineering,[7] bio-imaging,[8] drug delivery,[9] and fabrica-
tion of biosensors.[10] However, the low water solubility of
these peptide NSs has partially limited their application in
nanomedicine. Very recently, we described the first examples
of NSs based on PEGylated (PEG=polyethylene glycol) cationic
poly-phenylalanines[5b,8, 11] or their analogues (di-naphthylala-
nine)[12] for bio-imaging applications. These peptide derivatives
contain an aromatic region to allow the self-assembly of the
NS, a gadolinium (Gd) complex for applications as in vivo con-
trast agent in magnetic resonance imaging (MRI), and a PEG
spacer at different length between the Gd-complex and the
peptide moiety. These peptides could be potentially proposed
for application in MRI owing to their high uptake and moder-
ately low toxicity on selected cell lines.[8] In more recent years,
a great interest has been generated around peptide-based NSs
with interesting photoluminescent (PL) properties. Peptide-
based NSs can exhibit blue photoluminescence when excited
at a wavelength of 370 or 410 nm. This PL phenomenon has
also been observed in FF and FFF NSs upon thermally induced
reconstructive phase transition (heating sample at 140–180 8C)
as shown by Rosenman and co-workers,[4a,13] or in amyloid-like
fibrils rich in b-sheet structures.[14] Some hypotheses on the
origin of this PL, such as electron delocalization through hy-
drogen bonds in the b-sheet-rich structure[13] or proton trans-
fer,[15] have been proposed until now. We recently reported on
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the synthesis and structural characterization of a novel PEGy-
lated hexaphenylalanine peptide, PEG8-F6 (Figure 1a), made of
aromatic and hydrophilic moieties, which forms NSs with re-
markable PL properties.[16] The structural characterization of
PEG8-F6 in solution highlighted its strong propensity to self-as-
semble in stable and well-organized NSs with a hydrodynamic
diameter of approximately 60 nm and an antiparallel b-sheet
arrangement. Wide-angle X-ray scattering (WAXS) characteriza-
tion on dried fibers also revealed a typical cross-b diffraction
pattern observed for amyloid-like fibers with meridional and
equatorial peaks at 4.8 and 12.5 a, respectively. PEG8-F6 NSs
showed a blue PL between 420 and 460 nm when excited at
wavelengths of 370 or 410 nm.[16] Here, we explored the possi-
bility to transfer by foster resonance electron transfer (FRET)
phenomenon the fluorescence of a cross-b material (donor)
such as PEG8-F6-based NSs into an encapsulated fluorescent
dye such as 4-chloro-7-nitrobenzofurazan (NBD, Figure 1b).
Owing to its spectral window (lex=465 nm; lem=530 nm), the
poorly water-soluble NBD was chosen as a suitable model fluo-
rophore to investigate the capability of these peptide-based
NSs to transfer by FRET their intrinsic fluorescence to a fluoro-
phore, strictly associated with the peptide NS. The FRET should
cause a red-shift of the PL of the NSs, thus providing an oppor-
tunity for their application in the bio-imaging field.[17] Nowa-
days, the major obstacle for many applications of light in bio-
medicine is represented by the limited penetration of light
into biological tissue. Optical fibers represent the current gold-
standard solution in clinical uses.[18] However, most light-guid-
ing systems are based on solid materials, which are not com-
patible with in vivo application.[19] In contrast, optical wave-
guides based on biocompatible materials such as PEG,[20] silk,
and agarose gel[21] present a scarce efficiency for delivering
light over an organ-scale distance. The employment of water-
soluble, biocompatible optical fibers based on peptide build-
ing blocks with enhanced PL properties could help to over-
come these limitations.
Results and Discussion
Synthesis of NBD-filled NSs
PEG8-F6, composed of six phenylalanine residues and eight
ethoxylic groups, is poorly soluble in water but soluble in
1,1,1,3,3,3-hexafluoro-2-propanol (HFIP) up to 100 mgmL@1.
Stable and well-organized NSs were obtained by five-fold dilut-
ing this stock solution in water and removing the organic sol-
vent by a slow nitrogen flow. NBD dye also shows very limited
water solubility and good solubility in HFIP. Consequently,
NBD-filled NSs were synthetized by dissolving both PEG8-F6
and NBD powders (Figure 1a,b) in HFIP in a 10:1 (w/w) ratio.
In this solution, the starting peptide and fluorophore concen-
trations were 100 and 10 mgmL@1, which corresponds to 6.8V
10@5 and 5.0V10@5 mol, respectively. Subsequently, this solu-
tion was diluted in water, HFIP was removed, and the resulting
solution was centrifuged to remove the excess of non-encap-
sulated NBD (Figure 1c). The light-yellow supernatant was fur-
ther purified from potential traces of free NBD by gel-filtration
on a Sephadex G-50 column. According to the dilution ach-
ieved during the purification, the final concentration of hexa-
phenylalanine estimated by UV/Vis spectroscopy was
10 mgmL@1. Owing to its low water solubility, the detection
and the quantification of encapsulated NBD were unfeasible in
water. As a consequence, the amount of NBD encapsulated in
NSs (200 mgmL@1) was determined by UV/Vis spectroscopy on
a sample lyophilized and re-dissolved in methanol (Figure S1 in
the Supporting Information). From the experimental quantifica-
tion of the species, the molar ratio between NBD and PEG8-F6
peptide was determined to be 1:7. The fluorescent dye re-
mained associated with the NS even after repeated washing,
suggesting the existence of a strong interaction between the
dye and the NS. To exclude the occurrence of a covalent bond
between the NBD fluorophore and the N-terminus of the
oligo-peptide, we analyzed NBD/PEG8-F6 NSs by liquid chroma-
tography–mass spectroscopy (LC–MS). The mass spectrum, re-
ported in Figure S2 in the Supporting Information, showed
only the mass corresponding to the peptide. Altogether, these
experiments suggest that in this preparation protocol the NBD
encapsulation is favored by the self-aggregation of the pep-
tide-based NS directly around the NBD dye as a consequence
of the HFIP evaporation.
Structural characterization of NBD-filled NSs: secondary
structure
To evaluate the potential structural modifications induced by
the NBD encapsulation in the PEGylated peptide NSs, NBD/
PEG8-F6 was deeply characterized at the atomic level by circu-
Figure 1. Schematic representation of (a) PEG8-F6 and (b) NBD chloride, re-
spectively ; (c) preparation of NBD/PEG8-F6 NSs: both PEG8-F6 and NBD were
dissolved in HFIP in 10:1 (w/w) ratio. Then, this solution was ten-fold diluted
in water, and HFIP was removed with a slow nitrogen flow.
Chem. Eur. J. 2017, 23, 8741 – 8748 www.chemeurj.org T 2017 Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim8742
Full Paper
lar dichroism (CD) and Fourier-transform infrared (FTIR) spec-
troscopy. CD and FTIR spectra of the filled peptide NSs are re-
ported in Figure 2 and Figure 3, respectively. Spectra of the
empty NSs are also shown for comparison. The CD spectrum
of NBD/PEG8-F6 at 10 mgmL
@1 (Figure 2a) showed the same
dichroic tendency previously observed for the empty peptide
NSs with a maximum around 205 nm, attributable to aromatic
side-chain stacking, and a minimum around 230 nm, associated
with a b-structure. A slight red-shift of the minimum from 227
to 230 nm occurred for NSs encapsulating NBD. Moreover, the
molar ellipticity (q) of NBD/PEG8-F6 at 230 nm did not change
significantly as a function of time (see Figure 2b). A slight var-
iation of q was detectable over time with a more significant
variation during the first 10 min. This trend suggests a time-de-
pendent structural rearrangement of the dye-containing NSs.
Analogously to the CD data, the FTIR spectra of NBD-filled
PEG8-F6 in the region of the amide I vibrational band (1600–
1700 cm@1) were very similar to spectra of empty PEG8-F6 both
in solution and solid state (Figure 3). The FTIR spectra showed
a peak at approximately 1637–1640 cm@1 typically attributable
to b-sheet formation. In addition to this peak, all spectra
showed a secondary broad peak at approximately 1680 cm@1
that indicates an antiparallel orientation of the b-sheet. These
results clearly demonstrate that, despite the strong binding be-
tween the dye and the peptide NSs, the encapsulation of NBD
did not significantly alter the secondary structure of the supra-
molecular aggregate.
Photoluminescence properties
Recently, several authors reported a surprising PL phenomenon
for fibrillary networks such as amyloid fibrils and for peptide-
based NSs, both of them characterized by a high content of
cross-b structures.[13–16] These systems show a fluorescence
emission peak at 460 nm when excited at 370 or at 410 nm.
Owing to the close relationship between the optoelectronic
properties and the structural motif in these systems, PL is cur-
rently used as a promising probe to detect the formation of
amyloid fibrils. We demonstrated that empty PEG8-F6-based
NSs, at a concentration of 10 mgmL@1, are able to emit at
460 nm (Figure S3 in the Supporting Information).[16] At this
very high concentration it was possible to detect a broad peak
between 370 and 410 nm in the UV/Vis spectrum (Figure S4 in
the Supporting Information), partially affected by the tail of
the main absorbance peak centered at 257 nm, which is typical
for the phenyl ring. Here, we investigated how NBD encapsula-
tion in PEG8-F6 NSs can alter their optoelectronic properties
Figure 2. (a) Comparison between the CD spectra of PEG8-F6 and NBD/PEG8-
F6 in water at 10 mgmL@1. Spectra were recorded in the range between 280
and 195 nm and reported in mean residue ellipticity (q) ; (b) molar ellipticity
of NBD/PEG8-F6 in the minimum at 230 nm as function of time.
Figure 3. Characterization of the secondary structure: FTIR spectra of PEG8-
F6 and NBD/PEG8-F6 in (a) solution and (b) solid state in the amide I region.
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both in solution and solid state (Figure 4 and Figure 5). In con-
trast to the spectra of empty PEG8-F6 NSs (Figure S3 in the
Supporting Information), showing an emission peak at 460 nm,
NBD/PEG8-F6 spectra (see Figure 4a,b) showed a peak at
535 nm, corresponding to the typical emission wavelength of
NBD. The occurrence of this red-shift and the simultaneous dis-
appearance of the expected maximum at 460 nm led us to
speculate that the NBD dye was close enough to the NSs to
accept the energy emitted by the NS according to a FRET phe-
nomenon. FRET is a distance-dependent physical process by
which energy of an excited fluorophore (donor) is transferred
non-radiatively to another fluorophore (acceptor). FRET strong-
ly depends on the proximity between the donor and the ac-
ceptor species, and the maximum efficiency occurs if the
donor and acceptor are positioned within the Fçrster radius
(the distance at which half the excitation energy of the donor
is transferred to the acceptor; typically 3–6 nm). From a qualita-
tive point of view, a macroscopic variation in the color of the
solution from light to dark yellow was also detected during
the time (Figure S5 in the Supporting Information). This
change of color pushed us to follow the fluorescence of the
sample over time. Surprisingly, we observed a progressive in-
crease of the fluorescence up to 2 h, whereas no further in-
creases was observed after this time. The same behavior was
also observed for two other preparations, in which the peptide
concentration was kept fixed at 10 mgmL@1, whereas the NBD
amount was reduced to 100 or 10 mgmL@1 (see Figure S6 in
the Supporting Information). It is plausible to speculate that
this increase of the fluorescence intensity was the result of an
increase of the fibrillary species in solution over time. To verify
this hypothesis, the kinetics of aggregation of empty PEG8-F6
NSs were studied up to 24 h at the same concentration (Fig-
ure S7 in the Supporting Information). However, no significant
variation could be detected in the fluorescence spectra of
empty NSs. This result indicated that the kinetics of aggrega-
tion for empty NSs were very fast and thus not observable. In
contrast, the increase of the fluorescence of NBD/PEG8-F6
(Figure 4) could depend on a molecular rearrangement of the
Figure 4. PL of NBD/PEG8-F6 NSs at 10 mgmL
@1 as function of time. PL emis-
sion spectra for sample in solution upon excitation at (a) 370 nm and
(b) 410 nm.
Figure 5. Fluorescence microscopy images of a dried film of NBD/PEG8-F6 obtained by exciting in the UV spectral region of (a) 4’,6-diamidino-2-phenylindole
(DAPI), (b) green fluorescent protein (GFP), and (c) rhodamine filters ; images of NBD/PEG8-F6 fibers recorded by exciting in (d) bright light, (e) GFP, and
(f) rhodamine filters.
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dye in the peptide aggregate or on a slowing of the kinetics of
aggregation of the NS owing to the NBD encapsulation. NBD/
PEG8-F6 also emitted PL in the solid state. Figure 5 shows, re-
spectively, the immunofluorescence images of the dried
sample deposited on a clean coverslip glass (Figure 5a–c) and
of the oriented fibers (Figure 5d–f) obtained with the stretch-
frame method.[22] Both the microscopy images of the dried film
(Figure 5a–c) and of the oriented fiber (Figure 5d–f) demon-
strate the capability of NBD/PEG8-F6 to emit in blue, green,
and red fields. This result is in agreement with the width of
the emission peak observed for the sample in solution
(Figure 4). We ascertained that it was also possible to obtain
self-assembled NSs (Figure S8a in the Supporting Information)
starting from the peptide conjugate NBD-PEG8-F6, in which
NBD was covalently bound to the amine function of the PEGy-
lated hexaphenylalanine. These NSs, which have a univocally
defined NBD/PEG8-F6 ratio (1:1), retained the optoelectronic
properties of the NBD-filled NSs (see Figure S8b in the Sup-
porting Information) even if they presented a lower water solu-
bility owing to the N-terminus functionalization. The FRET ob-
served for NBD-PEG8-F6 was in good agreement with that de-
tected for the covalently conjugates between the a-Synuclein
and Yellow Fluorescent Protein (AS-YFP).[23] The definition of
the structural determinants of these intriguing PL properties
exhibited by cross-b-rich systems is still a debated topic and
the subject of intense current investigations. However,
a proven explanation on the origins of this unexpected PL has
not been provided until now, and this topic remains under
debate. The most accredited hypotheses concerning the origin
of the PL are electron delocalization through hydrogen bonds
in the b-sheet-rich structure[13] or proton transfer.[15] Moreover,
it is important to underline that the fluorescence signal of
these fibrillary structures is weak and that PL is obtained only
at very high concentrations.
Wide- and small-angle X-ray scattering
To gain deeper insight into the assembly process and molecu-
lar organization, we acquired wide-angle and small-angle X-ray
scattering (WAXS/SAXS) data on ordered fibers prepared by
the stretch-frame method.[22] Figure 6a,b show the as-prepared
fibers, which were placed under the X-ray beam in transmis-
sion geometry. The 2D WAXS and SAXS fiber diffraction pat-
terns, collected on PEG8-F6 and PEG8-F6/NDB samples, are dis-
played in Figure 6c,d and e, f, respectively. Two main directions
are indicated by the white arrows: the meridional direction,
which coincides with the fiber axis, and the equatorial direc-
tion, which is perpendicular to it. They show a cross-b diffrac-
tion pattern both in WAXS (atomic distances) and in SAXS
(nanoscale distances), the fingerprint of hierarchically organ-
ized fibers. The 2D patterns were centered, calibrated, and ra-
dially folded into 1D profiles. WAXS data were integrated
across the meridional and equatorial axes, and the resulting
1D WAXS profiles displayed in Figure 6g (blue for PEG8-F6 and
red for NBD/PEG8-F6), separately reporting the meridional
(upper) and equatorial (lower) profiles. SAXS data were inte-
grated across the whole azimuth, and the 1D SAXS profiles are
reported in Figure 6h. The peak positions (in q) of the most in-
Figure 6. (a,b) As-prepared fibers; (c, d) 2D WAXS data; (e, f) 2D SAXS data; (g) 1D WAXS profiles (upper : meridional, lower: equatorial) ; (h) 1D SAXS profiles ;
blue lines refer to empty PEG8-F6; red lines to NBD/PEG8-F6.
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tense WAXS and SAXS peaks, measured along the equatorial
and meridional directions, are summarized in Table 1. Collec-
tively, these experiments indicate that the encapsulation of the
dye had a minimal impact on the atomic structure of the pep-
tide spine of these assemblies. PEG8-F6 and NBD/PEG8-F6 share
several meridional and equatorial reflections. The only signifi-
cant difference is related to the m1 reflection (d=48 a) of
PEG8-F6, which disappears in NDB/PEG8-F6 (marked by the
arrows in Figure 6e, f, h). These observations suggest that the
3D model proposed for the peptide spine PEG8-F6, which cor-
responds to anti-parallel b-sheets separated by a dry interface
consisting of interacting Phe side chains,[16] can be reliable ex-
tended to NDB/PEG8-F6. In particular, the preservation of the
equatorial reflection e1 at 12.2 a, which is indicative of the
inter-sheet distance, suggests that the dye was not inserted in
the dry interface, in contrast with observations on the com-
plexation of the dye orange G with the cross-b assembly
formed by the peptide KLVFFA.[24] It is likely that, in analogy
with the proposed binding of ThT to amyloid-like nanofibers,[25]
the dye may either bind at the groove parallel to the fiber axis
formed by the side-chain ladders or at the edges of the flat b-
sheet surface.
Scanning electron microscopy
Scanning electron microscopy (SEM) images of NBD-filled NSs
at different concentrations (50, 200 mgmL@1, and 2.0 mgmL@1)
are reported in Figure 7. Our previous SEM studies on the
empty PEG8-F6 self-assembled NSs indicated a high morpho-
logical variability of this aromatic peptide. At low concentra-
tions (50 and 200 mgmL@1), NBD/PEG8-F6 formed either amor-
phous conglomerates or crystalline structures (Figure 7a,b), in
line with the empty PEG8-F6 aggregates. However, at high con-
centration (2.0 mgmL@1), images of NBD-containing NSs re-
vealed the presence of branched structures instead of the
sheaf of fibers and of long NSs (flat or twisted ribbon shape)
previously observed for empty NSs. These branched structures
are typically observed for aromatic peptides dissolved in solu-
tions with high ionic strength. According to the models pro-
posed for these solutions, branched architectures in NBD/PEG8-
F6 could be explained hypothesizing that the some NBD crys-
tals coat the surface of peptide fibers, and the growth of the
branch occurs in correspondence to these nucleation sites.
Conclusion
Recently, PL phenomena have been observed in fibrillary net-
works such as amyloid fibrils and in others peptide-based NSs
with a high content of cross-b structures. However, the intensi-
ty of fluorescence emitted by these structures is weak, and the
signal remains confined in the near-Vis region. The develop-
ment of biocompatible peptide NSs as bio-imaging tools re-
quires the improvement of their performance in terms of PL in-
tensity and wavelength range compatible with in vivo applica-
tions. A possible strategy could be the close association (en-
capsulation, binding, or absorption) of a small fluorescent dye
such as NBD to the photoluminescent NS. The close proximity
at the atomic level between the dye and the NS should pro-
mote the energy transfer. With this goal in the mind, we en-
capsulated NBD in PEG8-F6 NSs that exhibit blue PL owing to
the high content of cross-b structures. The entrapment of NBD
in these NSs caused a red-shift from 460 to 530 nm that we at-
tribute to a FRET phenomenon. Structural characterization per-
formed on NBD-filled PEG8-F6 NSs, both in solution and solid
state, did not highlight significant differences of the sample
compared to empty PEG8-F6 NSs. However, SEM images ac-
quired at 2.0 mgmL@1 showed the presence of branched struc-
tures. The branching of the peptide structures could be attrib-
Table 1. Meridional and equatorial reflections of NBD/PEG8-F6 measured
from WAXS and SAXS data.
Label q [a] d [a] :0.3 a
Equatorial reflections
e1 0.51 12
e2 1.0 6.1
e3 1.3 4.8
e5 1.4 4.5
e6 1.6 4.1
e7 1.7 3.8
e8 2.1 3.1
e9 2.2 2.8
Meridional reflections
m1 0.13 48
m2 0.17 37
m3 1.3 4.8
m4 1.4 4.5
m5 1.6 4.1
m6 1.7 3.8
m7 2.2 2.8
Figure 7. Selected SEM microphotos for NBD-filled PEG8-F6: (a) 50 mgmL
@1 (24000V , 5 mm scale bar) ; (b) 200 mgmL@1 (50000V , 3 mm scale bar) ;
(c) 2.0 mgmL@1 (80000 V, 2 mm scale bar).
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uted to the coating of the fiber surface with NBD crystals. Fur-
ther structural information on the positioning of the NBD in
the 3D model proposed for the peptide-spine PEG8-F6 was ob-
tained by WAXS/SAXS measurements. From the comparison of
the diffraction patterns, it emerged that in NDB/PEG8-F6 the
m1 reflection (d=48 a) disappeared, whereas the equatorial
reflection e1 at 12.2 a, indicative of the inter-sheet distance,
was preserved. These findings suggest that NBD was arranged
outward from the dry interface but remained close enough to
the origin of the PL to accept the energy transfer. The capabili-
ty to transfer fluorescence between the NS and the dye was re-
tained even if the dye was covalently bound to the peptide
NS. This evidences led us to envisage new applications for
dye-encapsulating peptides as innovative biomaterials. Encap-
sulation or conjugation of small-molecule dyes in/to NSs repre-
sents an alternative and complementary strategy[23] for the de-
tection of the aggregation process of endogenous proteins,
which, in their physio-pathological form, are known to adopt
a cross-b structural motif.
Experimental Section
Material and Methods : NBD and HFIP were purchased from
Sigma–Aldrich (Milan, Italy). All solutions were prepared by weight
with doubly distilled water. UV/Vis measurements were performed
on a Thermo Fisher Scientific Inc (Wilmington, Delaware USA)
Nanodrop 2000c spectrophotometer equipped with a 1.0 cm
quartz cuvette (Hellma). Analytical LC–MS analyses were assessed
using a Finnigan Surveyor MSQ single quadrupole electrospray ion-
ization (Finnigan/Thermo Electron Corporation San Jose, CA), with
a C18-Phenomenex column eluted with H2O/0.1% TFA (A) and
CH3CN/0.1% TFA (B) from 20 to 80% over 20 min at 200 mLmin
@1
flow rate.
Peptide synthesis : The PEGylated peptide PEG8-F6, reported in
Figure S1 in the Supporting Information, was synthesized by solid-
phase synthesis and purified by reverse-phase (RP)-HPLC chroma-
tography, according to the procedure previously described.[16]
Synthesis of NBD/PEG8-F6 NSs : PEG8-F6 peptide NBD-filled NSs
were prepared by dissolving fluorescent NBD dye and PEG8-F6
peptide in HFIP. The peptide and NBD concentrations in HFIP were
100 and 10 mgmL@1, respectively. This solution was ten-fold dilut-
ed in water, and the organic solvent was removed by a slow nitro-
gen flow. The solution was centrifuged 5 min at 13500 rpm, and
the supernatant was purified from free NBD by gel-filtration with
a Sephadex G-50 column pre-equilibrated with water. For the de-
termination of the amount of NBD encapsulated in NSs, a sample
was lyophilized and spectroscopically investigated by UV/Vis meas-
urements at l=340 nm on the powder dissolved in CH3OH. The
molar absorptivity (e) at 340 nm (9352m@1cm@1) was calculated by
a calibration curve. The identity of NBD after loading in PEG8-F6
was determined by LC–MS.
Synthesis of NBD/PEG8-F6 peptide conjugate : NBD-PEG8-F6 pep-
tide conjugate was synthesized according to the standard solid-
phase 9-fluorenylmethoxycarbonyl (Fmoc) protocols on Rink amide
MBHA resin (substitution 0.65 mmolg@1). The elongation of PEG8-
F6 on the resin was achieved as previously reported.[16] NBD-label-
ing was performed on resin-bound peptides as previously reported
by Rapaport and Shai.[26] Briefly, after removal of the Fmoc protect-
ing group of the N-terminal amino acid, the resin-bound peptide
was treated with NBD-Cl in N,N-diisopropylethylamine (2 m in DMF,
3–4 equiv.). After 24 h, the resin-bound peptides were washed
thoroughly with CH2Cl2, and the peptides were cleaved and puri-
fied as previously described. The identity of the NBD peptides was
confirmed by LC–MS. Retention time=18.1 min; MS (ESI+): m/z
calcd for C84H102N14O21: 1642.2 [M+2H
+]/2=822.6.
Dynamic Light Scattering (DLS): Mean diameter and diffusion co-
efficient (D) of NBD-PEG8-F6 NSs were measured by DLS measure-
ments using a Zetasizer Nano ZS (Malvern Instruments, Westbor-
ough, MA) that employs a 1738 backscatter detector. Other instru-
mental settings were: measurement position 4.65 mm; attenuator
9; temperature 25 8C; disposable sizing cuvette as cell. DLS meas-
urements in triplicate were performed on the peptide conjugate at
1 mgmL@1 after room temperature centrifugation at 13000 rpm for
5 min.
CD : Far-UV CD spectra of the NBD/PEG8-F6 NSs in aqueous solu-
tion were recorded on a Jasco J-810 spectropolarimeter equipped
with a NesLab RTE111 thermal controller unit and a 0.1 mm quartz
cell at 25 8C. The spectra were acquired from 280 to 195 nm for
samples at concentrations ranging between 0.5 and 10.0 mgmL@1.
Other experimental settings were: scan speed 10 nmmin@1; sensi-
tivity 50 mdeg; time constant 16 s; bandwidth 1 nm. Each spec-
trum was obtained by averaging three scans and corrected for the
blank contribute. Here, q represents the mean residue ellipticity
(MRE), that is, the ellipticity per mol peptide divided by the
number of amino acid residues in the peptide.
FTIR spectroscopy : FTIR spectra of NBD/PEG8-F6 and NBD
(2.0 mgmL@1) were collected on a Jasco FT/IR 4100 spectrometer
(Easton, MD) in an attenuated total reflection (ATR) mode with
a Ge single-crystal at a resolution of 4 cm@1. All spectral data were
processed using built-in software. Spectra were collected in trans-
mission mode and then converted into emission. Each sample was
recorded with a total of 100 scans with a rate of 2 mms@1 against
a KBr background.
Optical Spectrofluorometry : Measurements of PL were performed
on a Jasco Model FP-750 spectrofluorophotometer in a 1.0 cm
path length quartz cell. Aqueous NBD/PEG8-F6 NSs (10 mgmL
@1)
were prepared as previously described by diluting HFIP in water.
Immediately after the purification of the NSs by gel-filtration, the
fluorescence measurements on the sample were recorded by excit-
ing it at 370 or 410 nm. This acquisition was indicated as time=0.
Starting from this measure, we followed the fluorescence behav-
iour up to 24 h, recording a spectrum at different time points.
NBD-PEG8-F6 conjugate (1.0 mgmL
@1) was prepared by sonicating
the powder in acetonitrile (1.5 mL) for 5 min and then diluting the
solution with water (1:1). After this dilution, the sample appeared
perfectly clear, and the fluorescence emission was measured ac-
cording to the experimental details reported above.
Fluorescence microscopy : NBD/PEG8-F6 solution (15 mL;
10 mgmL@1), prepared 24 h before, was deposited on a clean cov-
erslip glass, dried, and imaged with fluorescence microscopy. Im-
munofluorescence images were taken with a Leica DFC320 video
camera (Leica, Milan, Italy) connected to a Leica DMRB microscope
equipped with 10 X and 40 X objectives, and the Image J Software
(National Institutes of Health, Bethesda, MD) was used for analy-
sis.[27]
WAXS and SAXS : Fiber diffraction WAXS and SAXS patterns were
recorded from dried fibers prepared by the stretch-frame
method.[22] Briefly, a droplet (10 mL) of peptide aqueous solution
(3 wt%) was suspended between the ends of a wax-coated capilla-
ry (spaced 2 mm apart). The droplet was allowed to dry gently at
room temperature overnight to obtain oriented fibers. WAXS and
SAXS data were collected at the X-ray MicroImaging Laboratory
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(XMI-L@b) equipped with a Fr-E+ SuperBright rotating anode
copper anode microsource (CuKa, l=0.15405 nm, 2475 W), a multi-
layer focusing optics (Confocal Max-Flux; CMF 15–105), and
a three-pinhole camera (Rigaku SMAX-3000).[3] For WAXS data col-
lection an image plate (IP) detector with 100 mm pixel size was
placed at 10 cm from the sample and calibrated by means of the
Si NIST standard reference material (SRM 640b); for SAXS data col-
lection a Triton 20 gas-filled photon counter detector with approxi-
mately 200 mm pixel size was placed at 2.2 m from the sample and
calibrated by means of silver behenate. A detailed description of
the XMI-L@b performances can be found in reports by Altamura
et al.[28] and Sibillano et al.[29]
SEM : Morphological analysis of the NSs was performed by using
a field-emission scanning electron microscope (Nova NanoSem
450-FEI). Samples at several concentrations (50, 200 mgmL@1, and
2.0 mgmL@1) were prepared by sequential dilution of NBD/PEG8-F6,
prepared as described above. These peptide solutions were placed
on an aluminum stub. The air-dried sample was covered with
a thin coat of gold and palladium sputtered on the stub at a cur-
rent of 20 mA for 90 s. The images of the sample were acquired
with an Everhart Thornley Detector (ETD) and a Through the Lens
Detector (TLD) using an accelerating voltage of 2–5 kV.
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& Peptide-Polymer Conjugates
Structural Characterization of PEGylated Hexaphenylalanine
Nanostructures Exhibiting Green Photoluminescence Emission
Carlo Diaferia,[a] Teresa Sibillano,[b] Davide Altamura,[b] Valentina Roviello,[c] Luigi Vitagliano,[d]
Cinzia Giannini,[b] Giancarlo Morelli,[a] and Antonella Accardo*[a]
Abstract: Peptides containing aromatic residues are known
to exhibit spontaneous phenomena of supramolecular or-
ganization into ordered nanostructures (NSs). In this work
we studied the structural behavior and optoelectronic prop-
erties of new biocompatible materials obtained by the self-
assembly of a series of hexaphenylalanines (F6) modified at
the N terminus by a PEG chain of different lengths. PEG12-F6,
PEG18-F6, and PEG24-F6 peptides were synthesized by cou-
pling sequentially two, three, or four units of amino-carboxy-
PEG6 blocks, each one containing six oxyethylene repeti-
tions. Changes in the length and composition of the PEG
chain were found to modulate the structural organization of
the phenylalanine-based nanostructures. An increase in the
self-aggregation tendency was observed with longer PEG
chains, whereas, independently of the PEG length, the pep-
tide NSs display cross-b-like secondary structures with an an-
tiparallel b-strand arrangement. WAXS/GIWAXS diffraction
patterns indicate a progressive decrease in fiber order along
the series. All the PEG-F6 derivatives present blue photolu-
minescent (PL) emission at 460 nm, with the adduct with
the longest PEG chain (PEG24-F6) showing an additional
green emission at 530 nm.
Introduction
Self-assembling peptides are a class of building blocks that un-
dergo spontaneous supramolecular organization into ordered
structure on the nanoscale. The ability of peptides to self-as-
semble, adopting stable secondary conformations, has allowed
them to be used in nanotechnology and in materials science
as very multifunctional tools.[1] Superhydrophobic coating,[2]
tissue engineering,[3] cell culturing,[4] biosensing,[5] and drug de-
livery[6] are only some of the possible areas of application of
peptide-based supramolecular systems. The driving forces that
hold up spontaneous aggregations are pinpointed in hydrogen
bonds and hydrophobic and aromatic interactions. Peptides
also exhibit versatile features such as resistance to pH[7] as well
as high[8] or low temperatures,[9] mutual recognition,[10] func-
tionality,[11] high mechanical performance,[12] and intrinsic bio-
compatibility.[13] In addition to these characteristics, the rational
design of peptide building blocks and the convenient synthet-
ic procedures of decoration also make it possible to combine
self-assembling peptides with a range of other functional moi-
eties (such as lipids,[14] metallic centers,[15] and nucleic acid de-
rivatives).[16] The mix of peptides with synthetic polymers (e.g. ,
poly(ethylene oxide) (PEO),[17] poly(ethylene glycol) (PEG),[18]
polycaprolactone (PCL),[19] poly(propylene oxide) (PPO),[20] or
poly(acrylic acid) (PPA)[21]) allows (generally in amphiphilic
blocks) peptide functionality and recognition capability to be
synergistically combined with polymer cheapness and respon-
siveness to obtain new hybrid materials. Since the early 1950s,
when Jatzkewitz described the first example of a peptide/poly-
mer conjugate,[22] several reviews,[23] communications,[24] and
perspectives[25] on their synthesis and potential applications
have been reported. It has been observed that the conjugation
of polymers (with particular reference to PEG chains) to natural
or synthetic peptides such as poly(g-benzyl-l-aspartate),[26]
[(AG)3EG]10,
[27] DGRFFF,[28] (LELL)4,
[29] and oligo(phenylalanines)[17]
can strongly affect their structural properties. Moreover, owing
to the crystallization phenomenon, PEG could inhibit the
fibrillation of amyloid peptide sequences (i.e. , Ab16-20
[30] and
Ab10-35
[31]), a function not available to the unmodified peptide.
In the last decade, homo-peptides have been identified as
the simplest class of self-assembling elements and diphenylala-
nine (FF) represents the most well-known peptide building
block.[32] Also, tetra- and pentaphenylalanines have been pro-
posed as promising building blocks for future technological
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applications.[33] We recently proposed and investigated the
supramolecular properties of an FF analogue, PEG8-F6, in
which the aromatic framework, formed by triplication of the FF
motif (i.e. , hexaphenylalanine, F6), was decorated at the N ter-
minus with eight repeating oxyethylene units (PEG8).
[34] The F6
homo-peptide is poorly soluble in water, and PEGylation leads
to a notable increase in its water solubility maintaining unal-
tered the net charge of the peptide derivative. PEG8-F6 self-ag-
gregates in well-ordered and stable nanostructures in water
solution exhibiting photoluminescence (PL) properties. The PL
phenomenon has been ascribed to the dipolar coupling be-
tween the excited states of aromatic residues[35] or associated
with the dense network of hydrogen bonds interlocking the b-
strands. Indeed, fluorescence has also been observed from fi-
brils free of any aromatic group.[36] The most accredited hy-
pothesis is that the proton transfer occurring in the extensive
hydrogen-bond network in peptide fibrils may be responsible
for the fluorescence of these structures.[37] However, the fluo-
rescence intensity of these structures is rather weak and the
signal remains confined to the near-Vis region. To develop
novel bioimaging tools based on peptide nanostructures (NSs),
we recently encapsulated a small fluorescent dye, 4-chloro-7-
nitrobenzofurazan (NBD), in self-assembled PEG8-F6 NSs (NBD/
PEG8-F6).
[38] The close proximity, at the atomic level, of the dye
and PL nanostructure promotes a redshift of the emission peak
from 460 to 530 nm, attributable to a Foster resonance elec-
tron transfer (FRET) phenomenon.
Here we report the synthesis, self-assembling properties,
and PL behavior of a series of PEGylated hexaphenylalanines
(PEG12-F6, PEG18-F6, and PEG24-F6), obtained by coupling,
through an amide bond, two, three, or four amino-hexaoxye-
thylenic acid moieties at the N terminus of the hexaphenylala-
nine. The supramolecular behavior of the F6 copolymers, both
in solution and in the solid state, has been investigated by
fluorescence, circular dichroism (CD), Fourier-transform IR
(FTIR) spectroscopy, polarized optical microscopy (POM), dy-
namic light scattering (DLS), scanning electron microscopy
(SEM), and wide-angle X-ray scattering (WAXS) both in trans-
mission and reflection (GIWAXS) mode. Particular attention was
given to the effects of PEG polymer length and the presence
of the amide bonds on the supramolecular organization. The
optoelectronic properties of the PEG series were also studied
and compared with the PL properties of the PEG8-F6 or NBD/
PEG8-F6 NSs previously reported.
[34,38] Our investigations have
revealed the capability of the cross-b nanostructures based on
these PEGylated hexaphenylalanines to exhibit green fluores-
cence emission.
Results and Discussion
Design, synthesis, and fluorescence studies
PEGylated hexaphenylalanine conjugates (PEG12-F6, PEG18-F6,
and PEG24-F6), schematically represented in Figure 1a, were
manually synthesized by a solid-phase method according to
the fluoren-9-ylmethoxycarbonyl (Fmoc) protocols. The poly-
mer/peptide derivatives PEG12-F6, PEG18-F6, and PEG24-F6 were
obtained in good yields and with high purity, by coupling, re-
spectively, two, three, or four units of commercial poly(ethy-
lene glycol) using the Fmoc derivative Fmoc-Ahoh-OH (PEG6),
each containing six oxyethylene repetitions. The coupling reac-
tion of Fmoc-Ahoh-OH was achieved directly in the solid phase
by carbodiimide activation. This synthetic method, largely used
to prepare short PEG conjugates with molecular weights of
350–800,[23a,25] allows the preparation of PEGylated conjugates
with monodisperse profiles.
Nullifying the predictable effect of PEG polydispersity, it is
possible to obtain amphiphilic peptides with a well-defined hy-
drophile/lipophile balance (HLB). The PEG moiety is expected
to enhance the peptide water solubility ; nevertheless, owing
to the high hydrophobicity of phenylalanine residues, the
three peptides show moderate solubility (ca. 20.0 mgmL@1). As
is predictable, the progressive increase in oxyethylene frag-
ments also translates into shorter retention times (tR) in RP-
Figure 1. (a) Schematic representation of PEGylated hexaphenylalanine
PEG12-F6, PEG18-F6, and PEG24-F6. (b) Fluorescence emission spectra of PEG24-
F6 at several concentrations in the range 0.01–5.0 mgmL@1. Samples were
excited at 257 nm and the spectra recorded between 270 and 400 nm. Both
PEG12-F6 and PEG18-F6 show the same behavior as PEG24-F6 (data not
shown). (c) Fluorescence intensity of the ANS fluorophore at 475 nm versus
concentration of PEG12-F6, PEG18-F6, and PEG24-F6. CAC values are estab-
lished from the break points.
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HPLC for the three polymer/peptide conjugates (see Table 1).
Similarly to the previously studied PEG8-F6 compound, which
contains the same F6 aromatic framework, these peptides also
show a high tendency to self-assemble. The first evidence for
their aggregation phenomena comes from the inspection of
the fluorescence spectra, presented in Figure 1b, for peptides
at different concentrations (between 0.025 and 5.0 mgmL@1).
Samples were excited at 257 nm, which corresponds to the
lmax of the Phe residue, and the emission spectra were record-
ed between 270 and 400 nm. All the spectra show a weak
emission peak at 282 nm, expected for the nude Phe chromo-
phore, and a well-observable peak centered at 312 nm, typical-
ly attributed to Phe excimers, induced by p–p interactions be-
tween the aromatic side-chain rings. Besides these two peaks,
a third band centered around 350–360 nm appears at concen-
trations above 1.0 mgmL@1. These peaks (312 and 350 nm) are
indicative of a complex supramolecular organization of PEGy-
lated hexaphenylalanines.
The aggregation properties of these PEGylated peptides
were analytically characterized by a fluorescence-based
method, which allows evaluation of the critical aggregate con-
centration (CAC). The fluorescent probe, 8-anilinonaphthalene-
1-sulfonate ammonium salt (ANS), was titrated with increasing
amounts of the peptides.[39] No fluorescence emission is ex-
pected for the ANS fluorophore in water. However, ANS shows
an emission peak at 460–480 nm when surrounded by a hydro-
phobic environment, such as in a micelle core.[39] CAC values
for the three peptide polymers were established from the
graphical break points of the plots in Figure 1c. The CAC
values, summarized in Table 1, are 60.9, 20.4, and 13.9 mgmL@1
for the PEG12, PEG18, and PEG24 oligopeptides, respectively.
These values suggest a direct dependence of the PEG length
on the aggregation tendency: Self-aggregation seems favored
in polymers with the highest hydrophilicity (PEG12>PEG18>
PEG24). However, in traditional di- or tri-block copolymers, the
CAC value depends on the hydrophobic/hydrophilic ratio, and
the CAC is expected to be higher for monomers with shorter
hydrophilic portions.[40] The observed discrepancy led us to
speculate that the self-assembling phenomena in these com-
pounds could be due to more than one factor. In addition to
aromatic stacking, we suggest the formation of additional in-
tramolecular hydrogen bonds between the amide bonds in
the PEG chain. These hydrogen bonds could encourage the
self-aggregation of the entire PEG-peptide conjugates. This hy-
pothesis is also supported by comparison of the CAC value
found for PEG24-F6 with those of two other hexaphenylalanine
PEGylated analogues: PEG8-F6 and PEGMW1300-F6 (see Figure S1a
and the experimental details in the Supporting Information).
The first, PEG8-F6, previously characterized by us,
[34] contains
four amide bonds in the PEG fraction, like PEG24-F6, and exhib-
its a CAC value of about 10 mgmL@1 (7.5 mm), slightly lower
than that of PEG24-F6. However, PEGMW1300-F6, with a PEG chain
similar to that in PEG24-F6 but lacking the amide bonds, self-as-
sembles above a CAC value of 40 mgmL@1 (15.2 mm), which is
roughly three-fold higher than the CAC value of the analogous
peptide containing amide bonds in the PEG chain (see Fig-
ure S1b).
Dynamic light scattering (DLS)
The capability of the peptides to self-assemble above their
CAC values was assessed by DLS. DLS studies, previously re-
ported for PEGylated hexaphenylalanine PEG8-F6, indicated the
high kinetic stability of the self-assembled nanostructures and
the low incidence of the concentration on their size. The same
size stability over time was also observed for the series of PEG-
peptides studied here (data not shown). The intensity profiles
of the PEG12, PEG18, and PEG24 oligopeptides in water solution,
at 5.0 mgmL@1, are presented in Figure 2. The intensity profile
of PEG12-F6 shows a monomodal distribution with a mean di-
ameter of around 172 nm. In contrast, both the PEG18 and
PEG24 derivatives show a bimodal distribution, which indicates
the presence of two aggregate populations, the first centered
at 185 nm and the second at 25 nm.
Secondary structure characterization
The secondary structures of the PEGylated oligopeptides in so-
lution were fully investigated by circular dichroism (CD), FTIR,
and UV/Vis spectroscopy. The first two techniques are typically
Table 1. Formulae, retention times (Rt), theoretical molecular weights
(Mw) of PEGylated hexaphenylalanines, and critical aggregate concentra-
tions (CACs) of the PEGylated derivatives.[a]
Sample Formula Rt [min] MW [u.m.a.] CAC [mm] CAC [mgmL
@1]
PEG12-F6 C84H115N9O20 12.5 1570 38.8 60.9
PEG18-F6 C99H144N10O27 11.9 1905 10.7 20.4
PEG24-F6 C114H173N11O34 11.2 2240 6.2 13.9
[a] The RP-HPLC method and column details are reported in the Experi-
mental Section. The CAC values were determined by titration against the
ANS fluorophore.
Figure 2. DLS intensity profiles of PEGylated hexaphenylalanine at
5.0 mgmL@1 in water.
Chem. Eur. J. 2017, 23, 14039 – 14048 www.chemeurj.org T 2017 Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim14041
Full Paper
employed for revealing secondary structural features of pep-
tide-based nanostructures.[41] Figure 3a shows the CD spectra
of the three PEGylated hexaphenylalanine conjugates at
5.0 mgmL@1, well above their CAC values. All the spectra show
a maximum centered between 205 and 207 nm, typical of the
stacking of aromatic side-chains, and a minimum at 227 nm,
associated with a b-sheet arrangement.[42] This dichroic tenden-
cy is similar to that previously observed for the PEG8-F6 ana-
logue.[34] However, a progressive reduction of the intensity of
the two peaks can be detected upon increasing the PEG
length. The reduction of both peaks confirms the capability of
the PEG length to affect the self-aggregation propensity of the
hexaphenylalanine and, in agreement with the fluorescence
studies, the polymeric peptide containing the PEG24 moiety
presents a higher tendency to self-aggregate under the same
conditions of concentration.
The occurrence of b-sheet formation was also confirmed by
FTIR spectroscopy in the amide I spectral region (1600–
1700 cm@1). The deconvolution of the absorbance of the FTIR
spectra in this region for secondary structure prediction is pre-
sented in Figure 3b (2.0 mgmL@1 in water solution). All the
hexaphenylalanine derivatives show a similar FTIR spectrum
with two peaks at 1638 and 1680 cm@1. This profile is typically
observed for b-sheets with antiparallel orientation of the b-
strands.[43] Moreover, the NH stretching occurring at 3280 cm@1
in the amide A region (see Figure S2 in the Supporting Infor-
mation) indicates strong intermolecular amide–amide bonds.
The absence of a band at around 3400 cm@1 and the presence
of a band at 1530 cm@1 in the amide II region indicate that all
the NH groups in PEG24-F6 are involved in strong intermolecu-
lar hydrogen-bonding interactions in the fibrillary network. As
previously observed for PEG8-F6, the FTIR spectra of these pep-
tides dissolved in 1,1,1,3,3,3-hexafluoroisopropanol (disaggre-
gating conditions) do not show peaks in the amide I region
(data not shown).
All these structural data support the hypothesis of a supra-
molecular organization in an amyloid-like fibrillary nanostruc-
ture. Confirmation of this structural organization was obtained
through a Congo Red (CR) staining assay. CR, an azoic dye that
exhibits a UV/Vis absorbance maximum at around 490 nm, un-
dergoes a redshift of the maximum to 540 nm when interact-
ing with amyloid like-fibrillary structures.[44] As expected, the
UV/Vis spectra show a bathochromic shift of the maximum
when the azoic dye is incubated with the PEGylated-F6 pep-
tides at 1.0 and 2.5 mgmL@1 (Figure 3c and Figure S3 in the
Supporting Information), which supports the hypothesis of
amyloid-like organization.
Wide-angle X-ray scattering (WAXS)
A detailed characterization of the nanostructures in the solid
state was performed by WAXS and grazing-incidence WAXS
(GIWAXS) techniques in transmission and reflection modes, re-
spectively. Figure 4b–d (left panel) display the two-dimensional
(2D) WAXS patterns collected for the fibers with PEGs of differ-
ent lengths (PEG12, PEG18, and PEG24, respectively). The 2D
WAXS pattern of the PEG8 derivative, previously studied,
[34] is
also presented for comparison (Figure 4a). The 2D patterns,
once centered, calibrated, and radially folded into 1D profiles,
are shown in Figure 4a–d (right panel). Figure 4e shows the
same 1D patterns shifted vertically for the sake of comparison.
It reveals that the diffraction patterns are almost identical, with
two important peaks occurring at q=0.518 and 1.32 a@1,
which we have assigned to the equatorial b-sheet distance
de=12.2:0.3 a and to the meridional b-strand distance of
dm=4.8:0.3 a, respectively. The reflection corresponding to
d=4.8 a could, in principle, be ascribed to PEG crystallization
(4.7 a).[45] However, the simultaneous presence of the equatori-
al reflection at d=12.2 a is symptomatic of cross-b amyloid
structures. Overlaying the diffraction patterns so that their
backgrounds coincide, as shown in Figure 4 f, allows one to ap-
preciate the difference in the intensities of the most significant
reflection at q=0.518 a@1, which corresponds to the equatorial
Figure 3. (a) CD spectra of PEG12-F6, PEG18-F6, and PEG24-F6. All the samples
are at 5.0 mgmL@1 (concentration above the CAC). b) FTIR spectra of the F6/
polymer conjugates at 2.0 mgmL@1 in the amide I region. c) UV/Vis spectra
of PEG12-F6, PEG18-F6, and PEG24-F6 at 2.5 mgmL
@1 after incubation with
Congo Red. The spectrum of Congo Red is also presented for comparison.
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b-sheet. Thus, it can be seen that the most intense peak is reg-
istered for PEG8, almost equal intensities are found for PEG12
and PEG18, and the lowest intensity for the PEG24 fiber. This dif-
ference in intensity can be attributed to the partial effect of
PEG crystallization that occurs in proportion to the PEG length/
molecular weight. Finally, for the same equatorial b-sheet re-
flection, we estimated the full-width-at-half-maximum (FWHM)
along the azimuth F angle (i.e. , along the diffraction circle):
FWHM(PEG8)=FWHM(PEG12)=54:28, FWHM(PEG18)=62:28,
and FWHM(PEG24)>1808 (see Figure 4g). These values reflect a
clear increase in fiber disorder,[15] which is a maximum for the
PEG24 sample, for which it is not possible to identify any pre-
ferred orientation direction of the fiber. We exclude that fiber
disorder can be attributed to PEG crystallization. Indeed, polar-
ized optical microscopy images of dried samples at high con-
centration (5 wt%) do not show the typical spherulite struc-
tures of PEG crystallization, but the formation of a liquid crystal
phase through birefringence (data not shown). To analyze pos-
sible differences in the fiber structure due to different sample
preparation or influences of the substrate, fibers were deposit-
ed on the top surface of silicon substrates and studied by
GIWAXS. Figure 5a–d shows the GIWAXS 2D data for the PEG8,
PEG12, PEG18, and PEG24 fibers, respectively (upper panels) ; the
corresponding lower panels display the horizontal cut (green
line) extracted from each set of 2D GIWAXS data along the
green arrow, which are compared with the relevant meridional
WAXS profiles (black line) previously shown in Figure 4. The
comparison clearly shows that the same peaks at q=0.518 a@1
(equatorial b-sheet distance de=12.2:0.3 a) and q=1.32 a@1
(meridional b-strands of dm=4.8:0.3 a) are measured for the
fibers studied in both the transmission (WAXS, Figure 4) and
reflection (GIWAXS, Figure 5) modes, which proves that the
sample preparation does not modify the atomic arrangement
of the fibers. The WAXS and GIWAXS characterizations of
PEGMW1300-F6 are presented in Figure 6. Figure 6a,b show the
optical microscopy images of a single fiber of PEGMW1300-F6 and
of the same material deposited on silicon substrate, respective-
ly. The corresponding 2D WAXS and GIWAXS data are dis-
played in Figure 6c,d with the integrated 1D profiles shown in
Figure 6e as green (GIWAXS cut of the 2D data, extracted
along the green arrow) and black (WAXS) lines. Also, in this
case, the most important reflections, which correspond to the
equatorial b-sheet (de=12.2:0.3 a) and the meridional b-
strand (dm=4.8:0.3 a) distances, coincide in the WAXS and
GIWAXS data. In analogy to the measurements taken on the
PEG8, PEG12, PEG18, and PEG24 fibers (see Figure 4g), we also es-
timated for the PEGMW1300-F6 sample the full-width-at-half-maxi-
mum (FWHM) along the azimuth F angle for the same equato-
rial b-sheet reflection (see comparison in Figure S4 in the Sup-
porting Information, in which the added magenta profile corre-
sponds to the PEGMW1300-F6 sample). The FWHM(PEGMW1300)
value is same to that measured for PEG18-F6, which confirms
an effect of the amide bonds in the PEG chain also on fiber
order.
Scanning electron microscopy (SEM)
The SEM images of PEGylated F6 peptides at 2.0 mgmL@1, pre-
sented in Figure 7, confirm their aptitude to self-assemble in
supramolecular NSs. The micrograph of PEG12-F6 (Figure 7a)
shows braid-like microstructures growing from thin scratches.
PEG18-F6 self-aggregates in a sheaf formed by small fibers of
60–500 nm placed side by side. Each fiber has a thickness of
between 60 and 200 nm. In contrast, SEM images of PEG24-F6
show nanostructures with lengths of 600–1000 mm and widths
of around 20 mm with a twisted ribbon shape (Figure 7c,d).
Figure 5. 2D GIWAXS (upper panels) and corresponding 1D GIWAXS data
(lower panels, green curves) for (a) PEG8, (b) PEG12, (c) PEG18, and (d) PEG24
fibers deposited on silicon substrates. The black lines in the lower panels are
the corresponding WAXS profiles collected for the same samples.
Figure 6. Optical microscopy images of (a) a single PEGMW1300-F6 fiber and
(b) fibers deposited on a silicon substrate. (c) 2D WAXS data for a single
fiber and (d) 2D GIWAXS data for fibers on a silicon substrate. (e) Integrated
1D GIWAXS (green) and WAXS (black) profiles.
Figure 4. (a–d) 2D (left panel) and 1D (right panel) WAXS data. (e) 1D WAXS
patterns vertically shifted for comparison. (f) Detail of the equatorial b-sheet
distance at q=0.158 a@1 (de=12.2:0.3 a). (g) Equatorial b-sheet reflection
integrated along the azimuth F angle (i.e. , across the diffraction circle).
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These kinds of structures are expected for amyloid peptides
functionalized with short PEG chains.
In accord with the results of polarized optical microscopy,
we do not observe in the SEM images the effect of crystalliza-
tion typically displayed by PEGylated peptides. The absence of
crystallization phenomenon in the SEM images further con-
firms that the continuous rings measured in the WAXS diffrac-
tion patterns are due to the low orientation of dried PEG24-F6
fibers in space. A comparison of the SEM images of the three
PEGylated derivatives shows that the PEG length affects the hi-
erarchical organization of the peptide and the elongation of
the nanostructure. The trend observed here is opposite to the
conventional one shown by Hamley for PEGylated amyloid
peptides.[23a] However, the fibers observed for PEG24-F6 are
very similar to those previously observed for PEG8-F6, in which
the oxyethylene chain is shorter than in PEG24-F6, but the
number of the amide bonds in the PEG moiety is the same.
This result suggests once more a strong relationship between
the number of amide bonds and the structural aggregation of
these peptides.
Photoluminescence in peptide nanofibers
The fluorescence behavior of the PEGylated peptides (PEG12-F6,
PEG18-F6, and PEG24-F6) was investigated both in solution
(Figure 8) and in the solid state (Figure 9) and compared with
the fluorescence of PEG8-F6 nanostructures, empty or filled
with the NBD dye.[34,38] Several hypotheses have been pro-
posed to explain the origin of the blue-green photolumines-
cence (PL) of peptide-based nanostructures containing only
chromophore groups typical of peptides and proteins (i.e. ,
amide bonds and aromatic rings).[36a,46] One of the most ac-
credited hypotheses reported in the literature for this unex-
pected fluorescence invokes electron delocalization through
hydrogen bonds in the b-sheet-rich structure.[37] Indeed, PEG8-
F6 NSs, rich in cross-b structures, exhibit blue PL both in aque-
ous solution (at a concentration of 10 mgmL@1) and in the
solid state.[34] The maximum fluorescence is observed at
460 nm when a sample is excited at 370 or 410 nm. These op-
toelectronic properties were also observed in NBD-encapsulat-
ing PEG8-F6 NSs.
[38] However, in this latter case, we observed a
redshift of the emission peak from 460 to 535 nm, which corre-
Figure 7. Selected SEM images of PEGylated oligomers: (a) PEG12-F6
(30000V , 5 mm scale bar), (b) PEG18-F6 (30000V , 5 mm scale bar), and
(c,d) PEG24-F6 (400V , 400 mm and 3000V , 50 mm scale bar, respectively). In
the insert of panel (b) an additional view of PEG18-F6 (30000V , 5 mm scale
bar) on an aluminum stub showing an intricate sheaf of fibers.
Figure 8. (a) PL emission spectra of the PEGylated-F6 nanostructures at
10 mgmL@1 upon excitation at lexc=460 nm. (b) Selected PL emission spec-
tra of PEG24-F6 excited at several wavelengths in the range 370–480 nm.
(c) Plot of the fluorescence intensity of PEG24-F6 at 530 nm as a function of
the excitation wavelength.
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sponds to the characteristic emission wavelength of NBD. The
redshift was attributed by us to a FRET phenomenon between
the PL of the NS (donor) tightly associated with the NBD fluo-
rophore (acceptor). Moreover, a significant increase in terms of
relative signal was also observed. Similarly to PEG8-F6 NSs, the
PEG12-F6, PEG18-F6, and PEG24-F6 derivatives, having a high
content of b-sheet structures, also show optoelectronic proper-
ties in water when excited at 370 or 410 nm (see Figure S5 in
the Supporting Information). However, in addition to the emis-
sion peak at 460 nm, a PL emission peak at 530 nm can also
be observed upon excitation of the solutions at 460 nm (Fig-
ure 8a). This peak at 530 nm is most evident for PEG24-F6,
whereas it appears to be absent or very weak for PEG12-F6 and
PEG18-F6 (Figure 8a). The green PL emission of the PEG24 deriv-
ative is also easily distinguishable when the peptide solution is
excited at different wavelengths (Figure 8b). The plot of fluo-
rescence intensity at the maximum as a function of the excita-
tion wavelength is presented in Figure 8c. This additional exci-
tation/emission pair for PEG24-F6 can be traced back to the for-
mation of more stable electronic states resulting from the ad-
ditional contribution of amide noncovalent interactions.
The fluorescence microscopy images of the air-dried samples
deposited on clean coverslip glasses are presented in Figure 9
and Figure S6 in the Supporting Information. Owing to the
wide spectral region over which the samples in solution can
be observed, immunofluorescence images in the solid state
were obtained by using as filters 4’,6-diamidino-2-phenylindole
(DAPI), Green Fluorescent Protein (GFP), and Rhodamine (Rho),
which cover the entire range of excitation and emission wave-
lengths. The images of PEG24-F6 (Figure 9) show the capability
of this peptide nanostructure to emit in the blue, green, and
red regions. On the other hand, the images of PEG12 and PEG18
show good emission only in the blue region (see Figure S6).
These results indicate the capability of these peptides to retain
the same optoelectronic properties both in solution and in the
solid state. Taking into account the different number of hydro-
gen-bonding donors/acceptors in PEG24-F6 compared with
other PEGylated analogues, we assumed that the distinct PL
behavior of these compounds could be, at least in part, due to
the different hydrogen-bonding potential of these compounds.
This hypothesis has been supported by the investigation of
the PL properties of PEGMW1300-F6, which has a PEG moiety
comparable in size to that of PEG24-F6, although lacking the
amide groups that could be potentially involved in hydrogen
bonding. In line with our suggestion, PEGMW1300-F6 does not
show an emission peak at 530 nm under the same experimen-
tal conditions, although it retains the usual emissions when ex-
cited at 370 and 410 nm (see Figure S7 in the Supporting Infor-
mation).
Conclusion
The PEGylation of natural or synthetic peptides permits hybrid
materials to be obtained. The in vivo stability to protease deg-
radation of PEGylated materials, like micelles and liposomes,
makes them potentially suitable for biomedical applications. In
this work we studied the effect of PEG derivatization, both
length and composition of the PEG chain, on the hierarchical
organization and optical properties of hexaphenylalanine (F6)-
based nanostructures. PEG12-F6, PEG18-F6, and PEG24-F6 pep-
tides were synthesized by coupling sequentially two, three, or
four units of amino-carboxy-PEG6 blocks, each one containing
six oxyethylene repetitions. On the other hand, PEGMW1300-F6
was synthesized by coupling a single polydisperse PEG chain
having the desired molecular weight to the peptide. The two
synthetic approaches yield final peptide derivatives with differ-
ent degrees of polydispersity and different numbers of amide
bonds. Owing to their capability to stabilize new intermolecu-
lar hydrogen bonds, the amide bonds in the PEG chains affect
the structural and functional properties of the peptides. We
observed that independently of the PEG length and the
number of amide bonds, all the peptide NSs display cross-b-
like secondary structures with an antiparallel b-strand arrange-
ment. However, a certain decrease in fiber order was observed
along the series PEG8>PEG12>PEG18>PEG24. All the peptide
nanostructures exhibit blue PL emission at 460 nm upon exci-
tation at 370 or 410 nm. In addition to this blue fluorescence
emission, PEG24-F6 also shows an additional green PL emission
at 530 nm when excited at 460 nm. This different optoelectron-
ic behavior can plausibly be attributed to the higher number
of amide bonds in the PEG chain, which may either produce a
more extended electron delocalization through hydrogen
bonds or a fine re-adjustment of the cross-b structure of the
peptide spine. As a result of the ample debate on the origins
of PL phenomena,[35–37] we do not completely exclude other
factors that can affect the PL behavior. The interpretation of
the PL properties of PEG24-F6 could represent an interesting
challenge for future studies. The possibility to modulate struc-
tural organization and to obtain new biocompatible and bio-
degradable materials, able to emit fluorescence at high wave-
Figure 9. Fluorescence microscopy images of PEG24-F6 at 10 mgmL
@1 depos-
ited on clean coverslip glasses and slowly dried at room temperature. The
PL images were obtained by exciting the air-dried sample in the spectral re-
gions of (a) DAPI (lexc=359 nm, lem=461 nm), (b) GFP (lexc=488 nm,
lem=507 nm), (c) Rho (lexc=555 nm, lem=580 nm), and (d) in brightfield.
The scale bar is 50 mm for all images.
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length, opens new perspectives in the field of bioimaging, that
is, the detection of the aggregation of endogenous proteins,
which, in their physio-pathological form, are known to adopt
cross-b structural motifs.
Experimental Section
Materials : Protected Na-Fmoc-amino acid derivatives, coupling re-
agents, and Rink amide MBHA (4-methylbenzhydrylamine) resin
were purchased from Calbiochem-Novabiochem (Laufelfingen,
Switzerland). The Fmoc-21-amino-4,7,10,13,16,19-hexaoxaheneico-
sanoic acid (Fmoc-Ahoh-OH, PEG6) was purchased from Neosystem
(Strasbourg, France). All other chemicals were commercially avail-
able from Sigma–Aldrich (Milan, Italy), Fluka (Bucks, Switzerland),
or LabScan (Stillorgan, Dublin, Ireland) and were used as received
unless stated otherwise. All solutions were prepared by weight
with doubly distilled water. Preparative RP-HPLC was carried out
on an LC8 Shimadzu HPLC system (Shimadzu Corporation, Kyoto,
Japan) equipped with a UV lambda-Max Model 481detector using
a Phenomenex (Torrance, CA) C18 column. Elution solvents were
H2O/0.1% TFA (A) and CH3CN/0.1% TFA (B) from 5 to 70% over
30 min at a flow rate of 20 mLmin@1. The purity and identities of
the products were assessed by analytical LC-MS analyses using a
Finnigan Surveyor MSQ single quadrupole electrospray ionization
spectrometer (Finnigan/Thermo Electron Corporation San Jose, CA)
with a C18-Phenomenex column eluting with H2O/0.1% TFA (A)
and CH3CN/0.1% TFA (B) from 5 to 70% over 15 min at a flow rate
of 200 mLmin@1.
Synthesis of peptide derivatives : PEGylated hexaphenylalanines
were synthesized by using standard solid-phase fluoren-9-ylme-
thoxycarbonyl (Fmoc) procedures. The Rink amide MBHA resin
(substitution 0.65 mmolg@1, 0.2 mmol) was used as the solid-phase
support to provide the peptides as C-terminus amides. The resin
was swollen in DMF for 30 min. Fmoc removal was performed
twice, treating the resin for 10 min with a mixture of DMF/piperi-
dine (70:30, v/v). The coupling of the Fmoc-Phe-OH and of the
Fmoc-Ahoh-OH was achieved by adding a two-fold molar excess
of the amino acid, mixed with equimolar amounts of 1-hydroxy-
benzotriazole (HOBt), benzotriazol-1-yloxytripyrrolidinophosphoni-
um (PyBop), and a four-fold molar excess of N,N-diisopropylethyla-
mine (DIPEA) in DMF for 1 h. The peptides were fully deprotected
from the resin by using TFA/H2O (95:5.0, v/v) at room temperature
for 3 h. The peptides were precipitated with ice-cold diethyl ether,
dissolved in H2O/CH3CN, and freeze-dried. The crude products
were purified by RP-HPLC. The mass spectra confirmed the identi-
ties of the products. The retention times (Rt) and molecular weights
(Mw) of the peptide derivatives are reported in Table 1.
PEG12-F6 :
1H NMR (CD3OD; CH3OH as internal standard, d=
3.55 ppm): d=7.51–7.42 (m, 30H; CH aromatic), 4.86–4.75 (m, 6H;
CH Phe a), 3.80 (s, 44H; OCH2CH2O), 3.75 (t, 4H; RNHCH2CH2O),
3.60 (t, 4H; RNHCH2CH2O), 3.16–2.90 (m, 12H; CH2 Phe b),
2.58 ppm(t, 4H; NHCOCH2CH2O).
PEG18-F6 :
1H NMR (CD3OD; CH3OH as internal standard, d=
3.55 ppm): d=7.51–7.42 (m, 30H; CH aromatic), 4.86–4.75 (m, 6H;
CH Phe a), 3.80 (s, 66H; OCH2CH2O), 3.75 (t, 6H; RNHCH2CH2O),
3.60 (t, 6H; RNHCH2CH2O), 3.16–2.90 (m, 12H; CH2 Phe b),
2.58 ppm (t, 6H; NHCOCH2CH2O).
PEG24-F6 :
1H NMR (CD3OD; CH3OH as internal standard, d=
3.55 ppm) : d= =7.51–7.42 (m, 30H; CH aromatic), 4.86–4.75 (m,
6H; CH Phe a), 3.80 (s, 88H; OCH2CH2O), 3.75 (t, 8H; RNHCH2CH2O),
3.60 (t, 8H; RNHCH2CH2O), 3.16–2.90 (m, 12H; CH2 Phe b),
2.58 ppm (t, 8H; NHCOCH2CH2O).
Preparation of peptide solutions : Peptide solutions were pre-
pared by dissolving the lyophilized powder in double-distilled
water sonicating the sample for 15 min. The peptide concentration
was determined with a UV/Vis Thermo Fisher Scientific (Wilming-
ton, Delaware USA) Nanodrop 2000c spectrophotometer equipped
with a 1.0 cm quartz cuvette (Hellma) based on a molar absorptivi-
ty (e257) of 1170m
@1cm@1.
Fluorescence studies : Critical aggregate concentrations (CACs)
were determined by fluorescence measurements. Fluorescence
spectra were recorded at room temperature on a Jasco Model FP-
750 spectrofluorophotometer in a 1.0 cm path length quartz cell.
Equal excitation and emission bandwidths (5 nm) were used
throughout the experiments with a recording speed of
125 nmmin@1 and automatic selection of the time constant. The
CAC values were measured by using 8-anilino-1-naphthalenesul-
fonic acid ammonium salt (ANS) as the fluorescent probe.[33] Small
aliquots of peptide derivatives in water solutions were added to
aqueous solutions of ANS (20 mm, 1.0 mL). The final spectra, to be
used for calculations, were obtained after blank correction and ad-
justment for dilution. The fluorescence intensity of ANS was moni-
tored as a function of peptide concentration. The CAC values were
determined, upon excitation at 350 nm, by linear least-squares fit-
ting of the fluorescence emission at 475 nm versus the poly-phe-
nylalanine concentration, as the crossing point between the
changes of slope.
DLS measurements : The hydrodynamic radii (RH) and diffusion co-
efficients (D) of the hexaphenylalanine nanostructures were mea-
sured by DLS. The DLS measurements were carried out by using a
Zetasizer Nano ZS instrument (Malvern Instruments, Westborough,
MA) employing a 1738 backscatter detector. Other instrumental
settings were as follows: measurement position: 4.65 mm; attenua-
tor: 8; temperature: 25 8C; cell : disposable sizing cuvette. DLS
measurements in triplicate were carried out on aqueous samples
at 2.0 mgmL@1 after centrifugation at room temperature at
13000 rpm for 5 min.
Circular dichroism : Far-UV CD spectra of the peptides in aqueous
solution were collected on a Jasco J-810 spectropolarimeter
equipped with a NesLab RTE111 thermal controller unit using a
0.1 mm quartz cell at 25 8C. The spectra of samples at 5.0 mgmL@1
were recorded in the range 280–195 nm. Other experimental set-
tings were as follows: scan speed: 10 nmmin@1; sensitivity:
50 mdeg; time constant: 16 s; bandwidth: 1 nm. Each spectrum
was obtained by averaging three scans and was corrected with the
blank. Here, q represents the mean residue ellipticity (MRE), that is,
the ellipticity per mole of peptide divided by the number of amino
acid residues in the peptide.
Fourier-transform infrared spectroscopy : The FTIR spectra of
dried films (2.0 mgmL@1) were recorded on a Jasco FT/IR 4100
spectrometer (Easton, MD) in attenuated total reflection (ATR)
mode using a single crystal of germanium at a resolution of
4 cm@1. To estimate the secondary structures, all the spectral data
were processed by using built-in software. The spectra were col-
lected in transmission mode and then converted into emission.
Each sample was recorded with a total of 100 scans at a rate of
2 mms@1 against a KBr background.
Congo Red spectroscopic assay : The UV/Vis spectra of the Congo
Red (CR) dye alone or incubated with oligo-phenylalanine deriva-
tives were recorded on a Nanodrop 2000c spectrophotometer
equipped with a 1.0 cm quartz cuvette (Hellma). A stock solution
of CR (3.5 mg in 500 mL) was freshly prepared in 10 mm phosphate
buffer at pH 7.4 and filtered through a 0.2 mm syringe. A small ali-
quot (5 mL) of this solution was diluted with water to give a final
concentration of 12.5 mm and the UV/Vis spectrum was recorded
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between 400 and 700 nm at room temperature. Aliquots of 5, 50,
and 125 mL of PEG12-F6, PEG18-F6, or PEG24-F6 (20 mgmL
@1) were
added to the CR solution and the samples were incubated for
30 min at room temperature. The spectra were recorded and back-
ground-subtracted by using the Congo Red spectrum in phos-
phate buffer as the reference solution.
Wide-angle X-ray scattering : Fiber diffraction WAXS patterns were
recorded from stalks by the stretch frame method.[47] Briefly, a
droplet (10 mL) of aqueous peptide solution (3 wt%) was suspend-
ed between the ends of a wax-coated capillary (spaced 2 mm
apart) to collect wide-angle X-ray scattering data (WAXS) in trans-
mission mode. The droplet was allowed to dry slowly at room tem-
perature overnight to obtain oriented fibers. For WAXS in reflection
mode (GIWAXS) some droplets of solutions were deposited on the
top surface of silicon substrates and allowed to dry at room tem-
perature. WAXS and GIWAXS data were collected at the X-ray Mi-
croImaging Laboratory (XMI-L@b) with a Fr-E+ SuperBright rotat-
ing anode copper anode microsource (CuKa, l=0.15405 nm,
2475 W), a multilayer focusing optics (Confocal Max-Flux; CMF 15–
105), and a three-pinhole camera (Rigaku SMAX-3000).[48] For data
collection an image plate (IP) detector with 100 mm pixel size was
placed at 10 cm (WAXS) and 8.7 cm (GIWAXS) from the sample and
calibrated by using the silicon NIST standard reference material
(SRM 640b). A 200 mm (diameter) X-ray beam was employed.
GIWAXS patterns were collected at an incidence angle of 0.28. A
detailed description of the XMI-L@b performances can be found in
reports of Altamura et al.[48a] and Sibillano et al.[48b]
Polarized optical microscopy : Dried films of PEGylated hexaphe-
nylalanines were obtained by placing the aqueous peptide solution
(10 mL, 5 wt%) on a glass slide and leaving it to dry at room tem-
perature. Then, the air-dried samples were observed between
crossed polars by using a Nikon AZ100 microscope.
Scanning electron microscopy : Morphological analysis of the
nanostructures was carried out by field-emission scanning electron
microscopy (Nova NanoSem 450-FEI). Samples at 2.0 mgmL@1, pre-
pared as above described, were placed on an aluminium stub by
using a graphite adhesive tape. A thin layer of gold and palladium
was sputtered at a current of 20 mA for 90 s. The coated samples
were then introduced into the specimen chamber and the images
were acquired at an accelerating voltage of 2–5 kV, spot 3, by
using an Everhart Thornley detector (ETD) and a through-lens de-
tector (TLD).
Optical spectrofluorimetry : Photoluminescence (PL) measure-
ments were performed by using a Jasco Model FP-750 spectro-
fluorophotometer in a 1.0 cm path length quartz cell. Aqueous PE-
Gylated nanostructures (10 mgmL@1) were prepared as described
above, and the PL was measured on samples excited at various
wavelengths in the range 370–480 nm.
Fluorescence microscopy : PEGylated oligopeptide solutions at
10 mgmL@1 were deposited on clean coverslip glasses, dried, and
imaged by fluorescence microscopy. Immunofluorescence images
were collected with a Leica DFC320 video camera (Leica, Milan,
Italy) connected to a Leica DMRB microscope equipped with 10V
and 40V objectives and the Image J Software (National Institutes
of Health, Bethesda, MD) was used for analysis.[49]
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Amyloid-like fibrillary morphology originated by tyrosine 
containing aromatic hexapeptides. 
Carlo Diaferia,[a] Nicole Balasco,[b] Teresa Sibillano,[c] Moumita Ghosh,[d] Lihi Adler-Abramovich, [d] 
Cinzia Giannini,[c] Luigi Vitagliano,[b] Giancarlo Morelli,[a] and Antonella Accardo*[a] 
Abstract: Diphenylalanine based nanostructures have attracted great 
attention in the material science for their functional properties. These 
properties strongly depend from that hierarchic organization of the 
nanostructure that in turn can be fine tunes by punctual chemical 
modifications of the building blocks. Here we investigate how the 
partial or the complete replacement of the Phe residue with Tyr one 
(PEG8-Y6 and PEG8-(FY)3) in ancestor PEG8-F6 can alter the 
structure of the nanomaterial. The effect of the PEG derivatization was 
also evaluated in peptides lacking of the PEG moiety (Y6 and (FY)3). 
Both PEG8-Y6 and PEG8-(FY)3 self-assemble in water at micromolar 
concentration in β-sheet rich nanostructures. Instead, WAXS 
diffraction patterns show significant structural differences between the 
samples. (FY)3 and Y6 show a 2D WAXS profile typically observed in 
cross-β amyloid like structures with a meridional  and the equatorial 
reflections at 4.7 and 12.5 Å, respectively. The addition of the PEG 
moiety affects the diffraction pattern of PEG8-Y6, there are circle 
typically observed in presence of PEG crystallization. MD simulations 
are in good agreement with experimental WAXS data. Gelation 
phenomenon was detected only for PEG8-(FY)3 above a 
concentration of 1.0 wt% as confirmed by storage (G′~100 Pa) and 
loss (G′′~28 Pa) moduli in rheological studies. The cell viability on 
CHO cells of this soft hydrogel was certified to be 90% after 24 hours 
of incubation.   
Introduction 
In the last years, nanotechnology has imposed itself as 
revolutionary scientific area at the interface between different 
disciplines, which include chemistry, medicine, material science 
and biology. A large variety of nanoplatforms (NPs) with different 
morphology, shape, compatibility and functionality have been 
obtained by opportunely manipulating matter.[1] The need to 
obtain nanostructures (NSs) with well-defined characteristics of 
uniformity, purity, size, and chemical compositions brought to the 
development of many technologies and approaches for their 
manufacturing.[2] One of the most common strategy takes 
advantage of self-assembling phenomena that rely on 
associations through non-covalent interactions between 
monomers.[3] Intensive investigations, carried out over the last two 
decades, have highlighted an extraordinary propensity of proteins, 
peptides and even single amino acids to form assemblies with 
well-defined structural, chemical and physical properties.[3-4] 
Protein and peptide self-association has a huge impact in different, 
apparently unrelated, scientific areas. Indeed, it is commonly 
believed that protein/peptide self-association generates the 
molecular species that are causative agents of 
neurodegenerative diseases.[5] On the other hand, the ability of 
proteins, peptides and amino acids to form non-covalent, through 
highly stable, assemblies have been envisaged as an extremely 
powerful tool to generate innovative entities with widespread 
applications. Interestingly, being the process of protein/peptide 
aggregation common to all these studies, there has been a fruitful 
flow of information from one field to the other. The tendency of 
these compounds to undergo self-aggregation is obviously linked 
to the ability of main chain atoms to form hydrogen bonding 
interactions. A contribution to the formation of these assemblies 
can also be occasionally provided by electrostatic interactions 
established by terminal charged groups. In addition to that, it has 
been well established that also interactions involving side chains 
may be crucial for these associations. For example, it has been 
shown that glutamine (Gln) and asparagine (Asn) residues can 
stabilize amyloid-like aggregates as their side chains can form 
ladders of hydrogen bonds.[6] Moreover, the suggestion that 
aromatic side chains could stabilize amyloid fibrils through the 
formation of -interactions[7] has led to the development of 
assemblies with mechanical, thermal and chemical properties 
that are not typically well-spotted in biological matter.[8] 
Particularly impressive in this context is the case of the 
diphenylalanine homopeptide (FF) which is the most studied 
peptide able to self-assemble in well-organized amyloid-like 
materials.[9] Indeed, depending on the experimental conditions,[10] 
FF is able to self-organize in different kind of nano and micro 
morphologies (hollow nanotubes,[9] fibers,[11] vesicles,[10c] 
metastable hydrogels[12] or organogels[13]) through the 
combination of - stacking and hydrogen-bonding 
interactions.[14] Based on this evidence, FF became one of the 
prototypes of the amyloid-based materials and many structural 
analogues were synthesized and studied (for example FW [15], 
FFF[16], PEGylated FFFF,[17] di-3,4-
dihydroxyphenylalanine/DOPA-DOPA,[18] Fmoc-FG,[19] and 
Fmoc-FF[20]). In this scenario, we recently reported on the 
synthesis and on the structural characterization of a novel 
PEGylated Phe-based compound, which is composed by six 
phenylalanine (F6) residues and eight PEG repetitive units 
(PEG8) (PEG8-F6).[21]  
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Figure 1: Schematic representation of PEGylated hexapeptides: PEG8-Y6 (a) 
and PEG8-(FY)3 (b).Fluorescence intensity emission of ANS fluorophore at 475 
nm vs. concentration of PEG8-Y6 and PEG8-(FY)3 (c). CAC values are 
established from the break points. 
 
This peptide-polymer conjugate is able to self-assemble in stable 
and well-organized nanostructures endowed with a cross-β 
structure. The supramolecular organization of PEG8-F6 in β-rich 
materials confers them interesting optoelectronic properties.[21] 
Based on these results and, considering that aromaticity is a key 
factor for ordered aggregation, we here investigated the 
properties of PEG8-F6 analogues in which some or all of Phe 
residues were replaced with Tyr (Y). This residue was selected 
as, at its side chain, the aromaticity is coupled to a phenolic group 
that can be involved in H-bond formation as acceptor and donor. 
Here we report on the characterization of two analogues of the 
ancestor PEG8-F6, named as PEG8-Y6 and PEG8-(FY)3, 
depicted in Figure 1.  
In the former the peptide moiety is composed exclusively by Tyr 
whereas in the latter there is a Phe-Tyr alternation. In order to 
evaluate the effect of PEG on the structural properties of these 
hexapeptides, we also synthesized the corresponding peptides 
without the PEG moiety (named Y6 and (FY)3). All these 
hexapeptides were structurally characterized both in solution and 
at the solid state by fluorescence, Circular Dicrohism (CD), 
Fourier Transform Infrared spectroscopy (FTIR), Transmission 
Electron Microscopy (TEM) and Wide Angle X-ray Scattering 
(WAXS). The physicochemical behavior of these peptides was 
also compared with the previously studied PEG8-F6 homologous. 
Moreover, an atomic-level definition of the three-dimensional 
structure of the peptide spine of both PEG8-(FY)3 and PEG8-Y6 
was achieved through extensive molecular dynamics (MD) 
simulations. Although, on the basis of the sequence, the 
properties of PEG8-(FY)3 were expected to be intermediate 
between those exhibited by PEG8-F6 and PEG8-Y6, this analog 
showed a distinct behavior with a remarkable propensity to form 
a hydrogel. Rheological properties and in vitro cell toxicity of this 
hydrogel are here preliminary investigated. 
Results 
Design, synthesis and fluorescence studies 
PEG8-F6 peptide is a synthetic polymer-peptide able to self-
assemble in fibrillar amyloid like networks.[21] This structural 
behavior was expected for phenylalanine (Phe) containing 
polypeptides.[9] The impact of this key aromatic amino acid on the 
supramolecular structural organization was here evaluated by 
replacing it in PEG8-F6 with tyrosine, another aromatic residue. 
Similar to its ancestor peptide PEG8-F6, PEG8-Y6 (Figure 1a) 
keeps the same molecular architecture composed of an aromatic 
framework of six amino acid residues and a polymer functionality. 
In order to evaluate the effect of a partial replacement of Phe with 
Tyr, we also synthesized PEG8-(FY)3 (Figure 1b) in which the two 
aromatic residues are alternated in the sequence. PEG moiety in 
these peptides is expected to increase their water solubility. 
According to this finding, we observed a clear drop of the water 
solubility and self-assembling capability for PEG8-F6 as a 
consequence of the PEG removal (data not shown). However, an 
additional role of PEG in alteration of the structural/functional 
properties of these systems cannot be excluded. Indeed, it is well-
know from the literature that PEG moiety bound at N or C-
terminus of short peptides can induce crystallization effects,[22] 
particularly evident in dried samples.[23] In order to assess the 
influence of PEG on the self-assembling process, we also 
synthesized Y6 and (FY)3, that are two analogues peptides 
without PEG functionalization. All the peptides were synthesized 
in good yields and high purity according to the standard protocols 
of the solid phase peptide synthesis (Fmoc/tBu). For PEGylated 
peptides, PEG moiety was inserted at the N-terminus of the 
peptide sequences through the sequential coupling of four 
monodisperse commercial oxyethylene linkers (Fmoc-AdOO-OH, 
PEG2). Differently from PEG8-F6, which requires a pre-dissolution 
in 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP),[21] PEG-tyrosinate 
analogues, having additional sites for hydrogen bonding and an 
increased side chain polarity, present good solubility in water and 
were directly dissolved in water at the final desired concentration. 
Fluorescence spectra of PEG8-(FY)3 and of PEG8-Y6 peptides 
(Figure S1 and S2) were recorded in water at several 
concentrations (0.05, 0.1, 0.25, 0.5, 1.0, 2.0, 4.0 and 10 mg/mL). 
Spectra of PEG8-(FY)3 were recorded by exciting the peptide at 
both 257 and 276 nm, that correspond to the absorbance 
wavelengths for Phe and Tyr chromophores, respectively. On the 
other hand, PEG8-Y6 samples were excited only at 276 nm. 
Independently from the λex and from the concentration studied, all 
the spectra of PEG8-(FY)3 show only the emission peak at 305 
nm, typically observed for Tyr residue, whereas the peak at 282 
nm, associated to the Phe emission, is absent. The absence of 
this peak can easily be explained as a consequence of a RET 
(resonance energy transfer) phenomenon occurring between Phe 
and Tyr residues. Beside the peak at 305 nm, two additional 
peaks at 360 and 376 nm appear for the sample at the highest 
studied concentration (10 mg/mL). The same peaks were also 
found in the fluorescence spectrum of PEG8-Y6 at 10 mg/mL. The 
critical aggregate concentration (CAC) of PEGylated peptides 
was achieved by the well-known fluorescence-based method, in 
which the fluorescent probe, 8-anilinonaphthalene-1-sulfonate 
ammonium salt (ANS), is titrated with increasing amount of the 
peptide. ANS fluorophore shows a typical emission peak between 
460-480 nm when surrounded by a hydrophobic environment, 
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such as in the micelle core or in the dry interface of peptide 
nanostructures. On the contrary, ANS fluorescence is completely 
silent when the fluorophore is immersed in water solution. CAC 
values were established from the graphical break point of the plots 
in Figure 1c. ANS dye shows a very similar behavior upon titration 
with PEG8-(FY)3 and PEG8-Y6 solutions and the CAC values are 
1.5·10-5 M (22.8 g/mL) and 2.0·10-5 M (31.4 g/mL), respectively. 
These values are of the same order of magnitude and slightly 
higher than the CAC value previously found for the more 
hydrophobic hexaphenylalanine analog (7.5 μM, 10μg/mL). This 
result was expected due to the higher hydrophobicity of the 
phenylalanine with respect to the tyrosine. Moreover, the partial 
or complete replacement of the phenylalanine residues with the 
tyrosine ones does not affect significantly the aggregation 
propensity of the peptide derivative. 
 
Structural characterization in solution 
The structural organization of PEGylated aromatic hexapeptides 
was investigated by Circular Dichroism (CD) and by Fourier 
Transform Infrared (FTIR), two spectroscopic techniques largely 
utilized for determining secondary structure in peptide-based 
nanostructures.[21, 24] CD spectra of PEG8-(FY)3 and PEG8-Y6 in 
water at several concentrations (0.1, 1.0, 2.0 and 5.0 mg/mL) are 
reported in Figures 2a and 2b. All the spectra of PEG8-(FY)3, in 
Figure 2a, show a very similar dichroic tendency with respect to 
PEG8-F6 with two maxima at 226 and 202 nm, and a minimum 
around 235 nm. The two maxima (226 and 202 nm) can be 
associated with the n→π* transition of the peptide bond and to 
the π→π* transition of the peptide bond and/or phenyl moieties, 
respectively. In details, the peak at 202 nm is characteristic of 
peptides in which an aromatic side-chain stacking occurs, 
whereas the minimum at 235 nm is associated with a β-sheet 
secondary structure arrangement. The decreasing intensity of the 
peak at 202 nm, as function of concentration, is due to a gradual 
subtraction and consequent silencing of chromophores in the final 
spectrum. This evidence confirms a progressive self-aggregation 
of the peptide derivative driven by aromatic interactions. The other 
PEGylated peptide, PEG8-Y6, shows a slightly different CD 
behavior compared to PEG8-(FY)3. In the spectra of PEG8-Y6 in 
Figure 2b, two maxima red shifted at 207 and 230 nm are well 
detectable. Beyond these two maxima, there is a pronounced 
minimum at 193 nm, whereas the minimum around 235-240 nm 
is absent. These spectral differences reflect fine dissimilarities in 
the secondary structure of the two compounds. The obtained 
aggregates were also structurally examined by FTIR 
spectroscopy in the spectral region of the stretching of amide I 
(1600-1700 cm-1). FTIR spectra of PEG8-(FY)3 and PEG8-Y6 
peptides in water solution at 5.0 mg/mL, reported in Figure 2c, 
show a similar profile with two peaks at 1638 and 1680 cm-1. This 
profile, typically observed for β-sheets with an antiparallel 
orientation of the β-strands, was previously observed also for 
PEG8-F6.[21] 
 
Structural characterization at the solid state 
Self-assembled aromatic peptides and their PEGylated 
analogues were further characterized at the solid state by 
Transmission Electron Microscopy (TEM) and WAXS techniques.  
 
Figure 2: CD spectra of: (a) PEG8-(FY)3 and (b) PEG8-Y6 in water at several 
concentrations (0.1, 1.0, 2.0 and 5.0 mg/mL). (c) FTIR spectra of PEG8-Y6 and 
PEG8-(FY)3 in water at 5.0 mg/mL in the amide I region. 
 
In Figure 3 TEM images of at 5.0 mg/mL are reported. Images of 
PEG8-(FY)3 in Figure 3e and 3f show a continuous network of 
fibers interconnected by physical cross-link points. The analogue 
(FY)3, lacking of PEG decoration, showed a smaller amount of 
fibrils at the same concentration. This result can be related to a 
less fiber entangling that has as consequence the absence of 
gelation ability for (FY)3. 
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Figure 3: Selected TEM images for oligomers: (a) Y6, (b) PEG8-Y6, (c,d) (FY)3, 
and (e,f) PEG8-(FY)3. 
 
WAXS measurements were collected on dried fibers obtained by 
the stretch frame method.[25] Figure 4 shows the microscopic 
image of the fibers (upper row), the 2D WAXS data (middle row), 
and the 1D WAXS profiles (lower row). A comparative analysis of 
these experiments highlights analogies and differences.  
 
Table 1: Meridional and equatorial peaks position in q (Å-1) and corresponding 
distance d=2π/q (Å). 
 
 (FY)3 PEG8-(FY)3 Y6 PEG8-Y6 
 q(Å-1) 
±0.02 
d(Å) 
±0.5 
q(Å-1) 
±0.02 
d(Å) 
±0.5 
q(Å-1) 
±0.02 
d(Å) 
±0.5 
q(Å-1) 
±0.02 
d(
Å) 
±0.
5 
0 0.32 19.6 0.29 21.5     
1 0.49 12.8 0.52 12.0
5 
0.51 12.3 0.53 11.
9 
2 1.12 5.6 1.12 5.6 1.05 6.0 1.05 6.0 
3 1.33 4.7 1.33 4.7 1.29 4.9 1.29 4.9 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Microscopic image of the fibers (upper row), 2D WAXS data (middle 
row), 1D WAXS meridional/equatorial (red/black) profiles (lower row). The scale 
bar of the images is 0.5 mm. 
 
In all cases, the WAXS data present the typical fiber diffraction 
pattern with two crossed main axes: the meridional along the fiber 
direction and the equatorial perpendicular to it (see white dotted 
arrows). The 2D data were integrated along these orthogonal 
axes and the corresponding 1D profiles, displayed in Figure 4 
(lower row) as red (meridional) and black (equatorial) profiles, 
present almost the same reflections. The 0-3 labelled meridional 
and equatorial peaks were summarized in the Table 1, where the 
diffraction peak at q=1.29-1.33 Å-1 (d=4.7-4.9Å) corresponds to 
the distance between adjacent peptide backbones organized into 
β-strands along the fiber axis[26] and the diffraction peak at 
q=0.49-0.3 Å-1 (d=11.9-12.8Å) corresponds to the distance 
between two distinct β-sheets.[21]  
It is, however, important to note that the addition of the PEG 
moiety has different consequences on (FY)3 and Y6 assembly. 
Indeed, while the (FY)3 fiber are marginally affected by the 
addition of the PEG, the 2D WAXS diffraction patterns of Y6 and 
PEG8-Y6 show significant differences. In particular, the pattern 
exhibited by PEG8-Y6 is characterized by the presence of 
additional circles which are likely produced by the crystallization 
of PEG.  
 
Molecular modelling and dynamics  
In order to gain atomic-level structural data on the peptide moiety 
of the assemblies formed by Y6 and (FY)3 we performed 
molecular modelling and molecular dynamics (MD) analyses. As 
detailed in the methods section, different models made of one, 
two, or three β-sheets, each composed of fifty β-strands, were 
generated taking the crystalline assembly of the hexapeptide 
KLVFFA fragment as reference. [27] For the Y6 hexapeptide, 
models composed by either one or two sheets were considered 
(Y_ST50_SH1 and Y_ST50_SH2). For the (FY)3 system, which 
is endowed with a larger sequence complexity, we generated 
models made of either two or three β-sheets (FY_ST50_SH2 and  
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Figure 5: Three-dimensional representations of the starting flat models used in 
the Molecular Dynamics studies: Y_ST50_SH1 (a), Y_ST50_SH2 (b), 
FY_ST50_SH2 (c), and FY_ST50_SH3 (d). 
 
FY_ST50_SH3). Representations of the starting models are 
shown in Figure 5. Timescales and parameters of the simulations 
are reported in Table S1. The RMSIP values reported in this table 
indicate that all simulations reached a satisfactory level of 
convergence.  
 
Y6 system 
To gain insights into the ability of a Tyr-rich peptide to adopt β-
structures, initial MD investigations were performed considering a 
single sheet made of fifty β-strands (Y_ST50_SH1, Figure 5a). 
The evaluation of the geometrical parameters commonly used to 
assess the structural stability of trajectory structures (RSMD 
deviations from the starting structure and gyration radius) 
indicates that the system undergoes a major structural transition 
in the initial 50 ns of the simulation associated with the overall 
twisting (Figure S3). Although the secondary structure of the 
system is rather conserved (Figure S3c), significant fluctuations 
are evident also in the later stages of the trajectory (Figure S3a,b). 
These findings indicate that Y6 has a propensity to adopt β-
structures, although the overall structure of the single sheet model 
is somewhat unstable. We, then, evaluated the possibility that Y6 
could form assemblies through the tight lateral association of Tyr 
side chains. To this aim, we generated a double strand model 
denoted as Y_ST50_SH2 and shown in Figure 5b. The inspection 
of the trajectory frames of the resulting simulation clearly indicates 
that, after an initial structural transition (0-100 ns), the model 
reaches a rather stable structural state (Figure S4). The analysis 
of the individual trajectory structures demonstrates that the initial 
structural transition corresponds to the twisting of the originally flat 
model (Figure S4c and Figure 5b). 
 
 
 
 
Figure 6: RMSF values of the Y_ST50_SH2 model computed in the equilibrated 
region of the trajectory (100-400 ns) are shown in panel (a). For clarity only the 
values of the central ten β-strands are reported. Representative examples of 
inter-sheet H-bonding interactions are reported in panel (b). Conformations of 
the Tyr side chains at the exposed and dry interfaces are shown in panel (c). 
Representative examples of the time evolution of the χ1 dihedral angle are 
reported. The time evolution of the distance between two representative Cα 
atoms of the facing sheets along the trajectory and of the distance along the 
same polypeptide chain between Tyr residues which present the same 
orientation of the side chain is reported in panel (d). 
 
The evaluation of the main chain and side chain flexibility of Y6 
residues indicates that Tyr side chains located at the inter-sheet 
interface are endowed with a limited mobility (Figure 6a). It is also 
worth mentioning that also the flexibility of the solvent exposed 
residues is rather limited. To unravel the structural determinants 
that confer stability to this assembly, we evaluated the occurrence 
of preferred Tyr rotameric states and H-bonding interactions. 
Interestingly, the structure of the assembly is characterized by an 
alternation of Y6 peptides in which all Tyr side chains adopt trans 
states (≈ 180°) for the χ1 dihedral angle with peptides whose 
residues are in gauge (either ≈ -60° or ≈ 60°) rotameric states 
(Figure 6c). This juxtaposition of the side chains combined with 
the antiparallel arrangement of the main chain leads to the 
formation of stacking interactions between Tyr residues of 
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consecutive strands (Figure 6b). These stacking intra-sheet 
interactions also occur for exposed Tyr residues, thus limiting their 
mobility and somewhat favoring their propensity to form larger Y6 
aggregates. Networks of inter-sheet H-bonds contribute to the 
overall stability of the Tyr interface (Figure 6b). The analysis of 
other structural periodicities of Y_ST50_SH2 assembly indicates 
that the distance along the same polypeptide chain between Tyr 
residues which present the same orientation of the side chain is ≈ 
6.5 -7.0 Å (Figure 6d). The inter-sheet distance between facing 
Tyr residues is approximately 12.5 Å (Figure 6d). Notably, these 
values are in close agreement with the equatorial reflections 
detected in the WAXS analyses (Table 1). 
 
(FY)3 system 
A three-dimensional model for (FY)3 was generated by using a 
step-wise procedure. As detailed in the methods section, taking 
into account the elevated hydrophobicity of Phe residues, we 
preliminarily generated a model composed of two sheets with 
facing Phe side chains at the dry interface and exposed Tyr side 
chains (FY_ST50_SH2) (Figure 5c). MD simulations carried out 
on this system clearly indicate that it reaches a stable state after 
an initial structural transition (0-250 ns) (Figure S5). As for Y6, this 
transition corresponds to the twisting of the model (Figure S5). 
The inspection of the trajectory structures indicates that, for the 
Phe moieties, this system recapitulates the structural features of 
the previously characterized F6 assembly[21]. On the other hand, 
the exposed Tyr residues behave like the exposed residues of Y6 
(data not shown). 
The ability of the Phe residues of (FY)3 to form a stable apolar 
interface and the capability of Tyr residues of Y6 to tightly 
associate led us to generate a three-sheet model characterized 
by two distinct interfaces: one apolar made of Phe residues and 
the other more polar made of Tyr residues (Figure 5d). MD 
simulations clearly indicate that this assembly is rather stable as 
demonstrated by the monitoring of several structural parameters 
(Figure S6). The analysis of both the apolar and polar interface 
clearly unravels the basis of their stability. In both of them the  
alternation of peptides with trans and gauche+ rotameric states of 
the side chains leads to the formation of stabilizing stacking 
interactions (Figure 7b-c). At the Phe-interface additional 
interactions are established by the aromatic rings of facing 
residues. On the other hand, the Tyr-interface is stabilized by both 
intra-sheet and inter-sheet H-bonds (Figure 7b). As expected, the 
inter-sheet distances of both Phe- and Tyr-interface are 
approximately 12.5 Å (Figure 7d). The combination of these two 
interfaces leads to a model characterized by a periodicity of 21 Å  
(Figure 7d). These values are in close agreement with those 
experimentally derived by WAXS (Figure 4 and Table 1). 
 
PEG8-(FY)3 gel: rheological characterization  
From the qualitative point of view, PEG8-(FY)3 showed a certain 
tendency to gelificate in water above a concentration of 0.5wt %. 
Indeed in the inverted vial images, a progressive gain of viscosity 
can be observed by increasing the concentration and a stable 
self-supporting hydrogel is obtained when the peptide 
concentration is brought to 1.0wt % (Figure S7).[28] The monitoring 
of the stability of the 1.0wt % gel over time indicated that at this  
 
Figure 7: RMSF values of the FY_ST50_SH3model computed in the 
equilibrated region of the trajectory (100-350 ns) are shown in panel (a). For 
clarity only the values of the central fifteen β-strands are reported. 
Representative examples of inter-sheet H-bonding interactions at the Tyr-Tyr 
interfaces are reported in panel (b). Conformations of the residue side chains 
are shown in panel (c). Representative examples of the time evolution of the χ1 
dihedral angle are reported. The time evolution of the distance between two 
representative Cα atoms of the external sheets along the trajectory is reported 
in panel (d). 
 
concentration the gel maintains its ultrastructure up to 60 days 
(Figure 8a). Although, based on sequence considerations, PEG8-
(FY)3 is expected to have intermediate properties between PEG8-
F6 and PEG8-Y6, none of these two latter compounds form 
hydrogels under the same concentration and temperature used to 
prepare the PEG8-(FY)3 hydrogel. For the PEG8-(FY)3 system the 
PEG moiety is essential for gelification as the peptide (FY)3 
peptides, lacking the PEG portion, present a very limited water 
solubility, also after pre-dissolution in organic solvent, leading to 
the formation of solid precipitates.  
In order to further examine the mechanical properties of the 
PEG8-(FY)3 hydrogel, rheological analysis was performed at 
1.0wt % concentration. The results of the experiments are 
reported in terms of storage modulus (G′) and of loss modulus 
(G′′). The optimal measurement parameters were defined 
according to dynamic strain sweep (at a frequency of 1 Hz) and 
frequency sweep (at 0.1 % strain) oscillatory tests, both of them 
reported in Figure S8.[29] A linear viscoelastic region (LVR) is 
present in the range 0.1-15 Hz in the frequency sweep diagram. 
The effect of the oscillatory strain was studied performing a 0.01-
100% strain sweep and a breakage strain was detected at 16.6 %.  
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Figure 8: (a) Inverted tube test for PEG8-(FY)3 at 1.0wt % until two months. (b) 
Time sweep (1 hour experiment) for PEG8-(FY)3 gel at 1.0wt % concentration. 
Rheological results expressed in terms of storage (G') and loss modulus (G''). 
 
Figure 9: Representative merged image for live/dead assay after six (a) and 
twenty-four (b) hours incubation of CHO cells with extract media of PEG8-(YF)3 
at 1.0wt %. The MTT viability test result are reported in the insert of the two 
panels. 
 
According to these results, the time sweep measurement was 
performed with 1 Hz frequency and 0.1 % strain for a time period 
of 1 h. G' and G'' time sweep curves are presented in Figure 8b. 
The evidence that the value of storage modulus (G′~100 Pa) is 
higher than that of the loss one (G′′~28 Pa) confirms analytically 
the gel state of the system, excluding the possibility that the 
supramolecular material has a high viscose liquid behaviour.[29] 
Furthermore, if compared with other organogelator system, [30] 
this modulus values point out the weak nature of the self-
supporting hydrogel.  
 
In vitro biocompatibility profiles of PEG8-(FY)3 gel 
Biocompatibility of the PEG8-(FY)3 hydrogel at a concentration of 
1.0 wt% was evaluated on Chinese Hamster Ovarian (CHO) cells 
cultured in Dulbecco's Modified Eagle's medium (DMEM). The 
elution test, coupled with MTT viability assay, is an in vitro 
cytotoxicity study designed to detect the possible presence of 
toxic material eluted in the media from the gel sample. The DMEM 
media was incubated with the gel overnight. The extracted media 
was used to culture CHO cells and the viability was determined 
after six and twenty-four hours of incubation.. The cell viability, 
estimated by MTT assay, was certified to be 93 % and 90% for 
six and twenty-four hours incubation times, respectively (Figure 
9a and 9b, inserts).  
Viability test on cells, treated with DMEM alone were also reported 
in graph for comparison. Simultaneously, after the treatment with 
the extracted media, cells were analysed for viability using live-
dead staining with fluorescein diacetate (FDA), a cell membrane 
dye indicating live cells (green), and with propidium iodide (PI), a 
DNA stain indicating dead cells (red)[31]. The degree of death was 
determined by fluorescence microscopy imaging. Fluorescence 
micrograph (merged in red and green field) for live/dead assay 
after six hours shows high confluent live cells with no red spots 
(Figure 9a). A very similar result was detected for the sample with 
longer incubation (Figure 9b). The high cytocompatibility detected 
in vitro can be probably attributed to the hydrogel preparation 
method that, contrarily to others peptide hydrogels, does not 
require the employment of any organic solvents (like DMSO, HFIP 
or MeOH).[32]  
Discussion 
The high propensity of Phe-based oligopeptides to self-assemble 
has been investigated in many literature studies.[9-13] Indeed, the 
discovery that the FF homodimer, a core motif in Aβ40 and Aβ42 
peptides, is able to self-assemble in well-ordered nanostructures 
at high morphological variability[9] has stimulated the use of FF 
and its variants as biocompatible building blocks for the 
development of novel nanostructures. In this scenario, it has been 
shown that the elongation of this aromatic framework from two to 
four or to six residues favors the progressive increase of β-
structures in solutions.[21] This structural behavior, at the atomic 
level, was obviously ascribed to the increase of -stacking 
interactions between the aromatic rings of Phe side chains. Here 
we investigated the effect of the partial or the complete 
replacement of Phe residues in the previously characterized 
PEG8-F6 self-assembling compound with the more hydrophilic 
Tyr one. The effect of the PEG chain on the aggregation 
properties was also investigated. The hydroxyl group in the 
tyrosine side chain should favor a major number of hydrogen 
bonding interactions with water molecules or main chain 
carbonyls with respect to the Phe residue. Indeed, Tyr is often 
positioned on the solvent-exposed surface of proteins. The 
structural characterization performed in solution highlights a 
similar behavior of the three PEGylated peptides (PEG8-(FY)3, 
PEG8-Y6, and PEG8-F6) thus showing that, at micromolar 
concentration, these systems share a common mechanism of 
self-assembling characterized by the formation of nanostructures 
which are rich in antiparallel β-sheets. However, significant 
structural differences were observed for the samples at the solid 
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state. Both PEGylated peptides (PEG8-(FY)3 and PEG8-Y6) and 
their analogues lacking of the PEG chain ((FY)3 andY6) show 
fibrillary nanostructures in TEM images. WAXS diffraction pattern 
recorded on the dried fibers of (FY)3 and Y6 show the typical 
meridional and equatorial reflections (4.7 and 12.5 Å, 
respectively) of cross-β amyloid like structures. MD simulations, 
which represent a powerful tool to obtain atomic level 
representation on self-assembling systems (see for example ref. 
[33]), confirmed the capability of Tyr-rich peptides to form cross-β 
structures characterized by stable anhydrous interfaces, in which 
the inter-sheet distances of both Phe- and Tyr-interface at 12.5 
Å are in good agreement with experimental WAXS data. These 
interfaces are stabilized by both stacking interactions and H-
bonding pattern. (FY)3 is characterized by the combination of an 
apolar Phe-rich and a more polar Tyr-rich interface. 2D WAXS 
diffraction patters highlight the effect of the PEG moiety on (FY)3 
and Y6 assembly. It was extensively reported that the addition of 
long PEG moiety (3000-5000 Da) on short aromatic peptides 
causes crystallization effect in samples at the solid state. In our 
case very short PEG moiety (600 Da) seems not affect the 
structural organization of (FY)3 nanostructure. On the contrary a 
clear difference can be evidenced between the diffraction patterns 
of Y6 and PEG8-Y6 fibers. In the diffraction pattern of PEG8-Y6 
there are circle typically observed in presence of PEG 
crystallization effect.  These most evident effect of the PEG on Y6 
with respect to (FY)3 is likely due to the more limited hydrophobic 
interactions occurring in Y6. It is likely that the presence of a more 
polar interface that can be efficiently solvated somewhat limits the 
formation of large ordered fibers.  
At macroscopic level, we observed that up to 1.0 wt% PEG8-(FY)3 
forms stable hydrogels in water, whereas solutions of PEG8-Y6 
and PEG8-F6 appear not gelificated in the same experimental 
conditions. This finding is somewhat surprising since the 
sequence and the hydrophobicity of PEG8-(FY)3 are intermediate 
between those exhibited by PEG8-Y6 and PEG8-F6. The inability 
of PEG8-F6 to form gels is due to the elevated hydrophobicity of 
this system. On the other hand, the inability of PEG8-Y6 to 
gelificate seems to be a direct consequence of the relative ratio 
between the two hydrophilic/hydrophobic blocks (MWTyr/MWPEG  
1.70). It is worth mentioning that the different balance between 
the two blocks is an essential requirement for hydrogel formation. 
Indeed, Heise et al. [34] reported several PEGylated poly-tyrosines 
(for example PEGMW2000-Y6) that undergoes thermosensitive 
hydrogelation in the concentration range 0.25-3.0 wt %. 
PEGMW2000-Y6, in which the relative ratio between the 
hydrophilic/hydrophobic blocks (MWTyr/MWPEG) is  0.50 is able to 
gelificate, whereas an increase of MWTyr/MWPEG ratio above 0.80 
brought to the loss of gelification. In our case, PEG8-Y6 has a 
relative ratio between the two blocks of  1.70. Collectively, these 
findings indicates that the PEG adduct of (FY)3 presents an 
efficient compromise between hydrophobicity/hydrophilicity to 
achieve gelification. Rheological studies performed on PEG8-
(FY)3 gel at 1.0 wt% confirms analytically the gel state of the 
system. Furthermore, if compared with other hydrogelator 
systems, the modulus values point out the weak nature of the self-
supporting hydrogel formed by PEG8-(FY)3. The in vitro cell 
viability assays shown that this soft hydrogels present a very low 
toxicity on CHO cells up to 24 hours.   
 
Conclusions 
Structural and functional properties of oligophenylalanine based 
nanostructures are strongly affected by punctual chemical 
modifications. The partial or complete replacement of the six Phe 
residues in PEG8-F6 peptide-polymer with the more hydrophilic 
aromatic Tyr alters the supramolecular hierarchic organization of 
the nanostructure. PEG8-(FY)3 forms stable soft hydrogels above 
1.0 wt%. The hydrogel formation is attributable to the higher 
tendency of Tyr to establish extended hydrogen bonding networks. 
The good water solubility and the low toxicity of PEG8-(FY)3 
suggest that this polymer-peptide could be fruitfully exploited for 
generating self-supporting biocompatible hydrogels in future 
studies. 
Experimental Section 
Materials: Protected N -Fmoc-amino acid derivatives, coupling reagents 
and Rink amide MBHA (4-methylbenzhydrylamine) resin were purchased 
from Calbiochem-Novabiochem (Laufelfingen, Switzerland). The Fmoc-8-
amino-3,6-dioxaoctanoic acid, [Fmoc-AdOO-OH,PEG2] was purchased 
from Neosystem (Strasbourg, France). All other chemicals were 
commercially available by Sigma-Aldrich (Milan, Italy) or Fluka (Bucks, 
Switzerland) or LabScan (Stillorgan, Dublin, Ireland) and were used as 
received unless otherwise stated. All solutions were prepared by weight 
with doubly distilled water. Preparative RP-HPLCs were carried out on a 
LC8 Shimadzu HPLC system (Shimadzu Corporation, Kyoto, Japan) 
equipped with a UV lambda-Max Model 481detector using Phenomenex 
(Torrance, CA) C18 column. Elution solvents are H2O/0.1% TFA (A) and 
CH3CN/0.1% TFA (B), from 5% to 70% over 30 minutes at 20 mL/min flow 
rate. Purity and identity of the products were assessed by analytical LC-
MS analyses by using Finnigan Surveyor MSQ single quadrupole 
electrospray ionization (Finnigan/Thermo Electron Corporation San Jose, 
CA), column: C18-Phenomenex eluted with an H2O/0.1% TFA (A) and 
CH3CN/0.1% TFA (B) from 5% to 70% over 15 minutes at 1mL/min flow 
rate. 
Peptide synthesis: Peptides Y6 and (FY)3 and their PEGylated 
analogues PEG8-Y6, PEG8-(FY)3 were synthesized according to the 
experimental protocol previously reported.[21] Briefly, peptides were 
elongated on Rink amide MBHA resin (substitution 0.65 mmol/g, 0.2 mmol) 
by adding amino acids and PEG spacers twice in N, N-
dimethylformammide for 30 min in presence of activating agents. Peptides 
were cleaved from the polymeric support treating the peptidyl resin with a 
solution of TFA (trifluoroacetic acid)/ TIS (triisopropylsilane)/ H2O 
(92.5/5.0/2.5 v/v/v) at room temperature for 2 hours. Crude product were 
precipitated with ice-cold ethyl ether, dissolved in H2O/CH3CN and freeze-
dried. Products were then purified by RP-HPLC chromatography and 
characterized by ESI mass spectra, analytical RP-HPLC and 1H NMR.:  
Y6 characterization: tR = 13.30 min, MS (ESI+): m/z 966.1calcd. for 
C54H57N7O12: [M+H+] = 967.1; 1H-NMR (CD3OD) (chemical shifts in , 
CH3OH as internal standard 3.55) = 7.26-7.14 (m, 6 CH aromatic Tyr), 
6.88-6.85 (m, 6 CH aromatic Tyr), 4.77-4.58 (m, 6H, CHTyr), 3.28-2.92 
(m, 12H, CH2βTyr). 
PEG8-Y6 characterization: tR = 11.56 min, MS (ESI+): m/z 1576.7 calcd. 
for C78H101N11O24: [M+H+] = 1577.7; 1H-NMR (CD3OD) (chemical shifts in 
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, CH3OH as internal standard 3.55) = 7.18-7.10 (m, 6 CH aromatic Tyr), 
6.91-6.82 (m, 6 CH aromatic Tyr), 4.73-4.51 (m, 6H, CHTyr), 3.87 (s, 
16H, OCH2CH2O), 3.82 (t, 8H, RNH-CH2CH2O), 3.74-3.71 (m, 8H, 
OCH2COR), 3.63 (t, 8H, RNH-CH2CH2O), 3.31-2.92 (m, 12H, CH2βTyr). 
(FY)3 characterization: tR = 14.52 min, MS (ESI+): m/z 948.1calcd. for 
C54H57N7O9: [M+H+] = 949.1; 1H-NMR (CD3OD) (chemical shifts in , 
CH3OH as internal standard 3.55) = 7.48-7.35 (m, 15 CH aromatic Phe), 
7.18-7.10 (m, 6 CH aromatic Tyr), 6.88-6.85 (m, 6 CH aromatic Tyr), 
4.81-4.54 (m, 6H, CH of Phe and Tyr), 3.35-2.94 (m, 12H, CH2β of Phe 
and Tyr). 
PEG8-(FY)3 characterization: tR = 12.21 min, MS (ESI+): m/z 1528.7 
calcd. for C78H101N11O21: [M+H+] = 1526.7; 1H-NMR (CD3OD) (chemical 
shifts in , CH3OH as internal standard 3.55) = 7.48-7.35 (m, 15 CH 
aromatic Phe), 7.18-7.10 (m, 6 CHaromatic Tyr), 6.88-6.85 (m, 6 CH 
aromatic Tyr),4.81-4.54 (m, 6H, CH of Phe and Tyr), 3.83 (s, 16H, 
OCH2CH2O), 3.80 (t, 8H, RNH-CH2CH2O), 3.75-3.72 (m, 8H, OCH2COR), 
3.63 (t, 8H, RNH-CH2CH2O), 3.35-2.94 (m, 12H, CH2β of Phe and Tyr). 
Preparation of peptide solutions: PEG8-Y6 and PEG8-(FY)3 solutions 
were prepared dissolving the powders in water at the desired 
concentration. The concentration of the solutions was spectroscopically 
determined by absorbance on UV-vis Thermo Fisher Scientific Inc 
(Wilmington, Delaware USA) Nanodrop 2000c spectrophotometer 
equipped with a 1.0 cm quartz cuvette (Hellma) using a molar absorptivity 
(ε) of 1170, 7290 and 4230 M-1 cm-1for F6, Y6 and (FY)3, respectively. 
Fluorescence studies: Critical aggregate concentration (CAC) values for 
peptides were measured by fluorescence spectroscopy, using 8-anilino-1-
naphthalene sulfonic acid ammonium salt (ANS) as fluorescent probe. All 
the spectra were recorded at room temperature with a 
spectrofluorophotometer Jasco (Model FP-750) and the sample was 
allocated in a quartz cell with 1.0 cm path length. The others setting are: 
excitation and emission bandwidths = 5 nm; recording speed = 125 nm/min 
and automatic selection of the time constant. The experiment was carried 
out by adding small aliquots of peptide derivatives in 1 mL of 20 μM ANS 
water solution. Spectra were corrected for the blank and adjusted for 
dilution. Fluorescence emission of PEG8-Y6 and PEG8-(FY)3 was studied 
for peptide water solutions at several concentrations (0.05, 0.1, 0.25, 0.5, 
1.0, 2.0, 4.0 and 10 mg/mL). Spectra of PEG8-Y6 were obtained by exciting 
sample at λex= 276 nm, whereas spectra of PEG8-(FY)3 were obtained by 
exciting sample both at λex= 257 and 276 nm.  
Circular Dichroism: Far-UV CD spectra of the peptides in water were 
collected with a Jasco J-810 spectropolarimeter equipped with a NesLab 
RTE111 thermal controller unit using a 0.1 mm quartz cell at 25 °C. The 
spectra of samples at several concentrations are recorded from 280 to 
195nm. Other experimental settings were: scan speed=10 nm/min, 
sensitivity=50 mdeg, time constant=16 s, bandwidth=1 nm. Each spectrum 
was obtained by averaging three scans and corrected for the blank. Here 
ty (MRE), i.e. the ellipticity per 
mole of peptide divided by the number of amino acid residues in the 
peptide. 
Fourier Transform Infrared spectroscopy (FTIR): Fourier Transform 
Infrared spectra of PEGylated peptides in solution at the concentration of 
5.0 mg/mL and at the solid state were collected on a Jasco FT/IR 4100 
spectrometer (Easton, MD) in an attenuated total reflection (ATR) mode 
and using a Ge single-crystal at a resolution of 4 cm-1. Each sample was 
recorded with a total of 100 scans with a rate of 2 mm·s-1 against a KBr 
background. After collection in transmission mode, spectra were converted 
in emission. 
Transmission Electron Microscopy (TEM) images: TEM images were 
acquired with FEI TECNAI G12 Spirit-Twin microscope (LaB6 source) 
equipped with a bottom mounted FEI Eagle-4k CCD camera (Eindhoven, 
The Netherlands), operating with an acceleration voltage of 120 kV. 
(LaMest Pozzuoli, Italy). The samples for the observation were prepared 
by placing a droplet of the solution (5.0 mg/mL) onto a 400 mesh holey-
carbon coated copper grid. The sample was air-dried for 1 hour and then 
negatively stained with phosphotungstic acid in water solution (1.0wt %). 
Digital images were obtained by Tomography holder with FEI Eagle 4K 
CCD camera and Xplore3D software. 
Wide-Angle X-ray Scattering (WAXS): Fiber diffraction WAXS patterns 
were recorded from stalks by the stretch frame method.[25] Briefly, a droplet 
(10 μL) of peptide (2.0wt %) was suspended between the ends of a wax-
coated capillary (spaced 2 mm apart), and was left to air dry. Fibers of 
PEGylated and not PEGylated peptides were prepared by starting from 
peptide solution in water and in MeOH, respectively. WAXS data were 
collected at the X-ray MicroImaging Laboratory (XMI-L@b) equipped with 
a Fr-E+ SuperBright rotating anode table-topmicrosource (Cu K, 
=0.15405 nm, 2475W), a multilayer focusing optics (Confocal Max-Flux; 
CMF 15-105) and a three-pinhole camera (Rigaku SMAX-3000). An image 
plate (IP) detector with 100 µm pixel size was placed at 10 cm from the 
sample to acquire WAXS data. Once acquired, 2D data were calibrated[35] 
by means of the Si NIST standard reference material (SRM 640b) and 
folded into 1D profiles. A detailed description of the XMI-L@b 
performances can be found in Altamura et al. [36] and Sibillano et al. [37] 
Rheological characterization: Gels of PEG8-(FY)3 1.0wt % were 
prepared by suspending the peptide powder in water at above described. 
A bath sonication was required for obtain homogeneous self-supporting 
gels. Inverted and sloping tube tests were performed with a sample volume 
of 500 μL. Rheological measurements for 1.0 wt % PEG8-(FY)3 self-
supporting gels were performed on an AR-G2 controlled-stress rheometer 
(TA Instruments, USA). A parallel plate geometry was used. Oscillatory 
frequency (0.01-100 Hz) and strain sweep (0.01-100%) at 4°C were 
conducted with the aim to determine the linear viscoelastic region. Time-
sweep oscillatory test was performed for one hour on 300μL of fresh gelat 
temperature of 4°C with 0.1 % strain and 1Hz frequency. All the rheological 
data were reported in Pascal (Pa) as G' and G", the storage and loss 
moduli, respectively. 
Biocompatibility profile of PEG8-(FY)3 gels: In vitro biocompatibility 
profile of PEG8-(FY)3 gels was studied performing elution test and 
live/dead assay. The cell line was Chinese Hamster Ovarian (CHO) cells, 
purchased from ATCC. CHO cell line was cultured in Dulbecco's Modified 
Eagle's medium (DMEM) supplemented with 100 U mL-1 penicillin, 100 U 
mL-1 streptomycin, 10% fetal calf serum, and 2 mmol L-1 of L-glutamine (all 
these materials are available at Biological Industries, Israel). The cells 
were stored in a wall-plate in a 5% CO2 humidified atmosphere at the 
temperature of 37 °C. For elution test, 200 μL of PEG8-(FY)3 gel at 1.0wt % 
were prepared in sterile condition (with UV-sterilization) and incubated 
overnight with 1 mL of DMEM (ratio gel-extracting media 1/5 v/v). No color 
change was detected for the media after the incubation and the tested pH 
value (7.5-7.8) was suitable for culturing. The efficient gel extraction and 
permeability was confirmed by its pink coloration. The extracted media was 
used to grow the cells for 6 hours and, after this time incubation, the 
viability was determined by MTT test. 20 μL of a MTT solution (5 mg/mL) 
in phosphate buffer saline (PBS) was added to each well. After 4 hour 
incubation, 100 μL of DMSO was added to extract the MTT reduced adduct 
(Formazan). All the samples were shacked for 20 minute to allow a 
complete dissolution of the precipitated Formazan in DMSO. Absorbance 
was measured using Tecan Spark plate reader at 570 nm. Background 
was measure at 680 nm. The viability was expressed as percentage. The 
live/dead assay was performed using a kit (Sigma Aldrich) containing FDA 
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(6.6 μg/mL) and PI (5 μg/mL). After the addiction of the two fluorescent 
dyes, cells were incubated for ~10 minutes in the same previously reported 
condition Labeled cells were immediately viewed using a Nikon Eclipse 
Tifluorescent microscope and images (reported as merged figure) were 
captured by a ZylascMOS camera using Nikon Intensilight C-HGFI 
fluorescent lamp.  
Molecular modelling and dynamics 
Systems and notations: Three-dimensional model for Y6 and (FY)3 
aggregates were generated following the procedure reported in Diaferia et 
al.[21] In particular, monomers for the two peptides were generated using 
the structure of the hexapeptide fragment KLVFFA of the amyloid-beta 
peptide II (Protein Data Bank entry 3OW9)[27] by replacing the non-
Phe/non-Tyr residues of the model with Phe or Tyr. A single sheet model 
of Y6 was generated starting from the hexapeptide fragment KLVFFA by 
replacing all side chains with Tyr residues. Starting from these structures, 
models composed of a single β-sheet made of fifty strands were generated 
(Y_ST50_SH1 and FY_ST50_SH1). For both systems steric zipper 
models were generated through the association of a pair of these sheets 
using the organization of the KLVFFA in the crystalline state[27] 
(Y_ST50_SH2 and FY_ST50_SH2) (Figures5b-c). Taking into account the 
hydrophobicity/hydrophilicity of Tyr and Phe, the two-sheet model of (FY)3 
was built by locating the Phe side chain at the dry interface. Consequently 
Tyr residues were solvent exposed. For (FY)3 a more complex system was 
generated through the association of a further β-sheet to FY_ST50_SH2. 
This assembly (FY_ST50_SH3) contains two distinct steric zipper 
interfaces: a hydrophobic one composed by Phe side chains and a more 
hydrophilic one made of Tyr residues (Figure 5d). 
 
Molecular dynamics protocol :Molecular Dynamics (MD) simulations 
were performed on the generated models (Y_ST50_SH1, Y_ST50_SH2, 
FY_ST50_SH2, and FY_ST50_SH3) using the GROMACS software 
package 5.1.2[38] with Amber03 as force field. The models were immersed 
in triclinic boxes filled with water molecules (TIP4PEW water model). 
Timescales and several parameters of the simulations (box dimensions, 
number of water molecules) are reported in Table S1. The simulations 
were run applying periodic boundary conditions. The systems were 
equilibrated at the temperature of 300 K and the pressure of 1 atm. We 
first minimized energies by fixing the protein atoms and subsequently 
without any restraint. The Particle Mesh Ewald (PME) method[39] using a 
grid spacing of 0.12 nm was used to calculate the electrostatic interactions. 
For Lennard-Jones interactions a cutoff of 10 Å was applied. Bond lengths 
were constrained using the LINCS algorithm.[40] The analysis of trajectory 
structures was performed by using the VMD program[41] and Gromacs 
routines.[38] The achievement of an adequate convergence in the MD 
simulation was checked by calculating the root mean square inner product 
(RMSIP) [42] between the two halves of the equilibrated trajectories (Table 
S1). 
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